id	sid	tid	token	lemma	pos
ajmsi-505	1	1	pa	pa	PROPN
ajmsi-505	1	2	ge	ge	PROPN
ajmsi-505	1	3	1	1	NUM
ajmsi-505	1	4	pa	pa	PROPN
ajmsi-505	1	5	ge	ge	PROPN
ajmsi-505	1	6	1	1	NUM
ajmsi-505	1	7	american	american	PROPN
ajmsi-505	1	8	journal	journal	PROPN
ajmsi-505	1	9	of	of	ADP
ajmsi-505	1	10	medical	medical	ADJ
ajmsi-505	1	11	science	science	NOUN
ajmsi-505	1	12	and	and	CCONJ
ajmsi-505	1	13	innovation	innovation	NOUN
ajmsi-505	1	14	(	(	PUNCT
ajmsi-505	1	15	ajmsi	ajmsi	NOUN
ajmsi-505	1	16	)	)	PUNCT
ajmsi-505	1	17	role	role	NOUN
ajmsi-505	1	18	of	of	ADP
ajmsi-505	1	19	hiv	hiv	PROPN
ajmsi-505	1	20	infection	infection	NOUN
ajmsi-505	1	21	in	in	ADP
ajmsi-505	1	22	multi	multi	ADJ
ajmsi-505	1	23	-	-	ADJ
ajmsi-505	1	24	drug	drug	ADJ
ajmsi-505	1	25	resistant	resistant	ADJ
ajmsi-505	1	26	tuberculosis	tuberculosis	NOUN
ajmsi-505	1	27	in	in	ADP
ajmsi-505	1	28	parts	part	NOUN
ajmsi-505	1	29	of	of	ADP
ajmsi-505	1	30	benue	benue	NOUN
ajmsi-505	1	31	state	state	PROPN
ajmsi-505	1	32	,	,	PUNCT
ajmsi-505	1	33	nigeria	nigeria	PROPN
ajmsi-505	1	34	lan	lan	PROPN
ajmsi-505	1	35	,	,	PUNCT
ajmsi-505	1	36	abraham	abraham	PROPN
ajmsi-505	1	37	ternaa1	ternaa1	PROPN
ajmsi-505	1	38	*	*	PROPN
ajmsi-505	1	39	,	,	PUNCT
ajmsi-505	1	40	amuta	amuta	ADJ
ajmsi-505	1	41	u	u	NOUN
ajmsi-505	1	42	elizabeth2	elizabeth2	PROPN
ajmsi-505	1	43	,	,	PUNCT
ajmsi-505	1	44	terzungue	terzungue	NOUN
ajmsi-505	1	45	sarc1	sarc1	NOUN
ajmsi-505	1	46	volume	volume	NOUN
ajmsi-505	1	47	1	1	NUM
ajmsi-505	1	48	issue	issue	NOUN
ajmsi-505	1	49	1	1	NUM
ajmsi-505	1	50	,	,	PUNCT
ajmsi-505	1	51	year	year	NOUN
ajmsi-505	1	52	2022	2022	NUM
ajmsi-505	1	53	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	1	54	article	article	NOUN
ajmsi-505	1	55	information	information	NOUN
ajmsi-505	1	56	abstract	abstract	ADV
ajmsi-505	1	57	received	receive	VERB
ajmsi-505	1	58	:	:	PUNCT
ajmsi-505	1	59	august	august	PROPN
ajmsi-505	1	60	15	15	NUM
ajmsi-505	1	61	,	,	PUNCT
ajmsi-505	1	62	2022	2022	NUM
ajmsi-505	1	63	accepted	accept	VERB
ajmsi-505	1	64	:	:	PUNCT
ajmsi-505	1	65	september	september	PROPN
ajmsi-505	1	66	02	02	NUM
ajmsi-505	1	67	,	,	PUNCT
ajmsi-505	1	68	2022	2022	NUM
ajmsi-505	1	69	published	publish	VERB
ajmsi-505	1	70	:	:	PUNCT
ajmsi-505	1	71	september	september	PROPN
ajmsi-505	1	72	06	06	NUM
ajmsi-505	1	73	,	,	PUNCT
ajmsi-505	1	74	2022	2022	NUM
ajmsi-505	1	75	the	the	DET
ajmsi-505	1	76	pathogenesis	pathogenesis	NOUN
ajmsi-505	1	77	of	of	ADP
ajmsi-505	1	78	tuberculosis	tuberculosis	NOUN
ajmsi-505	1	79	shows	show	VERB
ajmsi-505	1	80	that	that	SCONJ
ajmsi-505	1	81	m.	m.	NOUN
ajmsi-505	1	82	tuberculosis	tuberculosis	NOUN
ajmsi-505	1	83	target	target	NOUN
ajmsi-505	1	84	and	and	CCONJ
ajmsi-505	1	85	persist	persist	VERB
ajmsi-505	1	86	within	within	ADP
ajmsi-505	1	87	phagocytes	phagocyte	NOUN
ajmsi-505	1	88	including	include	VERB
ajmsi-505	1	89	t	t	NOUN
ajmsi-505	1	90	-	-	PUNCT
ajmsi-505	1	91	lymphocytes	lymphocyte	NOUN
ajmsi-505	1	92	in	in	ADP
ajmsi-505	1	93	blood	blood	NOUN
ajmsi-505	1	94	circulation	circulation	NOUN
ajmsi-505	1	95	.	.	PUNCT
ajmsi-505	2	1	as	as	ADP
ajmsi-505	2	2	a	a	DET
ajmsi-505	2	3	result	result	NOUN
ajmsi-505	2	4	,	,	PUNCT
ajmsi-505	2	5	the	the	DET
ajmsi-505	2	6	possibility	possibility	NOUN
ajmsi-505	2	7	of	of	ADP
ajmsi-505	2	8	cellular	cellular	ADJ
ajmsi-505	2	9	interaction	interaction	NOUN
ajmsi-505	2	10	between	between	ADP
ajmsi-505	2	11	m.	m.	NOUN
ajmsi-505	2	12	tuberculosis	tuberculosis	NOUN
ajmsi-505	2	13	and	and	CCONJ
ajmsi-505	2	14	hiv	hiv	PROPN
ajmsi-505	2	15	,	,	PUNCT
ajmsi-505	2	16	especially	especially	ADV
ajmsi-505	2	17	for	for	ADP
ajmsi-505	2	18	patients	patient	NOUN
ajmsi-505	2	19	that	that	PRON
ajmsi-505	2	20	are	be	AUX
ajmsi-505	2	21	co	co	ADJ
ajmsi-505	2	22	-	-	VERB
ajmsi-505	2	23	infected	infected	ADJ
ajmsi-505	2	24	with	with	ADP
ajmsi-505	2	25	hiv	hiv	PROPN
ajmsi-505	2	26	and	and	CCONJ
ajmsi-505	2	27	tb	tb	NOUN
ajmsi-505	2	28	,	,	PUNCT
ajmsi-505	2	29	and	and	CCONJ
ajmsi-505	2	30	subsequent	subsequent	ADJ
ajmsi-505	2	31	exchange	exchange	NOUN
ajmsi-505	2	32	of	of	ADP
ajmsi-505	2	33	genetic	genetic	ADJ
ajmsi-505	2	34	material	material	NOUN
ajmsi-505	2	35	via	via	ADP
ajmsi-505	2	36	transduction	transduction	NOUN
ajmsi-505	2	37	needs	need	VERB
ajmsi-505	2	38	to	to	PART
ajmsi-505	2	39	be	be	AUX
ajmsi-505	2	40	investigated	investigate	VERB
ajmsi-505	2	41	.	.	PUNCT
ajmsi-505	3	1	three	three	NUM
ajmsi-505	3	2	hundred	hundred	NUM
ajmsi-505	3	3	and	and	CCONJ
ajmsi-505	3	4	eighty	eighty	NUM
ajmsi-505	3	5	sputum	sputum	NOUN
ajmsi-505	3	6	samples	sample	NOUN
ajmsi-505	3	7	mostly	mostly	ADV
ajmsi-505	3	8	from	from	ADP
ajmsi-505	3	9	suspected	suspect	VERB
ajmsi-505	3	10	rifampicin	rifampicin	VERB
ajmsi-505	3	11	-	-	PUNCT
ajmsi-505	3	12	resistance	resistance	NOUN
ajmsi-505	3	13	patients	patient	NOUN
ajmsi-505	3	14	were	be	AUX
ajmsi-505	3	15	collected	collect	VERB
ajmsi-505	3	16	from	from	ADP
ajmsi-505	3	17	nigerian	nigerian	PROPN
ajmsi-505	3	18	airforce	airforce	PROPN
ajmsi-505	3	19	(	(	PUNCT
ajmsi-505	3	20	naf	naf	PROPN
ajmsi-505	3	21	)	)	PUNCT
ajmsi-505	3	22	hospital	hospital	NOUN
ajmsi-505	3	23	makurdi	makurdi	NOUN
ajmsi-505	3	24	,	,	PUNCT
ajmsi-505	3	25	and	and	CCONJ
ajmsi-505	3	26	federal	federal	ADJ
ajmsi-505	3	27	medical	medical	ADJ
ajmsi-505	3	28	centre	centre	NOUN
ajmsi-505	3	29	(	(	PUNCT
ajmsi-505	3	30	fmc	fmc	NOUN
ajmsi-505	3	31	)	)	PUNCT
ajmsi-505	3	32	makurdi	makurdi	NOUN
ajmsi-505	3	33	.	.	PUNCT
ajmsi-505	4	1	in	in	ADP
ajmsi-505	4	2	vitro	vitro	X
ajmsi-505	4	3	culture	culture	NOUN
ajmsi-505	4	4	of	of	ADP
ajmsi-505	4	5	sputum	sputum	NOUN
ajmsi-505	4	6	samples	sample	NOUN
ajmsi-505	4	7	,	,	PUNCT
ajmsi-505	4	8	drugs	drug	NOUN
ajmsi-505	4	9	susceptibility	susceptibility	NOUN
ajmsi-505	4	10	testing	testing	NOUN
ajmsi-505	4	11	(	(	PUNCT
ajmsi-505	4	12	dst	dst	NOUN
ajmsi-505	4	13	)	)	PUNCT
ajmsi-505	4	14	of	of	ADP
ajmsi-505	4	15	m.	m.	NOUN
ajmsi-505	4	16	tuberculosis	tuberculosis	NOUN
ajmsi-505	4	17	isolates	isolate	NOUN
ajmsi-505	4	18	,	,	PUNCT
ajmsi-505	4	19	and	and	CCONJ
ajmsi-505	4	20	transduction	transduction	NOUN
ajmsi-505	4	21	protocol	protocol	NOUN
ajmsi-505	4	22	were	be	AUX
ajmsi-505	4	23	carried	carry	VERB
ajmsi-505	4	24	out	out	ADP
ajmsi-505	4	25	at	at	ADP
ajmsi-505	4	26	the	the	DET
ajmsi-505	4	27	national	national	ADJ
ajmsi-505	4	28	tuberculosis	tuberculosis	NOUN
ajmsi-505	4	29	and	and	CCONJ
ajmsi-505	4	30	leprosy	leprosy	NOUN
ajmsi-505	4	31	training	training	NOUN
ajmsi-505	4	32	centre	centre	NOUN
ajmsi-505	4	33	(	(	PUNCT
ajmsi-505	4	34	ntbltc	ntbltc	ADJ
ajmsi-505	4	35	)	)	PUNCT
ajmsi-505	4	36	zaria	zaria	PROPN
ajmsi-505	4	37	,	,	PUNCT
ajmsi-505	4	38	nigeria	nigeria	PROPN
ajmsi-505	4	39	.	.	PUNCT
ajmsi-505	5	1	statistical	statistical	ADJ
ajmsi-505	5	2	analysis	analysis	NOUN
ajmsi-505	5	3	was	be	AUX
ajmsi-505	5	4	carried	carry	VERB
ajmsi-505	5	5	out	out	ADP
ajmsi-505	5	6	using	use	VERB
ajmsi-505	5	7	student	student	NOUN
ajmsi-505	5	8	’s	’s	PART
ajmsi-505	5	9	t	t	PROPN
ajmsi-505	5	10	-	-	PUNCT
ajmsi-505	5	11	test	test	NOUN
ajmsi-505	5	12	.	.	PUNCT
ajmsi-505	6	1	minitab	minitab	PROPN
ajmsi-505	6	2	version	version	PROPN
ajmsi-505	6	3	14.0	14.0	NUM
ajmsi-505	6	4	statistical	statistical	ADJ
ajmsi-505	6	5	software	software	NOUN
ajmsi-505	6	6	was	be	AUX
ajmsi-505	6	7	used	use	VERB
ajmsi-505	6	8	for	for	ADP
ajmsi-505	6	9	data	datum	NOUN
ajmsi-505	6	10	analysis	analysis	NOUN
ajmsi-505	6	11	.	.	PUNCT
ajmsi-505	7	1	p	p	X
ajmsi-505	7	2	-	-	PUNCT
ajmsi-505	7	3	values	value	NOUN
ajmsi-505	7	4	<	<	X
ajmsi-505	7	5	0.05	0.05	NUM
ajmsi-505	7	6	were	be	AUX
ajmsi-505	7	7	considered	consider	VERB
ajmsi-505	7	8	significant	significant	ADJ
ajmsi-505	7	9	.	.	PUNCT
ajmsi-505	8	1	twenty	twenty	NUM
ajmsi-505	8	2	-	-	PUNCT
ajmsi-505	8	3	six	six	NUM
ajmsi-505	8	4	(	(	PUNCT
ajmsi-505	8	5	9.7	9.7	NUM
ajmsi-505	8	6	%	%	NOUN
ajmsi-505	8	7	)	)	PUNCT
ajmsi-505	8	8	cases	case	NOUN
ajmsi-505	8	9	of	of	ADP
ajmsi-505	8	10	multi	multi	ADJ
ajmsi-505	8	11	-	-	ADJ
ajmsi-505	8	12	drug	drug	ADJ
ajmsi-505	8	13	resistant	resistant	ADJ
ajmsi-505	8	14	tuberculosis	tuberculosis	NOUN
ajmsi-505	8	15	(	(	PUNCT
ajmsi-505	8	16	mdr	mdr	PROPN
ajmsi-505	8	17	-	-	NOUN
ajmsi-505	8	18	tb	tb	NOUN
ajmsi-505	8	19	)	)	PUNCT
ajmsi-505	8	20	were	be	AUX
ajmsi-505	8	21	detected	detect	VERB
ajmsi-505	8	22	(	(	PUNCT
ajmsi-505	8	23	retreated	retreat	VERB
ajmsi-505	8	24	cases	case	NOUN
ajmsi-505	8	25	7.1	7.1	NUM
ajmsi-505	8	26	%	%	NOUN
ajmsi-505	8	27	;	;	PUNCT
ajmsi-505	8	28	treatment	treatment	NOUN
ajmsi-505	8	29	naive	naive	ADJ
ajmsi-505	8	30	2.6	2.6	NUM
ajmsi-505	8	31	%	%	NOUN
ajmsi-505	8	32	)	)	PUNCT
ajmsi-505	8	33	.	.	PUNCT
ajmsi-505	9	1	twenty	twenty	NUM
ajmsi-505	9	2	-	-	PUNCT
ajmsi-505	9	3	one	one	NUM
ajmsi-505	9	4	(	(	PUNCT
ajmsi-505	9	5	80.8	80.8	NUM
ajmsi-505	9	6	%	%	NOUN
ajmsi-505	9	7	)	)	PUNCT
ajmsi-505	9	8	were	be	AUX
ajmsi-505	9	9	males	male	NOUN
ajmsi-505	9	10	and	and	CCONJ
ajmsi-505	9	11	5(19.2	5(19.2	NUM
ajmsi-505	9	12	%	%	NOUN
ajmsi-505	9	13	)	)	PUNCT
ajmsi-505	9	14	were	be	AUX
ajmsi-505	9	15	females	female	NOUN
ajmsi-505	9	16	.	.	PUNCT
ajmsi-505	10	1	there	there	PRON
ajmsi-505	10	2	was	be	VERB
ajmsi-505	10	3	statistical	statistical	ADJ
ajmsi-505	10	4	difference	difference	NOUN
ajmsi-505	10	5	in	in	ADP
ajmsi-505	10	6	mdr	mdr	PROPN
ajmsi-505	10	7	-	-	NOUN
ajmsi-505	10	8	tb	tb	X
ajmsi-505	10	9	between	between	ADP
ajmsi-505	10	10	male	male	NOUN
ajmsi-505	10	11	and	and	CCONJ
ajmsi-505	10	12	female	female	ADJ
ajmsi-505	10	13	in	in	ADP
ajmsi-505	10	14	benue	benue	NOUN
ajmsi-505	10	15	state	state	NOUN
ajmsi-505	10	16	(	(	PUNCT
ajmsi-505	10	17	p<0.05	p<0.05	NOUN
ajmsi-505	10	18	)	)	PUNCT
ajmsi-505	10	19	.	.	PUNCT
ajmsi-505	11	1	the	the	DET
ajmsi-505	11	2	mean	mean	ADJ
ajmsi-505	11	3	age	age	NOUN
ajmsi-505	11	4	group	group	NOUN
ajmsi-505	11	5	35	35	NUM
ajmsi-505	11	6	-	-	SYM
ajmsi-505	11	7	45	45	NUM
ajmsi-505	11	8	years	year	NOUN
ajmsi-505	11	9	had	have	VERB
ajmsi-505	11	10	the	the	DET
ajmsi-505	11	11	highest	high	ADJ
ajmsi-505	11	12	cases	case	NOUN
ajmsi-505	11	13	of	of	ADP
ajmsi-505	11	14	mdr	mdr	PROPN
ajmsi-505	11	15	-	-	PROPN
ajmsi-505	11	16	tb	tb	ADP
ajmsi-505	11	17	accounting	account	VERB
ajmsi-505	11	18	for	for	ADP
ajmsi-505	11	19	35	35	NUM
ajmsi-505	11	20	%	%	NOUN
ajmsi-505	11	21	of	of	ADP
ajmsi-505	11	22	mdr	mdr	PROPN
ajmsi-505	11	23	-	-	PROPN
ajmsi-505	11	24	tb	tb	PROPN
ajmsi-505	11	25	.	.	PUNCT
ajmsi-505	12	1	human	human	ADJ
ajmsi-505	12	2	-	-	PUNCT
ajmsi-505	12	3	immunodeficiency	immunodeficiency	NOUN
ajmsi-505	12	4	virus	virus	NOUN
ajmsi-505	12	5	and	and	CCONJ
ajmsi-505	12	6	tuberculosis	tuberculosis	PRON
ajmsi-505	12	7	co	co	ADJ
ajmsi-505	12	8	-	-	ADJ
ajmsi-505	12	9	infected	infected	ADJ
ajmsi-505	12	10	patients	patient	NOUN
ajmsi-505	12	11	(	(	PUNCT
ajmsi-505	12	12	category	category	NOUN
ajmsi-505	12	13	i	i	NOUN
ajmsi-505	12	14	)	)	PUNCT
ajmsi-505	12	15	had	have	VERB
ajmsi-505	12	16	the	the	DET
ajmsi-505	12	17	highest	high	ADJ
ajmsi-505	12	18	mdr	mdr	ADJ
ajmsi-505	12	19	-	-	ADJ
ajmsi-505	12	20	tb	tb	ADP
ajmsi-505	12	21	incidence	incidence	NOUN
ajmsi-505	12	22	of	of	ADP
ajmsi-505	12	23	10(38.5	10(38.5	NUM
ajmsi-505	12	24	%	%	NOUN
ajmsi-505	12	25	)	)	PUNCT
ajmsi-505	12	26	.	.	PUNCT
ajmsi-505	13	1	there	there	PRON
ajmsi-505	13	2	was	be	VERB
ajmsi-505	13	3	no	no	DET
ajmsi-505	13	4	significant	significant	ADJ
ajmsi-505	13	5	difference	difference	NOUN
ajmsi-505	13	6	between	between	ADP
ajmsi-505	13	7	category-1	category-1	NOUN
ajmsi-505	13	8	and	and	CCONJ
ajmsi-505	13	9	category	category	NOUN
ajmsi-505	13	10	-	-	PUNCT
ajmsi-505	13	11	iii	iii	NOUN
ajmsi-505	14	1	[	[	X
ajmsi-505	14	2	patient	patient	NOUN
ajmsi-505	14	3	with	with	ADP
ajmsi-505	14	4	only	only	ADV
ajmsi-505	14	5	tb	tb	ADP
ajmsi-505	14	6	disease	disease	NOUN
ajmsi-505	14	7	(	(	PUNCT
ajmsi-505	14	8	p>0.05	p>0.05	NOUN
ajmsi-505	14	9	)	)	PUNCT
ajmsi-505	14	10	]	]	PUNCT
ajmsi-505	14	11	.	.	PUNCT
ajmsi-505	15	1	however	however	ADV
ajmsi-505	15	2	,	,	PUNCT
ajmsi-505	15	3	there	there	PRON
ajmsi-505	15	4	were	be	VERB
ajmsi-505	15	5	elevated	elevated	ADJ
ajmsi-505	15	6	cases	case	NOUN
ajmsi-505	15	7	of	of	ADP
ajmsi-505	15	8	mdr	mdr	PROPN
ajmsi-505	15	9	-	-	NOUN
ajmsi-505	15	10	tb	tb	NOUN
ajmsi-505	15	11	in	in	ADP
ajmsi-505	15	12	category	category	NOUN
ajmsi-505	15	13	-	-	PUNCT
ajmsi-505	15	14	iii	iii	NUM
ajmsi-505	15	15	patients	patient	NOUN
ajmsi-505	15	16	from	from	ADP
ajmsi-505	15	17	7(26.9	7(26.9	NUM
ajmsi-505	15	18	%	%	NOUN
ajmsi-505	15	19	)	)	PUNCT
ajmsi-505	15	20	to	to	ADP
ajmsi-505	15	21	10(38.5	10(38.5	NUM
ajmsi-505	15	22	%	%	NOUN
ajmsi-505	15	23	)	)	PUNCT
ajmsi-505	16	1	following	follow	VERB
ajmsi-505	16	2	transduction	transduction	NOUN
ajmsi-505	16	3	protocol	protocol	NOUN
ajmsi-505	16	4	.	.	PUNCT
ajmsi-505	17	1	multi	multi	ADJ
ajmsi-505	17	2	-	-	ADJ
ajmsi-505	17	3	drugs	drug	NOUN
ajmsi-505	17	4	resistant	resistant	ADJ
ajmsi-505	17	5	tuberculosis	tuberculosis	NOUN
ajmsi-505	17	6	is	be	AUX
ajmsi-505	17	7	prevalent	prevalent	ADJ
ajmsi-505	17	8	in	in	ADP
ajmsi-505	17	9	benue	benue	PROPN
ajmsi-505	17	10	state	state	NOUN
ajmsi-505	17	11	,	,	PUNCT
ajmsi-505	17	12	affecting	affect	VERB
ajmsi-505	17	13	the	the	DET
ajmsi-505	17	14	most	most	ADV
ajmsi-505	17	15	economically	economically	ADV
ajmsi-505	17	16	active	active	ADJ
ajmsi-505	17	17	youths	youth	NOUN
ajmsi-505	17	18	within	within	ADP
ajmsi-505	17	19	the	the	DET
ajmsi-505	17	20	age	age	NOUN
ajmsi-505	17	21	group	group	NOUN
ajmsi-505	17	22	of	of	ADP
ajmsi-505	17	23	35	35	NUM
ajmsi-505	17	24	-	-	SYM
ajmsi-505	17	25	45	45	NUM
ajmsi-505	17	26	years	year	NOUN
ajmsi-505	17	27	,	,	PUNCT
ajmsi-505	17	28	as	as	ADP
ajmsi-505	17	29	a	a	DET
ajmsi-505	17	30	result	result	NOUN
ajmsi-505	17	31	the	the	DET
ajmsi-505	17	32	need	need	NOUN
ajmsi-505	17	33	to	to	PART
ajmsi-505	17	34	direct	direct	VERB
ajmsi-505	17	35	more	more	ADJ
ajmsi-505	17	36	attention	attention	NOUN
ajmsi-505	17	37	on	on	ADP
ajmsi-505	17	38	molecular	molecular	ADJ
ajmsi-505	17	39	basis	basis	NOUN
ajmsi-505	17	40	for	for	ADP
ajmsi-505	17	41	m.	m.	NOUN
ajmsi-505	17	42	tuberculosis	tuberculosis	NOUN
ajmsi-505	17	43	drugs	drug	NOUN
ajmsi-505	17	44	resistance	resistance	NOUN
ajmsi-505	17	45	is	be	AUX
ajmsi-505	17	46	keywords	keyword	NOUN
ajmsi-505	17	47	bacteriophage	bacteriophage	NOUN
ajmsi-505	17	48	,	,	PUNCT
ajmsi-505	17	49	isoniazid	isoniazid	NOUN
ajmsi-505	17	50	,	,	PUNCT
ajmsi-505	17	51	multidrug	multidrug	NOUN
ajmsi-505	17	52	resistance	resistance	NOUN
ajmsi-505	17	53	,	,	PUNCT
ajmsi-505	17	54	mycobacterium	mycobacterium	NOUN
ajmsi-505	17	55	tuberculosis	tuberculosis	NOUN
ajmsi-505	17	56	,	,	PUNCT
ajmsi-505	17	57	rifampicin	rifampicin	VERB
ajmsi-505	17	58	,	,	PUNCT
ajmsi-505	17	59	1	1	NUM
ajmsi-505	17	60	department	department	NOUN
ajmsi-505	17	61	of	of	ADP
ajmsi-505	17	62	microbiology	microbiology	NOUN
ajmsi-505	17	63	,	,	PUNCT
ajmsi-505	17	64	federal	federal	ADJ
ajmsi-505	17	65	university	university	PROPN
ajmsi-505	17	66	of	of	ADP
ajmsi-505	17	67	agriculture	agriculture	PROPN
ajmsi-505	17	68	,	,	PUNCT
ajmsi-505	17	69	makurdi	makurdi	PROPN
ajmsi-505	17	70	nigeria	nigeria	PROPN
ajmsi-505	17	71	2	2	NUM
ajmsi-505	17	72	department	department	NOUN
ajmsi-505	17	73	of	of	ADP
ajmsi-505	17	74	zoology	zoology	NOUN
ajmsi-505	17	75	,	,	PUNCT
ajmsi-505	17	76	federal	federal	ADJ
ajmsi-505	17	77	university	university	PROPN
ajmsi-505	17	78	of	of	ADP
ajmsi-505	17	79	agriculture	agriculture	PROPN
ajmsi-505	17	80	,	,	PUNCT
ajmsi-505	17	81	makurdi	makurdi	PROPN
ajmsi-505	17	82	,	,	PUNCT
ajmsi-505	17	83	nigeria	nigeria	PROPN
ajmsi-505	17	84	*	*	PUNCT
ajmsi-505	17	85	corresponding	correspond	VERB
ajmsi-505	17	86	author	author	NOUN
ajmsi-505	17	87	’s	’s	PART
ajmsi-505	17	88	e	e	NOUN
ajmsi-505	17	89	-	-	NOUN
ajmsi-505	17	90	mail	mail	NOUN
ajmsi-505	17	91	:	:	PUNCT
ajmsi-505	17	92	abrahamlanterna@gmail.com	abrahamlanterna@gmail.com	X
ajmsi-505	18	1	introduction	introduction	NOUN
ajmsi-505	18	2	the	the	DET
ajmsi-505	18	3	genus	genus	NOUN
ajmsi-505	18	4	mycobacterium	mycobacterium	NOUN
ajmsi-505	18	5	are	be	AUX
ajmsi-505	18	6	non	non	ADJ
ajmsi-505	18	7	-	-	ADJ
ajmsi-505	18	8	motile	motile	ADJ
ajmsi-505	18	9	,	,	PUNCT
ajmsi-505	18	10	non	non	ADJ
ajmsi-505	18	11	-	-	ADJ
ajmsi-505	18	12	sporulating	sporulating	ADJ
ajmsi-505	18	13	,	,	PUNCT
ajmsi-505	18	14	weakly	weakly	ADJ
ajmsi-505	18	15	gram	gram	NOUN
ajmsi-505	18	16	-	-	PUNCT
ajmsi-505	18	17	positive	positive	ADJ
ajmsi-505	18	18	,	,	PUNCT
ajmsi-505	18	19	acid	acid	NOUN
ajmsi-505	18	20	-	-	PUNCT
ajmsi-505	18	21	fast	fast	ADJ
ajmsi-505	18	22	bacilli	bacilli	NOUN
ajmsi-505	18	23	that	that	PRON
ajmsi-505	18	24	appear	appear	VERB
ajmsi-505	18	25	microscopically	microscopically	ADV
ajmsi-505	18	26	as	as	ADP
ajmsi-505	18	27	straight	straight	ADV
ajmsi-505	18	28	or	or	CCONJ
ajmsi-505	18	29	slightly	slightly	ADV
ajmsi-505	18	30	curved	curved	ADJ
ajmsi-505	18	31	rods	rod	NOUN
ajmsi-505	18	32	measuring	measure	VERB
ajmsi-505	18	33	0.2	0.2	NUM
ajmsi-505	18	34	to	to	ADP
ajmsi-505	18	35	0.4	0.4	NUM
ajmsi-505	18	36	µm	µm	NOUN
ajmsi-505	18	37	in	in	ADP
ajmsi-505	18	38	length	length	NOUN
ajmsi-505	18	39	(	(	PUNCT
ajmsi-505	18	40	willey	willey	PROPN
ajmsi-505	18	41	et	et	PROPN
ajmsi-505	18	42	al	al	PROPN
ajmsi-505	18	43	.	.	PROPN
ajmsi-505	18	44	,	,	PUNCT
ajmsi-505	18	45	2011	2011	NUM
ajmsi-505	18	46	)	)	PUNCT
ajmsi-505	18	47	.	.	PUNCT
ajmsi-505	19	1	mycobacteria	mycobacterium	NOUN
ajmsi-505	19	2	are	be	AUX
ajmsi-505	19	3	within	within	ADP
ajmsi-505	19	4	the	the	DET
ajmsi-505	19	5	order	order	NOUN
ajmsi-505	19	6	actinomycetales	actinomycetale	VERB
ajmsi-505	19	7	,	,	PUNCT
ajmsi-505	19	8	which	which	PRON
ajmsi-505	19	9	it	it	PRON
ajmsi-505	19	10	shares	share	VERB
ajmsi-505	19	11	with	with	ADP
ajmsi-505	19	12	bacteria	bacteria	NOUN
ajmsi-505	19	13	such	such	ADJ
ajmsi-505	19	14	as	as	ADP
ajmsi-505	19	15	corynebacterium	corynebacterium	NOUN
ajmsi-505	19	16	,	,	PUNCT
ajmsi-505	19	17	norcadia	norcadia	NOUN
ajmsi-505	19	18	and	and	CCONJ
ajmsi-505	19	19	rhodococcus	rhodococcus	NOUN
ajmsi-505	19	20	.	.	PUNCT
ajmsi-505	20	1	mycobacteria	mycobacterium	NOUN
ajmsi-505	20	2	have	have	AUX
ajmsi-505	20	3	been	be	AUX
ajmsi-505	20	4	divided	divide	VERB
ajmsi-505	20	5	into	into	ADP
ajmsi-505	20	6	two	two	NUM
ajmsi-505	20	7	major	major	ADJ
ajmsi-505	20	8	groups	group	NOUN
ajmsi-505	20	9	based	base	VERB
ajmsi-505	20	10	on	on	ADP
ajmsi-505	20	11	fundamental	fundamental	ADJ
ajmsi-505	20	12	differences	difference	NOUN
ajmsi-505	20	13	in	in	ADP
ajmsi-505	20	14	epidemiology	epidemiology	NOUN
ajmsi-505	20	15	and	and	CCONJ
ajmsi-505	20	16	association	association	NOUN
ajmsi-505	20	17	with	with	ADP
ajmsi-505	20	18	disease	disease	NOUN
ajmsi-505	20	19	.	.	PUNCT
ajmsi-505	21	1	those	those	PRON
ajmsi-505	21	2	belonging	belong	VERB
ajmsi-505	21	3	to	to	ADP
ajmsi-505	21	4	the	the	DET
ajmsi-505	21	5	mycobacterium	mycobacterium	NOUN
ajmsi-505	21	6	tuberculosis	tuberculosis	NOUN
ajmsi-505	21	7	complex	complex	NOUN
ajmsi-505	21	8	(	(	PUNCT
ajmsi-505	21	9	mtbc	mtbc	PROPN
ajmsi-505	21	10	)	)	PUNCT
ajmsi-505	21	11	(	(	PUNCT
ajmsi-505	21	12	m.	m.	NOUN
ajmsi-505	21	13	tuberculosis	tuberculosis	NOUN
ajmsi-505	21	14	,	,	PUNCT
ajmsi-505	21	15	m.	m.	NOUN
ajmsi-505	21	16	bovis	bovis	NOUN
ajmsi-505	21	17	,	,	PUNCT
ajmsi-505	21	18	m.	m.	NOUN
ajmsi-505	21	19	africanun	africanun	PROPN
ajmsi-505	21	20	,	,	PUNCT
ajmsi-505	21	21	m.	m.	NOUN
ajmsi-505	21	22	canetti	canetti	PROPN
ajmsi-505	21	23	,	,	PUNCT
ajmsi-505	21	24	and	and	CCONJ
ajmsi-505	21	25	m.	m.	NOUN
ajmsi-505	21	26	microti	microti	PROPN
ajmsi-505	21	27	,	,	PUNCT
ajmsi-505	21	28	with	with	ADP
ajmsi-505	21	29	m.	m.	NOUN
ajmsi-505	21	30	laprae	laprae	PROPN
ajmsi-505	21	31	and	and	CCONJ
ajmsi-505	21	32	m.	m.	NOUN
ajmsi-505	21	33	pinnipedii	pinnipedii	PROPN
ajmsi-505	21	34	considered	consider	VERB
ajmsi-505	21	35	variants	variant	NOUN
ajmsi-505	21	36	of	of	ADP
ajmsi-505	21	37	m.	m.	NOUN
ajmsi-505	21	38	bovis	bovis	NOUN
ajmsi-505	21	39	)	)	PUNCT
ajmsi-505	21	40	,	,	PUNCT
ajmsi-505	21	41	and	and	CCONJ
ajmsi-505	21	42	those	those	PRON
ajmsi-505	21	43	referred	refer	VERB
ajmsi-505	21	44	to	to	ADP
ajmsi-505	21	45	as	as	ADP
ajmsi-505	21	46	the	the	DET
ajmsi-505	21	47	nontuberculous	nontuberculous	ADJ
ajmsi-505	21	48	mycobacteria	mycobacterium	NOUN
ajmsi-505	21	49	(	(	PUNCT
ajmsi-505	21	50	ntm	ntm	PROPN
ajmsi-505	21	51	)	)	PUNCT
ajmsi-505	21	52	such	such	ADJ
ajmsi-505	21	53	as	as	ADP
ajmsi-505	21	54	m.	m.	NOUN
ajmsi-505	21	55	avium	avium	NOUN
ajmsi-505	21	56	complex	complex	NOUN
ajmsi-505	21	57	,	,	PUNCT
ajmsi-505	21	58	m.	m.	NOUN
ajmsi-505	21	59	haemophilum	haemophilum	NOUN
ajmsi-505	21	60	,	,	PUNCT
ajmsi-505	21	61	m.	m.	NOUN
ajmsi-505	21	62	ulcerans	ulceran	NOUN
ajmsi-505	21	63	,	,	PUNCT
ajmsi-505	21	64	m.	m.	NOUN
ajmsi-505	21	65	leprae	leprae	NOUN
ajmsi-505	21	66	(	(	PUNCT
ajmsi-505	21	67	nonculturable	nonculturable	ADJ
ajmsi-505	21	68	)	)	PUNCT
ajmsi-505	21	69	,	,	PUNCT
ajmsi-505	21	70	and	and	CCONJ
ajmsi-505	21	71	the	the	DET
ajmsi-505	21	72	potentially	potentially	ADV
ajmsi-505	21	73	pathogenic	pathogenic	ADJ
ajmsi-505	21	74	species	specie	NOUN
ajmsi-505	21	75	such	such	ADJ
ajmsi-505	21	76	as	as	ADP
ajmsi-505	21	77	m.	m.	NOUN
ajmsi-505	21	78	smegmatis	smegmatis	PROPN
ajmsi-505	21	79	and	and	CCONJ
ajmsi-505	21	80	m.	m.	PROPN
ajmsi-505	21	81	abscessus	abscessus	PROPN
ajmsi-505	21	82	(	(	PUNCT
ajmsi-505	21	83	forbes	forbes	PROPN
ajmsi-505	21	84	et	et	PROPN
ajmsi-505	21	85	al	al	PROPN
ajmsi-505	21	86	.	.	PROPN
ajmsi-505	21	87	,2002	,2002	PUNCT
ajmsi-505	21	88	)	)	PUNCT
ajmsi-505	21	89	.	.	PUNCT
ajmsi-505	22	1	a	a	DET
ajmsi-505	22	2	very	very	ADV
ajmsi-505	22	3	important	important	ADJ
ajmsi-505	22	4	and	and	CCONJ
ajmsi-505	22	5	unique	unique	ADJ
ajmsi-505	22	6	characteristic	characteristic	NOUN
ajmsi-505	22	7	of	of	ADP
ajmsi-505	22	8	mycobacteria	mycobacteria	NOUN
ajmsi-505	22	9	is	be	AUX
ajmsi-505	22	10	that	that	SCONJ
ajmsi-505	22	11	the	the	DET
ajmsi-505	22	12	organisms	organism	NOUN
ajmsi-505	22	13	grow	grow	VERB
ajmsi-505	22	14	more	more	ADV
ajmsi-505	22	15	slowly	slowly	ADV
ajmsi-505	22	16	than	than	ADP
ajmsi-505	22	17	most	most	ADJ
ajmsi-505	22	18	other	other	ADJ
ajmsi-505	22	19	human	human	ADJ
ajmsi-505	22	20	pathogenic	pathogenic	ADJ
ajmsi-505	22	21	bacteria	bacteria	NOUN
ajmsi-505	22	22	because	because	SCONJ
ajmsi-505	22	23	of	of	ADP
ajmsi-505	22	24	their	their	PRON
ajmsi-505	22	25	hydrophobic	hydrophobic	NOUN
ajmsi-505	22	26	cell	cell	NOUN
ajmsi-505	22	27	surfaces	surface	NOUN
ajmsi-505	22	28	(	(	PUNCT
ajmsi-505	22	29	forbes	forbes	PROPN
ajmsi-505	22	30	et	et	PROPN
ajmsi-505	22	31	al	al	PROPN
ajmsi-505	22	32	.	.	PROPN
ajmsi-505	22	33	,2002	,2002	PUNCT
ajmsi-505	22	34	)	)	PUNCT
ajmsi-505	22	35	.	.	PUNCT
ajmsi-505	23	1	tuberculosis	tuberculosis	NOUN
ajmsi-505	23	2	is	be	AUX
ajmsi-505	23	3	a	a	DET
ajmsi-505	23	4	common	common	ADJ
ajmsi-505	23	5	,	,	PUNCT
ajmsi-505	23	6	and	and	CCONJ
ajmsi-505	23	7	in	in	ADP
ajmsi-505	23	8	many	many	ADJ
ajmsi-505	23	9	cases	case	NOUN
ajmsi-505	23	10	fatal	fatal	ADJ
ajmsi-505	23	11	,	,	PUNCT
ajmsi-505	23	12	infectious	infectious	ADJ
ajmsi-505	23	13	disease	disease	NOUN
ajmsi-505	23	14	caused	cause	VERB
ajmsi-505	23	15	by	by	ADP
ajmsi-505	23	16	various	various	ADJ
ajmsi-505	23	17	strains	strain	NOUN
ajmsi-505	23	18	of	of	ADP
ajmsi-505	23	19	mycobacteria	mycobacterium	NOUN
ajmsi-505	23	20	,	,	PUNCT
ajmsi-505	23	21	usually	usually	ADV
ajmsi-505	23	22	m.	m.	NOUN
ajmsi-505	23	23	tuberculosis	tuberculosis	NOUN
ajmsi-505	23	24	(	(	PUNCT
ajmsi-505	23	25	kumar	kumar	PROPN
ajmsi-505	23	26	et	et	PROPN
ajmsi-505	23	27	al	al	PROPN
ajmsi-505	23	28	.	.	PROPN
ajmsi-505	23	29	,	,	PUNCT
ajmsi-505	23	30	2007	2007	NUM
ajmsi-505	23	31	)	)	PUNCT
ajmsi-505	23	32	.	.	PUNCT
ajmsi-505	24	1	tuberculosis	tuberculosis	NOUN
ajmsi-505	24	2	is	be	AUX
ajmsi-505	24	3	an	an	DET
ajmsi-505	24	4	airborne	airborne	ADJ
ajmsi-505	24	5	disease	disease	NOUN
ajmsi-505	24	6	that	that	PRON
ajmsi-505	24	7	affects	affect	VERB
ajmsi-505	24	8	the	the	DET
ajmsi-505	24	9	lungs	lung	NOUN
ajmsi-505	24	10	(	(	PUNCT
ajmsi-505	24	11	pulmonary	pulmonary	NOUN
ajmsi-505	24	12	tb	tb	NOUN
ajmsi-505	24	13	)	)	PUNCT
ajmsi-505	24	14	,	,	PUNCT
ajmsi-505	24	15	but	but	CCONJ
ajmsi-505	24	16	can	can	AUX
ajmsi-505	24	17	also	also	ADV
ajmsi-505	24	18	affect	affect	VERB
ajmsi-505	24	19	other	other	ADJ
ajmsi-505	24	20	parts	part	NOUN
ajmsi-505	24	21	of	of	ADP
ajmsi-505	24	22	the	the	DET
ajmsi-505	24	23	body	body	NOUN
ajmsi-505	24	24	(	(	PUNCT
ajmsi-505	24	25	extra	extra	ADJ
ajmsi-505	24	26	pulmonary	pulmonary	ADJ
ajmsi-505	24	27	tb	tb	NOUN
ajmsi-505	24	28	)	)	PUNCT
ajmsi-505	24	29	such	such	ADJ
ajmsi-505	24	30	as	as	ADP
ajmsi-505	24	31	the	the	DET
ajmsi-505	24	32	larynx	larynx	NOUN
ajmsi-505	24	33	,	,	PUNCT
ajmsi-505	24	34	the	the	DET
ajmsi-505	24	35	lymph	lymph	NOUN
ajmsi-505	24	36	nodes	nod	VERB
ajmsi-505	24	37	,	,	PUNCT
ajmsi-505	24	38	the	the	DET
ajmsi-505	24	39	pleura	pleura	NOUN
ajmsi-505	24	40	,	,	PUNCT
ajmsi-505	24	41	the	the	DET
ajmsi-505	24	42	brain	brain	NOUN
ajmsi-505	24	43	,	,	PUNCT
ajmsi-505	24	44	the	the	DET
ajmsi-505	24	45	kidneys	kidney	NOUN
ajmsi-505	24	46	,	,	PUNCT
ajmsi-505	24	47	or	or	CCONJ
ajmsi-505	24	48	the	the	DET
ajmsi-505	24	49	bones	bone	NOUN
ajmsi-505	24	50	and	and	CCONJ
ajmsi-505	24	51	joints	joint	NOUN
ajmsi-505	24	52	(	(	PUNCT
ajmsi-505	24	53	bardarov	bardarov	PROPN
ajmsi-505	24	54	et	et	PROPN
ajmsi-505	24	55	al	al	PROPN
ajmsi-505	24	56	.	.	PROPN
ajmsi-505	24	57	,	,	PUNCT
ajmsi-505	24	58	2002	2002	NUM
ajmsi-505	24	59	)	)	PUNCT
ajmsi-505	24	60	.	.	PUNCT
ajmsi-505	25	1	based	base	VERB
ajmsi-505	25	2	on	on	ADP
ajmsi-505	25	3	clinical	clinical	ADJ
ajmsi-505	25	4	presentation	presentation	NOUN
ajmsi-505	25	5	,	,	PUNCT
ajmsi-505	25	6	tb	tb	X
ajmsi-505	25	7	can	can	AUX
ajmsi-505	25	8	be	be	AUX
ajmsi-505	25	9	categorized	categorize	VERB
ajmsi-505	25	10	into	into	ADP
ajmsi-505	25	11	active	active	ADJ
ajmsi-505	25	12	tb	tb	NOUN
ajmsi-505	25	13	disease	disease	NOUN
ajmsi-505	25	14	characterized	characterize	VERB
ajmsi-505	25	15	by	by	ADP
ajmsi-505	25	16	chronic	chronic	ADJ
ajmsi-505	25	17	cough	cough	NOUN
ajmsi-505	25	18	with	with	ADP
ajmsi-505	25	19	blood	blood	NOUN
ajmsi-505	25	20	-	-	PUNCT
ajmsi-505	25	21	tinged	tinge	VERB
ajmsi-505	25	22	sputum	sputum	NOUN
ajmsi-505	25	23	,	,	PUNCT
ajmsi-505	25	24	fever	fever	NOUN
ajmsi-505	25	25	,	,	PUNCT
ajmsi-505	25	26	night	night	NOUN
ajmsi-505	25	27	sweats	sweat	NOUN
ajmsi-505	25	28	and	and	CCONJ
ajmsi-505	25	29	weight	weight	NOUN
ajmsi-505	25	30	loss	loss	NOUN
ajmsi-505	25	31	(	(	PUNCT
ajmsi-505	25	32	the	the	DET
ajmsi-505	25	33	latter	latter	ADJ
ajmsi-505	25	34	giving	give	VERB
ajmsi-505	25	35	rise	rise	NOUN
ajmsi-505	25	36	to	to	ADP
ajmsi-505	25	37	the	the	DET
ajmsi-505	25	38	formerly	formerly	ADV
ajmsi-505	25	39	common	common	ADJ
ajmsi-505	25	40	term	term	NOUN
ajmsi-505	25	41	consumption	consumption	NOUN
ajmsi-505	25	42	)	)	PUNCT
ajmsi-505	25	43	,	,	PUNCT
ajmsi-505	25	44	most	most	ADJ
ajmsi-505	25	45	infections	infection	NOUN
ajmsi-505	25	46	do	do	AUX
ajmsi-505	25	47	not	not	PART
ajmsi-505	25	48	have	have	VERB
ajmsi-505	25	49	classical	classical	ADJ
ajmsi-505	25	50	symptoms	symptom	NOUN
ajmsi-505	25	51	and	and	CCONJ
ajmsi-505	25	52	are	be	AUX
ajmsi-505	25	53	thus	thus	ADV
ajmsi-505	25	54	referred	refer	VERB
ajmsi-505	25	55	to	to	ADP
ajmsi-505	25	56	as	as	ADP
ajmsi-505	25	57	latent	latent	NOUN
ajmsi-505	25	58	tb	tb	ADP
ajmsi-505	25	59	infection	infection	NOUN
ajmsi-505	25	60	(	(	PUNCT
ajmsi-505	25	61	ltbi	ltbi	NOUN
ajmsi-505	25	62	)	)	PUNCT
ajmsi-505	25	63	.	.	PUNCT
ajmsi-505	26	1	persons	person	NOUN
ajmsi-505	26	2	with	with	ADP
ajmsi-505	26	3	ltbi	ltbi	NOUN
ajmsi-505	26	4	have	have	AUX
ajmsi-505	26	5	m.	m.	NOUN
ajmsi-505	26	6	tuberculosis	tuberculosis	NOUN
ajmsi-505	26	7	in	in	ADP
ajmsi-505	26	8	their	their	PRON
ajmsi-505	26	9	bodies	body	NOUN
ajmsi-505	26	10	,	,	PUNCT
ajmsi-505	26	11	but	but	CCONJ
ajmsi-505	26	12	do	do	AUX
ajmsi-505	26	13	not	not	PART
ajmsi-505	26	14	have	have	VERB
ajmsi-505	26	15	tb	tb	ADP
ajmsi-505	26	16	disease	disease	NOUN
ajmsi-505	26	17	and	and	CCONJ
ajmsi-505	26	18	can	can	AUX
ajmsi-505	26	19	not	not	PART
ajmsi-505	26	20	spread	spread	VERB
ajmsi-505	26	21	the	the	DET
ajmsi-505	26	22	infection	infection	NOUN
ajmsi-505	26	23	to	to	ADP
ajmsi-505	26	24	other	other	ADJ
ajmsi-505	26	25	people	people	NOUN
ajmsi-505	26	26	(	(	PUNCT
ajmsi-505	26	27	bardarov	bardarov	PROPN
ajmsi-505	26	28	et	et	PROPN
ajmsi-505	26	29	al	al	PROPN
ajmsi-505	26	30	.	.	PROPN
ajmsi-505	26	31	,	,	PUNCT
ajmsi-505	26	32	2002	2002	NUM
ajmsi-505	26	33	)	)	PUNCT
ajmsi-505	26	34	.	.	PUNCT
ajmsi-505	27	1	it	it	PRON
ajmsi-505	27	2	is	be	AUX
ajmsi-505	27	3	estimated	estimate	VERB
ajmsi-505	27	4	that	that	SCONJ
ajmsi-505	27	5	one	one	NUM
ajmsi-505	27	6	-	-	PUNCT
ajmsi-505	27	7	third	third	NOUN
ajmsi-505	27	8	(	(	PUNCT
ajmsi-505	27	9	at	at	ADP
ajmsi-505	27	10	least	least	ADJ
ajmsi-505	27	11	2	2	NUM
ajmsi-505	27	12	billion	billion	NUM
ajmsi-505	27	13	people	people	NOUN
ajmsi-505	27	14	)	)	PUNCT
ajmsi-505	27	15	of	of	ADP
ajmsi-505	27	16	the	the	DET
ajmsi-505	27	17	world	world	NOUN
ajmsi-505	27	18	’s	’s	PART
ajmsi-505	27	19	human	human	ADJ
ajmsi-505	27	20	population	population	NOUN
ajmsi-505	27	21	is	be	AUX
ajmsi-505	27	22	infected	infect	VERB
ajmsi-505	27	23	(	(	PUNCT
ajmsi-505	27	24	willey	willey	PROPN
ajmsi-505	27	25	et	et	PROPN
ajmsi-505	27	26	al	al	PROPN
ajmsi-505	27	27	.	.	PROPN
ajmsi-505	27	28	,	,	PUNCT
ajmsi-505	27	29	2011	2011	NUM
ajmsi-505	27	30	)	)	PUNCT
ajmsi-505	27	31	.	.	PUNCT
ajmsi-505	28	1	of	of	ADP
ajmsi-505	28	2	the	the	DET
ajmsi-505	28	3	212	212	NUM
ajmsi-505	28	4	countries	country	NOUN
ajmsi-505	28	5	and	and	CCONJ
ajmsi-505	28	6	territories	territory	NOUN
ajmsi-505	28	7	in	in	ADP
ajmsi-505	28	8	the	the	DET
ajmsi-505	28	9	world	world	NOUN
ajmsi-505	28	10	,	,	PUNCT
ajmsi-505	28	11	202	202	NUM
ajmsi-505	28	12	,	,	PUNCT
ajmsi-505	28	13	(	(	PUNCT
ajmsi-505	28	14	99.6	99.6	NUM
ajmsi-505	28	15	%	%	NOUN
ajmsi-505	28	16	of	of	ADP
ajmsi-505	28	17	the	the	DET
ajmsi-505	28	18	world	world	NOUN
ajmsi-505	28	19	’s	’s	PART
ajmsi-505	28	20	population	population	NOUN
ajmsi-505	28	21	)	)	PUNCT
ajmsi-505	28	22	reported	report	VERB
ajmsi-505	28	23	tb	tb	ADP
ajmsi-505	28	24	cases	case	NOUN
ajmsi-505	28	25	in	in	ADP
ajmsi-505	28	26	2007	2007	NUM
ajmsi-505	28	27	;	;	PUNCT
ajmsi-505	28	28	the	the	DET
ajmsi-505	28	29	world	world	PROPN
ajmsi-505	28	30	health	health	NOUN
ajmsi-505	28	31	organization	organization	NOUN
ajmsi-505	28	32	(	(	PUNCT
ajmsi-505	28	33	who	who	PRON
ajmsi-505	28	34	)	)	PUNCT
ajmsi-505	28	35	reported	report	VERB
ajmsi-505	28	36	9.2	9.2	NUM
ajmsi-505	28	37	million	million	NUM
ajmsi-505	28	38	new	new	ADJ
ajmsi-505	28	39	tb	tb	NOUN
ajmsi-505	28	40	cases	case	NOUN
ajmsi-505	28	41	,	,	PUNCT
ajmsi-505	28	42	with	with	ADP
ajmsi-505	28	43	approximately	approximately	ADV
ajmsi-505	28	44	7.7	7.7	NUM
ajmsi-505	28	45	%	%	NOUN
ajmsi-505	28	46	being	be	AUX
ajmsi-505	28	47	hiv	hiv	ADV
ajmsi-505	28	48	positive	positive	ADJ
ajmsi-505	28	49	(	(	PUNCT
ajmsi-505	28	50	willey	willey	PROPN
ajmsi-505	28	51	et	et	PROPN
ajmsi-505	28	52	al	al	PROPN
ajmsi-505	28	53	.	.	PROPN
ajmsi-505	28	54	,	,	PUNCT
ajmsi-505	28	55	2011	2011	NUM
ajmsi-505	28	56	)	)	PUNCT
ajmsi-505	28	57	.	.	PUNCT
ajmsi-505	29	1	today	today	NOUN
ajmsi-505	29	2	,	,	PUNCT
ajmsi-505	29	3	tb	tb	X
ajmsi-505	29	4	is	be	AUX
ajmsi-505	29	5	second	second	ADJ
ajmsi-505	29	6	only	only	ADV
ajmsi-505	29	7	to	to	ADP
ajmsi-505	29	8	hiv	hiv	PROPN
ajmsi-505	29	9	/	/	SYM
ajmsi-505	29	10	aids	aids	PROPN
ajmsi-505	29	11	as	as	ADP
ajmsi-505	29	12	the	the	DET
ajmsi-505	29	13	greatest	great	ADJ
ajmsi-505	29	14	killer	killer	NOUN
ajmsi-505	29	15	worldwide	worldwide	ADV
ajmsi-505	29	16	due	due	ADP
ajmsi-505	29	17	to	to	ADP
ajmsi-505	29	18	a	a	DET
ajmsi-505	29	19	single	single	ADJ
ajmsi-505	29	20	infectious	infectious	ADJ
ajmsi-505	29	21	agent	agent	NOUN
ajmsi-505	29	22	,	,	PUNCT
ajmsi-505	29	23	in	in	ADP
ajmsi-505	29	24	2012	2012	NUM
ajmsi-505	29	25	for	for	ADP
ajmsi-505	29	26	instance	instance	NOUN
ajmsi-505	29	27	,	,	PUNCT
ajmsi-505	29	28	8.6	8.6	NUM
ajmsi-505	29	29	million	million	NUM
ajmsi-505	29	30	people	people	NOUN
ajmsi-505	29	31	fell	fall	VERB
ajmsi-505	29	32	ill	ill	ADJ
ajmsi-505	29	33	with	with	ADP
ajmsi-505	29	34	tb	tb	NOUN
ajmsi-505	29	35	and	and	CCONJ
ajmsi-505	29	36	1.3	1.3	NUM
ajmsi-505	29	37	million	million	NUM
ajmsi-505	29	38	died	die	VERB
ajmsi-505	29	39	from	from	ADP
ajmsi-505	29	40	tb	tb	NOUN
ajmsi-505	29	41	,	,	PUNCT
ajmsi-505	29	42	with	with	ADP
ajmsi-505	29	43	over	over	ADP
ajmsi-505	29	44	95	95	NUM
ajmsi-505	29	45	%	%	NOUN
ajmsi-505	29	46	of	of	ADP
ajmsi-505	29	47	tb	tb	ADP
ajmsi-505	29	48	deaths	death	NOUN
ajmsi-505	29	49	reported	report	VERB
ajmsi-505	29	50	in	in	ADP
ajmsi-505	29	51	low	low	ADJ
ajmsi-505	29	52	and	and	CCONJ
ajmsi-505	29	53	middle	middle	ADJ
ajmsi-505	29	54	-	-	PUNCT
ajmsi-505	29	55	income	income	NOUN
ajmsi-505	29	56	countries	country	NOUN
ajmsi-505	29	57	(	(	PUNCT
ajmsi-505	29	58	who	who	PRON
ajmsi-505	29	59	,	,	PUNCT
ajmsi-505	29	60	2014	2014	NUM
ajmsi-505	29	61	)	)	PUNCT
ajmsi-505	29	62	,	,	PUNCT
ajmsi-505	29	63	tuberculosis	tuberculosis	NOUN
ajmsi-505	29	64	is	be	AUX
ajmsi-505	29	65	still	still	ADV
ajmsi-505	29	66	among	among	ADP
ajmsi-505	29	67	the	the	DET
ajmsi-505	29	68	top	top	ADJ
ajmsi-505	29	69	three	three	NUM
ajmsi-505	29	70	causes	cause	NOUN
ajmsi-505	29	71	of	of	ADP
ajmsi-505	29	72	death	death	NOUN
ajmsi-505	29	73	for	for	ADP
ajmsi-505	29	74	women	woman	NOUN
ajmsi-505	29	75	aged	age	VERB
ajmsi-505	29	76	15	15	NUM
ajmsi-505	29	77	to	to	PART
ajmsi-505	29	78	44	44	NUM
ajmsi-505	29	79	years	year	NOUN
ajmsi-505	29	80	(	(	PUNCT
ajmsi-505	29	81	who	who	PRON
ajmsi-505	29	82	,	,	PUNCT
ajmsi-505	29	83	2014	2014	NUM
ajmsi-505	29	84	)	)	PUNCT
ajmsi-505	29	85	.	.	PUNCT
ajmsi-505	30	1	the	the	DET
ajmsi-505	30	2	emergence	emergence	NOUN
ajmsi-505	30	3	of	of	ADP
ajmsi-505	30	4	mdr	mdr	PROPN
ajmsi-505	30	5	-	-	PROPN
ajmsi-505	30	6	tb	tb	PROPN
ajmsi-505	30	7	,	,	PUNCT
ajmsi-505	30	8	first	first	ADV
ajmsi-505	30	9	reported	report	VERB
ajmsi-505	30	10	in	in	ADP
ajmsi-505	30	11	the	the	DET
ajmsi-505	30	12	late	late	ADJ
ajmsi-505	30	13	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	NOUN
ajmsi-505	30	14	mailto	mailto	NOUN
ajmsi-505	30	15	:	:	PUNCT
ajmsi-505	30	16	abrahamlanterna%40gmail.com?subject=	abrahamlanterna%40gmail.com?subject=	PROPN
ajmsi-505	30	17	pa	pa	PROPN
ajmsi-505	30	18	ge	ge	PROPN
ajmsi-505	30	19	2	2	NUM
ajmsi-505	30	20	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	30	21	am	be	AUX
ajmsi-505	30	22	.	.	PUNCT
ajmsi-505	31	1	j.	j.	PROPN
ajmsi-505	31	2	med	med	PROPN
ajmsi-505	31	3	.	.	PUNCT
ajmsi-505	32	1	sci	sci	PROPN
ajmsi-505	32	2	.	.	PUNCT
ajmsi-505	32	3	innov	innov	PROPN
ajmsi-505	32	4	.	.	PUNCT
ajmsi-505	33	1	1(1	1(1	NUM
ajmsi-505	33	2	)	)	PUNCT
ajmsi-505	33	3	1	1	NUM
ajmsi-505	33	4	-	-	SYM
ajmsi-505	33	5	9	9	NUM
ajmsi-505	33	6	,	,	PUNCT
ajmsi-505	33	7	2022	2022	NUM
ajmsi-505	33	8	1980s	1980	NOUN
ajmsi-505	33	9	(	(	PUNCT
ajmsi-505	33	10	cegielski	cegielski	ADJ
ajmsi-505	33	11	,	,	PUNCT
ajmsi-505	33	12	2010	2010	NUM
ajmsi-505	33	13	)	)	PUNCT
ajmsi-505	33	14	,	,	PUNCT
ajmsi-505	33	15	and	and	CCONJ
ajmsi-505	33	16	present	present	ADJ
ajmsi-505	33	17	in	in	ADP
ajmsi-505	33	18	virtually	virtually	ADV
ajmsi-505	33	19	all	all	DET
ajmsi-505	33	20	the	the	DET
ajmsi-505	33	21	countries	country	NOUN
ajmsi-505	33	22	surveyed	survey	VERB
ajmsi-505	33	23	has	have	AUX
ajmsi-505	33	24	posed	pose	VERB
ajmsi-505	33	25	a	a	DET
ajmsi-505	33	26	great	great	ADJ
ajmsi-505	33	27	obstacle	obstacle	NOUN
ajmsi-505	33	28	to	to	PART
ajmsi-505	33	29	effective	effective	VERB
ajmsi-505	33	30	tb	tb	ADP
ajmsi-505	33	31	control	control	NOUN
ajmsi-505	33	32	at	at	ADP
ajmsi-505	33	33	both	both	CCONJ
ajmsi-505	33	34	national	national	ADJ
ajmsi-505	33	35	and	and	CCONJ
ajmsi-505	33	36	global	global	ADJ
ajmsi-505	33	37	levels	level	NOUN
ajmsi-505	33	38	.	.	PUNCT
ajmsi-505	34	1	in	in	ADP
ajmsi-505	34	2	2010	2010	NUM
ajmsi-505	34	3	,	,	PUNCT
ajmsi-505	34	4	the	the	DET
ajmsi-505	34	5	world	world	PROPN
ajmsi-505	34	6	health	health	NOUN
ajmsi-505	34	7	organization	organization	NOUN
ajmsi-505	34	8	(	(	PUNCT
ajmsi-505	34	9	who	who	PRON
ajmsi-505	34	10	)	)	PUNCT
ajmsi-505	34	11	estimated	estimate	VERB
ajmsi-505	34	12	that	that	SCONJ
ajmsi-505	34	13	globally	globally	ADV
ajmsi-505	34	14	there	there	PRON
ajmsi-505	34	15	were	be	VERB
ajmsi-505	34	16	290	290	NUM
ajmsi-505	34	17	,	,	PUNCT
ajmsi-505	34	18	000	000	NUM
ajmsi-505	34	19	cases	case	NOUN
ajmsi-505	34	20	of	of	ADP
ajmsi-505	34	21	mdrtb	mdrtb	NOUN
ajmsi-505	34	22	among	among	ADP
ajmsi-505	34	23	reported	report	VERB
ajmsi-505	34	24	cases	case	NOUN
ajmsi-505	34	25	of	of	ADP
ajmsi-505	34	26	pulmonary	pulmonary	ADJ
ajmsi-505	34	27	tb	tb	NOUN
ajmsi-505	34	28	(	(	PUNCT
ajmsi-505	34	29	who	who	PRON
ajmsi-505	34	30	,	,	PUNCT
ajmsi-505	34	31	2011	2011	NUM
ajmsi-505	34	32	)	)	PUNCT
ajmsi-505	34	33	.	.	PUNCT
ajmsi-505	35	1	the	the	DET
ajmsi-505	35	2	world	world	PROPN
ajmsi-505	35	3	health	health	PROPN
ajmsi-505	35	4	organization	organization	NOUN
ajmsi-505	35	5	also	also	ADV
ajmsi-505	35	6	reported	report	VERB
ajmsi-505	35	7	an	an	DET
ajmsi-505	35	8	estimated	estimate	VERB
ajmsi-505	35	9	650	650	NUM
ajmsi-505	35	10	,	,	PUNCT
ajmsi-505	35	11	000	000	NUM
ajmsi-505	35	12	cases	case	NOUN
ajmsi-505	35	13	of	of	ADP
ajmsi-505	35	14	mdr	mdr	PROPN
ajmsi-505	35	15	-	-	NOUN
ajmsi-505	35	16	tb	tb	NOUN
ajmsi-505	35	17	among	among	ADP
ajmsi-505	35	18	the	the	DET
ajmsi-505	35	19	world	world	NOUN
ajmsi-505	35	20	’s	’s	PART
ajmsi-505	35	21	12	12	NUM
ajmsi-505	35	22	million	million	NUM
ajmsi-505	35	23	prevalent	prevalent	ADJ
ajmsi-505	35	24	cases	case	NOUN
ajmsi-505	35	25	of	of	ADP
ajmsi-505	35	26	tb	tb	NOUN
ajmsi-505	35	27	with	with	ADP
ajmsi-505	35	28	nigeria	nigeria	PROPN
ajmsi-505	35	29	alone	alone	ADV
ajmsi-505	35	30	accounting	account	VERB
ajmsi-505	35	31	for	for	ADP
ajmsi-505	35	32	95	95	NUM
ajmsi-505	35	33	reported	report	VERB
ajmsi-505	35	34	cases	case	NOUN
ajmsi-505	35	35	of	of	ADP
ajmsi-505	35	36	mdr	mdr	PROPN
ajmsi-505	35	37	-	-	PROPN
ajmsi-505	35	38	tb	tb	X
ajmsi-505	35	39	(	(	PUNCT
ajmsi-505	35	40	who	who	PRON
ajmsi-505	35	41	,	,	PUNCT
ajmsi-505	35	42	2011	2011	NUM
ajmsi-505	35	43	)	)	PUNCT
ajmsi-505	35	44	.	.	PUNCT
ajmsi-505	36	1	resistance	resistance	NOUN
ajmsi-505	36	2	to	to	ADP
ajmsi-505	36	3	tb	tb	NOUN
ajmsi-505	36	4	-	-	PUNCT
ajmsi-505	36	5	drugs	drug	NOUN
ajmsi-505	36	6	is	be	AUX
ajmsi-505	36	7	said	say	VERB
ajmsi-505	36	8	to	to	PART
ajmsi-505	36	9	arise	arise	VERB
ajmsi-505	36	10	from	from	ADP
ajmsi-505	36	11	both	both	PRON
ajmsi-505	36	12	service	service	NOUN
ajmsi-505	36	13	and	and	CCONJ
ajmsi-505	36	14	patient	patient	ADJ
ajmsi-505	36	15	related	relate	VERB
ajmsi-505	36	16	factors	factor	NOUN
ajmsi-505	36	17	in	in	ADP
ajmsi-505	36	18	the	the	DET
ajmsi-505	36	19	management	management	NOUN
ajmsi-505	36	20	of	of	ADP
ajmsi-505	36	21	tuberculosis	tuberculosis	NOUN
ajmsi-505	36	22	ranging	range	VERB
ajmsi-505	36	23	from	from	ADP
ajmsi-505	36	24	poor	poor	ADJ
ajmsi-505	36	25	compliance	compliance	NOUN
ajmsi-505	36	26	,	,	PUNCT
ajmsi-505	36	27	inadequate	inadequate	ADJ
ajmsi-505	36	28	supervision	supervision	NOUN
ajmsi-505	36	29	,	,	PUNCT
ajmsi-505	36	30	inadequate	inadequate	ADJ
ajmsi-505	36	31	dosing	dosing	NOUN
ajmsi-505	36	32	,	,	PUNCT
ajmsi-505	36	33	wrong	wrong	ADJ
ajmsi-505	36	34	drug	drug	NOUN
ajmsi-505	36	35	combination	combination	NOUN
ajmsi-505	36	36	,	,	PUNCT
ajmsi-505	36	37	lengthy	lengthy	ADJ
ajmsi-505	36	38	duration	duration	NOUN
ajmsi-505	36	39	of	of	ADP
ajmsi-505	36	40	treatment	treatment	NOUN
ajmsi-505	36	41	and	and	CCONJ
ajmsi-505	36	42	poor	poor	ADJ
ajmsi-505	36	43	training	training	NOUN
ajmsi-505	36	44	of	of	ADP
ajmsi-505	36	45	health	health	NOUN
ajmsi-505	36	46	personnel	personnel	NOUN
ajmsi-505	36	47	(	(	PUNCT
ajmsi-505	36	48	federal	federal	PROPN
ajmsi-505	36	49	ministry	ministry	PROPN
ajmsi-505	36	50	of	of	ADP
ajmsi-505	36	51	health	health	PROPN
ajmsi-505	36	52	fmoh	fmoh	PROPN
ajmsi-505	36	53	,	,	PUNCT
ajmsi-505	36	54	2005	2005	NUM
ajmsi-505	36	55	)	)	PUNCT
ajmsi-505	36	56	.	.	PUNCT
ajmsi-505	37	1	despite	despite	SCONJ
ajmsi-505	37	2	reasonable	reasonable	ADJ
ajmsi-505	37	3	degree	degree	NOUN
ajmsi-505	37	4	of	of	ADP
ajmsi-505	37	5	successes	success	NOUN
ajmsi-505	37	6	and	and	CCONJ
ajmsi-505	37	7	achievements	achievement	NOUN
ajmsi-505	37	8	recorded	record	VERB
ajmsi-505	37	9	in	in	ADP
ajmsi-505	37	10	the	the	DET
ajmsi-505	37	11	stop	stop	NOUN
ajmsi-505	37	12	tb	tb	ADP
ajmsi-505	37	13	targets	target	NOUN
ajmsi-505	37	14	of	of	ADP
ajmsi-505	37	15	the	the	DET
ajmsi-505	37	16	millennium	millennium	NOUN
ajmsi-505	37	17	development	development	NOUN
ajmsi-505	37	18	goals	goal	NOUN
ajmsi-505	37	19	(	(	PUNCT
ajmsi-505	37	20	mdgs	mdgs	NOUN
ajmsi-505	37	21	)	)	PUNCT
ajmsi-505	37	22	number-6	number-6	PROPN
ajmsi-505	37	23	,	,	PUNCT
ajmsi-505	37	24	target-8	target-8	NUM
ajmsi-505	37	25	of	of	ADP
ajmsi-505	37	26	reducing	reduce	VERB
ajmsi-505	37	27	the	the	DET
ajmsi-505	37	28	global	global	ADJ
ajmsi-505	37	29	burden	burden	NOUN
ajmsi-505	37	30	of	of	ADP
ajmsi-505	37	31	tb	tb	ADP
ajmsi-505	37	32	disease	disease	NOUN
ajmsi-505	37	33	(	(	PUNCT
ajmsi-505	37	34	death	death	NOUN
ajmsi-505	37	35	and	and	CCONJ
ajmsi-505	37	36	prevalence	prevalence	NOUN
ajmsi-505	37	37	)	)	PUNCT
ajmsi-505	37	38	by	by	ADP
ajmsi-505	37	39	50	50	NUM
ajmsi-505	37	40	%	%	NOUN
ajmsi-505	37	41	by	by	ADP
ajmsi-505	37	42	2015	2015	NUM
ajmsi-505	37	43	(	(	PUNCT
ajmsi-505	37	44	who	who	PRON
ajmsi-505	37	45	,	,	PUNCT
ajmsi-505	37	46	2011	2011	NUM
ajmsi-505	37	47	)	)	PUNCT
ajmsi-505	37	48	,	,	PUNCT
ajmsi-505	37	49	the	the	DET
ajmsi-505	37	50	second	second	ADJ
ajmsi-505	37	51	component	component	NOUN
ajmsi-505	37	52	of	of	ADP
ajmsi-505	37	53	the	the	DET
ajmsi-505	37	54	stop	stop	NOUN
ajmsi-505	37	55	tb	tb	ADP
ajmsi-505	37	56	strategy	strategy	NOUN
ajmsi-505	37	57	to	to	PART
ajmsi-505	37	58	address	address	VERB
ajmsi-505	37	59	tb	tb	PROPN
ajmsi-505	37	60	/	/	SYM
ajmsi-505	37	61	hiv	hiv	PROPN
ajmsi-505	37	62	and	and	CCONJ
ajmsi-505	37	63	mdr	mdr	PROPN
ajmsi-505	37	64	-	-	PROPN
ajmsi-505	37	65	tb	tb	PROPN
ajmsi-505	37	66	remains	remain	VERB
ajmsi-505	37	67	a	a	DET
ajmsi-505	37	68	global	global	ADJ
ajmsi-505	37	69	concern	concern	NOUN
ajmsi-505	37	70	.	.	PUNCT
ajmsi-505	38	1	the	the	DET
ajmsi-505	38	2	pathogenesis	pathogenesis	NOUN
ajmsi-505	38	3	of	of	ADP
ajmsi-505	38	4	tuberculosis	tuberculosis	NOUN
ajmsi-505	38	5	shows	show	VERB
ajmsi-505	38	6	that	that	SCONJ
ajmsi-505	38	7	m.	m.	NOUN
ajmsi-505	38	8	tuberculosis	tuberculosis	NOUN
ajmsi-505	38	9	is	be	AUX
ajmsi-505	38	10	often	often	ADV
ajmsi-505	38	11	acquired	acquire	VERB
ajmsi-505	38	12	early	early	ADV
ajmsi-505	38	13	in	in	ADP
ajmsi-505	38	14	life	life	NOUN
ajmsi-505	38	15	with	with	ADP
ajmsi-505	38	16	acute	acute	ADJ
ajmsi-505	38	17	infection	infection	NOUN
ajmsi-505	38	18	and	and	CCONJ
ajmsi-505	38	19	with	with	ADP
ajmsi-505	38	20	developing	develop	VERB
ajmsi-505	38	21	immunity	immunity	NOUN
ajmsi-505	38	22	,	,	PUNCT
ajmsi-505	38	23	granuloma	granuloma	ADJ
ajmsi-505	38	24	formation	formation	NOUN
ajmsi-505	38	25	,	,	PUNCT
ajmsi-505	38	26	and	and	CCONJ
ajmsi-505	38	27	calcification	calcification	NOUN
ajmsi-505	38	28	.	.	PUNCT
ajmsi-505	39	1	this	this	PRON
ajmsi-505	39	2	is	be	AUX
ajmsi-505	39	3	followed	follow	VERB
ajmsi-505	39	4	by	by	ADP
ajmsi-505	39	5	a	a	DET
ajmsi-505	39	6	long	long	ADJ
ajmsi-505	39	7	latent	latent	NOUN
ajmsi-505	39	8	period	period	NOUN
ajmsi-505	39	9	,	,	PUNCT
ajmsi-505	39	10	which	which	PRON
ajmsi-505	39	11	continues	continue	VERB
ajmsi-505	39	12	until	until	SCONJ
ajmsi-505	39	13	reactivation	reactivation	NOUN
ajmsi-505	39	14	occurs	occur	VERB
ajmsi-505	39	15	in	in	ADP
ajmsi-505	39	16	a	a	DET
ajmsi-505	39	17	proportion	proportion	NOUN
ajmsi-505	39	18	of	of	ADP
ajmsi-505	39	19	individuals	individual	NOUN
ajmsi-505	39	20	.	.	PUNCT
ajmsi-505	40	1	at	at	ADP
ajmsi-505	40	2	this	this	DET
ajmsi-505	40	3	period	period	NOUN
ajmsi-505	40	4	,	,	PUNCT
ajmsi-505	40	5	the	the	DET
ajmsi-505	40	6	organism	organism	NOUN
ajmsi-505	40	7	target	target	NOUN
ajmsi-505	40	8	and	and	CCONJ
ajmsi-505	40	9	persist	persist	VERB
ajmsi-505	40	10	within	within	ADP
ajmsi-505	40	11	phagocytic	phagocytic	ADJ
ajmsi-505	40	12	monocytes	monocyte	NOUN
ajmsi-505	40	13	,	,	PUNCT
ajmsi-505	40	14	macrophages	macrophage	NOUN
ajmsi-505	40	15	,	,	PUNCT
ajmsi-505	40	16	polymorphonuclear	polymorphonuclear	NOUN
ajmsi-505	40	17	neutrophils	neutrophil	NOUN
ajmsi-505	40	18	and	and	CCONJ
ajmsi-505	40	19	t	t	NOUN
ajmsi-505	40	20	-	-	PUNCT
ajmsi-505	40	21	lymphocytes	lymphocyte	NOUN
ajmsi-505	40	22	in	in	ADP
ajmsi-505	40	23	blood	blood	NOUN
ajmsi-505	40	24	circulation	circulation	NOUN
ajmsi-505	40	25	(	(	PUNCT
ajmsi-505	40	26	van	van	PROPN
ajmsi-505	40	27	crevel	crevel	PROPN
ajmsi-505	40	28	et	et	PROPN
ajmsi-505	40	29	al	al	PROPN
ajmsi-505	40	30	.	.	PROPN
ajmsi-505	40	31	,	,	PUNCT
ajmsi-505	40	32	2002	2002	NUM
ajmsi-505	40	33	)	)	PUNCT
ajmsi-505	40	34	.	.	PUNCT
ajmsi-505	41	1	as	as	ADP
ajmsi-505	41	2	a	a	DET
ajmsi-505	41	3	result	result	NOUN
ajmsi-505	41	4	,	,	PUNCT
ajmsi-505	41	5	there	there	PRON
ajmsi-505	41	6	is	be	VERB
ajmsi-505	41	7	a	a	DET
ajmsi-505	41	8	possibility	possibility	NOUN
ajmsi-505	41	9	of	of	ADP
ajmsi-505	41	10	cellular	cellular	ADJ
ajmsi-505	41	11	interaction	interaction	NOUN
ajmsi-505	41	12	between	between	ADP
ajmsi-505	41	13	m.	m.	NOUN
ajmsi-505	41	14	tuberculosis	tuberculosis	NOUN
ajmsi-505	41	15	and	and	CCONJ
ajmsi-505	41	16	hiv	hiv	PROPN
ajmsi-505	41	17	,	,	PUNCT
ajmsi-505	41	18	especially	especially	ADV
ajmsi-505	41	19	for	for	ADP
ajmsi-505	41	20	patients	patient	NOUN
ajmsi-505	41	21	that	that	PRON
ajmsi-505	41	22	are	be	AUX
ajmsi-505	41	23	coinfected	coinfecte	VERB
ajmsi-505	41	24	with	with	ADP
ajmsi-505	41	25	hiv	hiv	PROPN
ajmsi-505	41	26	and	and	CCONJ
ajmsi-505	41	27	tb	tb	NOUN
ajmsi-505	41	28	,	,	PUNCT
ajmsi-505	41	29	and	and	CCONJ
ajmsi-505	41	30	subsequent	subsequent	ADJ
ajmsi-505	41	31	exchange	exchange	NOUN
ajmsi-505	41	32	of	of	ADP
ajmsi-505	41	33	genetic	genetic	ADJ
ajmsi-505	41	34	information	information	NOUN
ajmsi-505	41	35	via	via	ADP
ajmsi-505	41	36	transduction	transduction	NOUN
ajmsi-505	41	37	.	.	PUNCT
ajmsi-505	42	1	it	it	PRON
ajmsi-505	42	2	has	have	AUX
ajmsi-505	42	3	therefore	therefore	ADV
ajmsi-505	42	4	become	become	VERB
ajmsi-505	42	5	necessary	necessary	ADJ
ajmsi-505	42	6	to	to	PART
ajmsi-505	42	7	determine	determine	VERB
ajmsi-505	42	8	the	the	DET
ajmsi-505	42	9	role	role	NOUN
ajmsi-505	42	10	of	of	ADP
ajmsi-505	42	11	hiv	hiv	PROPN
ajmsi-505	42	12	in	in	ADP
ajmsi-505	42	13	the	the	DET
ajmsi-505	42	14	emergence	emergence	NOUN
ajmsi-505	42	15	of	of	ADP
ajmsi-505	42	16	mdr	mdr	PROPN
ajmsi-505	42	17	-	-	NOUN
ajmsi-505	42	18	tb	tb	NOUN
ajmsi-505	42	19	in	in	ADP
ajmsi-505	42	20	hiv	hiv	PROPN
ajmsi-505	42	21	/	/	SYM
ajmsi-505	42	22	tb	tb	ADP
ajmsi-505	42	23	co	co	NOUN
ajmsi-505	42	24	-	-	NOUN
ajmsi-505	42	25	infection	infection	NOUN
ajmsi-505	42	26	dynamics	dynamic	NOUN
ajmsi-505	42	27	.	.	PUNCT
ajmsi-505	43	1	considering	consider	VERB
ajmsi-505	43	2	the	the	DET
ajmsi-505	43	3	fact	fact	NOUN
ajmsi-505	43	4	that	that	SCONJ
ajmsi-505	43	5	hiv	hiv	PROPN
ajmsi-505	43	6	plays	play	VERB
ajmsi-505	43	7	a	a	DET
ajmsi-505	43	8	major	major	ADJ
ajmsi-505	43	9	role	role	NOUN
ajmsi-505	43	10	in	in	ADP
ajmsi-505	43	11	infectious	infectious	ADJ
ajmsi-505	43	12	diseases	disease	NOUN
ajmsi-505	43	13	generally	generally	ADV
ajmsi-505	43	14	,	,	PUNCT
ajmsi-505	43	15	and	and	CCONJ
ajmsi-505	43	16	tb	tb	X
ajmsi-505	43	17	in	in	ADP
ajmsi-505	43	18	particular	particular	ADJ
ajmsi-505	43	19	(	(	PUNCT
ajmsi-505	43	20	bardarov	bardarov	PROPN
ajmsi-505	43	21	et	et	PROPN
ajmsi-505	43	22	al	al	PROPN
ajmsi-505	43	23	.	.	PROPN
ajmsi-505	43	24	,	,	PUNCT
ajmsi-505	43	25	2002	2002	NUM
ajmsi-505	43	26	)	)	PUNCT
ajmsi-505	43	27	,	,	PUNCT
ajmsi-505	43	28	the	the	DET
ajmsi-505	43	29	need	need	NOUN
ajmsi-505	43	30	to	to	PART
ajmsi-505	43	31	focus	focus	VERB
ajmsi-505	43	32	attention	attention	NOUN
ajmsi-505	43	33	on	on	ADP
ajmsi-505	43	34	understanding	understand	VERB
ajmsi-505	43	35	the	the	DET
ajmsi-505	43	36	molecular	molecular	ADJ
ajmsi-505	43	37	basis	basis	NOUN
ajmsi-505	43	38	of	of	ADP
ajmsi-505	43	39	tb	tb	ADP
ajmsi-505	43	40	pathogenesis	pathogenesis	NOUN
ajmsi-505	43	41	especially	especially	ADV
ajmsi-505	43	42	mdr	mdr	PROPN
ajmsi-505	43	43	-	-	NOUN
ajmsi-505	43	44	tb	tb	X
ajmsi-505	43	45	with	with	ADP
ajmsi-505	43	46	particular	particular	ADJ
ajmsi-505	43	47	emphasis	emphasis	NOUN
ajmsi-505	43	48	on	on	ADP
ajmsi-505	43	49	hiv/	hiv/	PROPN
ajmsi-505	43	50	tb	tb	ADP
ajmsi-505	43	51	co	co	NOUN
ajmsi-505	43	52	-	-	NOUN
ajmsi-505	43	53	infection	infection	NOUN
ajmsi-505	43	54	has	have	AUX
ajmsi-505	43	55	become	become	VERB
ajmsi-505	43	56	a	a	DET
ajmsi-505	43	57	top	top	ADJ
ajmsi-505	43	58	priority	priority	NOUN
ajmsi-505	43	59	.	.	PUNCT
ajmsi-505	44	1	materials	material	NOUN
ajmsi-505	44	2	and	and	CCONJ
ajmsi-505	44	3	methods	method	NOUN
ajmsi-505	44	4	a	a	DET
ajmsi-505	44	5	total	total	NOUN
ajmsi-505	44	6	of	of	ADP
ajmsi-505	44	7	380	380	NUM
ajmsi-505	44	8	sputum	sputum	NOUN
ajmsi-505	44	9	samples	sample	NOUN
ajmsi-505	44	10	determined	determine	VERB
ajmsi-505	44	11	by	by	ADP
ajmsi-505	44	12	raosoft	raosoft	ADJ
ajmsi-505	44	13	sample	sample	NOUN
ajmsi-505	44	14	size	size	NOUN
ajmsi-505	44	15	calculator	calculator	NOUN
ajmsi-505	44	16	(	(	PUNCT
ajmsi-505	44	17	raosoft	raosoft	ADV
ajmsi-505	44	18	,	,	PUNCT
ajmsi-505	44	19	2015	2015	NUM
ajmsi-505	44	20	)	)	PUNCT
ajmsi-505	44	21	were	be	AUX
ajmsi-505	44	22	collected	collect	VERB
ajmsi-505	44	23	from	from	ADP
ajmsi-505	44	24	a	a	DET
ajmsi-505	44	25	wide	wide	ADJ
ajmsi-505	44	26	spectrum	spectrum	NOUN
ajmsi-505	44	27	of	of	ADP
ajmsi-505	44	28	tb	tb	ADP
ajmsi-505	44	29	patients	patient	NOUN
ajmsi-505	44	30	from	from	ADP
ajmsi-505	44	31	two	two	NUM
ajmsi-505	44	32	geographically	geographically	ADV
ajmsi-505	44	33	distinct	distinct	ADJ
ajmsi-505	44	34	sites	site	NOUN
ajmsi-505	44	35	:	:	PUNCT
ajmsi-505	44	36	three	three	NUM
ajmsi-505	44	37	hundred	hundred	NUM
ajmsi-505	44	38	and	and	CCONJ
ajmsi-505	44	39	three	three	NUM
ajmsi-505	44	40	sputum	sputum	NOUN
ajmsi-505	44	41	samples	sample	NOUN
ajmsi-505	44	42	were	be	AUX
ajmsi-505	44	43	collected	collect	VERB
ajmsi-505	44	44	from	from	ADP
ajmsi-505	44	45	nigerian	nigerian	PROPN
ajmsi-505	44	46	airforce	airforce	PROPN
ajmsi-505	44	47	(	(	PUNCT
ajmsi-505	44	48	naf	naf	PROPN
ajmsi-505	44	49	)	)	PUNCT
ajmsi-505	44	50	hospital/	hospital/	NUM
ajmsi-505	44	51	cdc	cdc	PROPN
ajmsi-505	44	52	laboratory	laboratory	NOUN
ajmsi-505	44	53	,	,	PUNCT
ajmsi-505	44	54	while	while	SCONJ
ajmsi-505	44	55	the	the	DET
ajmsi-505	44	56	remaining	remain	VERB
ajmsi-505	44	57	seventy	seventy	NUM
ajmsi-505	44	58	-	-	PUNCT
ajmsi-505	44	59	seven	seven	NUM
ajmsi-505	44	60	sputum	sputum	NOUN
ajmsi-505	44	61	samples	sample	NOUN
ajmsi-505	44	62	were	be	AUX
ajmsi-505	44	63	collected	collect	VERB
ajmsi-505	44	64	from	from	ADP
ajmsi-505	44	65	federal	federal	ADJ
ajmsi-505	44	66	medical	medical	ADJ
ajmsi-505	44	67	centre	centre	NOUN
ajmsi-505	44	68	(	(	PUNCT
ajmsi-505	45	1	fmc)/apin	fmc)/apin	NOUN
ajmsi-505	45	2	laboratory	laboratory	NOUN
ajmsi-505	45	3	,	,	PUNCT
ajmsi-505	45	4	in	in	ADP
ajmsi-505	45	5	makurdi	makurdi	PROPN
ajmsi-505	45	6	benue	benue	PROPN
ajmsi-505	45	7	state	state	NOUN
ajmsi-505	45	8	.	.	PUNCT
ajmsi-505	46	1	between	between	SCONJ
ajmsi-505	46	2	three	three	NUM
ajmsi-505	46	3	to	to	PART
ajmsi-505	46	4	ten	ten	NUM
ajmsi-505	46	5	millilitres	millilitre	NOUN
ajmsi-505	46	6	of	of	ADP
ajmsi-505	46	7	sputum	sputum	NOUN
ajmsi-505	46	8	samples	sample	NOUN
ajmsi-505	46	9	were	be	AUX
ajmsi-505	46	10	collected	collect	VERB
ajmsi-505	46	11	in	in	ADP
ajmsi-505	46	12	cotylpyridinium	cotylpyridinium	NOUN
ajmsi-505	46	13	chloride	chloride	NOUN
ajmsi-505	46	14	(	(	PUNCT
ajmsi-505	46	15	bromide	bromide	NOUN
ajmsi-505	46	16	)	)	PUNCT
ajmsi-505	46	17	containing	contain	VERB
ajmsi-505	46	18	universal	universal	ADJ
ajmsi-505	46	19	bottles	bottle	NOUN
ajmsi-505	46	20	,	,	PUNCT
ajmsi-505	46	21	and	and	CCONJ
ajmsi-505	46	22	immediately	immediately	ADV
ajmsi-505	46	23	refrigerated	refrigerate	VERB
ajmsi-505	46	24	at	at	ADP
ajmsi-505	46	25	2	2	NUM
ajmsi-505	46	26	-	-	SYM
ajmsi-505	46	27	8	8	NUM
ajmsi-505	46	28	°	°	NOUN
ajmsi-505	46	29	c	c	NOUN
ajmsi-505	46	30	.	.	PUNCT
ajmsi-505	47	1	patients	patient	NOUN
ajmsi-505	47	2	who	who	PRON
ajmsi-505	47	3	test	test	VERB
ajmsi-505	47	4	positive	positive	ADJ
ajmsi-505	47	5	for	for	ADP
ajmsi-505	47	6	acid	acid	NOUN
ajmsi-505	47	7	fast	fast	ADJ
ajmsi-505	47	8	bacilli	bacilli	NOUN
ajmsi-505	47	9	(	(	PUNCT
ajmsi-505	47	10	afb	afb	PROPN
ajmsi-505	47	11	)	)	PUNCT
ajmsi-505	47	12	after	after	ADP
ajmsi-505	47	13	two	two	NUM
ajmsi-505	47	14	months	month	NOUN
ajmsi-505	47	15	of	of	ADP
ajmsi-505	47	16	intensive	intensive	ADJ
ajmsi-505	47	17	phase	phase	NOUN
ajmsi-505	47	18	tb	tb	ADP
ajmsi-505	47	19	dots	dot	NOUN
ajmsi-505	47	20	therapy	therapy	NOUN
ajmsi-505	47	21	(	(	PUNCT
ajmsi-505	47	22	suspected	suspect	VERB
ajmsi-505	47	23	rifampicin	rifampicin	VERB
ajmsi-505	47	24	resistance	resistance	NOUN
ajmsi-505	47	25	)	)	PUNCT
ajmsi-505	47	26	was	be	AUX
ajmsi-505	47	27	enrollment	enrollment	NOUN
ajmsi-505	47	28	criteria	criterion	NOUN
ajmsi-505	47	29	.	.	PUNCT
ajmsi-505	48	1	demographic	demographic	ADJ
ajmsi-505	48	2	information	information	NOUN
ajmsi-505	48	3	of	of	ADP
ajmsi-505	48	4	subjects	subject	NOUN
ajmsi-505	48	5	was	be	AUX
ajmsi-505	48	6	obtained	obtain	VERB
ajmsi-505	48	7	from	from	ADP
ajmsi-505	48	8	medical	medical	ADJ
ajmsi-505	48	9	records	record	NOUN
ajmsi-505	48	10	.	.	PUNCT
ajmsi-505	49	1	data	datum	NOUN
ajmsi-505	49	2	was	be	AUX
ajmsi-505	49	3	collected	collect	VERB
ajmsi-505	49	4	all	all	DET
ajmsi-505	49	5	age	age	NOUN
ajmsi-505	49	6	groups	group	NOUN
ajmsi-505	49	7	.	.	PUNCT
ajmsi-505	50	1	the	the	DET
ajmsi-505	50	2	study	study	NOUN
ajmsi-505	50	3	design	design	NOUN
ajmsi-505	50	4	was	be	AUX
ajmsi-505	50	5	approved	approve	VERB
ajmsi-505	50	6	by	by	ADP
ajmsi-505	50	7	research	research	NOUN
ajmsi-505	50	8	and	and	CCONJ
ajmsi-505	50	9	ethics	ethic	NOUN
ajmsi-505	50	10	committee	committee	NOUN
ajmsi-505	50	11	,	,	PUNCT
ajmsi-505	50	12	benue	benue	VERB
ajmsi-505	50	13	state	state	PROPN
ajmsi-505	50	14	ministry	ministry	PROPN
ajmsi-505	50	15	of	of	ADP
ajmsi-505	50	16	health	health	PROPN
ajmsi-505	50	17	.	.	PUNCT
ajmsi-505	51	1	out	out	ADP
ajmsi-505	51	2	of	of	ADP
ajmsi-505	51	3	380	380	NUM
ajmsi-505	51	4	sputum	sputum	NOUN
ajmsi-505	51	5	samples	sample	NOUN
ajmsi-505	51	6	analysed	analyse	VERB
ajmsi-505	51	7	,	,	PUNCT
ajmsi-505	51	8	130	130	NUM
ajmsi-505	51	9	(	(	PUNCT
ajmsi-505	51	10	34.2	34.2	NUM
ajmsi-505	51	11	%	%	NOUN
ajmsi-505	51	12	)	)	PUNCT
ajmsi-505	51	13	were	be	AUX
ajmsi-505	51	14	from	from	ADP
ajmsi-505	51	15	tb	tb	ADP
ajmsi-505	51	16	patients	patient	NOUN
ajmsi-505	51	17	co	co	VERB
ajmsi-505	51	18	-	-	VERB
ajmsi-505	51	19	infected	infected	ADJ
ajmsi-505	51	20	with	with	ADP
ajmsi-505	51	21	hiv	hiv	PROPN
ajmsi-505	51	22	,	,	PUNCT
ajmsi-505	51	23	and	and	CCONJ
ajmsi-505	51	24	who	who	PRON
ajmsi-505	51	25	were	be	AUX
ajmsi-505	51	26	positive	positive	ADJ
ajmsi-505	51	27	for	for	ADP
ajmsi-505	51	28	afb	afb	NOUN
ajmsi-505	51	29	after	after	ADP
ajmsi-505	51	30	more	more	ADJ
ajmsi-505	51	31	than	than	ADP
ajmsi-505	51	32	two	two	NUM
ajmsi-505	51	33	months	month	NOUN
ajmsi-505	51	34	’	'	PUNCT
ajmsi-505	51	35	intensive	intensive	ADJ
ajmsi-505	51	36	phase	phase	NOUN
ajmsi-505	51	37	of	of	ADP
ajmsi-505	51	38	tb	tb	ADP
ajmsi-505	51	39	dots	dot	NOUN
ajmsi-505	51	40	therapy	therapy	NOUN
ajmsi-505	51	41	(	(	PUNCT
ajmsi-505	51	42	category	category	NOUN
ajmsi-505	51	43	i	i	PRON
ajmsi-505	51	44	patients	patient	NOUN
ajmsi-505	51	45	)	)	PUNCT
ajmsi-505	51	46	.	.	PUNCT
ajmsi-505	52	1	another	another	DET
ajmsi-505	52	2	130	130	NUM
ajmsi-505	52	3	(	(	PUNCT
ajmsi-505	52	4	34.2	34.2	NUM
ajmsi-505	52	5	%	%	NOUN
ajmsi-505	52	6	)	)	PUNCT
ajmsi-505	52	7	were	be	AUX
ajmsi-505	52	8	from	from	ADP
ajmsi-505	52	9	hiv	hiv	PROPN
ajmsi-505	52	10	negative	negative	ADJ
ajmsi-505	52	11	tb	tb	ADP
ajmsi-505	52	12	patients	patient	NOUN
ajmsi-505	52	13	who	who	PRON
ajmsi-505	52	14	were	be	AUX
ajmsi-505	52	15	positive	positive	ADJ
ajmsi-505	52	16	for	for	ADP
ajmsi-505	52	17	afb	afb	NOUN
ajmsi-505	52	18	after	after	ADP
ajmsi-505	52	19	more	more	ADJ
ajmsi-505	52	20	than	than	ADP
ajmsi-505	52	21	two	two	NUM
ajmsi-505	52	22	months	month	NOUN
ajmsi-505	52	23	of	of	ADP
ajmsi-505	52	24	intensive	intensive	ADJ
ajmsi-505	52	25	tb	tb	ADP
ajmsi-505	52	26	dots	dot	NOUN
ajmsi-505	52	27	therapy	therapy	NOUN
ajmsi-505	52	28	(	(	PUNCT
ajmsi-505	52	29	category	category	NOUN
ajmsi-505	52	30	ii	ii	NOUN
ajmsi-505	52	31	patients	patient	NOUN
ajmsi-505	52	32	)	)	PUNCT
ajmsi-505	52	33	,	,	PUNCT
ajmsi-505	52	34	while	while	SCONJ
ajmsi-505	52	35	120	120	NUM
ajmsi-505	52	36	(	(	PUNCT
ajmsi-505	52	37	31.6	31.6	NUM
ajmsi-505	52	38	%	%	NOUN
ajmsi-505	52	39	)	)	PUNCT
ajmsi-505	52	40	sputum	sputum	NOUN
ajmsi-505	52	41	samples	sample	NOUN
ajmsi-505	52	42	were	be	AUX
ajmsi-505	52	43	collected	collect	VERB
ajmsi-505	52	44	from	from	ADP
ajmsi-505	52	45	hiv	hiv	PROPN
ajmsi-505	52	46	negative	negative	ADJ
ajmsi-505	52	47	tb	tb	ADP
ajmsi-505	52	48	patients	patient	NOUN
ajmsi-505	52	49	who	who	PRON
ajmsi-505	52	50	yet	yet	ADV
ajmsi-505	52	51	to	to	PART
ajmsi-505	52	52	commence	commence	VERB
ajmsi-505	52	53	tb	tb	ADP
ajmsi-505	52	54	dots	dot	NOUN
ajmsi-505	52	55	therapy	therapy	NOUN
ajmsi-505	52	56	(	(	PUNCT
ajmsi-505	52	57	treatment	treatment	NOUN
ajmsi-505	52	58	naïve)-category	naïve)-category	PROPN
ajmsi-505	52	59	iii	iii	NUM
ajmsi-505	52	60	patients	patient	NOUN
ajmsi-505	52	61	)	)	PUNCT
ajmsi-505	52	62	.	.	PUNCT
ajmsi-505	53	1	detection	detection	NOUN
ajmsi-505	53	2	of	of	ADP
ajmsi-505	53	3	rifampicin	rifampicin	VERB
ajmsi-505	53	4	resistance	resistance	NOUN
ajmsi-505	53	5	was	be	AUX
ajmsi-505	53	6	by	by	ADP
ajmsi-505	53	7	genexpert	genexpert	ADJ
ajmsi-505	53	8	technology	technology	NOUN
ajmsi-505	53	9	.	.	PUNCT
ajmsi-505	54	1	all	all	DET
ajmsi-505	54	2	sputum	sputum	NOUN
ajmsi-505	54	3	samples	sample	NOUN
ajmsi-505	54	4	were	be	AUX
ajmsi-505	54	5	plated	plate	VERB
ajmsi-505	54	6	on	on	ADP
ajmsi-505	54	7	lowenstein	lowenstein	PROPN
ajmsi-505	54	8	-	-	PUNCT
ajmsi-505	54	9	jensen	jensen	PROPN
ajmsi-505	54	10	(	(	PUNCT
ajmsi-505	54	11	lj	lj	PROPN
ajmsi-505	54	12	)	)	PUNCT
ajmsi-505	54	13	medium	medium	NOUN
ajmsi-505	54	14	for	for	ADP
ajmsi-505	54	15	pure	pure	ADJ
ajmsi-505	54	16	cultures	culture	NOUN
ajmsi-505	54	17	of	of	ADP
ajmsi-505	54	18	m.	m.	NOUN
ajmsi-505	54	19	tuberculosis	tuberculosis	NOUN
ajmsi-505	54	20	and	and	CCONJ
ajmsi-505	54	21	confirmed	confirm	VERB
ajmsi-505	54	22	by	by	ADP
ajmsi-505	54	23	biochemical	biochemical	ADJ
ajmsi-505	54	24	tests	test	NOUN
ajmsi-505	54	25	.	.	PUNCT
ajmsi-505	55	1	pure	pure	ADJ
ajmsi-505	55	2	cultures	culture	NOUN
ajmsi-505	55	3	of	of	ADP
ajmsi-505	55	4	m.	m.	NOUN
ajmsi-505	55	5	tuberculosis	tuberculosi	NOUN
ajmsi-505	55	6	were	be	AUX
ajmsi-505	55	7	preserved	preserve	VERB
ajmsi-505	55	8	by	by	ADP
ajmsi-505	55	9	refrigeration	refrigeration	NOUN
ajmsi-505	55	10	as	as	ADP
ajmsi-505	55	11	stock	stock	NOUN
ajmsi-505	55	12	cultures	culture	NOUN
ajmsi-505	55	13	at	at	ADP
ajmsi-505	55	14	-20	-20	PROPN
ajmsi-505	55	15	°	°	ADP
ajmsi-505	55	16	c	c	NOUN
ajmsi-505	55	17	(	(	PUNCT
ajmsi-505	55	18	david	david	PROPN
ajmsi-505	55	19	,	,	PUNCT
ajmsi-505	55	20	1970	1970	NUM
ajmsi-505	55	21	)	)	PUNCT
ajmsi-505	55	22	.	.	PUNCT
ajmsi-505	56	1	anti	anti	ADJ
ajmsi-505	56	2	-	-	ADJ
ajmsi-505	56	3	tb	tb	ADJ
ajmsi-505	56	4	drugs	drug	NOUN
ajmsi-505	56	5	susceptibility	susceptibility	NOUN
ajmsi-505	56	6	testing	testing	NOUN
ajmsi-505	56	7	(	(	PUNCT
ajmsi-505	56	8	dst	dst	NOUN
ajmsi-505	56	9	)	)	PUNCT
ajmsi-505	56	10	of	of	ADP
ajmsi-505	56	11	m.	m.	NOUN
ajmsi-505	56	12	tuberculosis	tuberculosis	NOUN
ajmsi-505	56	13	isolates	isolate	NOUN
ajmsi-505	56	14	was	be	AUX
ajmsi-505	56	15	carried	carry	VERB
ajmsi-505	56	16	out	out	ADP
ajmsi-505	56	17	using	use	VERB
ajmsi-505	56	18	the	the	DET
ajmsi-505	56	19	proportion	proportion	NOUN
ajmsi-505	56	20	method	method	NOUN
ajmsi-505	56	21	on	on	ADP
ajmsi-505	56	22	bactec	bactec	ADJ
ajmsi-505	56	23	mgit	mgit	NOUN
ajmsi-505	56	24	960	960	NUM
ajmsi-505	56	25	tb	tb	ADP
ajmsi-505	56	26	system	system	NOUN
ajmsi-505	56	27	(	(	PUNCT
ajmsi-505	56	28	becton	becton	NOUN
ajmsi-505	56	29	and	and	CCONJ
ajmsi-505	56	30	dickinson	dickinson	PROPN
ajmsi-505	56	31	,	,	PUNCT
ajmsi-505	56	32	new	new	PROPN
ajmsi-505	56	33	jersey	jersey	PROPN
ajmsi-505	56	34	usa	usa	PROPN
ajmsi-505	56	35	)	)	PUNCT
ajmsi-505	56	36	.	.	PUNCT
ajmsi-505	57	1	stock	stock	NOUN
ajmsi-505	57	2	cultures	culture	NOUN
ajmsi-505	57	3	of	of	ADP
ajmsi-505	57	4	human	human	PROPN
ajmsi-505	57	5	t	t	PROPN
ajmsi-505	57	6	-	-	PUNCT
ajmsi-505	57	7	cell	cell	NOUN
ajmsi-505	57	8	lymphotrophic	lymphotrophic	NOUN
ajmsi-505	57	9	virus-3	virus-3	PRON
ajmsi-505	57	10	(	(	PUNCT
ajmsi-505	57	11	htlv	htlv	PROPN
ajmsi-505	57	12	-	-	PUNCT
ajmsi-505	57	13	iii	iii	PROPN
ajmsi-505	57	14	)	)	PUNCT
ajmsi-505	57	15	polyclonal	polyclonal	ADJ
ajmsi-505	57	16	unconjugated	unconjugated	ADJ
ajmsi-505	57	17	preparation	preparation	NOUN
ajmsi-505	57	18	procured	procure	VERB
ajmsi-505	57	19	from	from	ADP
ajmsi-505	57	20	gentaur	gentaur	NOUN
ajmsi-505	57	21	molecular	molecular	ADJ
ajmsi-505	57	22	genway	genway	NOUN
ajmsi-505	57	23	products	product	NOUN
ajmsi-505	57	24	,	,	PUNCT
ajmsi-505	57	25	u.s.a	u.s.a	NOUN
ajmsi-505	57	26	,	,	PUNCT
ajmsi-505	57	27	were	be	AUX
ajmsi-505	57	28	used	use	VERB
ajmsi-505	57	29	as	as	ADP
ajmsi-505	57	30	specialized	specialized	ADJ
ajmsi-505	57	31	transducing	transducing	NOUN
ajmsi-505	57	32	phage	phage	NOUN
ajmsi-505	57	33	in	in	ADP
ajmsi-505	57	34	transduction	transduction	NOUN
ajmsi-505	57	35	protocols	protocol	NOUN
ajmsi-505	57	36	.	.	PUNCT
ajmsi-505	58	1	drugs	drug	NOUN
ajmsi-505	58	2	susceptibility	susceptibility	NOUN
ajmsi-505	58	3	testing	testing	NOUN
ajmsi-505	58	4	of	of	ADP
ajmsi-505	58	5	transductants	transductant	NOUN
ajmsi-505	58	6	was	be	AUX
ajmsi-505	58	7	also	also	ADV
ajmsi-505	58	8	carried	carry	VERB
ajmsi-505	58	9	out	out	ADP
ajmsi-505	58	10	by	by	ADP
ajmsi-505	58	11	proportion	proportion	NOUN
ajmsi-505	58	12	method	method	NOUN
ajmsi-505	58	13	on	on	ADP
ajmsi-505	58	14	bactec	bactec	ADJ
ajmsi-505	58	15	mgit	mgit	NOUN
ajmsi-505	58	16	960	960	NUM
ajmsi-505	58	17	tb	tb	ADP
ajmsi-505	58	18	system	system	NOUN
ajmsi-505	58	19	(	(	PUNCT
ajmsi-505	58	20	becton	becton	NOUN
ajmsi-505	58	21	and	and	CCONJ
ajmsi-505	58	22	dickinson	dickinson	PROPN
ajmsi-505	58	23	,	,	PUNCT
ajmsi-505	58	24	new	new	PROPN
ajmsi-505	58	25	jersey	jersey	PROPN
ajmsi-505	58	26	usa	usa	PROPN
ajmsi-505	58	27	)	)	PUNCT
ajmsi-505	58	28	.	.	PUNCT
ajmsi-505	59	1	all	all	DET
ajmsi-505	59	2	procedures	procedure	NOUN
ajmsi-505	59	3	were	be	AUX
ajmsi-505	59	4	carried	carry	VERB
ajmsi-505	59	5	out	out	ADP
ajmsi-505	59	6	at	at	ADP
ajmsi-505	59	7	biosafety	biosafety	NOUN
ajmsi-505	59	8	level	level	NOUN
ajmsi-505	59	9	two	two	NUM
ajmsi-505	59	10	(	(	PUNCT
ajmsi-505	59	11	bsl-11	bsl-11	NOUN
ajmsi-505	59	12	)	)	PUNCT
ajmsi-505	59	13	.	.	PUNCT
ajmsi-505	60	1	genexpertgenexpert	genexpertgenexpert	ADJ
ajmsi-505	60	2	procedure	procedure	NOUN
ajmsi-505	60	3	xpert	xpert	PROPN
ajmsi-505	60	4	mtb	mtb	PROPN
ajmsi-505	60	5	-	-	PUNCT
ajmsi-505	60	6	rif	rif	PROPN
ajmsi-505	60	7	assay	assay	PROPN
ajmsi-505	60	8	g4	g4	NOUN
ajmsi-505	60	9	version	version	NOUN
ajmsi-505	60	10	5	5	NUM
ajmsi-505	60	11	(	(	PUNCT
ajmsi-505	60	12	cepheid	cepheid	PROPN
ajmsi-505	60	13	,	,	PUNCT
ajmsi-505	60	14	usa	usa	PROPN
ajmsi-505	60	15	)	)	PUNCT
ajmsi-505	60	16	was	be	AUX
ajmsi-505	60	17	used	use	VERB
ajmsi-505	60	18	.	.	PUNCT
ajmsi-505	61	1	briefly	briefly	ADV
ajmsi-505	61	2	,	,	PUNCT
ajmsi-505	61	3	2.0	2.0	NUM
ajmsi-505	61	4	ml	ml	NOUN
ajmsi-505	61	5	of	of	ADP
ajmsi-505	61	6	sputum	sputum	PROPN
ajmsi-505	61	7	sample	sample	NOUN
ajmsi-505	61	8	was	be	AUX
ajmsi-505	61	9	added	add	VERB
ajmsi-505	61	10	into	into	ADP
ajmsi-505	61	11	4.0	4.0	NUM
ajmsi-505	61	12	ml	ml	NOUN
ajmsi-505	61	13	of	of	ADP
ajmsi-505	61	14	xpert	xpert	PROPN
ajmsi-505	61	15	reagent	reagent	NOUN
ajmsi-505	61	16	in	in	ADP
ajmsi-505	61	17	a	a	DET
ajmsi-505	61	18	ratio	ratio	NOUN
ajmsi-505	61	19	of	of	ADP
ajmsi-505	61	20	1:2	1:2	NUM
ajmsi-505	61	21	.	.	PUNCT
ajmsi-505	62	1	the	the	DET
ajmsi-505	62	2	closed	closed	ADJ
ajmsi-505	62	3	specimen	speciman	NOUN
ajmsi-505	62	4	was	be	AUX
ajmsi-505	62	5	manually	manually	ADV
ajmsi-505	62	6	agitated	agitated	ADJ
ajmsi-505	62	7	twenty	twenty	NUM
ajmsi-505	62	8	times	time	NOUN
ajmsi-505	62	9	and	and	CCONJ
ajmsi-505	62	10	incubated	incubate	VERB
ajmsi-505	62	11	at	at	ADP
ajmsi-505	62	12	room	room	NOUN
ajmsi-505	62	13	temperature	temperature	NOUN
ajmsi-505	62	14	(	(	PUNCT
ajmsi-505	62	15	20	20	NUM
ajmsi-505	62	16	-	-	SYM
ajmsi-505	62	17	25	25	NUM
ajmsi-505	62	18	°	°	PROPN
ajmsi-505	62	19	c	c	NOUN
ajmsi-505	62	20	)	)	PUNCT
ajmsi-505	62	21	for	for	ADP
ajmsi-505	62	22	15	15	NUM
ajmsi-505	62	23	minutes	minute	NOUN
ajmsi-505	62	24	.	.	PUNCT
ajmsi-505	63	1	two	two	NUM
ajmsi-505	63	2	millilitres	millilitre	NOUN
ajmsi-505	63	3	of	of	ADP
ajmsi-505	63	4	the	the	DET
ajmsi-505	63	5	reagent	reagent	ADJ
ajmsi-505	63	6	-	-	PUNCT
ajmsi-505	63	7	sample	sample	NOUN
ajmsi-505	63	8	mixture	mixture	NOUN
ajmsi-505	63	9	was	be	AUX
ajmsi-505	63	10	transferred	transfer	VERB
ajmsi-505	63	11	to	to	ADP
ajmsi-505	63	12	xpert	xpert	PROPN
ajmsi-505	63	13	test	test	NOUN
ajmsi-505	63	14	cartridges	cartridge	NOUN
ajmsi-505	63	15	and	and	CCONJ
ajmsi-505	63	16	inserted	insert	VERB
ajmsi-505	63	17	into	into	ADP
ajmsi-505	63	18	the	the	DET
ajmsi-505	63	19	xpert	xpert	PROPN
ajmsi-505	63	20	device	device	NOUN
ajmsi-505	63	21	.	.	PUNCT
ajmsi-505	64	1	results	result	NOUN
ajmsi-505	64	2	(	(	PUNCT
ajmsi-505	64	3	for	for	ADP
ajmsi-505	64	4	m.	m.	NOUN
ajmsi-505	64	5	tb	tb	ADP
ajmsi-505	64	6	either	either	CCONJ
ajmsi-505	64	7	detected	detect	VERB
ajmsi-505	64	8	or	or	CCONJ
ajmsi-505	64	9	not	not	PART
ajmsi-505	64	10	,	,	PUNCT
ajmsi-505	64	11	and	and	CCONJ
ajmsi-505	64	12	with	with	ADP
ajmsi-505	64	13	or	or	CCONJ
ajmsi-505	64	14	without	without	ADP
ajmsi-505	64	15	rifampicin	rifampicin	VERB
ajmsi-505	64	16	resistance	resistance	NOUN
ajmsi-505	64	17	)	)	PUNCT
ajmsi-505	64	18	were	be	AUX
ajmsi-505	64	19	obtained	obtain	VERB
ajmsi-505	64	20	in	in	ADP
ajmsi-505	64	21	exactly	exactly	ADV
ajmsi-505	64	22	110	110	NUM
ajmsi-505	64	23	minutes	minute	NOUN
ajmsi-505	64	24	(	(	PUNCT
ajmsi-505	64	25	cepheid	cepheid	NOUN
ajmsi-505	64	26	,	,	PUNCT
ajmsi-505	64	27	2014	2014	NUM
ajmsi-505	64	28	)	)	PUNCT
ajmsi-505	64	29	.	.	PUNCT
ajmsi-505	65	1	processing	processing	NOUN
ajmsi-505	65	2	of	of	ADP
ajmsi-505	65	3	sputum	sputum	NOUN
ajmsi-505	65	4	for	for	ADP
ajmsi-505	65	5	m.	m.	NOUN
ajmsi-505	65	6	tuberculosis	tuberculosis	NOUN
ajmsi-505	65	7	culture	culture	NOUN
ajmsi-505	65	8	modified	modify	VERB
ajmsi-505	65	9	petroff	petroff	NOUN
ajmsi-505	65	10	’s	’s	PART
ajmsi-505	65	11	method	method	NOUN
ajmsi-505	65	12	2012	2012	NUM
ajmsi-505	65	13	for	for	ADP
ajmsi-505	65	14	culture	culture	NOUN
ajmsi-505	65	15	of	of	ADP
ajmsi-505	65	16	m.	m.	NOUN
ajmsi-505	65	17	tuberculosis	tuberculosis	NOUN
ajmsi-505	65	18	was	be	AUX
ajmsi-505	65	19	used	use	VERB
ajmsi-505	65	20	.	.	PUNCT
ajmsi-505	66	1	between	between	SCONJ
ajmsi-505	66	2	3	3	NUM
ajmsi-505	66	3	-	-	SYM
ajmsi-505	66	4	5	5	NUM
ajmsi-505	66	5	ml	ml	NOUN
ajmsi-505	66	6	sputum	sputum	PROPN
ajmsi-505	66	7	was	be	AUX
ajmsi-505	66	8	homogenized	homogenize	VERB
ajmsi-505	66	9	in	in	ADP
ajmsi-505	66	10	a	a	DET
ajmsi-505	66	11	shaker	shaker	NOUN
ajmsi-505	66	12	using	use	VERB
ajmsi-505	66	13	an	an	DET
ajmsi-505	66	14	equal	equal	ADJ
ajmsi-505	66	15	volume	volume	NOUN
ajmsi-505	66	16	of	of	ADP
ajmsi-505	66	17	4	4	NUM
ajmsi-505	66	18	%	%	NOUN
ajmsi-505	66	19	naoh	naoh	NOUN
ajmsi-505	66	20	and	and	CCONJ
ajmsi-505	66	21	centrifuged	centrifuge	VERB
ajmsi-505	66	22	at	at	ADP
ajmsi-505	66	23	3000rpm	3000rpm	NUM
ajmsi-505	66	24	for	for	ADP
ajmsi-505	66	25	15	15	NUM
ajmsi-505	66	26	minutes	minute	NOUN
ajmsi-505	66	27	.	.	PUNCT
ajmsi-505	67	1	then	then	ADV
ajmsi-505	67	2	0.067	0.067	NUM
ajmsi-505	67	3	m	m	NOUN
ajmsi-505	67	4	phosphate	phosphate	ADJ
ajmsi-505	67	5	buffer	buffer	NOUN
ajmsi-505	67	6	(	(	PUNCT
ajmsi-505	67	7	ph	ph	NOUN
ajmsi-505	67	8	6.8	6.8	NUM
ajmsi-505	67	9	)	)	PUNCT
ajmsi-505	67	10	was	be	AUX
ajmsi-505	67	11	added	add	VERB
ajmsi-505	67	12	to	to	ADP
ajmsi-505	67	13	the	the	DET
ajmsi-505	67	14	digested	digested	ADV
ajmsi-505	67	15	-	-	PUNCT
ajmsi-505	67	16	decontaminated	decontaminate	VERB
ajmsi-505	67	17	sample	sample	NOUN
ajmsi-505	67	18	(	(	PUNCT
ajmsi-505	67	19	deposit	deposit	NOUN
ajmsi-505	67	20	)	)	PUNCT
ajmsi-505	67	21	up	up	ADP
ajmsi-505	67	22	to	to	ADP
ajmsi-505	67	23	the	the	DET
ajmsi-505	67	24	45.0ml	45.0ml	PROPN
ajmsi-505	67	25	mark	mark	NOUN
ajmsi-505	67	26	to	to	PART
ajmsi-505	67	27	reduce	reduce	VERB
ajmsi-505	67	28	the	the	DET
ajmsi-505	67	29	continued	continue	VERB
ajmsi-505	67	30	action	action	NOUN
ajmsi-505	67	31	of	of	ADP
ajmsi-505	67	32	naoh	naoh	NOUN
ajmsi-505	67	33	,	,	PUNCT
ajmsi-505	67	34	while	while	SCONJ
ajmsi-505	67	35	the	the	DET
ajmsi-505	67	36	sediment	sediment	NOUN
ajmsi-505	67	37	was	be	AUX
ajmsi-505	67	38	re	re	VERB
ajmsi-505	67	39	-	-	VERB
ajmsi-505	67	40	suspended	suspend	VERB
ajmsi-505	67	41	in	in	ADP
ajmsi-505	67	42	2.0ml	2.0ml	NUM
ajmsi-505	67	43	of	of	ADP
ajmsi-505	67	44	buffer	buffer	NOUN
ajmsi-505	67	45	.	.	PUNCT
ajmsi-505	68	1	the	the	DET
ajmsi-505	68	2	sediment	sediment	NOUN
ajmsi-505	68	3	was	be	AUX
ajmsi-505	68	4	now	now	ADV
ajmsi-505	68	5	ready	ready	ADJ
ajmsi-505	68	6	for	for	ADP
ajmsi-505	68	7	inoculation	inoculation	NOUN
ajmsi-505	68	8	unto	unto	ADP
ajmsi-505	68	9	lj	lj	ADJ
ajmsi-505	68	10	slants	slant	NOUN
ajmsi-505	68	11	,	,	PUNCT
ajmsi-505	68	12	or	or	CCONJ
ajmsi-505	68	13	refrigerated	refrigerate	VERB
ajmsi-505	68	14	at	at	ADP
ajmsi-505	68	15	28	28	NUM
ajmsi-505	68	16	°	°	ADP
ajmsi-505	68	17	c	c	NOUN
ajmsi-505	68	18	(	(	PUNCT
ajmsi-505	68	19	joshua	joshua	PROPN
ajmsi-505	68	20	et	et	PROPN
ajmsi-505	68	21	al	al	PROPN
ajmsi-505	68	22	.	.	PROPN
ajmsi-505	68	23	,	,	PUNCT
ajmsi-505	68	24	2013	2013	NUM
ajmsi-505	68	25	)	)	PUNCT
ajmsi-505	68	26	.	.	PUNCT
ajmsi-505	69	1	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	69	2	pa	pa	PROPN
ajmsi-505	69	3	ge	ge	PROPN
ajmsi-505	69	4	3	3	NUM
ajmsi-505	69	5	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	69	6	am	be	AUX
ajmsi-505	69	7	.	.	PUNCT
ajmsi-505	70	1	j.	j.	PROPN
ajmsi-505	70	2	med	med	PROPN
ajmsi-505	70	3	.	.	PUNCT
ajmsi-505	71	1	sci	sci	PROPN
ajmsi-505	71	2	.	.	PUNCT
ajmsi-505	71	3	innov	innov	PROPN
ajmsi-505	71	4	.	.	PUNCT
ajmsi-505	72	1	1(1	1(1	NUM
ajmsi-505	72	2	)	)	PUNCT
ajmsi-505	72	3	1	1	NUM
ajmsi-505	72	4	-	-	SYM
ajmsi-505	72	5	9	9	NUM
ajmsi-505	72	6	,	,	PUNCT
ajmsi-505	72	7	2022	2022	NUM
ajmsi-505	72	8	culture	culture	NOUN
ajmsi-505	72	9	of	of	ADP
ajmsi-505	72	10	processed	process	VERB
ajmsi-505	72	11	sputum	sputum	NOUN
ajmsi-505	72	12	sample	sample	NOUN
ajmsi-505	72	13	for	for	ADP
ajmsi-505	72	14	m.	m.	NOUN
ajmsi-505	72	15	tuberculosis	tuberculosis	ADP
ajmsi-505	72	16	lowenstein	lowenstein	PROPN
ajmsi-505	72	17	-	-	PUNCT
ajmsi-505	72	18	jensen	jensen	PROPN
ajmsi-505	72	19	medium	medium	PROPN
ajmsi-505	72	20	(	(	PUNCT
ajmsi-505	72	21	oxoid	oxoid	PROPN
ajmsi-505	72	22	biologicals	biological	NOUN
ajmsi-505	72	23	,	,	PUNCT
ajmsi-505	72	24	canada	canada	PROPN
ajmsi-505	72	25	)	)	PUNCT
ajmsi-505	72	26	was	be	AUX
ajmsi-505	72	27	used	use	VERB
ajmsi-505	72	28	.	.	PUNCT
ajmsi-505	73	1	lowenstein	lowenstein	PROPN
ajmsi-505	73	2	-	-	PUNCT
ajmsi-505	73	3	jensen	jensen	PROPN
ajmsi-505	73	4	slants	slant	NOUN
ajmsi-505	73	5	(	(	PUNCT
ajmsi-505	73	6	egg	egg	NOUN
ajmsi-505	73	7	based	base	VERB
ajmsi-505	73	8	)	)	PUNCT
ajmsi-505	73	9	were	be	AUX
ajmsi-505	73	10	prepared	prepare	VERB
ajmsi-505	73	11	according	accord	VERB
ajmsi-505	73	12	to	to	ADP
ajmsi-505	73	13	manufacturer	manufacturer	NOUN
ajmsi-505	73	14	’s	’s	PART
ajmsi-505	73	15	instructions	instruction	NOUN
ajmsi-505	73	16	and	and	CCONJ
ajmsi-505	73	17	stored	store	VERB
ajmsi-505	73	18	at	at	ADP
ajmsi-505	73	19	2	2	NUM
ajmsi-505	73	20	-	-	SYM
ajmsi-505	73	21	8	8	NUM
ajmsi-505	73	22	°	°	ADP
ajmsi-505	73	23	c	c	NOUN
ajmsi-505	73	24	in	in	ADP
ajmsi-505	73	25	the	the	DET
ajmsi-505	73	26	dark	dark	NOUN
ajmsi-505	73	27	.	.	PUNCT
ajmsi-505	74	1	three	three	NUM
ajmsi-505	74	2	drops	drop	NOUN
ajmsi-505	74	3	of	of	ADP
ajmsi-505	74	4	processed	process	VERB
ajmsi-505	74	5	sputum	sputum	NOUN
ajmsi-505	74	6	sediment	sediment	NOUN
ajmsi-505	74	7	were	be	AUX
ajmsi-505	74	8	added	add	VERB
ajmsi-505	74	9	to	to	ADP
ajmsi-505	74	10	each	each	DET
ajmsi-505	74	11	lowensteinjensen	lowensteinjensen	ADJ
ajmsi-505	74	12	tube	tube	NOUN
ajmsi-505	74	13	using	use	VERB
ajmsi-505	74	14	a	a	DET
ajmsi-505	74	15	sterile	sterile	ADJ
ajmsi-505	74	16	plastic	plastic	NOUN
ajmsi-505	74	17	pipette	pipette	NOUN
ajmsi-505	74	18	.	.	PUNCT
ajmsi-505	75	1	the	the	DET
ajmsi-505	75	2	inoculum	inoculum	NOUN
ajmsi-505	75	3	was	be	AUX
ajmsi-505	75	4	spread	spread	VERB
ajmsi-505	75	5	over	over	ADP
ajmsi-505	75	6	the	the	DET
ajmsi-505	75	7	surface	surface	NOUN
ajmsi-505	75	8	of	of	ADP
ajmsi-505	75	9	the	the	DET
ajmsi-505	75	10	slant	slant	NOUN
ajmsi-505	75	11	by	by	ADP
ajmsi-505	75	12	gently	gently	ADV
ajmsi-505	75	13	rolling	roll	VERB
ajmsi-505	75	14	the	the	DET
ajmsi-505	75	15	liquid	liquid	NOUN
ajmsi-505	75	16	over	over	ADP
ajmsi-505	75	17	the	the	DET
ajmsi-505	75	18	slant	slant	NOUN
ajmsi-505	75	19	and	and	CCONJ
ajmsi-505	75	20	incubated	incubate	VERB
ajmsi-505	75	21	at	at	ADP
ajmsi-505	75	22	3537	3537	NUM
ajmsi-505	75	23	°	°	NOUN
ajmsi-505	75	24	/7	/7	NUM
ajmsi-505	75	25	days	day	NOUN
ajmsi-505	75	26	in	in	ADP
ajmsi-505	75	27	a	a	DET
ajmsi-505	75	28	slanted	slanted	ADJ
ajmsi-505	75	29	position	position	NOUN
ajmsi-505	75	30	with	with	ADP
ajmsi-505	75	31	loose	loose	ADJ
ajmsi-505	75	32	screw	screw	NOUN
ajmsi-505	75	33	for	for	ADP
ajmsi-505	75	34	even	even	ADJ
ajmsi-505	75	35	distribution	distribution	NOUN
ajmsi-505	75	36	and	and	CCONJ
ajmsi-505	75	37	adsorption	adsorption	NOUN
ajmsi-505	75	38	of	of	ADP
ajmsi-505	75	39	inoculum	inoculum	NOUN
ajmsi-505	75	40	.	.	PUNCT
ajmsi-505	76	1	after	after	ADP
ajmsi-505	76	2	one	one	NUM
ajmsi-505	76	3	week	week	NOUN
ajmsi-505	76	4	,	,	PUNCT
ajmsi-505	76	5	inoculated	inoculate	VERB
ajmsi-505	76	6	slants	slant	NOUN
ajmsi-505	76	7	were	be	AUX
ajmsi-505	76	8	incubated	incubate	VERB
ajmsi-505	76	9	at	at	ADP
ajmsi-505	76	10	35	35	NUM
ajmsi-505	76	11	-	-	SYM
ajmsi-505	76	12	37	37	NUM
ajmsi-505	76	13	°	°	NOUN
ajmsi-505	76	14	c	c	NOUN
ajmsi-505	76	15	,	,	PUNCT
ajmsi-505	76	16	and	and	CCONJ
ajmsi-505	76	17	examined	examine	VERB
ajmsi-505	76	18	respectively	respectively	ADV
ajmsi-505	76	19	at	at	ADP
ajmsi-505	76	20	three	three	NUM
ajmsi-505	76	21	and	and	CCONJ
ajmsi-505	76	22	seven	seven	NUM
ajmsi-505	76	23	days	day	NOUN
ajmsi-505	76	24	of	of	ADP
ajmsi-505	76	25	incubation	incubation	NOUN
ajmsi-505	76	26	to	to	PART
ajmsi-505	76	27	allow	allow	VERB
ajmsi-505	76	28	early	early	ADJ
ajmsi-505	76	29	detection	detection	NOUN
ajmsi-505	76	30	of	of	ADP
ajmsi-505	76	31	contaminants	contaminant	NOUN
ajmsi-505	76	32	(	(	PUNCT
ajmsi-505	76	33	or	or	CCONJ
ajmsi-505	76	34	rapidly	rapidly	ADV
ajmsi-505	76	35	growing	grow	VERB
ajmsi-505	76	36	mycobacteria	mycobacterium	NOUN
ajmsi-505	76	37	)	)	PUNCT
ajmsi-505	76	38	.	.	PUNCT
ajmsi-505	77	1	thereafter	thereafter	ADV
ajmsi-505	77	2	cultures	culture	NOUN
ajmsi-505	77	3	were	be	AUX
ajmsi-505	77	4	examined	examine	VERB
ajmsi-505	77	5	weekly	weekly	ADV
ajmsi-505	77	6	for	for	ADP
ajmsi-505	77	7	growth	growth	NOUN
ajmsi-505	77	8	of	of	ADP
ajmsi-505	77	9	m.	m.	NOUN
ajmsi-505	77	10	tuberculosis	tuberculosis	NOUN
ajmsi-505	77	11	.	.	PUNCT
ajmsi-505	78	1	negative	negative	ADJ
ajmsi-505	78	2	cultures	culture	NOUN
ajmsi-505	78	3	were	be	AUX
ajmsi-505	78	4	discarded	discard	VERB
ajmsi-505	78	5	after	after	ADP
ajmsi-505	78	6	8	8	NUM
ajmsi-505	78	7	weeks	week	NOUN
ajmsi-505	78	8	of	of	ADP
ajmsi-505	78	9	incubation	incubation	NOUN
ajmsi-505	78	10	.	.	PUNCT
ajmsi-505	79	1	pale	pale	ADJ
ajmsi-505	79	2	cream	cream	NOUN
ajmsi-505	79	3	colonies	colony	NOUN
ajmsi-505	79	4	which	which	PRON
ajmsi-505	79	5	were	be	AUX
ajmsi-505	79	6	granular	granular	ADJ
ajmsi-505	79	7	,	,	PUNCT
ajmsi-505	79	8	rough	rough	ADJ
ajmsi-505	79	9	or	or	CCONJ
ajmsi-505	79	10	dry	dry	ADJ
ajmsi-505	79	11	were	be	AUX
ajmsi-505	79	12	suggestive	suggestive	ADJ
ajmsi-505	79	13	of	of	ADP
ajmsi-505	79	14	m.	m.	NOUN
ajmsi-505	79	15	tuberculosis	tuberculosis	NOUN
ajmsi-505	79	16	.	.	PUNCT
ajmsi-505	80	1	ziehl	ziehl	PROPN
ajmsi-505	80	2	neelsen	neelsen	PROPN
ajmsi-505	80	3	(	(	PUNCT
ajmsi-505	80	4	zn	zn	NOUN
ajmsi-505	80	5	)	)	PUNCT
ajmsi-505	80	6	staining	stain	VERB
ajmsi-505	80	7	confirmed	confirm	VERB
ajmsi-505	80	8	growth	growth	NOUN
ajmsi-505	80	9	of	of	ADP
ajmsi-505	80	10	mycobacteria	mycobacterium	NOUN
ajmsi-505	80	11	.	.	PUNCT
ajmsi-505	81	1	growth	growth	NOUN
ajmsi-505	81	2	was	be	AUX
ajmsi-505	81	3	reported	report	VERB
ajmsi-505	81	4	as	as	ADP
ajmsi-505	81	5	none	none	NOUN
ajmsi-505	81	6	(	(	PUNCT
ajmsi-505	81	7	no	no	DET
ajmsi-505	81	8	visible	visible	ADJ
ajmsi-505	81	9	growth	growth	NOUN
ajmsi-505	81	10	)	)	PUNCT
ajmsi-505	81	11	,	,	PUNCT
ajmsi-505	81	12	contamination	contamination	NOUN
ajmsi-505	81	13	(	(	PUNCT
ajmsi-505	81	14	c	c	NOUN
ajmsi-505	81	15	)	)	PUNCT
ajmsi-505	81	16	,	,	PUNCT
ajmsi-505	81	17	<	<	X
ajmsi-505	81	18	50	50	NUM
ajmsi-505	81	19	colonies	colony	NOUN
ajmsi-505	81	20	(	(	PUNCT
ajmsi-505	81	21	actual	actual	ADJ
ajmsi-505	81	22	count	count	NOUN
ajmsi-505	81	23	)	)	PUNCT
ajmsi-505	81	24	,	,	PUNCT
ajmsi-505	81	25	50	50	NUM
ajmsi-505	81	26	-	-	SYM
ajmsi-505	81	27	100	100	NUM
ajmsi-505	81	28	colonies	colony	NOUN
ajmsi-505	81	29	(	(	PUNCT
ajmsi-505	81	30	1	1	NUM
ajmsi-505	81	31	+	+	NOUN
ajmsi-505	81	32	)	)	PUNCT
ajmsi-505	81	33	,	,	PUNCT
ajmsi-505	81	34	100200	100200	NUM
ajmsi-505	81	35	colonies	colony	NOUN
ajmsi-505	81	36	(	(	PUNCT
ajmsi-505	81	37	2	2	NUM
ajmsi-505	81	38	+	+	NOUN
ajmsi-505	81	39	)	)	PUNCT
ajmsi-505	81	40	>	>	PUNCT
ajmsi-505	81	41	200	200	NUM
ajmsi-505	81	42	colonies	colony	NOUN
ajmsi-505	81	43	(	(	PUNCT
ajmsi-505	81	44	3	3	NUM
ajmsi-505	81	45	+	+	NOUN
ajmsi-505	81	46	)	)	PUNCT
ajmsi-505	81	47	,	,	PUNCT
ajmsi-505	81	48	confluent	confluent	ADJ
ajmsi-505	81	49	growth	growth	NOUN
ajmsi-505	81	50	(	(	PUNCT
ajmsi-505	81	51	4	4	NUM
ajmsi-505	81	52	+	+	NOUN
ajmsi-505	81	53	)	)	PUNCT
ajmsi-505	81	54	(	(	PUNCT
ajmsi-505	81	55	joshua	joshua	PROPN
ajmsi-505	81	56	et	et	PROPN
ajmsi-505	81	57	al	al	PROPN
ajmsi-505	81	58	.	.	PROPN
ajmsi-505	81	59	,	,	PUNCT
ajmsi-505	81	60	2013	2013	NUM
ajmsi-505	81	61	)	)	PUNCT
ajmsi-505	81	62	.	.	PUNCT
ajmsi-505	82	1	conventional	conventional	ADJ
ajmsi-505	82	2	biochemical	biochemical	ADJ
ajmsi-505	82	3	tests	test	NOUN
ajmsi-505	82	4	such	such	ADJ
ajmsi-505	82	5	as	as	ADP
ajmsi-505	82	6	catalase	catalase	NOUN
ajmsi-505	82	7	test	test	NOUN
ajmsi-505	82	8	,	,	PUNCT
ajmsi-505	82	9	growth	growth	NOUN
ajmsi-505	82	10	on	on	ADP
ajmsi-505	82	11	p	p	ADJ
ajmsi-505	82	12	-	-	PUNCT
ajmsi-505	82	13	nitro	nitro	NOUN
ajmsi-505	82	14	benzoate	benzoate	NOUN
ajmsi-505	82	15	(	(	PUNCT
ajmsi-505	82	16	pnb	pnb	NOUN
ajmsi-505	82	17	)	)	PUNCT
ajmsi-505	82	18	,	,	PUNCT
ajmsi-505	82	19	and	and	CCONJ
ajmsi-505	82	20	nitrate	nitrate	NOUN
ajmsi-505	82	21	reduction	reduction	NOUN
ajmsi-505	82	22	were	be	AUX
ajmsi-505	82	23	used	use	VERB
ajmsi-505	82	24	to	to	PART
ajmsi-505	82	25	distinguish	distinguish	VERB
ajmsi-505	82	26	and	and	CCONJ
ajmsi-505	82	27	differentiate	differentiate	VERB
ajmsi-505	82	28	m.	m.	NOUN
ajmsi-505	82	29	tuberculosis	tuberculosis	NOUN
ajmsi-505	82	30	from	from	ADP
ajmsi-505	82	31	other	other	ADJ
ajmsi-505	82	32	mycobacteria	mycobacterium	NOUN
ajmsi-505	82	33	.	.	PUNCT
ajmsi-505	83	1	pure	pure	ADJ
ajmsi-505	83	2	cultures	culture	NOUN
ajmsi-505	83	3	of	of	ADP
ajmsi-505	83	4	m.	m.	NOUN
ajmsi-505	83	5	tuberculosis	tuberculosi	NOUN
ajmsi-505	83	6	were	be	AUX
ajmsi-505	83	7	inoculated	inoculate	VERB
ajmsi-505	83	8	on	on	ADP
ajmsi-505	83	9	lowensteinjensen	lowensteinjensen	ADJ
ajmsi-505	83	10	broth	broth	NOUN
ajmsi-505	83	11	and	and	CCONJ
ajmsi-505	83	12	preserved	preserve	VERB
ajmsi-505	83	13	as	as	ADP
ajmsi-505	83	14	stock	stock	NOUN
ajmsi-505	83	15	cultures	culture	NOUN
ajmsi-505	83	16	in	in	ADP
ajmsi-505	83	17	2ml	2ml	ADJ
ajmsi-505	83	18	cryovials	cryovial	NOUN
ajmsi-505	83	19	at	at	ADP
ajmsi-505	83	20	-20	-20	PROPN
ajmsi-505	83	21	°	°	ADP
ajmsi-505	83	22	c	c	NOUN
ajmsi-505	83	23	for	for	ADP
ajmsi-505	83	24	drugs	drug	NOUN
ajmsi-505	83	25	susceptibility	susceptibility	NOUN
ajmsi-505	83	26	testing	testing	NOUN
ajmsi-505	83	27	and	and	CCONJ
ajmsi-505	83	28	transduction	transduction	NOUN
ajmsi-505	83	29	protocols	protocol	NOUN
ajmsi-505	83	30	.	.	PUNCT
ajmsi-505	84	1	staining	stain	VERB
ajmsi-505	84	2	mycobacterial	mycobacterial	ADJ
ajmsi-505	84	3	isolates	isolate	NOUN
ajmsi-505	84	4	from	from	ADP
ajmsi-505	84	5	lj	lj	PROPN
ajmsi-505	84	6	slants	slant	NOUN
ajmsi-505	84	7	ziehl	ziehl	PROPN
ajmsi-505	84	8	neelson	neelson	PROPN
ajmsi-505	84	9	(	(	PUNCT
ajmsi-505	84	10	zn	zn	X
ajmsi-505	84	11	)	)	PUNCT
ajmsi-505	84	12	staining	stain	VERB
ajmsi-505	84	13	method	method	NOUN
ajmsi-505	84	14	was	be	AUX
ajmsi-505	84	15	used	use	VERB
ajmsi-505	84	16	.	.	PUNCT
ajmsi-505	85	1	one	one	NUM
ajmsi-505	85	2	drop	drop	NOUN
ajmsi-505	85	3	of	of	ADP
ajmsi-505	85	4	distilled	distil	VERB
ajmsi-505	85	5	water	water	NOUN
ajmsi-505	85	6	was	be	AUX
ajmsi-505	85	7	placed	place	VERB
ajmsi-505	85	8	in	in	ADP
ajmsi-505	85	9	the	the	DET
ajmsi-505	85	10	middle	middle	NOUN
ajmsi-505	85	11	of	of	ADP
ajmsi-505	85	12	a	a	DET
ajmsi-505	85	13	clean	clean	ADJ
ajmsi-505	85	14	grease	grease	NOUN
ajmsi-505	85	15	free	free	ADJ
ajmsi-505	85	16	slide	slide	NOUN
ajmsi-505	85	17	.	.	PUNCT
ajmsi-505	86	1	growth	growth	NOUN
ajmsi-505	86	2	from	from	ADP
ajmsi-505	86	3	the	the	DET
ajmsi-505	86	4	lj	lj	PROPN
ajmsi-505	86	5	slope	slope	NOUN
ajmsi-505	86	6	was	be	AUX
ajmsi-505	86	7	scrapped	scrap	VERB
ajmsi-505	86	8	off	off	ADP
ajmsi-505	86	9	and	and	CCONJ
ajmsi-505	86	10	emulsified	emulsify	VERB
ajmsi-505	86	11	in	in	ADP
ajmsi-505	86	12	saline	saline	NOUN
ajmsi-505	86	13	on	on	ADP
ajmsi-505	86	14	the	the	DET
ajmsi-505	86	15	slide	slide	NOUN
ajmsi-505	86	16	using	use	VERB
ajmsi-505	86	17	a	a	DET
ajmsi-505	86	18	sterile	sterile	ADJ
ajmsi-505	86	19	disposable	disposable	ADJ
ajmsi-505	86	20	loop	loop	NOUN
ajmsi-505	86	21	.	.	PUNCT
ajmsi-505	87	1	the	the	DET
ajmsi-505	87	2	smear	smear	NOUN
ajmsi-505	87	3	was	be	AUX
ajmsi-505	87	4	allowed	allow	VERB
ajmsi-505	87	5	to	to	PART
ajmsi-505	87	6	air	air	VERB
ajmsi-505	87	7	dry	dry	VERB
ajmsi-505	87	8	thoroughly	thoroughly	ADV
ajmsi-505	87	9	and	and	CCONJ
ajmsi-505	87	10	was	be	AUX
ajmsi-505	87	11	fixed	fix	VERB
ajmsi-505	87	12	by	by	ADP
ajmsi-505	87	13	passing	pass	VERB
ajmsi-505	87	14	the	the	DET
ajmsi-505	87	15	reverse	reverse	NOUN
ajmsi-505	87	16	three	three	NUM
ajmsi-505	87	17	times	time	NOUN
ajmsi-505	87	18	through	through	ADP
ajmsi-505	87	19	a	a	DET
ajmsi-505	87	20	blue	blue	ADJ
ajmsi-505	87	21	flame	flame	NOUN
ajmsi-505	87	22	.	.	PUNCT
ajmsi-505	88	1	a	a	DET
ajmsi-505	88	2	negative	negative	ADJ
ajmsi-505	88	3	control	control	NOUN
ajmsi-505	88	4	slide	slide	NOUN
ajmsi-505	88	5	was	be	AUX
ajmsi-505	88	6	also	also	ADV
ajmsi-505	88	7	prepared	prepare	VERB
ajmsi-505	88	8	from	from	ADP
ajmsi-505	88	9	a	a	DET
ajmsi-505	88	10	genexpert	genexpert	ADJ
ajmsi-505	88	11	negative	negative	ADJ
ajmsi-505	88	12	sample	sample	NOUN
ajmsi-505	88	13	as	as	SCONJ
ajmsi-505	88	14	earlier	early	ADV
ajmsi-505	88	15	described	describe	VERB
ajmsi-505	88	16	.	.	PUNCT
ajmsi-505	89	1	the	the	DET
ajmsi-505	89	2	slides	slide	NOUN
ajmsi-505	89	3	were	be	AUX
ajmsi-505	89	4	arranged	arrange	VERB
ajmsi-505	89	5	on	on	ADP
ajmsi-505	89	6	a	a	DET
ajmsi-505	89	7	staining	stain	VERB
ajmsi-505	89	8	rack	rack	NOUN
ajmsi-505	89	9	,	,	PUNCT
ajmsi-505	89	10	flooded	flood	VERB
ajmsi-505	89	11	with	with	ADP
ajmsi-505	89	12	carbol	carbol	NOUN
ajmsi-505	89	13	fuschsin	fuschsin	ADJ
ajmsi-505	89	14	working	working	NOUN
ajmsi-505	89	15	solution	solution	NOUN
ajmsi-505	89	16	and	and	CCONJ
ajmsi-505	89	17	heated	heat	VERB
ajmsi-505	89	18	to	to	PART
ajmsi-505	89	19	steam	steam	VERB
ajmsi-505	89	20	for	for	ADP
ajmsi-505	89	21	five	five	NUM
ajmsi-505	89	22	minutes	minute	NOUN
ajmsi-505	89	23	without	without	ADP
ajmsi-505	89	24	drying	dry	VERB
ajmsi-505	89	25	or	or	CCONJ
ajmsi-505	89	26	boiling	boiling	NOUN
ajmsi-505	89	27	.	.	PUNCT
ajmsi-505	90	1	the	the	DET
ajmsi-505	90	2	slides	slide	NOUN
ajmsi-505	90	3	were	be	AUX
ajmsi-505	90	4	washed	wash	VERB
ajmsi-505	90	5	gently	gently	ADV
ajmsi-505	90	6	with	with	ADP
ajmsi-505	90	7	tap	tap	NOUN
ajmsi-505	90	8	running	running	NOUN
ajmsi-505	90	9	water	water	NOUN
ajmsi-505	90	10	to	to	PART
ajmsi-505	90	11	remove	remove	VERB
ajmsi-505	90	12	excess	excess	ADJ
ajmsi-505	90	13	carbol	carbol	NOUN
ajmsi-505	90	14	fuschsin	fuschsin	ADJ
ajmsi-505	90	15	and	and	CCONJ
ajmsi-505	90	16	flooded	flood	VERB
ajmsi-505	90	17	with	with	ADP
ajmsi-505	90	18	3	3	NUM
ajmsi-505	90	19	%	%	NOUN
ajmsi-505	90	20	acid	acid	NOUN
ajmsi-505	90	21	alcohol	alcohol	NOUN
ajmsi-505	90	22	for	for	ADP
ajmsi-505	90	23	three	three	NUM
ajmsi-505	90	24	minutes	minute	NOUN
ajmsi-505	90	25	to	to	PART
ajmsi-505	90	26	decolorize	decolorize	VERB
ajmsi-505	90	27	completely	completely	ADV
ajmsi-505	90	28	,	,	PUNCT
ajmsi-505	90	29	and	and	CCONJ
ajmsi-505	90	30	washed	wash	VERB
ajmsi-505	90	31	under	under	ADP
ajmsi-505	90	32	running	run	VERB
ajmsi-505	90	33	water	water	NOUN
ajmsi-505	90	34	for	for	ADP
ajmsi-505	90	35	one	one	NUM
ajmsi-505	90	36	minute	minute	NOUN
ajmsi-505	90	37	.	.	PUNCT
ajmsi-505	91	1	the	the	DET
ajmsi-505	91	2	slides	slide	NOUN
ajmsi-505	91	3	were	be	AUX
ajmsi-505	91	4	flooded	flood	VERB
ajmsi-505	91	5	with	with	ADP
ajmsi-505	91	6	methylene	methylene	ADJ
ajmsi-505	91	7	blue	blue	NOUN
ajmsi-505	91	8	and	and	CCONJ
ajmsi-505	91	9	counterstained	counterstaine	VERB
ajmsi-505	91	10	for	for	ADP
ajmsi-505	91	11	1	1	NUM
ajmsi-505	91	12	minute	minute	NOUN
ajmsi-505	91	13	.	.	PUNCT
ajmsi-505	92	1	the	the	DET
ajmsi-505	92	2	slides	slide	NOUN
ajmsi-505	92	3	were	be	AUX
ajmsi-505	92	4	rinsed	rinse	VERB
ajmsi-505	92	5	with	with	ADP
ajmsi-505	92	6	tap	tap	NOUN
ajmsi-505	92	7	running	running	NOUN
ajmsi-505	92	8	water	water	NOUN
ajmsi-505	92	9	,	,	PUNCT
ajmsi-505	92	10	drained	drain	VERB
ajmsi-505	92	11	and	and	CCONJ
ajmsi-505	92	12	air	air	NOUN
ajmsi-505	92	13	dried	dry	VERB
ajmsi-505	92	14	,	,	PUNCT
ajmsi-505	92	15	examined	examine	VERB
ajmsi-505	92	16	under	under	ADP
ajmsi-505	92	17	oil	oil	NOUN
ajmsi-505	92	18	immersion	immersion	NOUN
ajmsi-505	92	19	magnification	magnification	NOUN
ajmsi-505	92	20	(	(	PUNCT
ajmsi-505	92	21	x100	x100	PROPN
ajmsi-505	92	22	)	)	PUNCT
ajmsi-505	92	23	.	.	PUNCT
ajmsi-505	93	1	acid	acid	PROPN
ajmsi-505	93	2	fast	fast	ADJ
ajmsi-505	93	3	bacilli	bacilli	NOUN
ajmsi-505	93	4	appeared	appear	VERB
ajmsi-505	93	5	as	as	ADV
ajmsi-505	93	6	pink	pink	ADJ
ajmsi-505	93	7	or	or	CCONJ
ajmsi-505	93	8	red	red	ADJ
ajmsi-505	93	9	bacilli	bacilli	NOUN
ajmsi-505	93	10	while	while	SCONJ
ajmsi-505	93	11	the	the	DET
ajmsi-505	93	12	negative	negative	ADJ
ajmsi-505	93	13	control	control	NOUN
ajmsi-505	93	14	slide	slide	NOUN
ajmsi-505	93	15	appeared	appear	VERB
ajmsi-505	93	16	blue	blue	ADJ
ajmsi-505	93	17	(	(	PUNCT
ajmsi-505	93	18	joshua	joshua	PROPN
ajmsi-505	93	19	et	et	PROPN
ajmsi-505	93	20	al	al	PROPN
ajmsi-505	93	21	.	.	PROPN
ajmsi-505	93	22	,	,	PUNCT
ajmsi-505	93	23	2013	2013	NUM
ajmsi-505	93	24	)	)	PUNCT
ajmsi-505	93	25	.	.	PUNCT
ajmsi-505	94	1	preparation	preparation	NOUN
ajmsi-505	94	2	of	of	ADP
ajmsi-505	94	3	mycobacteria	mycobacteria	NOUN
ajmsi-505	94	4	growth	growth	NOUN
ajmsi-505	94	5	indicator	indicator	NOUN
ajmsi-505	94	6	tube	tube	NOUN
ajmsi-505	94	7	(	(	PUNCT
ajmsi-505	94	8	mgit	mgit	ADJ
ajmsi-505	94	9	)	)	PUNCT
ajmsi-505	94	10	plastic	plastic	NOUN
ajmsi-505	94	11	caps	cap	NOUN
ajmsi-505	94	12	from	from	ADP
ajmsi-505	94	13	the	the	DET
ajmsi-505	94	14	streptomycin	streptomycin	PROPN
ajmsi-505	94	15	isoniazid	isoniazid	PROPN
ajmsi-505	94	16	rifampicin	rifampicin	VERB
ajmsi-505	94	17	and	and	CCONJ
ajmsi-505	94	18	ethambutol	ethambutol	X
ajmsi-505	94	19	(	(	PUNCT
ajmsi-505	94	20	sire	sire	NOUN
ajmsi-505	94	21	)	)	PUNCT
ajmsi-505	94	22	supplements	supplement	NOUN
ajmsi-505	94	23	were	be	AUX
ajmsi-505	94	24	removed	remove	VERB
ajmsi-505	94	25	.	.	PUNCT
ajmsi-505	95	1	caps	cap	NOUN
ajmsi-505	95	2	from	from	ADP
ajmsi-505	95	3	mgit	mgit	NOUN
ajmsi-505	95	4	were	be	AUX
ajmsi-505	95	5	also	also	ADV
ajmsi-505	95	6	removed	remove	VERB
ajmsi-505	95	7	,	,	PUNCT
ajmsi-505	95	8	and	and	CCONJ
ajmsi-505	95	9	0.8ml	0.8ml	NUM
ajmsi-505	95	10	supplements	supplement	NOUN
ajmsi-505	95	11	were	be	AUX
ajmsi-505	95	12	aseptically	aseptically	ADV
ajmsi-505	95	13	dispensed	dispense	VERB
ajmsi-505	95	14	into	into	ADP
ajmsi-505	95	15	each	each	DET
ajmsi-505	95	16	mgit	mgit	NOUN
ajmsi-505	95	17	using	use	VERB
ajmsi-505	95	18	sterile	sterile	ADJ
ajmsi-505	95	19	pipette	pipette	NOUN
ajmsi-505	95	20	.	.	PUNCT
ajmsi-505	96	1	the	the	DET
ajmsi-505	96	2	tubes	tube	NOUN
ajmsi-505	96	3	were	be	AUX
ajmsi-505	96	4	immediately	immediately	ADV
ajmsi-505	96	5	recapped	recap	VERB
ajmsi-505	96	6	.	.	PUNCT
ajmsi-505	97	1	the	the	DET
ajmsi-505	97	2	procedure	procedure	NOUN
ajmsi-505	97	3	was	be	AUX
ajmsi-505	97	4	repeated	repeat	VERB
ajmsi-505	97	5	using	use	VERB
ajmsi-505	97	6	pza	pza	NOUN
ajmsi-505	97	7	supplement	supplement	NOUN
ajmsi-505	97	8	.	.	PUNCT
ajmsi-505	98	1	five	five	NUM
ajmsi-505	98	2	mgit	mgit	NOUN
ajmsi-505	98	3	(	(	PUNCT
ajmsi-505	98	4	7.0ml	7.0ml	NUM
ajmsi-505	98	5	)	)	PUNCT
ajmsi-505	98	6	were	be	AUX
ajmsi-505	98	7	labeled	label	VERB
ajmsi-505	98	8	with	with	ADP
ajmsi-505	98	9	sire	sire	NOUN
ajmsi-505	98	10	supplement	supplement	NOUN
ajmsi-505	98	11	for	for	ADP
ajmsi-505	98	12	each	each	DET
ajmsi-505	98	13	test	test	NOUN
ajmsi-505	98	14	isolate	isolate	NOUN
ajmsi-505	98	15	as	as	ADP
ajmsi-505	98	16	(	(	PUNCT
ajmsi-505	98	17	growth	growth	NOUN
ajmsi-505	98	18	control	control	NOUN
ajmsi-505	98	19	)	)	PUNCT
ajmsi-505	98	20	,	,	PUNCT
ajmsi-505	98	21	s(sm	s(sm	PROPN
ajmsi-505	98	22	)	)	PUNCT
ajmsi-505	98	23	,	,	PUNCT
ajmsi-505	98	24	i(inh	i(inh	PROPN
ajmsi-505	98	25	)	)	PUNCT
ajmsi-505	98	26	,	,	PUNCT
ajmsi-505	98	27	r(rif	r(rif	ADJ
ajmsi-505	98	28	)	)	PUNCT
ajmsi-505	98	29	,	,	PUNCT
ajmsi-505	98	30	and	and	CCONJ
ajmsi-505	98	31	e(emb	e(emb	NOUN
ajmsi-505	98	32	)	)	PUNCT
ajmsi-505	98	33	.	.	PUNCT
ajmsi-505	99	1	two	two	NUM
ajmsi-505	99	2	mgit	mgit	NOUN
ajmsi-505	99	3	(	(	PUNCT
ajmsi-505	99	4	7.0ml	7.0ml	NUM
ajmsi-505	99	5	)	)	PUNCT
ajmsi-505	99	6	were	be	AUX
ajmsi-505	99	7	labeled	label	VERB
ajmsi-505	99	8	with	with	ADP
ajmsi-505	99	9	pza	pza	NOUN
ajmsi-505	99	10	supplements	supplement	NOUN
ajmsi-505	99	11	for	for	ADP
ajmsi-505	99	12	each	each	DET
ajmsi-505	99	13	test	test	NOUN
ajmsi-505	99	14	isolate	isolate	NOUN
ajmsi-505	99	15	as	as	ADP
ajmsi-505	99	16	c	c	PROPN
ajmsi-505	99	17	(	(	PUNCT
ajmsi-505	99	18	growth	growth	NOUN
ajmsi-505	99	19	control	control	NOUN
ajmsi-505	99	20	)	)	PUNCT
ajmsi-505	99	21	,	,	PUNCT
ajmsi-505	99	22	s(sm	s(sm	PROPN
ajmsi-505	99	23	)	)	PUNCT
ajmsi-505	99	24	,	,	PUNCT
ajmsi-505	99	25	i(inh	i(inh	PROPN
ajmsi-505	99	26	)	)	PUNCT
ajmsi-505	99	27	,	,	PUNCT
ajmsi-505	99	28	r(rif	r(rif	ADJ
ajmsi-505	99	29	)	)	PUNCT
ajmsi-505	99	30	,	,	PUNCT
ajmsi-505	99	31	and	and	CCONJ
ajmsi-505	99	32	e(emb	e(emb	NOUN
ajmsi-505	99	33	)	)	PUNCT
ajmsi-505	99	34	.	.	PUNCT
ajmsi-505	100	1	two	two	NUM
ajmsi-505	100	2	mgit	mgit	NOUN
ajmsi-505	100	3	(	(	PUNCT
ajmsi-505	100	4	7.0ml	7.0ml	NUM
ajmsi-505	100	5	)	)	PUNCT
ajmsi-505	100	6	were	be	AUX
ajmsi-505	100	7	labeled	label	VERB
ajmsi-505	100	8	with	with	ADP
ajmsi-505	100	9	pza	pza	NOUN
ajmsi-505	100	10	supplement	supplement	NOUN
ajmsi-505	100	11	for	for	ADP
ajmsi-505	100	12	each	each	DET
ajmsi-505	100	13	test	test	NOUN
ajmsi-505	100	14	isolate	isolate	NOUN
ajmsi-505	100	15	as	as	ADP
ajmsi-505	100	16	c	c	PROPN
ajmsi-505	100	17	(	(	PUNCT
ajmsi-505	100	18	growth	growth	NOUN
ajmsi-505	100	19	control	control	NOUN
ajmsi-505	100	20	)	)	PUNCT
ajmsi-505	100	21	,	,	PUNCT
ajmsi-505	100	22	and	and	CCONJ
ajmsi-505	100	23	pza	pza	NOUN
ajmsi-505	100	24	.	.	PUNCT
ajmsi-505	101	1	micropipette	micropipette	PROPN
ajmsi-505	101	2	was	be	AUX
ajmsi-505	101	3	used	use	VERB
ajmsi-505	101	4	to	to	PART
ajmsi-505	101	5	aseptically	aseptically	ADV
ajmsi-505	101	6	pipette	pipette	PROPN
ajmsi-505	101	7	100µl	100µl	PROPN
ajmsi-505	101	8	working	work	VERB
ajmsi-505	101	9	drug	drug	NOUN
ajmsi-505	101	10	concentrations	concentration	NOUN
ajmsi-505	101	11	into	into	ADP
ajmsi-505	101	12	each	each	PRON
ajmsi-505	101	13	of	of	ADP
ajmsi-505	101	14	the	the	DET
ajmsi-505	101	15	appropriately	appropriately	ADV
ajmsi-505	101	16	labeled	label	VERB
ajmsi-505	101	17	mgit	mgit	NOUN
ajmsi-505	101	18	.	.	PUNCT
ajmsi-505	102	1	no	no	DET
ajmsi-505	102	2	antibiotics	antibiotic	NOUN
ajmsi-505	102	3	were	be	AUX
ajmsi-505	102	4	added	add	VERB
ajmsi-505	102	5	to	to	ADP
ajmsi-505	102	6	mgit	mgit	PROPN
ajmsi-505	102	7	control	control	PROPN
ajmsi-505	102	8	tubes	tubes	PROPN
ajmsi-505	102	9	.	.	PUNCT
ajmsi-505	103	1	0.5	0.5	NUM
ajmsi-505	103	2	ml	ml	NOUN
ajmsi-505	103	3	of	of	ADP
ajmsi-505	103	4	the	the	DET
ajmsi-505	103	5	organism	organism	NOUN
ajmsi-505	103	6	suspension	suspension	NOUN
ajmsi-505	103	7	was	be	AUX
ajmsi-505	103	8	aseptically	aseptically	ADV
ajmsi-505	103	9	dispensed	dispense	VERB
ajmsi-505	103	10	into	into	ADP
ajmsi-505	103	11	each	each	PRON
ajmsi-505	103	12	of	of	ADP
ajmsi-505	103	13	the	the	DET
ajmsi-505	103	14	five	five	NUM
ajmsi-505	103	15	tubes	tube	NOUN
ajmsi-505	103	16	containing	contain	VERB
ajmsi-505	103	17	drugs	drug	NOUN
ajmsi-505	103	18	(	(	PUNCT
ajmsi-505	103	19	sm	sm	PROPN
ajmsi-505	103	20	,	,	PUNCT
ajmsi-505	103	21	inh	inh	PROPN
ajmsi-505	103	22	,	,	PUNCT
ajmsi-505	103	23	rif	rif	PROPN
ajmsi-505	103	24	,	,	PUNCT
ajmsi-505	103	25	emb	emb	PROPN
ajmsi-505	103	26	,	,	PUNCT
ajmsi-505	103	27	pza	pza	NOUN
ajmsi-505	103	28	)	)	PUNCT
ajmsi-505	103	29	.	.	PUNCT
ajmsi-505	104	1	1:10	1:10	NUM
ajmsi-505	104	2	growth	growth	NOUN
ajmsi-505	104	3	control	control	NOUN
ajmsi-505	104	4	suspension	suspension	NOUN
ajmsi-505	104	5	was	be	AUX
ajmsi-505	104	6	prepared	prepare	VERB
ajmsi-505	104	7	by	by	ADP
ajmsi-505	104	8	aseptically	aseptically	ADV
ajmsi-505	104	9	adding	add	VERB
ajmsi-505	104	10	0.5	0.5	NUM
ajmsi-505	104	11	ml	ml	NOUN
ajmsi-505	104	12	of	of	ADP
ajmsi-505	104	13	the	the	DET
ajmsi-505	104	14	organism	organism	NOUN
ajmsi-505	104	15	suspension	suspension	NOUN
ajmsi-505	104	16	into	into	ADP
ajmsi-505	104	17	4.5	4.5	NUM
ajmsi-505	104	18	ml	ml	NOUN
ajmsi-505	104	19	of	of	ADP
ajmsi-505	104	20	sterile	sterile	ADJ
ajmsi-505	104	21	saline	saline	NOUN
ajmsi-505	104	22	.	.	PUNCT
ajmsi-505	105	1	the	the	DET
ajmsi-505	105	2	1:10	1:10	NUM
ajmsi-505	105	3	suspension	suspension	NOUN
ajmsi-505	105	4	was	be	AUX
ajmsi-505	105	5	mixed	mix	VERB
ajmsi-505	105	6	thoroughly	thoroughly	ADV
ajmsi-505	105	7	,	,	PUNCT
ajmsi-505	105	8	and	and	CCONJ
ajmsi-505	105	9	0.5ml	0.5ml	NUM
ajmsi-505	105	10	inoculated	inoculate	VERB
ajmsi-505	105	11	into	into	ADP
ajmsi-505	105	12	mgit	mgit	ADJ
ajmsi-505	105	13	-	-	PUNCT
ajmsi-505	105	14	pza	pza	NOUN
ajmsi-505	105	15	control	control	NOUN
ajmsi-505	105	16	tube	tube	NOUN
ajmsi-505	105	17	,	,	PUNCT
ajmsi-505	105	18	0.5ml	0.5ml	PROPN
ajmsi-505	105	19	was	be	AUX
ajmsi-505	105	20	further	far	ADV
ajmsi-505	105	21	diluted	dilute	VERB
ajmsi-505	105	22	with	with	ADP
ajmsi-505	105	23	4.5	4.5	NUM
ajmsi-505	105	24	ml	ml	NOUN
ajmsi-505	105	25	sterile	sterile	ADJ
ajmsi-505	105	26	saline	saline	NOUN
ajmsi-505	105	27	from	from	ADP
ajmsi-505	105	28	the	the	DET
ajmsi-505	105	29	previous	previous	ADJ
ajmsi-505	105	30	1:10	1:10	NUM
ajmsi-505	105	31	growth	growth	NOUN
ajmsi-505	105	32	control	control	NOUN
ajmsi-505	105	33	suspension	suspension	NOUN
ajmsi-505	105	34	to	to	PART
ajmsi-505	105	35	produce	produce	VERB
ajmsi-505	105	36	1:100	1:100	NUM
ajmsi-505	105	37	dilutions	dilution	NOUN
ajmsi-505	105	38	.	.	PUNCT
ajmsi-505	106	1	the	the	DET
ajmsi-505	106	2	1:100	1:100	NUM
ajmsi-505	106	3	suspensions	suspension	NOUN
ajmsi-505	106	4	were	be	AUX
ajmsi-505	106	5	thoroughly	thoroughly	ADV
ajmsi-505	106	6	mixed	mixed	ADJ
ajmsi-505	106	7	and	and	CCONJ
ajmsi-505	106	8	0.5	0.5	NUM
ajmsi-505	106	9	ml	ml	NOUN
ajmsi-505	106	10	was	be	AUX
ajmsi-505	106	11	inoculated	inoculate	VERB
ajmsi-505	106	12	into	into	ADP
ajmsi-505	106	13	the	the	DET
ajmsi-505	106	14	mgit	mgit	PROPN
ajmsi-505	106	15	control	control	PROPN
ajmsi-505	106	16	tube	tube	PROPN
ajmsi-505	106	17	.	.	PUNCT
ajmsi-505	107	1	the	the	DET
ajmsi-505	107	2	tubes	tube	NOUN
ajmsi-505	107	3	were	be	AUX
ajmsi-505	107	4	tightly	tightly	ADV
ajmsi-505	107	5	recapped	recap	VERB
ajmsi-505	107	6	,	,	PUNCT
ajmsi-505	107	7	thoroughly	thoroughly	ADV
ajmsi-505	107	8	mixed	mix	VERB
ajmsi-505	107	9	by	by	ADP
ajmsi-505	107	10	gently	gently	ADV
ajmsi-505	107	11	inverting	invert	VERB
ajmsi-505	107	12	three	three	NUM
ajmsi-505	107	13	to	to	PART
ajmsi-505	107	14	four	four	NUM
ajmsi-505	107	15	times	time	NOUN
ajmsi-505	107	16	and	and	CCONJ
ajmsi-505	107	17	were	be	AUX
ajmsi-505	107	18	wiped	wipe	VERB
ajmsi-505	107	19	with	with	ADP
ajmsi-505	107	20	disinfectant	disinfectant	NOUN
ajmsi-505	107	21	,	,	PUNCT
ajmsi-505	107	22	loaded	load	VERB
ajmsi-505	107	23	into	into	ADP
ajmsi-505	107	24	the	the	DET
ajmsi-505	107	25	appropriate	appropriate	ADJ
ajmsi-505	107	26	dst	dst	NOUN
ajmsi-505	107	27	carrier	carrier	NOUN
ajmsi-505	107	28	.	.	PUNCT
ajmsi-505	108	1	sire	sire	NOUN
ajmsi-505	108	2	was	be	AUX
ajmsi-505	108	3	loaded	load	VERB
ajmsi-505	108	4	into	into	ADP
ajmsi-505	108	5	a	a	DET
ajmsi-505	108	6	five	five	NUM
ajmsi-505	108	7	-	-	PUNCT
ajmsi-505	108	8	carrier	carrier	NOUN
ajmsi-505	108	9	holder	holder	NOUN
ajmsi-505	108	10	,	,	PUNCT
ajmsi-505	108	11	while	while	SCONJ
ajmsi-505	108	12	pza	pza	NOUN
ajmsi-505	108	13	was	be	AUX
ajmsi-505	108	14	loaded	load	VERB
ajmsi-505	108	15	into	into	ADP
ajmsi-505	108	16	a	a	DET
ajmsi-505	108	17	two	two	NUM
ajmsi-505	108	18	-	-	PUNCT
ajmsi-505	108	19	carrier	carrier	NOUN
ajmsi-505	108	20	holder	holder	NOUN
ajmsi-505	108	21	.	.	PUNCT
ajmsi-505	109	1	one	one	NUM
ajmsi-505	109	2	drop	drop	NOUN
ajmsi-505	109	3	of	of	ADP
ajmsi-505	109	4	the	the	DET
ajmsi-505	109	5	organism	organism	NOUN
ajmsi-505	109	6	suspension	suspension	NOUN
ajmsi-505	109	7	from	from	ADP
ajmsi-505	109	8	the	the	DET
ajmsi-505	109	9	1:100	1:100	NUM
ajmsi-505	109	10	control	control	NOUN
ajmsi-505	109	11	tube	tube	NOUN
ajmsi-505	109	12	was	be	AUX
ajmsi-505	109	13	streaked	streak	VERB
ajmsi-505	109	14	on	on	ADP
ajmsi-505	109	15	a	a	DET
ajmsi-505	109	16	blood	blood	NOUN
ajmsi-505	109	17	agar	agar	NOUN
ajmsi-505	109	18	plate	plate	NOUN
ajmsi-505	109	19	(	(	PUNCT
ajmsi-505	109	20	bap	bap	PROPN
ajmsi-505	109	21	)	)	PUNCT
ajmsi-505	109	22	,	,	PUNCT
ajmsi-505	109	23	sealed	seal	VERB
ajmsi-505	109	24	with	with	ADP
ajmsi-505	109	25	paraffin	paraffin	NOUN
ajmsi-505	109	26	and	and	CCONJ
ajmsi-505	109	27	incubated	incubate	VERB
ajmsi-505	109	28	at	at	ADP
ajmsi-505	109	29	35	35	NUM
ajmsi-505	109	30	-	-	SYM
ajmsi-505	109	31	37	37	NUM
ajmsi-505	109	32	°	°	ADP
ajmsi-505	109	33	c	c	NOUN
ajmsi-505	109	34	for	for	ADP
ajmsi-505	109	35	four	four	NUM
ajmsi-505	109	36	days	day	NOUN
ajmsi-505	109	37	.	.	PUNCT
ajmsi-505	110	1	the	the	DET
ajmsi-505	110	2	bap	bap	NOUN
ajmsi-505	110	3	was	be	AUX
ajmsi-505	110	4	read	read	VERB
ajmsi-505	110	5	daily	daily	ADV
ajmsi-505	110	6	,	,	PUNCT
ajmsi-505	110	7	for	for	ADP
ajmsi-505	110	8	up	up	ADP
ajmsi-505	110	9	to	to	PART
ajmsi-505	110	10	four	four	NUM
ajmsi-505	110	11	days	day	NOUN
ajmsi-505	110	12	,	,	PUNCT
ajmsi-505	110	13	for	for	ADP
ajmsi-505	110	14	bacterial	bacterial	ADJ
ajmsi-505	110	15	contamination	contamination	NOUN
ajmsi-505	110	16	.	.	PUNCT
ajmsi-505	111	1	the	the	DET
ajmsi-505	111	2	dst	dst	PROPN
ajmsi-505	111	3	was	be	AUX
ajmsi-505	111	4	allowed	allow	VERB
ajmsi-505	111	5	to	to	PART
ajmsi-505	111	6	proceed	proceed	VERB
ajmsi-505	111	7	only	only	ADV
ajmsi-505	111	8	for	for	ADP
ajmsi-505	111	9	bap	bap	NOUN
ajmsi-505	111	10	that	that	PRON
ajmsi-505	111	11	showed	show	VERB
ajmsi-505	111	12	no	no	DET
ajmsi-505	111	13	growth	growth	NOUN
ajmsi-505	111	14	during	during	ADP
ajmsi-505	111	15	the	the	DET
ajmsi-505	111	16	four	four	NUM
ajmsi-505	111	17	days	day	NOUN
ajmsi-505	111	18	monitoring	monitor	VERB
ajmsi-505	111	19	(	(	PUNCT
ajmsi-505	111	20	joshua	joshua	PROPN
ajmsi-505	111	21	et	et	PROPN
ajmsi-505	111	22	al	al	PROPN
ajmsi-505	111	23	.	.	PROPN
ajmsi-505	111	24	,	,	PUNCT
ajmsi-505	111	25	2013	2013	NUM
ajmsi-505	111	26	)	)	PUNCT
ajmsi-505	111	27	.	.	PUNCT
ajmsi-505	112	1	drug	drug	NOUN
ajmsi-505	112	2	susceptibility	susceptibility	PROPN
ajmsi-505	112	3	test	test	NOUN
ajmsi-505	112	4	(	(	PUNCT
ajmsi-505	112	5	dst	dst	NOUN
ajmsi-505	112	6	)	)	PUNCT
ajmsi-505	112	7	for	for	ADP
ajmsi-505	112	8	m.	m.	NOUN
ajmsi-505	112	9	tuberculosis	tuberculosis	ADP
ajmsi-505	112	10	bactec	bactec	ADJ
ajmsi-505	112	11	mgit	mgit	NOUN
ajmsi-505	112	12	960	960	NUM
ajmsi-505	112	13	tb	tb	ADP
ajmsi-505	112	14	system	system	NOUN
ajmsi-505	112	15	(	(	PUNCT
ajmsi-505	112	16	becton	becton	NOUN
ajmsi-505	112	17	and	and	CCONJ
ajmsi-505	112	18	dickinson	dickinson	PROPN
ajmsi-505	112	19	,	,	PUNCT
ajmsi-505	112	20	new	new	PROPN
ajmsi-505	112	21	jersey	jersey	PROPN
ajmsi-505	112	22	usa	usa	PROPN
ajmsi-505	112	23	)	)	PUNCT
ajmsi-505	112	24	was	be	AUX
ajmsi-505	112	25	used	use	VERB
ajmsi-505	112	26	.	.	PUNCT
ajmsi-505	113	1	the	the	DET
ajmsi-505	113	2	system	system	NOUN
ajmsi-505	113	3	monitors	monitor	VERB
ajmsi-505	113	4	continuous	continuous	ADJ
ajmsi-505	113	5	growth	growth	NOUN
ajmsi-505	113	6	of	of	ADP
ajmsi-505	113	7	microorganisms	microorganism	NOUN
ajmsi-505	113	8	in	in	ADP
ajmsi-505	113	9	both	both	PRON
ajmsi-505	113	10	drugcontaining	drugcontaine	VERB
ajmsi-505	113	11	and	and	CCONJ
ajmsi-505	113	12	control	control	NOUN
ajmsi-505	113	13	tubes	tube	NOUN
ajmsi-505	113	14	to	to	PART
ajmsi-505	113	15	determine	determine	VERB
ajmsi-505	113	16	susceptibility	susceptibility	NOUN
ajmsi-505	113	17	or	or	CCONJ
ajmsi-505	113	18	resistance	resistance	NOUN
ajmsi-505	113	19	,	,	PUNCT
ajmsi-505	113	20	and	and	CCONJ
ajmsi-505	113	21	automatically	automatically	ADV
ajmsi-505	113	22	interprets	interpret	VERB
ajmsi-505	113	23	and	and	CCONJ
ajmsi-505	113	24	reports	report	VERB
ajmsi-505	113	25	results	result	NOUN
ajmsi-505	113	26	of	of	ADP
ajmsi-505	113	27	tests	test	NOUN
ajmsi-505	113	28	.	.	PUNCT
ajmsi-505	114	1	the	the	DET
ajmsi-505	114	2	following	follow	VERB
ajmsi-505	114	3	anti	anti	ADJ
ajmsi-505	114	4	-	-	ADJ
ajmsi-505	114	5	tb	tb	ADJ
ajmsi-505	114	6	drugs	drug	NOUN
ajmsi-505	114	7	(	(	PUNCT
ajmsi-505	114	8	sire	sire	NOUN
ajmsi-505	114	9	)	)	PUNCT
ajmsi-505	114	10	were	be	AUX
ajmsi-505	114	11	reconstituted	reconstitute	VERB
ajmsi-505	114	12	to	to	ADP
ajmsi-505	114	13	the	the	DET
ajmsi-505	114	14	following	follow	VERB
ajmsi-505	114	15	concentrations	concentration	NOUN
ajmsi-505	114	16	:	:	PUNCT
ajmsi-505	114	17	streptomycin	streptomycin	PROPN
ajmsi-505	114	18	1.0	1.0	NUM
ajmsi-505	114	19	μg	μg	PROPN
ajmsi-505	114	20	/	/	SYM
ajmsi-505	114	21	ml	ml	PROPN
ajmsi-505	114	22	,	,	PUNCT
ajmsi-505	114	23	isoniazid	isoniazid	NOUN
ajmsi-505	114	24	0.1	0.1	NUM
ajmsi-505	114	25	μg	μg	NOUN
ajmsi-505	114	26	/	/	SYM
ajmsi-505	114	27	ml	ml	PROPN
ajmsi-505	114	28	,	,	PUNCT
ajmsi-505	114	29	rifampicin	rifampicin	VERB
ajmsi-505	114	30	1.0	1.0	NUM
ajmsi-505	114	31	μg	μg	PROPN
ajmsi-505	114	32	/	/	SYM
ajmsi-505	114	33	ml	ml	PROPN
ajmsi-505	114	34	,	,	PUNCT
ajmsi-505	114	35	ethambutol	ethambutol	VERB
ajmsi-505	114	36	5.0	5.0	NUM
ajmsi-505	114	37	μg	μg	NOUN
ajmsi-505	114	38	/	/	SYM
ajmsi-505	114	39	ml	ml	PROPN
ajmsi-505	114	40	,	,	PUNCT
ajmsi-505	114	41	pyrazinamide	pyrazinamide	VERB
ajmsi-505	114	42	100	100	NUM
ajmsi-505	114	43	μg/	μg/	NOUN
ajmsi-505	114	44	ml	ml	ADP
ajmsi-505	114	45	(	(	PUNCT
ajmsi-505	114	46	pza	pza	NOUN
ajmsi-505	114	47	)	)	PUNCT
ajmsi-505	114	48	.	.	PUNCT
ajmsi-505	115	1	preserved	preserve	VERB
ajmsi-505	115	2	stock	stock	NOUN
ajmsi-505	115	3	cultures	culture	NOUN
ajmsi-505	115	4	of	of	ADP
ajmsi-505	115	5	0.1ml	0.1ml	ADJ
ajmsi-505	115	6	m.	m.	NOUN
ajmsi-505	115	7	tuberculosis	tuberculosi	NOUN
ajmsi-505	115	8	were	be	AUX
ajmsi-505	115	9	sub	sub	ADJ
ajmsi-505	115	10	-	-	ADJ
ajmsi-505	115	11	culturedm	culturedm	NOUN
ajmsi-505	115	12	to	to	ADP
ajmsi-505	115	13	mycobacterium	mycobacterium	NOUN
ajmsi-505	115	14	growth	growth	NOUN
ajmsi-505	115	15	indicator	indicator	NOUN
ajmsi-505	115	16	tube	tube	NOUN
ajmsi-505	115	17	(	(	PUNCT
ajmsi-505	115	18	mgit	mgit	PROPN
ajmsi-505	115	19	)	)	PUNCT
ajmsi-505	115	20	mcfarland	mcfarland	PROPN
ajmsi-505	115	21	standard	standard	NOUN
ajmsi-505	115	22	(	(	PUNCT
ajmsi-505	115	23	1.0	1.0	NUM
ajmsi-505	115	24	suspension	suspension	NOUN
ajmsi-505	115	25	)	)	PUNCT
ajmsi-505	115	26	equivalent	equivalent	ADJ
ajmsi-505	115	27	to	to	ADP
ajmsi-505	115	28	3.0	3.0	NUM
ajmsi-505	115	29	x	x	SYM
ajmsi-505	115	30	108	108	NUM
ajmsi-505	115	31	cfu	cfu	NOUN
ajmsi-505	115	32	/	/	SYM
ajmsi-505	115	33	ml	ml	NOUN
ajmsi-505	115	34	.	.	PUNCT
ajmsi-505	116	1	reconstituted	reconstitute	VERB
ajmsi-505	116	2	0.8	0.8	NUM
ajmsi-505	116	3	ml	ml	NOUN
ajmsi-505	116	4	sire	sire	NOUN
ajmsi-505	116	5	supplements	supplement	NOUN
ajmsi-505	116	6	were	be	AUX
ajmsi-505	116	7	aseptically	aseptically	ADV
ajmsi-505	116	8	dispensed	dispense	VERB
ajmsi-505	116	9	into	into	ADP
ajmsi-505	116	10	each	each	DET
ajmsi-505	116	11	mgit	mgit	NOUN
ajmsi-505	116	12	with	with	ADP
ajmsi-505	116	13	a	a	DET
ajmsi-505	116	14	pipette	pipette	NOUN
ajmsi-505	116	15	and	and	CCONJ
ajmsi-505	116	16	sterile	sterile	ADJ
ajmsi-505	116	17	tips	tip	NOUN
ajmsi-505	116	18	.	.	PUNCT
ajmsi-505	117	1	mgit	mgit	PROPN
ajmsi-505	117	2	was	be	AUX
ajmsi-505	117	3	immediately	immediately	ADV
ajmsi-505	117	4	recapped	recap	VERB
ajmsi-505	117	5	interpretations	interpretation	NOUN
ajmsi-505	117	6	of	of	ADP
ajmsi-505	117	7	dst	dst	PROPN
ajmsi-505	117	8	results	result	NOUN
ajmsi-505	117	9	were	be	AUX
ajmsi-505	117	10	read	read	VERB
ajmsi-505	117	11	between	between	ADP
ajmsi-505	117	12	days	day	NOUN
ajmsi-505	117	13	four	four	NUM
ajmsi-505	117	14	and	and	CCONJ
ajmsi-505	117	15	thirteen	thirteen	NUM
ajmsi-505	117	16	sire	sire	NOUN
ajmsi-505	117	17	,	,	PUNCT
ajmsi-505	117	18	pza	pza	NOUN
ajmsi-505	117	19	test	test	NOUN
ajmsi-505	117	20	.	.	PUNCT
ajmsi-505	118	1	control	control	VERB
ajmsi-505	118	2	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	118	3	pa	pa	PROPN
ajmsi-505	118	4	ge	ge	PROPN
ajmsi-505	118	5	4	4	NUM
ajmsi-505	118	6	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	118	7	am	be	AUX
ajmsi-505	118	8	.	.	PUNCT
ajmsi-505	119	1	j.	j.	PROPN
ajmsi-505	119	2	med	med	PROPN
ajmsi-505	119	3	.	.	PUNCT
ajmsi-505	120	1	sci	sci	PROPN
ajmsi-505	120	2	.	.	PUNCT
ajmsi-505	120	3	innov	innov	PROPN
ajmsi-505	120	4	.	.	PUNCT
ajmsi-505	121	1	1(1	1(1	NUM
ajmsi-505	121	2	)	)	PUNCT
ajmsi-505	121	3	1	1	NUM
ajmsi-505	121	4	-	-	SYM
ajmsi-505	121	5	9	9	NUM
ajmsi-505	121	6	,	,	PUNCT
ajmsi-505	121	7	2022	2022	NUM
ajmsi-505	121	8	tubes	tube	NOUN
ajmsi-505	121	9	that	that	PRON
ajmsi-505	121	10	flagged	flag	VERB
ajmsi-505	121	11	positive	positive	ADJ
ajmsi-505	121	12	before	before	ADP
ajmsi-505	121	13	day	day	NOUN
ajmsi-505	121	14	four	four	NUM
ajmsi-505	121	15	were	be	AUX
ajmsi-505	121	16	repeated	repeat	VERB
ajmsi-505	121	17	.	.	PUNCT
ajmsi-505	122	1	similarly	similarly	ADV
ajmsi-505	122	2	,	,	PUNCT
ajmsi-505	122	3	control	control	NOUN
ajmsi-505	122	4	tubes	tube	NOUN
ajmsi-505	122	5	that	that	PRON
ajmsi-505	122	6	remained	remain	VERB
ajmsi-505	122	7	negative	negative	ADJ
ajmsi-505	122	8	after	after	ADP
ajmsi-505	122	9	day	day	NOUN
ajmsi-505	122	10	thirteen	thirteen	NUM
ajmsi-505	122	11	were	be	AUX
ajmsi-505	122	12	also	also	ADV
ajmsi-505	122	13	repeated	repeat	VERB
ajmsi-505	122	14	.	.	PUNCT
ajmsi-505	123	1	the	the	DET
ajmsi-505	123	2	dst	dst	NOUN
ajmsi-505	123	3	for	for	ADP
ajmsi-505	123	4	the	the	DET
ajmsi-505	123	5	drugs	drug	NOUN
ajmsi-505	123	6	under	under	ADP
ajmsi-505	123	7	consideration	consideration	NOUN
ajmsi-505	123	8	was	be	AUX
ajmsi-505	123	9	reported	report	VERB
ajmsi-505	123	10	as	as	ADP
ajmsi-505	123	11	“	"	PUNCT
ajmsi-505	123	12	sensitive	sensitive	ADJ
ajmsi-505	123	13	”	"	PUNCT
ajmsi-505	123	14	when	when	SCONJ
ajmsi-505	123	15	the	the	DET
ajmsi-505	123	16	control	control	NOUN
ajmsi-505	123	17	tubes	tube	NOUN
ajmsi-505	123	18	reached	reach	VERB
ajmsi-505	123	19	growth	growth	NOUN
ajmsi-505	123	20	unit	unit	NOUN
ajmsi-505	123	21	(	(	PUNCT
ajmsi-505	123	22	gu	gu	NOUN
ajmsi-505	123	23	)	)	PUNCT
ajmsi-505	123	24	of	of	ADP
ajmsi-505	123	25	400	400	NUM
ajmsi-505	123	26	,	,	PUNCT
ajmsi-505	123	27	while	while	SCONJ
ajmsi-505	123	28	the	the	DET
ajmsi-505	123	29	drug	drug	NOUN
ajmsi-505	123	30	tubes	tube	NOUN
ajmsi-505	123	31	had	have	VERB
ajmsi-505	123	32	growth	growth	NOUN
ajmsi-505	123	33	units	unit	NOUN
ajmsi-505	123	34	(	(	PUNCT
ajmsi-505	123	35	gu	gu	NOUN
ajmsi-505	123	36	)	)	PUNCT
ajmsi-505	123	37	of	of	ADP
ajmsi-505	123	38	less	less	ADJ
ajmsi-505	123	39	than	than	ADP
ajmsi-505	123	40	100	100	NUM
ajmsi-505	123	41	.	.	PUNCT
ajmsi-505	124	1	the	the	DET
ajmsi-505	124	2	results	result	NOUN
ajmsi-505	124	3	were	be	AUX
ajmsi-505	124	4	reported	report	VERB
ajmsi-505	124	5	as	as	ADP
ajmsi-505	124	6	resistant	resistant	ADJ
ajmsi-505	124	7	with	with	ADP
ajmsi-505	124	8	a	a	DET
ajmsi-505	124	9	rise	rise	NOUN
ajmsi-505	124	10	in	in	ADP
ajmsi-505	124	11	gu	gu	NOUN
ajmsi-505	124	12	equal	equal	ADJ
ajmsi-505	124	13	to	to	ADP
ajmsi-505	124	14	or	or	CCONJ
ajmsi-505	124	15	greater	great	ADJ
ajmsi-505	124	16	than	than	ADP
ajmsi-505	124	17	100	100	NUM
ajmsi-505	124	18	and	and	CCONJ
ajmsi-505	124	19	growth	growth	NOUN
ajmsi-505	124	20	in	in	ADP
ajmsi-505	124	21	the	the	DET
ajmsi-505	124	22	control	control	NOUN
ajmsi-505	124	23	tube	tube	NOUN
ajmsi-505	124	24	equivalent	equivalent	ADJ
ajmsi-505	124	25	to	to	ADP
ajmsi-505	124	26	400	400	NUM
ajmsi-505	124	27	gu	gu	NOUN
ajmsi-505	124	28	(	(	PUNCT
ajmsi-505	124	29	siddiqui	siddiqui	NOUN
ajmsi-505	124	30	and	and	CCONJ
ajmsi-505	124	31	rusch	rusch	PROPN
ajmsi-505	124	32	-	-	PUNCT
ajmsi-505	124	33	gerdes	gerde	NOUN
ajmsi-505	124	34	2006	2006	NUM
ajmsi-505	124	35	)	)	PUNCT
ajmsi-505	124	36	.	.	PUNCT
ajmsi-505	125	1	m.	m.	NOUN
ajmsi-505	125	2	tuberculosis	tuberculosis	PRON
ajmsi-505	125	3	strains	strain	NOUN
ajmsi-505	125	4	that	that	PRON
ajmsi-505	125	5	exhibited	exhibit	VERB
ajmsi-505	125	6	combined	combined	ADJ
ajmsi-505	125	7	resistance	resistance	NOUN
ajmsi-505	125	8	to	to	ADP
ajmsi-505	125	9	rifampicin	rifampicin	VERB
ajmsi-505	125	10	and	and	CCONJ
ajmsi-505	125	11	isoniazid	isoniazid	NOUN
ajmsi-505	125	12	were	be	AUX
ajmsi-505	125	13	reported	report	VERB
ajmsi-505	125	14	as	as	ADP
ajmsi-505	125	15	mdr	mdr	PROPN
ajmsi-505	125	16	-	-	PROPN
ajmsi-505	125	17	tb	tb	X
ajmsi-505	125	18	(	(	PUNCT
ajmsi-505	125	19	willey	willey	PROPN
ajmsi-505	125	20	et	et	PROPN
ajmsi-505	125	21	al	al	PROPN
ajmsi-505	125	22	.	.	PROPN
ajmsi-505	125	23	,	,	PUNCT
ajmsi-505	125	24	2011	2011	NUM
ajmsi-505	125	25	)	)	PUNCT
ajmsi-505	125	26	.	.	PUNCT
ajmsi-505	126	1	transduction	transduction	NOUN
ajmsi-505	126	2	protocol	protocol	NOUN
ajmsi-505	126	3	transduction	transduction	NOUN
ajmsi-505	126	4	protocol	protocol	NOUN
ajmsi-505	126	5	was	be	AUX
ajmsi-505	126	6	carried	carry	VERB
ajmsi-505	126	7	out	out	ADP
ajmsi-505	126	8	as	as	SCONJ
ajmsi-505	126	9	described	describe	VERB
ajmsi-505	126	10	by	by	ADP
ajmsi-505	126	11	bardarov	bardarov	NOUN
ajmsi-505	126	12	and	and	CCONJ
ajmsi-505	126	13	co	co	NOUN
ajmsi-505	126	14	-	-	NOUN
ajmsi-505	126	15	researchers	researcher	NOUN
ajmsi-505	126	16	(	(	PUNCT
ajmsi-505	126	17	bardarov	bardarov	PROPN
ajmsi-505	126	18	et	et	PROPN
ajmsi-505	126	19	al	al	PROPN
ajmsi-505	126	20	.	.	PROPN
ajmsi-505	126	21	,	,	PUNCT
ajmsi-505	126	22	2002	2002	NUM
ajmsi-505	126	23	)	)	PUNCT
ajmsi-505	126	24	,	,	PUNCT
ajmsi-505	126	25	with	with	ADP
ajmsi-505	126	26	slight	slight	ADJ
ajmsi-505	126	27	modifications	modification	NOUN
ajmsi-505	126	28	.	.	PUNCT
ajmsi-505	127	1	preserved	preserve	VERB
ajmsi-505	127	2	cultures	culture	NOUN
ajmsi-505	127	3	of	of	ADP
ajmsi-505	127	4	m.	m.	NOUN
ajmsi-505	127	5	tuberculosis	tuberculosis	NOUN
ajmsi-505	127	6	from	from	ADP
ajmsi-505	127	7	category	category	NOUN
ajmsi-505	127	8	iii	iii	NUM
ajmsi-505	127	9	patients	patient	NOUN
ajmsi-505	127	10	were	be	AUX
ajmsi-505	127	11	used	use	VERB
ajmsi-505	127	12	.	.	PUNCT
ajmsi-505	128	1	one	one	NUM
ajmsi-505	128	2	milliliter	milliliter	NOUN
ajmsi-505	128	3	of	of	ADP
ajmsi-505	128	4	m.	m.	NOUN
ajmsi-505	128	5	tuberculosis	tuberculosis	NOUN
ajmsi-505	128	6	stock	stock	NOUN
ajmsi-505	128	7	was	be	AUX
ajmsi-505	128	8	inoculated	inoculate	VERB
ajmsi-505	128	9	into	into	ADP
ajmsi-505	128	10	10ml	10ml	PROPN
ajmsi-505	128	11	lj	lj	PROPN
ajmsi-505	128	12	broth	broth	NOUN
ajmsi-505	128	13	in	in	ADP
ajmsi-505	128	14	30ml	30ml	ADJ
ajmsi-505	128	15	plastic	plastic	NOUN
ajmsi-505	128	16	culture	culture	NOUN
ajmsi-505	128	17	bottles	bottle	NOUN
ajmsi-505	128	18	,	,	PUNCT
ajmsi-505	128	19	and	and	CCONJ
ajmsi-505	128	20	incubated	incubate	VERB
ajmsi-505	128	21	at	at	ADP
ajmsi-505	128	22	37	37	NUM
ajmsi-505	128	23	°	°	ADP
ajmsi-505	128	24	c	c	NOUN
ajmsi-505	128	25	in	in	ADP
ajmsi-505	128	26	an	an	DET
ajmsi-505	128	27	incubator	incubator	NOUN
ajmsi-505	128	28	shaker	shaker	NOUN
ajmsi-505	128	29	.	.	PUNCT
ajmsi-505	129	1	the	the	DET
ajmsi-505	129	2	m.	m.	NOUN
ajmsi-505	129	3	tuberculosis	tuberculosis	PRON
ajmsi-505	129	4	strains	strain	NOUN
ajmsi-505	129	5	were	be	AUX
ajmsi-505	129	6	grown	grow	VERB
ajmsi-505	129	7	to	to	ADP
ajmsi-505	129	8	optical	optical	ADJ
ajmsi-505	129	9	density	density	NOUN
ajmsi-505	129	10	od	od	ADV
ajmsi-505	129	11	of	of	ADP
ajmsi-505	129	12	600	600	NUM
ajmsi-505	129	13	~	~	SYM
ajmsi-505	129	14	0.8	0.8	NUM
ajmsi-505	129	15	-	-	PUNCT
ajmsi-505	129	16	1.0(6.0	1.0(6.0	NOUN
ajmsi-505	129	17	x	x	SYM
ajmsi-505	129	18	108	108	NUM
ajmsi-505	129	19	c.f.u	c.f.u	NOUN
ajmsi-505	129	20	ml-1	ml-1	NOUN
ajmsi-505	129	21	)	)	PUNCT
ajmsi-505	129	22	.	.	PUNCT
ajmsi-505	130	1	ten	ten	NUM
ajmsi-505	130	2	milliliters	milliliter	NOUN
ajmsi-505	130	3	of	of	ADP
ajmsi-505	130	4	the	the	DET
ajmsi-505	130	5	culture	culture	NOUN
ajmsi-505	130	6	were	be	AUX
ajmsi-505	130	7	centrifuged	centrifuge	VERB
ajmsi-505	130	8	at	at	ADP
ajmsi-505	130	9	2500	2500	NUM
ajmsi-505	130	10	g	g	NOUN
ajmsi-505	130	11	for	for	ADP
ajmsi-505	130	12	5minutes	5minutes	NUM
ajmsi-505	130	13	and	and	CCONJ
ajmsi-505	130	14	re	re	VERB
ajmsi-505	130	15	-	-	VERB
ajmsi-505	130	16	suspended	suspend	VERB
ajmsi-505	130	17	in	in	ADP
ajmsi-505	130	18	10ml	10ml	ADJ
ajmsi-505	130	19	washing	washing	NOUN
ajmsi-505	130	20	medium	medium	NOUN
ajmsi-505	130	21	of	of	ADP
ajmsi-505	130	22	1	1	NUM
ajmsi-505	130	23	%	%	NOUN
ajmsi-505	130	24	tween	tween	NOUN
ajmsi-505	130	25	80	80	NUM
ajmsi-505	130	26	phosphate	phosphate	ADJ
ajmsi-505	130	27	buffered	buffer	VERB
ajmsi-505	130	28	saline	saline	NOUN
ajmsi-505	130	29	(	(	PUNCT
ajmsi-505	130	30	pbs	pbs	PROPN
ajmsi-505	130	31	-	-	PUNCT
ajmsi-505	130	32	tw	tw	PROPN
ajmsi-505	130	33	ph	ph	PROPN
ajmsi-505	130	34	7.0	7.0	NUM
ajmsi-505	130	35	)	)	PUNCT
ajmsi-505	130	36	and	and	CCONJ
ajmsi-505	130	37	incubated	incubate	VERB
ajmsi-505	130	38	as	as	ADP
ajmsi-505	130	39	a	a	DET
ajmsi-505	130	40	standing	stand	VERB
ajmsi-505	130	41	culture	culture	NOUN
ajmsi-505	130	42	(	(	PUNCT
ajmsi-505	130	43	37	37	NUM
ajmsi-505	130	44	°	°	NOUN
ajmsi-505	130	45	c	c	NOUN
ajmsi-505	130	46	;	;	PUNCT
ajmsi-505	130	47	24hr	24hr	NOUN
ajmsi-505	130	48	)	)	PUNCT
ajmsi-505	130	49	.	.	PUNCT
ajmsi-505	131	1	after	after	ADP
ajmsi-505	131	2	the	the	DET
ajmsi-505	131	3	preparation	preparation	NOUN
ajmsi-505	131	4	period	period	NOUN
ajmsi-505	131	5	,	,	PUNCT
ajmsi-505	131	6	the	the	DET
ajmsi-505	131	7	cells	cell	NOUN
ajmsi-505	131	8	were	be	AUX
ajmsi-505	131	9	again	again	ADV
ajmsi-505	131	10	centrifuged	centrifuge	VERB
ajmsi-505	131	11	at	at	ADP
ajmsi-505	131	12	2500	2500	NUM
ajmsi-505	131	13	g	g	NOUN
ajmsi-505	131	14	for	for	ADP
ajmsi-505	131	15	five	five	NUM
ajmsi-505	131	16	minutes	minute	NOUN
ajmsi-505	131	17	and	and	CCONJ
ajmsi-505	131	18	re	re	VERB
ajmsi-505	131	19	-	-	VERB
ajmsi-505	131	20	suspended	suspend	VERB
ajmsi-505	131	21	in	in	ADP
ajmsi-505	131	22	10ml	10ml	NOUN
ajmsi-505	131	23	lj	lj	PROPN
ajmsi-505	131	24	broth	broth	NOUN
ajmsi-505	131	25	,	,	PUNCT
ajmsi-505	131	26	pre	pre	VERB
ajmsi-505	131	27	-	-	VERB
ajmsi-505	131	28	warmed	warm	VERB
ajmsi-505	131	29	at	at	ADP
ajmsi-505	131	30	37	37	NUM
ajmsi-505	131	31	°	°	NOUN
ajmsi-505	131	32	c	c	NOUN
ajmsi-505	131	33	and	and	CCONJ
ajmsi-505	131	34	mixed	mix	VERB
ajmsi-505	131	35	with	with	ADP
ajmsi-505	131	36	a	a	DET
ajmsi-505	131	37	specialized	specialized	ADJ
ajmsi-505	131	38	transducing	transduce	VERB
ajmsi-505	131	39	phage	phage	NOUN
ajmsi-505	131	40	(	(	PUNCT
ajmsi-505	131	41	human	human	PROPN
ajmsi-505	131	42	t	t	PROPN
ajmsi-505	131	43	-	-	PUNCT
ajmsi-505	131	44	cell	cell	NOUN
ajmsi-505	131	45	lymphotrophic	lymphotrophic	ADJ
ajmsi-505	131	46	virus-3	virus-3	NUM
ajmsi-505	131	47	)	)	PUNCT
ajmsi-505	131	48	in	in	ADP
ajmsi-505	131	49	a	a	DET
ajmsi-505	131	50	10ml	10ml	NOUN
ajmsi-505	131	51	:	:	PUNCT
ajmsi-505	131	52	1ml	1ml	ADJ
ajmsi-505	131	53	v	v	ADP
ajmsi-505	131	54	/	/	SYM
ajmsi-505	131	55	v	v	NOUN
ajmsi-505	131	56	ratio	ratio	NOUN
ajmsi-505	131	57	.	.	PUNCT
ajmsi-505	132	1	the	the	DET
ajmsi-505	132	2	cell	cell	NOUN
ajmsi-505	132	3	/	/	SYM
ajmsi-505	132	4	phage	phage	NOUN
ajmsi-505	132	5	mixture	mixture	NOUN
ajmsi-505	132	6	was	be	AUX
ajmsi-505	132	7	inoculated	inoculate	VERB
ajmsi-505	132	8	into	into	ADP
ajmsi-505	132	9	50ml	50ml	ADJ
ajmsi-505	132	10	lj	lj	ADJ
ajmsi-505	132	11	broth	broth	NOUN
ajmsi-505	132	12	and	and	CCONJ
ajmsi-505	132	13	incubated	incubate	VERB
ajmsi-505	132	14	at	at	ADP
ajmsi-505	132	15	37	37	NUM
ajmsi-505	132	16	°	°	NOUN
ajmsi-505	132	17	c	c	NOUN
ajmsi-505	132	18	.	.	PUNCT
ajmsi-505	133	1	outgrowth	outgrowth	NOUN
ajmsi-505	133	2	of	of	ADP
ajmsi-505	133	3	the	the	DET
ajmsi-505	133	4	cultures	culture	NOUN
ajmsi-505	133	5	was	be	AUX
ajmsi-505	133	6	performed	perform	VERB
ajmsi-505	133	7	for	for	ADP
ajmsi-505	133	8	24hr	24hr	NOUN
ajmsi-505	133	9	at	at	ADP
ajmsi-505	133	10	37	37	NUM
ajmsi-505	133	11	°	°	NOUN
ajmsi-505	133	12	c	c	NOUN
ajmsi-505	133	13	.	.	PUNCT
ajmsi-505	134	1	cells	cell	NOUN
ajmsi-505	134	2	were	be	AUX
ajmsi-505	134	3	then	then	ADV
ajmsi-505	134	4	pelleted	pellete	VERB
ajmsi-505	134	5	by	by	ADP
ajmsi-505	134	6	centrifugation	centrifugation	NOUN
ajmsi-505	134	7	at	at	ADP
ajmsi-505	134	8	2500	2500	NUM
ajmsi-505	134	9	g	g	NOUN
ajmsi-505	134	10	for	for	ADP
ajmsi-505	134	11	15minutes	15minutes	NUM
ajmsi-505	134	12	and	and	CCONJ
ajmsi-505	134	13	re	re	VERB
ajmsi-505	134	14	-	-	VERB
ajmsi-505	134	15	suspended	suspend	VERB
ajmsi-505	134	16	in	in	ADP
ajmsi-505	134	17	one	one	NUM
ajmsi-505	134	18	millilitre	millilitre	NOUN
ajmsi-505	134	19	pbs	pbs	PROPN
ajmsi-505	134	20	-	-	PUNCT
ajmsi-505	134	21	tw	tw	PROPN
ajmsi-505	134	22	(	(	PUNCT
ajmsi-505	134	23	1.0	1.0	NUM
ajmsi-505	134	24	%	%	NOUN
ajmsi-505	134	25	tween	tween	NOUN
ajmsi-505	134	26	80	80	NUM
ajmsi-505	134	27	in	in	ADP
ajmsi-505	134	28	phosphate	phosphate	ADJ
ajmsi-505	134	29	buffered	buffer	VERB
ajmsi-505	134	30	saline	saline	NOUN
ajmsi-505	134	31	)	)	PUNCT
ajmsi-505	134	32	.	.	PUNCT
ajmsi-505	135	1	dst	dst	PROPN
ajmsi-505	135	2	of	of	ADP
ajmsi-505	135	3	transductant	transductant	PROPN
ajmsi-505	135	4	was	be	AUX
ajmsi-505	135	5	also	also	ADV
ajmsi-505	135	6	carried	carry	VERB
ajmsi-505	135	7	out	out	ADP
ajmsi-505	135	8	using	use	VERB
ajmsi-505	135	9	bactec	bactec	ADJ
ajmsi-505	135	10	mgit	mgit	NOUN
ajmsi-505	135	11	960	960	NUM
ajmsi-505	135	12	tb	tb	ADP
ajmsi-505	135	13	system	system	NOUN
ajmsi-505	135	14	earlier	early	ADV
ajmsi-505	135	15	described	describe	VERB
ajmsi-505	135	16	.	.	PUNCT
ajmsi-505	136	1	the	the	DET
ajmsi-505	136	2	results	result	NOUN
ajmsi-505	136	3	of	of	ADP
ajmsi-505	136	4	dst	dst	NOUN
ajmsi-505	136	5	for	for	ADP
ajmsi-505	136	6	transductants	transductant	NOUN
ajmsi-505	136	7	were	be	AUX
ajmsi-505	136	8	interpreted	interpret	VERB
ajmsi-505	136	9	and	and	CCONJ
ajmsi-505	136	10	reported	report	VERB
ajmsi-505	136	11	using	use	VERB
ajmsi-505	136	12	the	the	DET
ajmsi-505	136	13	format	format	NOUN
ajmsi-505	136	14	for	for	ADP
ajmsi-505	136	15	pure	pure	ADJ
ajmsi-505	136	16	m.	m.	NOUN
ajmsi-505	136	17	tuberculosis	tuberculosis	NOUN
ajmsi-505	136	18	isolates	isolate	NOUN
ajmsi-505	136	19	earlier	early	ADV
ajmsi-505	136	20	described	describe	VERB
ajmsi-505	136	21	.	.	PUNCT
ajmsi-505	137	1	analysis	analysis	NOUN
ajmsi-505	137	2	of	of	ADP
ajmsi-505	137	3	data	datum	NOUN
ajmsi-505	137	4	the	the	DET
ajmsi-505	137	5	results	result	NOUN
ajmsi-505	137	6	were	be	AUX
ajmsi-505	137	7	analyzed	analyze	VERB
ajmsi-505	137	8	using	use	VERB
ajmsi-505	137	9	minitab	minitab	PROPN
ajmsi-505	137	10	version	version	NOUN
ajmsi-505	137	11	14.0	14.0	NUM
ajmsi-505	137	12	statistical	statistical	ADJ
ajmsi-505	137	13	softwares	software	NOUN
ajmsi-505	137	14	.	.	PUNCT
ajmsi-505	138	1	student	student	NOUN
ajmsi-505	138	2	’s	’s	PART
ajmsi-505	138	3	t	t	PROPN
ajmsi-505	138	4	-	-	PUNCT
ajmsi-505	138	5	test	test	NOUN
ajmsi-505	138	6	was	be	AUX
ajmsi-505	138	7	used	use	VERB
ajmsi-505	138	8	to	to	PART
ajmsi-505	138	9	compute	compute	VERB
ajmsi-505	138	10	frequencies	frequency	NOUN
ajmsi-505	138	11	and	and	CCONJ
ajmsi-505	138	12	proportions	proportion	NOUN
ajmsi-505	138	13	,	,	PUNCT
ajmsi-505	138	14	p	p	NOUN
ajmsi-505	138	15	-	-	PUNCT
ajmsi-505	138	16	values	value	NOUN
ajmsi-505	138	17	<	<	NOUN
ajmsi-505	138	18	0.05	0.05	NUM
ajmsi-505	138	19	were	be	AUX
ajmsi-505	138	20	considered	consider	VERB
ajmsi-505	138	21	significant	significant	ADJ
ajmsi-505	138	22	at	at	ADP
ajmsi-505	138	23	95.0	95.0	NUM
ajmsi-505	138	24	%	%	NOUN
ajmsi-505	138	25	confidence	confidence	NOUN
ajmsi-505	138	26	level	level	NOUN
ajmsi-505	138	27	.	.	PUNCT
ajmsi-505	139	1	results	result	NOUN
ajmsi-505	139	2	out	out	ADP
ajmsi-505	139	3	of	of	ADP
ajmsi-505	139	4	the	the	DET
ajmsi-505	139	5	380	380	NUM
ajmsi-505	139	6	sputum	sputum	NOUN
ajmsi-505	139	7	samples	sample	NOUN
ajmsi-505	139	8	collected	collect	VERB
ajmsi-505	139	9	and	and	CCONJ
ajmsi-505	139	10	analyzed	analyze	VERB
ajmsi-505	139	11	,	,	PUNCT
ajmsi-505	139	12	268(70.5	268(70.5	NUM
ajmsi-505	139	13	%	%	NOUN
ajmsi-505	139	14	)	)	PUNCT
ajmsi-505	139	15	yielded	yield	VERB
ajmsi-505	139	16	positive	positive	ADJ
ajmsi-505	139	17	mycobacterium	mycobacterium	NOUN
ajmsi-505	139	18	tuberculosis	tuberculosis	NOUN
ajmsi-505	139	19	cultures	culture	NOUN
ajmsi-505	139	20	.	.	PUNCT
ajmsi-505	140	1	the	the	DET
ajmsi-505	140	2	results	result	NOUN
ajmsi-505	140	3	of	of	ADP
ajmsi-505	140	4	dst	dst	PROPN
ajmsi-505	140	5	carried	carry	VERB
ajmsi-505	140	6	out	out	ADP
ajmsi-505	140	7	on	on	ADP
ajmsi-505	140	8	the	the	DET
ajmsi-505	140	9	268	268	NUM
ajmsi-505	140	10	m.	m.	NOUN
ajmsi-505	140	11	tuberculosis	tuberculosis	NOUN
ajmsi-505	140	12	strains	strain	NOUN
ajmsi-505	140	13	showed	show	VERB
ajmsi-505	140	14	that	that	SCONJ
ajmsi-505	140	15	mdr	mdr	PROPN
ajmsi-505	140	16	-	-	PROPN
ajmsi-505	140	17	tb	tb	X
ajmsi-505	140	18	(	(	PUNCT
ajmsi-505	140	19	combined	combined	ADJ
ajmsi-505	140	20	resistance	resistance	NOUN
ajmsi-505	140	21	to	to	ADP
ajmsi-505	140	22	rifampicin	rifampicin	NOUN
ajmsi-505	140	23	and	and	CCONJ
ajmsi-505	140	24	isoniazid	isoniazid	NOUN
ajmsi-505	140	25	)	)	PUNCT
ajmsi-505	140	26	was	be	AUX
ajmsi-505	140	27	detected	detect	VERB
ajmsi-505	140	28	in	in	ADP
ajmsi-505	140	29	26(9.7	26(9.7	NUM
ajmsi-505	140	30	%	%	NOUN
ajmsi-505	140	31	)	)	PUNCT
ajmsi-505	140	32	strains	strain	NOUN
ajmsi-505	140	33	.	.	PUNCT
ajmsi-505	141	1	twenty	twenty	NUM
ajmsi-505	141	2	-	-	PUNCT
ajmsi-505	141	3	one	one	NUM
ajmsi-505	141	4	(	(	PUNCT
ajmsi-505	141	5	80.8	80.8	NUM
ajmsi-505	141	6	%	%	NOUN
ajmsi-505	141	7	)	)	PUNCT
ajmsi-505	141	8	cases	case	NOUN
ajmsi-505	141	9	were	be	AUX
ajmsi-505	141	10	male	male	ADJ
ajmsi-505	141	11	,	,	PUNCT
ajmsi-505	141	12	while	while	SCONJ
ajmsi-505	141	13	five	five	NUM
ajmsi-505	141	14	(	(	PUNCT
ajmsi-505	141	15	19.2	19.2	NUM
ajmsi-505	141	16	%	%	NOUN
ajmsi-505	141	17	)	)	PUNCT
ajmsi-505	141	18	cases	case	NOUN
ajmsi-505	141	19	were	be	AUX
ajmsi-505	141	20	female	female	ADJ
ajmsi-505	141	21	.	.	PUNCT
ajmsi-505	142	1	there	there	PRON
ajmsi-505	142	2	was	be	VERB
ajmsi-505	142	3	statistically	statistically	ADV
ajmsi-505	142	4	significant	significant	ADJ
ajmsi-505	142	5	difference	difference	NOUN
ajmsi-505	142	6	in	in	ADP
ajmsi-505	142	7	mdr	mdr	PROPN
ajmsi-505	142	8	-	-	NOUN
ajmsi-505	142	9	tb	tb	X
ajmsi-505	142	10	between	between	ADP
ajmsi-505	142	11	males	male	NOUN
ajmsi-505	142	12	and	and	CCONJ
ajmsi-505	142	13	females	female	NOUN
ajmsi-505	142	14	(	(	PUNCT
ajmsi-505	142	15	p<0.05	p<0.05	NOUN
ajmsi-505	142	16	)	)	PUNCT
ajmsi-505	142	17	in	in	ADP
ajmsi-505	142	18	the	the	DET
ajmsi-505	142	19	study	study	NOUN
ajmsi-505	142	20	population	population	NOUN
ajmsi-505	142	21	.	.	PUNCT
ajmsi-505	143	1	the	the	DET
ajmsi-505	143	2	results	result	NOUN
ajmsi-505	143	3	of	of	ADP
ajmsi-505	143	4	dst	dst	NOUN
ajmsi-505	143	5	for	for	ADP
ajmsi-505	143	6	the	the	DET
ajmsi-505	143	7	three	three	NUM
ajmsi-505	143	8	categories	category	NOUN
ajmsi-505	143	9	of	of	ADP
ajmsi-505	143	10	patients	patient	NOUN
ajmsi-505	143	11	is	be	AUX
ajmsi-505	143	12	shown	show	VERB
ajmsi-505	143	13	in	in	ADP
ajmsi-505	143	14	table	table	NOUN
ajmsi-505	143	15	1	1	NUM
ajmsi-505	143	16	.	.	PUNCT
ajmsi-505	143	17	table	table	NOUN
ajmsi-505	143	18	1	1	NUM
ajmsi-505	143	19	:	:	PUNCT
ajmsi-505	143	20	overall	overall	ADJ
ajmsi-505	143	21	results	result	NOUN
ajmsi-505	143	22	m.	m.	NOUN
ajmsi-505	143	23	tb	tb	ADP
ajmsi-505	143	24	of	of	ADP
ajmsi-505	143	25	culture	culture	NOUN
ajmsi-505	143	26	and	and	CCONJ
ajmsi-505	143	27	anti	anti	ADJ
ajmsi-505	143	28	-	-	ADJ
ajmsi-505	143	29	tb	tb	ADJ
ajmsi-505	143	30	drugs	drug	NOUN
ajmsi-505	143	31	susceptibility	susceptibility	NOUN
ajmsi-505	143	32	testing	testing	NOUN
ajmsi-505	143	33	(	(	PUNCT
ajmsi-505	143	34	dst	dst	NOUN
ajmsi-505	143	35	)	)	PUNCT
ajmsi-505	143	36	age	age	NOUN
ajmsi-505	143	37	group	group	NOUN
ajmsi-505	143	38	(	(	PUNCT
ajmsi-505	143	39	years	year	NOUN
ajmsi-505	143	40	)	)	PUNCT
ajmsi-505	143	41	m.	m.	NOUN
ajmsi-505	143	42	tb	tb	ADP
ajmsi-505	143	43	+	+	NUM
ajmsi-505	143	44	cultures	culture	NOUN
ajmsi-505	143	45	cat	cat	NOUN
ajmsi-505	143	46	i	i	PRON
ajmsi-505	143	47	cat	cat	PROPN
ajmsi-505	143	48	ii	ii	PROPN
ajmsi-505	143	49	cat	cat	PROPN
ajmsi-505	143	50	iii	iii	PROPN
ajmsi-505	143	51	total	total	PROPN
ajmsi-505	143	52	mdr	mdr	PROPN
ajmsi-505	143	53	-	-	PROPN
ajmsi-505	143	54	tb	tb	NOUN
ajmsi-505	143	55	detected	detect	VERB
ajmsi-505	143	56	%	%	NOUN
ajmsi-505	144	1	m	m	NOUN
ajmsi-505	144	2	f	f	X
ajmsi-505	144	3	m	m	VERB
ajmsi-505	145	1	f	f	NOUN
ajmsi-505	145	2	m	m	NOUN
ajmsi-505	145	3	f	f	X
ajmsi-505	145	4	<	<	X
ajmsi-505	145	5	1	1	NUM
ajmsi-505	145	6	–	–	SYM
ajmsi-505	145	7	10	10	NUM
ajmsi-505	145	8	2	2	NUM
ajmsi-505	145	9	0	0	NUM
ajmsi-505	145	10	0	0	NUM
ajmsi-505	145	11	0	0	NUM
ajmsi-505	145	12	0	0	NUM
ajmsi-505	145	13	0	0	NUM
ajmsi-505	145	14	0	0	NUM
ajmsi-505	145	15	0	0	NUM
ajmsi-505	145	16	0	0	NUM
ajmsi-505	145	17	11	11	NUM
ajmsi-505	145	18	–	–	PUNCT
ajmsi-505	145	19	20	20	NUM
ajmsi-505	145	20	8	8	NUM
ajmsi-505	145	21	0	0	NUM
ajmsi-505	145	22	0	0	NUM
ajmsi-505	145	23	1	1	NUM
ajmsi-505	145	24	0	0	NUM
ajmsi-505	145	25	1	1	NUM
ajmsi-505	145	26	0	0	NUM
ajmsi-505	145	27	2	2	NUM
ajmsi-505	145	28	7.69	7.69	NUM
ajmsi-505	145	29	21	21	NUM
ajmsi-505	145	30	–	–	PUNCT
ajmsi-505	145	31	30	30	NUM
ajmsi-505	145	32	70	70	NUM
ajmsi-505	145	33	1	1	NUM
ajmsi-505	145	34	1	1	NUM
ajmsi-505	145	35	1	1	NUM
ajmsi-505	145	36	0	0	NUM
ajmsi-505	145	37	1	1	NUM
ajmsi-505	145	38	0	0	NUM
ajmsi-505	145	39	4	4	NUM
ajmsi-505	145	40	15.38	15.38	NUM
ajmsi-505	145	41	31	31	NUM
ajmsi-505	145	42	–	–	PUNCT
ajmsi-505	145	43	40	40	NUM
ajmsi-505	145	44	106	106	NUM
ajmsi-505	145	45	2	2	NUM
ajmsi-505	145	46	0	0	NUM
ajmsi-505	145	47	2	2	NUM
ajmsi-505	145	48	0	0	NUM
ajmsi-505	145	49	2	2	NUM
ajmsi-505	145	50	0	0	NUM
ajmsi-505	145	51	6	6	NUM
ajmsi-505	145	52	23.08	23.08	NUM
ajmsi-505	145	53	41	41	NUM
ajmsi-505	145	54	–	–	PUNCT
ajmsi-505	145	55	50	50	NUM
ajmsi-505	145	56	37	37	NUM
ajmsi-505	145	57	3	3	NUM
ajmsi-505	145	58	1	1	NUM
ajmsi-505	145	59	3	3	NUM
ajmsi-505	145	60	1	1	NUM
ajmsi-505	145	61	1	1	NUM
ajmsi-505	145	62	1	1	NUM
ajmsi-505	145	63	10	10	NUM
ajmsi-505	145	64	38.46	38.46	NUM
ajmsi-505	145	65	51	51	NUM
ajmsi-505	145	66	–	–	PUNCT
ajmsi-505	145	67	60	60	NUM
ajmsi-505	145	68	31	31	NUM
ajmsi-505	145	69	1	1	NUM
ajmsi-505	145	70	1	1	NUM
ajmsi-505	145	71	1	1	NUM
ajmsi-505	145	72	0	0	NUM
ajmsi-505	145	73	1	1	NUM
ajmsi-505	145	74	0	0	NUM
ajmsi-505	145	75	4	4	NUM
ajmsi-505	145	76	15.38	15.38	NUM
ajmsi-505	145	77	61	61	NUM
ajmsi-505	145	78	–	–	PUNCT
ajmsi-505	145	79	70	70	NUM
ajmsi-505	145	80	9	9	NUM
ajmsi-505	145	81	0	0	NUM
ajmsi-505	145	82	0	0	NUM
ajmsi-505	145	83	0	0	NUM
ajmsi-505	145	84	0	0	NUM
ajmsi-505	145	85	0	0	NUM
ajmsi-505	145	86	0	0	NUM
ajmsi-505	145	87	0	0	NUM
ajmsi-505	145	88	0	0	NUM
ajmsi-505	145	89	≥	≥	NOUN
ajmsi-505	145	90	71	71	NUM
ajmsi-505	145	91	5	5	NUM
ajmsi-505	145	92	0	0	NUM
ajmsi-505	145	93	0	0	NUM
ajmsi-505	145	94	0	0	NUM
ajmsi-505	145	95	0	0	NUM
ajmsi-505	145	96	0	0	NUM
ajmsi-505	145	97	0	0	NUM
ajmsi-505	145	98	0	0	NUM
ajmsi-505	145	99	0	0	NUM
ajmsi-505	146	1	total	total	NOUN
ajmsi-505	146	2	268	268	NUM
ajmsi-505	146	3	7	7	NUM
ajmsi-505	146	4	3	3	NUM
ajmsi-505	146	5	8	8	NUM
ajmsi-505	146	6	1	1	NUM
ajmsi-505	146	7	6	6	NUM
ajmsi-505	146	8	1	1	NUM
ajmsi-505	146	9	26	26	NUM
ajmsi-505	146	10	100	100	NUM
ajmsi-505	146	11	key	key	NOUN
ajmsi-505	146	12	:	:	PUNCT
ajmsi-505	146	13	m.	m.	NOUN
ajmsi-505	146	14	tb	tb	NOUN
ajmsi-505	146	15	=	=	PUNCT
ajmsi-505	146	16	mycobacterium	mycobacterium	NOUN
ajmsi-505	146	17	tuberculosis	tuberculosis	NOUN
ajmsi-505	146	18	,	,	PUNCT
ajmsi-505	146	19	mdr	mdr	PROPN
ajmsi-505	146	20	-	-	PROPN
ajmsi-505	146	21	tb=	tb=	PROPN
ajmsi-505	146	22	multi	multi	ADJ
ajmsi-505	146	23	-	-	ADJ
ajmsi-505	146	24	drug	drug	ADJ
ajmsi-505	146	25	resistant	resistant	ADJ
ajmsi-505	146	26	tuberculosis	tuberculosis	NOUN
ajmsi-505	146	27	,	,	PUNCT
ajmsi-505	146	28	m	m	NOUN
ajmsi-505	146	29	=	=	NOUN
ajmsi-505	146	30	total	total	ADJ
ajmsi-505	146	31	male	male	NOUN
ajmsi-505	146	32	,	,	PUNCT
ajmsi-505	146	33	f	f	PROPN
ajmsi-505	146	34	=	=	ADJ
ajmsi-505	146	35	total	total	ADJ
ajmsi-505	146	36	female	female	NOUN
ajmsi-505	146	37	,	,	PUNCT
ajmsi-505	146	38	+	+	NOUN
ajmsi-505	146	39	=	=	ADJ
ajmsi-505	146	40	positive	positive	ADJ
ajmsi-505	146	41	m.	m.	NOUN
ajmsi-505	146	42	tb	tb	ADP
ajmsi-505	146	43	cultures	culture	NOUN
ajmsi-505	146	44	,	,	PUNCT
ajmsi-505	146	45	cat	cat	NOUN
ajmsi-505	146	46	i	i	NOUN
ajmsi-505	146	47	=	=	NOUN
ajmsi-505	146	48	category	category	NOUN
ajmsi-505	146	49	1	1	NUM
ajmsi-505	146	50	,	,	PUNCT
ajmsi-505	146	51	cat	cat	NOUN
ajmsi-505	146	52	ii	ii	PROPN
ajmsi-505	146	53	=	=	NOUN
ajmsi-505	146	54	category	category	NOUN
ajmsi-505	146	55	2	2	NUM
ajmsi-505	146	56	,	,	PUNCT
ajmsi-505	146	57	cat	cat	NOUN
ajmsi-505	146	58	iii	iii	X
ajmsi-505	146	59	=	=	SYM
ajmsi-505	146	60	category	category	NOUN
ajmsi-505	146	61	3	3	NUM
ajmsi-505	146	62	the	the	DET
ajmsi-505	146	63	results	result	NOUN
ajmsi-505	146	64	of	of	ADP
ajmsi-505	146	65	dst	dst	NOUN
ajmsi-505	146	66	for	for	ADP
ajmsi-505	146	67	category	category	NOUN
ajmsi-505	146	68	i	i	PRON
ajmsi-505	146	69	patients	patient	NOUN
ajmsi-505	146	70	showed	show	VERB
ajmsi-505	146	71	that	that	SCONJ
ajmsi-505	146	72	mdr	mdr	PROPN
ajmsi-505	146	73	-	-	PROPN
ajmsi-505	146	74	tb	tb	PROPN
ajmsi-505	146	75	was	be	AUX
ajmsi-505	146	76	detected	detect	VERB
ajmsi-505	146	77	in	in	ADP
ajmsi-505	146	78	10(38.5	10(38.5	NUM
ajmsi-505	146	79	%	%	NOUN
ajmsi-505	146	80	)	)	PUNCT
ajmsi-505	146	81	cases	case	NOUN
ajmsi-505	146	82	while	while	SCONJ
ajmsi-505	146	83	rifampicin	rifampicin	VERB
ajmsi-505	146	84	resistance	resistance	NOUN
ajmsi-505	146	85	was	be	AUX
ajmsi-505	146	86	detected	detect	VERB
ajmsi-505	146	87	in	in	ADP
ajmsi-505	146	88	32(11.9	32(11.9	ADJ
ajmsi-505	146	89	%	%	NOUN
ajmsi-505	146	90	)	)	PUNCT
ajmsi-505	146	91	of	of	ADP
ajmsi-505	146	92	cases	case	NOUN
ajmsi-505	146	93	as	as	SCONJ
ajmsi-505	146	94	shown	show	VERB
ajmsi-505	146	95	in	in	ADP
ajmsi-505	146	96	table	table	NOUN
ajmsi-505	146	97	2	2	NUM
ajmsi-505	146	98	.	.	PUNCT
ajmsi-505	146	99	table	table	NOUN
ajmsi-505	146	100	2	2	NUM
ajmsi-505	146	101	:	:	PUNCT
ajmsi-505	146	102	sputum	sputum	NOUN
ajmsi-505	146	103	culture	culture	NOUN
ajmsi-505	146	104	and	and	CCONJ
ajmsi-505	146	105	anti	anti	ADJ
ajmsi-505	146	106	-	-	ADJ
ajmsi-505	146	107	tb	tb	ADJ
ajmsi-505	146	108	dst	dst	NOUN
ajmsi-505	146	109	(	(	PUNCT
ajmsi-505	146	110	category	category	NOUN
ajmsi-505	146	111	i	i	PRON
ajmsi-505	146	112	patients	patient	NOUN
ajmsi-505	146	113	)	)	PUNCT
ajmsi-505	146	114	age	age	NOUN
ajmsi-505	146	115	(	(	PUNCT
ajmsi-505	146	116	years	year	NOUN
ajmsi-505	146	117	)	)	PUNCT
ajmsi-505	146	118	no	no	NOUN
ajmsi-505	146	119	.	.	PUNCT
ajmsi-505	146	120	of	of	ADP
ajmsi-505	146	121	m.	m.	NOUN
ajmsi-505	146	122	tb	tb	ADP
ajmsi-505	146	123	+	+	NUM
ajmsi-505	146	124	cultures	culture	NOUN
ajmsi-505	146	125	rif	rif	PROPN
ajmsi-505	146	126	inh	inh	PROPN
ajmsi-505	146	127	s	s	PART
ajmsi-505	146	128	pza	pza	NOUN
ajmsi-505	146	129	emb	emb	X
ajmsi-505	146	130	mdr	mdr	PROPN
ajmsi-505	146	131	-	-	PROPN
ajmsi-505	146	132	tb	tb	NOUN
ajmsi-505	146	133	detected	detect	VERB
ajmsi-505	146	134	m	m	NOUN
ajmsi-505	147	1	f	f	NOUN
ajmsi-505	147	2	r	r	NOUN
ajmsi-505	147	3	s	s	NOUN
ajmsi-505	147	4	r	r	NOUN
ajmsi-505	147	5	s	s	NOUN
ajmsi-505	147	6	r	r	NOUN
ajmsi-505	147	7	s	s	NOUN
ajmsi-505	147	8	r	r	NOUN
ajmsi-505	147	9	s	s	NOUN
ajmsi-505	147	10	r	r	NOUN
ajmsi-505	147	11	s	s	X
ajmsi-505	147	12	<	<	X
ajmsi-505	147	13	1	1	NUM
ajmsi-505	147	14	–	–	PUNCT
ajmsi-505	147	15	10	10	NUM
ajmsi-505	147	16	0	0	NUM
ajmsi-505	147	17	0	0	NUM
ajmsi-505	147	18	0	0	NUM
ajmsi-505	147	19	0	0	NUM
ajmsi-505	147	20	0	0	NUM
ajmsi-505	147	21	0	0	NUM
ajmsi-505	147	22	0	0	NUM
ajmsi-505	147	23	0	0	NUM
ajmsi-505	147	24	0	0	NUM
ajmsi-505	147	25	0	0	NUM
ajmsi-505	147	26	0	0	NUM
ajmsi-505	147	27	0	0	NUM
ajmsi-505	147	28	0	0	NUM
ajmsi-505	147	29	0	0	NUM
ajmsi-505	147	30	11	11	NUM
ajmsi-505	147	31	–	–	PUNCT
ajmsi-505	147	32	20	20	NUM
ajmsi-505	147	33	3	3	NUM
ajmsi-505	147	34	0	0	NUM
ajmsi-505	147	35	3	3	NUM
ajmsi-505	147	36	0	0	NUM
ajmsi-505	147	37	3	3	NUM
ajmsi-505	147	38	0	0	NUM
ajmsi-505	147	39	3	3	NUM
ajmsi-505	147	40	0	0	NUM
ajmsi-505	147	41	3	3	NUM
ajmsi-505	147	42	2	2	NUM
ajmsi-505	147	43	1	1	NUM
ajmsi-505	147	44	0	0	NUM
ajmsi-505	147	45	0	0	NUM
ajmsi-505	147	46	0	0	NUM
ajmsi-505	147	47	21	21	NUM
ajmsi-505	147	48	–	–	PUNCT
ajmsi-505	147	49	30	30	NUM
ajmsi-505	147	50	26	26	NUM
ajmsi-505	147	51	9	9	NUM
ajmsi-505	147	52	17	17	NUM
ajmsi-505	147	53	2	2	NUM
ajmsi-505	147	54	24	24	NUM
ajmsi-505	147	55	7	7	NUM
ajmsi-505	147	56	19	19	NUM
ajmsi-505	147	57	2	2	NUM
ajmsi-505	147	58	24	24	NUM
ajmsi-505	147	59	16	16	NUM
ajmsi-505	147	60	10	10	NUM
ajmsi-505	147	61	2	2	NUM
ajmsi-505	147	62	1	1	NUM
ajmsi-505	147	63	1	1	NUM
ajmsi-505	147	64	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	147	65	pa	pa	PROPN
ajmsi-505	147	66	ge	ge	PROPN
ajmsi-505	147	67	5	5	NUM
ajmsi-505	147	68	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	147	69	am	be	AUX
ajmsi-505	147	70	.	.	PUNCT
ajmsi-505	148	1	j.	j.	PROPN
ajmsi-505	148	2	med	med	PROPN
ajmsi-505	148	3	.	.	PUNCT
ajmsi-505	149	1	sci	sci	PROPN
ajmsi-505	149	2	.	.	PUNCT
ajmsi-505	149	3	innov	innov	PROPN
ajmsi-505	149	4	.	.	PUNCT
ajmsi-505	150	1	1(1	1(1	NUM
ajmsi-505	150	2	)	)	PUNCT
ajmsi-505	150	3	1	1	NUM
ajmsi-505	150	4	-	-	SYM
ajmsi-505	150	5	9	9	NUM
ajmsi-505	150	6	,	,	PUNCT
ajmsi-505	150	7	2022	2022	NUM
ajmsi-505	150	8	table	table	NOUN
ajmsi-505	150	9	3	3	NUM
ajmsi-505	150	10	:	:	PUNCT
ajmsi-505	150	11	sputum	sputum	PROPN
ajmsi-505	150	12	culture	culture	NOUN
ajmsi-505	150	13	and	and	CCONJ
ajmsi-505	150	14	anti	anti	ADJ
ajmsi-505	150	15	-	-	ADJ
ajmsi-505	150	16	tb	tb	ADJ
ajmsi-505	150	17	dst	dst	NOUN
ajmsi-505	150	18	(	(	PUNCT
ajmsi-505	150	19	category	category	NOUN
ajmsi-505	150	20	ii	ii	NOUN
ajmsi-505	150	21	patients	patient	NOUN
ajmsi-505	150	22	)	)	PUNCT
ajmsi-505	150	23	age	age	NOUN
ajmsi-505	150	24	(	(	PUNCT
ajmsi-505	150	25	years	year	NOUN
ajmsi-505	150	26	)	)	PUNCT
ajmsi-505	150	27	no	no	NOUN
ajmsi-505	150	28	.	.	PUNCT
ajmsi-505	150	29	of	of	ADP
ajmsi-505	150	30	m.	m.	NOUN
ajmsi-505	150	31	tb	tb	ADP
ajmsi-505	150	32	+	+	NUM
ajmsi-505	150	33	cultures	culture	NOUN
ajmsi-505	150	34	rif	rif	PROPN
ajmsi-505	150	35	inh	inh	PROPN
ajmsi-505	150	36	s	s	PART
ajmsi-505	150	37	pza	pza	NOUN
ajmsi-505	150	38	emb	emb	X
ajmsi-505	150	39	mdr	mdr	PROPN
ajmsi-505	150	40	-	-	PROPN
ajmsi-505	150	41	tb	tb	NOUN
ajmsi-505	150	42	detected	detect	VERB
ajmsi-505	150	43	m	m	NOUN
ajmsi-505	150	44	f	f	NOUN
ajmsi-505	150	45	r	r	NOUN
ajmsi-505	151	1	s	s	NOUN
ajmsi-505	151	2	r	r	NOUN
ajmsi-505	151	3	s	s	NOUN
ajmsi-505	151	4	r	r	NOUN
ajmsi-505	151	5	s	s	NOUN
ajmsi-505	151	6	r	r	NOUN
ajmsi-505	151	7	s	s	NOUN
ajmsi-505	151	8	r	r	NOUN
ajmsi-505	151	9	s	s	X
ajmsi-505	151	10	<	<	X
ajmsi-505	151	11	1	1	NUM
ajmsi-505	151	12	–	–	PUNCT
ajmsi-505	151	13	10	10	NUM
ajmsi-505	151	14	0	0	NUM
ajmsi-505	151	15	0	0	NUM
ajmsi-505	151	16	0	0	NUM
ajmsi-505	151	17	0	0	NUM
ajmsi-505	151	18	0	0	NUM
ajmsi-505	151	19	0	0	NUM
ajmsi-505	151	20	0	0	NUM
ajmsi-505	151	21	0	0	NUM
ajmsi-505	151	22	0	0	NUM
ajmsi-505	151	23	0	0	NUM
ajmsi-505	151	24	0	0	NUM
ajmsi-505	151	25	0	0	NUM
ajmsi-505	151	26	0	0	NUM
ajmsi-505	151	27	0	0	NUM
ajmsi-505	151	28	11	11	NUM
ajmsi-505	151	29	–	–	PUNCT
ajmsi-505	151	30	20	20	NUM
ajmsi-505	151	31	1	1	NUM
ajmsi-505	151	32	1	1	NUM
ajmsi-505	151	33	0	0	NUM
ajmsi-505	151	34	1	1	NUM
ajmsi-505	151	35	0	0	NUM
ajmsi-505	151	36	0	0	NUM
ajmsi-505	151	37	1	1	NUM
ajmsi-505	151	38	0	0	NUM
ajmsi-505	151	39	1	1	NUM
ajmsi-505	151	40	0	0	NUM
ajmsi-505	151	41	1	1	NUM
ajmsi-505	151	42	1	1	NUM
ajmsi-505	151	43	1	1	NUM
ajmsi-505	151	44	0	0	NUM
ajmsi-505	151	45	21	21	NUM
ajmsi-505	151	46	–	–	PUNCT
ajmsi-505	151	47	30	30	NUM
ajmsi-505	151	48	18	18	NUM
ajmsi-505	151	49	6	6	NUM
ajmsi-505	151	50	12	12	NUM
ajmsi-505	151	51	1	1	NUM
ajmsi-505	151	52	17	17	NUM
ajmsi-505	151	53	2	2	NUM
ajmsi-505	151	54	15	15	NUM
ajmsi-505	151	55	5	5	NUM
ajmsi-505	151	56	12	12	NUM
ajmsi-505	151	57	8	8	NUM
ajmsi-505	151	58	11	11	NUM
ajmsi-505	151	59	1	1	NUM
ajmsi-505	151	60	1	1	NUM
ajmsi-505	151	61	0	0	NUM
ajmsi-505	151	62	31	31	NUM
ajmsi-505	151	63	–	–	PUNCT
ajmsi-505	151	64	40	40	NUM
ajmsi-505	151	65	31	31	NUM
ajmsi-505	151	66	11	11	NUM
ajmsi-505	151	67	20	20	NUM
ajmsi-505	151	68	2	2	NUM
ajmsi-505	151	69	29	29	NUM
ajmsi-505	151	70	3	3	NUM
ajmsi-505	151	71	28	28	NUM
ajmsi-505	151	72	6	6	NUM
ajmsi-505	151	73	25	25	NUM
ajmsi-505	151	74	11	11	NUM
ajmsi-505	151	75	20	20	NUM
ajmsi-505	151	76	2	2	NUM
ajmsi-505	151	77	2	2	NUM
ajmsi-505	151	78	0	0	NUM
ajmsi-505	151	79	41	41	NUM
ajmsi-505	151	80	–	–	PUNCT
ajmsi-505	151	81	50	50	NUM
ajmsi-505	151	82	7	7	NUM
ajmsi-505	151	83	4	4	NUM
ajmsi-505	151	84	3	3	NUM
ajmsi-505	151	85	4	4	NUM
ajmsi-505	151	86	3	3	NUM
ajmsi-505	151	87	1	1	NUM
ajmsi-505	151	88	6	6	NUM
ajmsi-505	151	89	0	0	NUM
ajmsi-505	151	90	7	7	NUM
ajmsi-505	151	91	2	2	NUM
ajmsi-505	151	92	5	5	NUM
ajmsi-505	151	93	4	4	NUM
ajmsi-505	151	94	3	3	NUM
ajmsi-505	151	95	1	1	NUM
ajmsi-505	151	96	51	51	NUM
ajmsi-505	151	97	–	–	PUNCT
ajmsi-505	151	98	60	60	NUM
ajmsi-505	151	99	14	14	NUM
ajmsi-505	151	100	2	2	NUM
ajmsi-505	151	101	12	12	NUM
ajmsi-505	151	102	1	1	NUM
ajmsi-505	151	103	12	12	NUM
ajmsi-505	151	104	1	1	NUM
ajmsi-505	151	105	13	13	NUM
ajmsi-505	151	106	1	1	NUM
ajmsi-505	151	107	15	15	NUM
ajmsi-505	151	108	2	2	NUM
ajmsi-505	151	109	12	12	NUM
ajmsi-505	151	110	1	1	NUM
ajmsi-505	151	111	1	1	NUM
ajmsi-505	151	112	0	0	NUM
ajmsi-505	151	113	61	61	NUM
ajmsi-505	151	114	–	–	PUNCT
ajmsi-505	151	115	70	70	NUM
ajmsi-505	151	116	6	6	NUM
ajmsi-505	151	117	2	2	NUM
ajmsi-505	151	118	4	4	NUM
ajmsi-505	151	119	0	0	NUM
ajmsi-505	151	120	6	6	NUM
ajmsi-505	151	121	0	0	NUM
ajmsi-505	151	122	6	6	NUM
ajmsi-505	151	123	0	0	NUM
ajmsi-505	151	124	6	6	NUM
ajmsi-505	151	125	1	1	NUM
ajmsi-505	151	126	5	5	NUM
ajmsi-505	151	127	0	0	NUM
ajmsi-505	151	128	0	0	NUM
ajmsi-505	151	129	0	0	NUM
ajmsi-505	151	130	≥	≥	NOUN
ajmsi-505	151	131	71	71	NUM
ajmsi-505	151	132	2	2	NUM
ajmsi-505	151	133	0	0	NUM
ajmsi-505	151	134	3	3	NUM
ajmsi-505	151	135	0	0	NUM
ajmsi-505	151	136	3	3	NUM
ajmsi-505	151	137	0	0	NUM
ajmsi-505	151	138	3	3	NUM
ajmsi-505	151	139	0	0	NUM
ajmsi-505	151	140	3	3	NUM
ajmsi-505	151	141	0	0	NUM
ajmsi-505	151	142	3	3	NUM
ajmsi-505	151	143	0	0	NUM
ajmsi-505	151	144	0	0	NUM
ajmsi-505	151	145	0	0	NUM
ajmsi-505	151	146	total	total	NOUN
ajmsi-505	151	147	79	79	NUM
ajmsi-505	151	148	26	26	NUM
ajmsi-505	151	149	54	54	NUM
ajmsi-505	151	150	9	9	NUM
ajmsi-505	151	151	70	70	NUM
ajmsi-505	151	152	7	7	NUM
ajmsi-505	151	153	72	72	NUM
ajmsi-505	151	154	12	12	NUM
ajmsi-505	151	155	69	69	NUM
ajmsi-505	151	156	24	24	NUM
ajmsi-505	151	157	57	57	NUM
ajmsi-505	151	158	9	9	NUM
ajmsi-505	151	159	8	8	NUM
ajmsi-505	151	160	1	1	NUM
ajmsi-505	151	161	t	t	NOUN
ajmsi-505	151	162	=	=	PUNCT
ajmsi-505	151	163	885.44	885.44	NUM
ajmsi-505	151	164	,	,	PUNCT
ajmsi-505	151	165	df	df	PROPN
ajmsi-505	151	166	=	=	NUM
ajmsi-505	151	167	10	10	NUM
ajmsi-505	151	168	,	,	PUNCT
ajmsi-505	151	169	p	p	X
ajmsi-505	151	170	<	<	X
ajmsi-505	151	171	0.05	0.05	NUM
ajmsi-505	151	172	key	key	NOUN
ajmsi-505	151	173	:	:	PUNCT
ajmsi-505	151	174	emb	emb	NOUN
ajmsi-505	151	175	=	=	SYM
ajmsi-505	151	176	etambutol	etambutol	NOUN
ajmsi-505	151	177	,	,	PUNCT
ajmsi-505	151	178	m.	m.	NOUN
ajmsi-505	151	179	tb	tb	NOUN
ajmsi-505	151	180	=	=	PUNCT
ajmsi-505	151	181	mycobacterium	mycobacterium	NOUN
ajmsi-505	151	182	tuberculosis	tuberculosis	NOUN
ajmsi-505	151	183	,	,	PUNCT
ajmsi-505	151	184	mdr	mdr	PROPN
ajmsi-505	151	185	-	-	PROPN
ajmsi-505	151	186	tb=	tb=	PROPN
ajmsi-505	151	187	multi	multi	ADJ
ajmsi-505	151	188	-	-	ADJ
ajmsi-505	151	189	drug	drug	ADJ
ajmsi-505	151	190	resistant	resistant	ADJ
ajmsi-505	151	191	tuberculosis	tuberculosis	NOUN
ajmsi-505	151	192	,	,	PUNCT
ajmsi-505	151	193	r	r	NOUN
ajmsi-505	151	194	=	=	SYM
ajmsi-505	151	195	resistant	resistant	ADJ
ajmsi-505	151	196	,	,	PUNCT
ajmsi-505	151	197	s	s	NOUN
ajmsi-505	151	198	=	=	NOUN
ajmsi-505	151	199	susceptible	susceptible	ADJ
ajmsi-505	151	200	,	,	PUNCT
ajmsi-505	151	201	rif	rif	PROPN
ajmsi-505	151	202	=	=	NOUN
ajmsi-505	151	203	rifampicin	rifampicin	VERB
ajmsi-505	151	204	,	,	PUNCT
ajmsi-505	151	205	inh	inh	PROPN
ajmsi-505	151	206	=	=	SYM
ajmsi-505	151	207	isoniazid	isoniazid	NOUN
ajmsi-505	151	208	,	,	PUNCT
ajmsi-505	151	209	s	s	PART
ajmsi-505	151	210	=	=	NOUN
ajmsi-505	151	211	streptomycin	streptomycin	PROPN
ajmsi-505	151	212	,	,	PUNCT
ajmsi-505	151	213	pza	pza	NOUN
ajmsi-505	151	214	=	=	SYM
ajmsi-505	151	215	parazinamide	parazinamide	NOUN
ajmsi-505	151	216	,	,	PUNCT
ajmsi-505	151	217	m	m	NOUN
ajmsi-505	151	218	=	=	NOUN
ajmsi-505	151	219	total	total	ADJ
ajmsi-505	151	220	male	male	NOUN
ajmsi-505	151	221	,	,	PUNCT
ajmsi-505	151	222	f	f	PROPN
ajmsi-505	151	223	=	=	ADJ
ajmsi-505	151	224	total	total	ADJ
ajmsi-505	151	225	female	female	NOUN
ajmsi-505	151	226	,	,	PUNCT
ajmsi-505	151	227	+	+	NOUN
ajmsi-505	151	228	=	=	ADJ
ajmsi-505	151	229	positive	positive	ADJ
ajmsi-505	151	230	m.	m.	NOUN
ajmsi-505	151	231	tb	tb	ADP
ajmsi-505	151	232	cultures	culture	NOUN
ajmsi-505	151	233	,	,	PUNCT
ajmsi-505	151	234	dst=	dst=	PROPN
ajmsi-505	151	235	drugs	drug	NOUN
ajmsi-505	151	236	susceptibility	susceptibility	NOUN
ajmsi-505	151	237	testing	testing	NOUN
ajmsi-505	151	238	table	table	NOUN
ajmsi-505	151	239	4	4	NUM
ajmsi-505	151	240	:	:	PUNCT
ajmsi-505	151	241	sputum	sputum	NOUN
ajmsi-505	151	242	culture	culture	NOUN
ajmsi-505	151	243	and	and	CCONJ
ajmsi-505	151	244	anti	anti	ADJ
ajmsi-505	151	245	-	-	ADJ
ajmsi-505	151	246	tb	tb	ADJ
ajmsi-505	151	247	dst	dst	NOUN
ajmsi-505	151	248	(	(	PUNCT
ajmsi-505	151	249	category	category	NOUN
ajmsi-505	151	250	iii	iii	NUM
ajmsi-505	151	251	patients	patient	NOUN
ajmsi-505	151	252	)	)	PUNCT
ajmsi-505	151	253	age	age	NOUN
ajmsi-505	151	254	(	(	PUNCT
ajmsi-505	151	255	years	year	NOUN
ajmsi-505	151	256	)	)	PUNCT
ajmsi-505	151	257	no	no	NOUN
ajmsi-505	151	258	.	.	PUNCT
ajmsi-505	151	259	of	of	ADP
ajmsi-505	151	260	m.	m.	NOUN
ajmsi-505	151	261	tb	tb	ADP
ajmsi-505	152	1	+	+	NUM
ajmsi-505	152	2	cultures	culture	NOUN
ajmsi-505	152	3	rif	rif	PROPN
ajmsi-505	152	4	inh	inh	PROPN
ajmsi-505	152	5	s	s	PART
ajmsi-505	152	6	pza	pza	NOUN
ajmsi-505	152	7	emb	emb	NOUN
ajmsi-505	152	8	mdrtb	mdrtb	PROPN
ajmsi-505	152	9	detected	detect	VERB
ajmsi-505	152	10	m	m	NOUN
ajmsi-505	153	1	f	f	NOUN
ajmsi-505	153	2	r	r	NOUN
ajmsi-505	153	3	s	s	NOUN
ajmsi-505	153	4	r	r	NOUN
ajmsi-505	153	5	s	s	NOUN
ajmsi-505	153	6	r	r	NOUN
ajmsi-505	153	7	s	s	NOUN
ajmsi-505	153	8	r	r	NOUN
ajmsi-505	153	9	s	s	NOUN
ajmsi-505	153	10	r	r	NOUN
ajmsi-505	153	11	s	s	X
ajmsi-505	153	12	<	<	X
ajmsi-505	153	13	1	1	NUM
ajmsi-505	153	14	–	–	SYM
ajmsi-505	153	15	10	10	NUM
ajmsi-505	153	16	2	2	NUM
ajmsi-505	153	17	0	0	NUM
ajmsi-505	153	18	2	2	NUM
ajmsi-505	153	19	0	0	NUM
ajmsi-505	153	20	2	2	NUM
ajmsi-505	153	21	0	0	NUM
ajmsi-505	153	22	2	2	NUM
ajmsi-505	153	23	0	0	NUM
ajmsi-505	153	24	2	2	NUM
ajmsi-505	153	25	0	0	NUM
ajmsi-505	153	26	2	2	NUM
ajmsi-505	153	27	0	0	NUM
ajmsi-505	153	28	0	0	NUM
ajmsi-505	153	29	0	0	NUM
ajmsi-505	153	30	11	11	NUM
ajmsi-505	153	31	–	–	PUNCT
ajmsi-505	153	32	20	20	NUM
ajmsi-505	153	33	4	4	NUM
ajmsi-505	153	34	3	3	NUM
ajmsi-505	153	35	1	1	NUM
ajmsi-505	153	36	1	1	NUM
ajmsi-505	153	37	3	3	NUM
ajmsi-505	153	38	0	0	NUM
ajmsi-505	153	39	4	4	NUM
ajmsi-505	153	40	1	1	NUM
ajmsi-505	153	41	3	3	NUM
ajmsi-505	153	42	0	0	NUM
ajmsi-505	153	43	4	4	NUM
ajmsi-505	153	44	1	1	NUM
ajmsi-505	153	45	1	1	NUM
ajmsi-505	153	46	0	0	NUM
ajmsi-505	153	47	21	21	NUM
ajmsi-505	153	48	–	–	PUNCT
ajmsi-505	153	49	30	30	NUM
ajmsi-505	153	50	26	26	NUM
ajmsi-505	153	51	6	6	NUM
ajmsi-505	153	52	20	20	NUM
ajmsi-505	153	53	1	1	NUM
ajmsi-505	153	54	25	25	NUM
ajmsi-505	153	55	5	5	NUM
ajmsi-505	153	56	21	21	NUM
ajmsi-505	153	57	2	2	NUM
ajmsi-505	153	58	24	24	NUM
ajmsi-505	153	59	4	4	NUM
ajmsi-505	153	60	22	22	NUM
ajmsi-505	153	61	1	1	NUM
ajmsi-505	153	62	1	1	NUM
ajmsi-505	153	63	0	0	NUM
ajmsi-505	153	64	31	31	NUM
ajmsi-505	153	65	–	–	PUNCT
ajmsi-505	153	66	40	40	NUM
ajmsi-505	153	67	37	37	NUM
ajmsi-505	153	68	4	4	NUM
ajmsi-505	153	69	33	33	NUM
ajmsi-505	153	70	2	2	NUM
ajmsi-505	153	71	35	35	NUM
ajmsi-505	153	72	4	4	NUM
ajmsi-505	153	73	33	33	NUM
ajmsi-505	153	74	8	8	NUM
ajmsi-505	153	75	29	29	NUM
ajmsi-505	153	76	6	6	NUM
ajmsi-505	153	77	31	31	NUM
ajmsi-505	153	78	2	2	NUM
ajmsi-505	153	79	2	2	NUM
ajmsi-505	153	80	0	0	NUM
ajmsi-505	153	81	41	41	NUM
ajmsi-505	153	82	–	–	PUNCT
ajmsi-505	153	83	50	50	NUM
ajmsi-505	153	84	16	16	NUM
ajmsi-505	153	85	6	6	NUM
ajmsi-505	153	86	10	10	NUM
ajmsi-505	153	87	2	2	NUM
ajmsi-505	153	88	14	14	NUM
ajmsi-505	153	89	2	2	NUM
ajmsi-505	153	90	14	14	NUM
ajmsi-505	153	91	6	6	NUM
ajmsi-505	153	92	10	10	NUM
ajmsi-505	153	93	4	4	NUM
ajmsi-505	153	94	12	12	NUM
ajmsi-505	153	95	2	2	NUM
ajmsi-505	153	96	1	1	NUM
ajmsi-505	153	97	1	1	NUM
ajmsi-505	153	98	51	51	NUM
ajmsi-505	153	99	–	–	PUNCT
ajmsi-505	153	100	60	60	NUM
ajmsi-505	153	101	12	12	NUM
ajmsi-505	153	102	3	3	NUM
ajmsi-505	153	103	9	9	NUM
ajmsi-505	153	104	1	1	NUM
ajmsi-505	153	105	11	11	NUM
ajmsi-505	153	106	2	2	NUM
ajmsi-505	153	107	10	10	NUM
ajmsi-505	153	108	1	1	NUM
ajmsi-505	153	109	11	11	NUM
ajmsi-505	153	110	3	3	NUM
ajmsi-505	153	111	9	9	NUM
ajmsi-505	153	112	1	1	NUM
ajmsi-505	153	113	1	1	NUM
ajmsi-505	153	114	0	0	NUM
ajmsi-505	153	115	61	61	NUM
ajmsi-505	153	116	–	–	SYM
ajmsi-505	153	117	70	70	NUM
ajmsi-505	153	118	2	2	NUM
ajmsi-505	153	119	1	1	NUM
ajmsi-505	153	120	1	1	NUM
ajmsi-505	153	121	0	0	NUM
ajmsi-505	153	122	2	2	NUM
ajmsi-505	153	123	0	0	NUM
ajmsi-505	153	124	2	2	NUM
ajmsi-505	153	125	0	0	NUM
ajmsi-505	153	126	2	2	NUM
ajmsi-505	153	127	0	0	NUM
ajmsi-505	153	128	2	2	NUM
ajmsi-505	153	129	0	0	NUM
ajmsi-505	153	130	0	0	NUM
ajmsi-505	153	131	0	0	NUM
ajmsi-505	153	132	≥	≥	NOUN
ajmsi-505	153	133	71	71	NUM
ajmsi-505	153	134	3	3	NUM
ajmsi-505	153	135	1	1	NUM
ajmsi-505	153	136	2	2	NUM
ajmsi-505	153	137	0	0	NUM
ajmsi-505	153	138	3	3	NUM
ajmsi-505	153	139	0	0	NUM
ajmsi-505	153	140	3	3	NUM
ajmsi-505	153	141	0	0	NUM
ajmsi-505	153	142	3	3	NUM
ajmsi-505	153	143	1	1	NUM
ajmsi-505	153	144	2	2	NUM
ajmsi-505	153	145	0	0	NUM
ajmsi-505	153	146	0	0	NUM
ajmsi-505	153	147	0	0	NUM
ajmsi-505	153	148	total	total	NOUN
ajmsi-505	153	149	102	102	NUM
ajmsi-505	153	150	24	24	NUM
ajmsi-505	153	151	78	78	NUM
ajmsi-505	153	152	7	7	NUM
ajmsi-505	153	153	95	95	NUM
ajmsi-505	153	154	13	13	NUM
ajmsi-505	153	155	89	89	NUM
ajmsi-505	153	156	18	18	NUM
ajmsi-505	153	157	84	84	NUM
ajmsi-505	153	158	18	18	NUM
ajmsi-505	153	159	84	84	NUM
ajmsi-505	153	160	7	7	NUM
ajmsi-505	153	161	6	6	NUM
ajmsi-505	153	162	1	1	NUM
ajmsi-505	153	163	t	t	NOUN
ajmsi-505	153	164	=	=	SYM
ajmsi-505	154	1	632.46	632.46	NUM
ajmsi-505	154	2	,	,	PUNCT
ajmsi-505	154	3	df	df	PROPN
ajmsi-505	154	4	=	=	NUM
ajmsi-505	154	5	10	10	NUM
ajmsi-505	154	6	,	,	PUNCT
ajmsi-505	154	7	p	p	X
ajmsi-505	154	8	<	<	X
ajmsi-505	154	9	0.05	0.05	NUM
ajmsi-505	154	10	key	key	NOUN
ajmsi-505	154	11	:	:	PUNCT
ajmsi-505	154	12	emb	emb	NOUN
ajmsi-505	154	13	=	=	SYM
ajmsi-505	154	14	etambutol	etambutol	NOUN
ajmsi-505	154	15	,	,	PUNCT
ajmsi-505	154	16	m.	m.	NOUN
ajmsi-505	154	17	tb	tb	NOUN
ajmsi-505	154	18	=	=	PUNCT
ajmsi-505	154	19	mycobacterium	mycobacterium	NOUN
ajmsi-505	154	20	tuberculosis	tuberculosis	NOUN
ajmsi-505	154	21	,	,	PUNCT
ajmsi-505	154	22	mdr	mdr	PROPN
ajmsi-505	154	23	-	-	PROPN
ajmsi-505	154	24	tb=	tb=	PROPN
ajmsi-505	154	25	multi	multi	ADJ
ajmsi-505	154	26	-	-	ADJ
ajmsi-505	154	27	drug	drug	ADJ
ajmsi-505	154	28	resistant	resistant	ADJ
ajmsi-505	154	29	tuberculosis	tuberculosis	NOUN
ajmsi-505	154	30	,	,	PUNCT
ajmsi-505	154	31	r	r	NOUN
ajmsi-505	154	32	=	=	SYM
ajmsi-505	154	33	resistant	resistant	ADJ
ajmsi-505	154	34	,	,	PUNCT
ajmsi-505	154	35	s	s	NOUN
ajmsi-505	154	36	=	=	NOUN
ajmsi-505	154	37	susceptible	susceptible	ADJ
ajmsi-505	154	38	,	,	PUNCT
ajmsi-505	154	39	rif	rif	PROPN
ajmsi-505	154	40	=	=	NOUN
ajmsi-505	154	41	rifampicin	rifampicin	VERB
ajmsi-505	154	42	,	,	PUNCT
ajmsi-505	154	43	inh	inh	PROPN
ajmsi-505	154	44	=	=	SYM
ajmsi-505	154	45	isoniazid	isoniazid	PROPN
ajmsi-505	154	46	,	,	PUNCT
ajmsi-505	154	47	s	s	NOUN
ajmsi-505	154	48	=	=	NOUN
ajmsi-505	154	49	streptomycin	streptomycin	PROPN
ajmsi-505	154	50	,	,	PUNCT
ajmsi-505	154	51	pza	pza	NOUN
ajmsi-505	154	52	=	=	SYM
ajmsi-505	154	53	parazinamide	parazinamide	NOUN
ajmsi-505	154	54	,	,	PUNCT
ajmsi-505	154	55	m	m	NOUN
ajmsi-505	154	56	=	=	NOUN
ajmsi-505	154	57	total	total	ADJ
ajmsi-505	154	58	male	male	NOUN
ajmsi-505	154	59	,	,	PUNCT
ajmsi-505	154	60	f	f	PROPN
ajmsi-505	154	61	=	=	ADJ
ajmsi-505	154	62	total	total	ADJ
ajmsi-505	154	63	female	female	NOUN
ajmsi-505	154	64	,	,	PUNCT
ajmsi-505	154	65	+	+	NOUN
ajmsi-505	154	66	=	=	ADJ
ajmsi-505	154	67	positive	positive	ADJ
ajmsi-505	154	68	m.	m.	NOUN
ajmsi-505	154	69	tb	tb	ADP
ajmsi-505	154	70	cultures	culture	NOUN
ajmsi-505	154	71	,	,	PUNCT
ajmsi-505	154	72	dst=	dst=	PROPN
ajmsi-505	154	73	drugs	drug	NOUN
ajmsi-505	154	74	susceptibility	susceptibility	NOUN
ajmsi-505	154	75	testing	test	VERB
ajmsi-505	154	76	31	31	NUM
ajmsi-505	154	77	–	–	PUNCT
ajmsi-505	154	78	40	40	NUM
ajmsi-505	154	79	38	38	NUM
ajmsi-505	154	80	15	15	NUM
ajmsi-505	154	81	23	23	NUM
ajmsi-505	154	82	2	2	NUM
ajmsi-505	154	83	36	36	NUM
ajmsi-505	154	84	7	7	NUM
ajmsi-505	154	85	31	31	NUM
ajmsi-505	154	86	1	1	NUM
ajmsi-505	154	87	37	37	NUM
ajmsi-505	154	88	17	17	NUM
ajmsi-505	154	89	21	21	NUM
ajmsi-505	154	90	2	2	NUM
ajmsi-505	154	91	2	2	NUM
ajmsi-505	154	92	0	0	NUM
ajmsi-505	154	93	41	41	NUM
ajmsi-505	154	94	–	–	PUNCT
ajmsi-505	154	95	50	50	NUM
ajmsi-505	154	96	14	14	NUM
ajmsi-505	154	97	5	5	NUM
ajmsi-505	154	98	9	9	NUM
ajmsi-505	154	99	4	4	NUM
ajmsi-505	154	100	10	10	NUM
ajmsi-505	154	101	2	2	NUM
ajmsi-505	154	102	12	12	NUM
ajmsi-505	154	103	0	0	NUM
ajmsi-505	154	104	14	14	NUM
ajmsi-505	154	105	8	8	NUM
ajmsi-505	154	106	6	6	NUM
ajmsi-505	154	107	4	4	NUM
ajmsi-505	154	108	3	3	NUM
ajmsi-505	154	109	1	1	NUM
ajmsi-505	154	110	51	51	NUM
ajmsi-505	154	111	–	–	PUNCT
ajmsi-505	154	112	60	60	NUM
ajmsi-505	154	113	5	5	NUM
ajmsi-505	154	114	2	2	NUM
ajmsi-505	154	115	3	3	NUM
ajmsi-505	154	116	2	2	NUM
ajmsi-505	154	117	3	3	NUM
ajmsi-505	154	118	0	0	NUM
ajmsi-505	154	119	5	5	NUM
ajmsi-505	154	120	0	0	NUM
ajmsi-505	154	121	5	5	NUM
ajmsi-505	154	122	5	5	NUM
ajmsi-505	154	123	0	0	NUM
ajmsi-505	154	124	2	2	NUM
ajmsi-505	154	125	1	1	NUM
ajmsi-505	154	126	1	1	NUM
ajmsi-505	154	127	61	61	NUM
ajmsi-505	154	128	–	–	PUNCT
ajmsi-505	154	129	70	70	NUM
ajmsi-505	154	130	1	1	NUM
ajmsi-505	154	131	1	1	NUM
ajmsi-505	154	132	0	0	NUM
ajmsi-505	154	133	1	1	NUM
ajmsi-505	154	134	0	0	NUM
ajmsi-505	154	135	0	0	NUM
ajmsi-505	154	136	1	1	NUM
ajmsi-505	154	137	0	0	NUM
ajmsi-505	154	138	1	1	NUM
ajmsi-505	154	139	1	1	NUM
ajmsi-505	154	140	0	0	NUM
ajmsi-505	154	141	0	0	NUM
ajmsi-505	154	142	0	0	NUM
ajmsi-505	154	143	0	0	NUM
ajmsi-505	154	144	≥	≥	NOUN
ajmsi-505	154	145	71	71	NUM
ajmsi-505	154	146	0	0	NUM
ajmsi-505	154	147	0	0	NUM
ajmsi-505	154	148	0	0	NUM
ajmsi-505	154	149	0	0	NUM
ajmsi-505	154	150	0	0	NUM
ajmsi-505	154	151	0	0	NUM
ajmsi-505	154	152	0	0	NUM
ajmsi-505	154	153	0	0	NUM
ajmsi-505	154	154	0	0	NUM
ajmsi-505	154	155	0	0	NUM
ajmsi-505	154	156	0	0	NUM
ajmsi-505	154	157	0	0	NUM
ajmsi-505	154	158	0	0	NUM
ajmsi-505	154	159	0	0	NUM
ajmsi-505	154	160	total	total	NOUN
ajmsi-505	154	161	87	87	NUM
ajmsi-505	154	162	32	32	NUM
ajmsi-505	154	163	55	55	NUM
ajmsi-505	154	164	11	11	NUM
ajmsi-505	154	165	76	76	NUM
ajmsi-505	154	166	16	16	NUM
ajmsi-505	154	167	71	71	NUM
ajmsi-505	154	168	3	3	NUM
ajmsi-505	154	169	84	84	NUM
ajmsi-505	154	170	49	49	NUM
ajmsi-505	154	171	38	38	NUM
ajmsi-505	154	172	10	10	NUM
ajmsi-505	154	173	7	7	NUM
ajmsi-505	154	174	3	3	NUM
ajmsi-505	154	175	t	t	NOUN
ajmsi-505	154	176	=	=	SYM
ajmsi-505	154	177	800.00	800.00	NUM
ajmsi-505	154	178	,	,	PUNCT
ajmsi-505	154	179	df	df	PROPN
ajmsi-505	154	180	=	=	SYM
ajmsi-505	154	181	14	14	NUM
ajmsi-505	154	182	,	,	PUNCT
ajmsi-505	154	183	p	p	X
ajmsi-505	154	184	<	<	X
ajmsi-505	154	185	0.05	0.05	NUM
ajmsi-505	154	186	key	key	NOUN
ajmsi-505	154	187	:	:	PUNCT
ajmsi-505	154	188	emb	emb	NOUN
ajmsi-505	154	189	=	=	SYM
ajmsi-505	154	190	etambutol	etambutol	NOUN
ajmsi-505	154	191	,	,	PUNCT
ajmsi-505	154	192	m.	m.	NOUN
ajmsi-505	154	193	tb	tb	NOUN
ajmsi-505	154	194	=	=	PUNCT
ajmsi-505	154	195	mycobacterium	mycobacterium	NOUN
ajmsi-505	154	196	tuberculosis	tuberculosis	NOUN
ajmsi-505	154	197	,	,	PUNCT
ajmsi-505	154	198	mdr	mdr	PROPN
ajmsi-505	154	199	-	-	PROPN
ajmsi-505	154	200	tb=	tb=	PROPN
ajmsi-505	154	201	multi	multi	ADJ
ajmsi-505	154	202	-	-	ADJ
ajmsi-505	154	203	drug	drug	ADJ
ajmsi-505	154	204	resistant	resistant	ADJ
ajmsi-505	154	205	tuberculosis	tuberculosis	NOUN
ajmsi-505	154	206	,	,	PUNCT
ajmsi-505	154	207	r	r	NOUN
ajmsi-505	154	208	=	=	SYM
ajmsi-505	154	209	resistant	resistant	ADJ
ajmsi-505	154	210	,	,	PUNCT
ajmsi-505	154	211	s	s	NOUN
ajmsi-505	154	212	=	=	NOUN
ajmsi-505	154	213	susceptible	susceptible	ADJ
ajmsi-505	154	214	,	,	PUNCT
ajmsi-505	154	215	rif	rif	PROPN
ajmsi-505	154	216	=	=	NOUN
ajmsi-505	154	217	rifampicin	rifampicin	VERB
ajmsi-505	154	218	,	,	PUNCT
ajmsi-505	154	219	inh	inh	PROPN
ajmsi-505	154	220	=	=	SYM
ajmsi-505	154	221	isoniazid	isoniazid	NOUN
ajmsi-505	154	222	,	,	PUNCT
ajmsi-505	154	223	s	s	PART
ajmsi-505	154	224	=	=	NOUN
ajmsi-505	154	225	streptomycin	streptomycin	PROPN
ajmsi-505	154	226	,	,	PUNCT
ajmsi-505	154	227	pza	pza	NOUN
ajmsi-505	154	228	=	=	SYM
ajmsi-505	154	229	parazinamide	parazinamide	NOUN
ajmsi-505	154	230	,	,	PUNCT
ajmsi-505	154	231	m	m	NOUN
ajmsi-505	154	232	=	=	NOUN
ajmsi-505	154	233	total	total	ADJ
ajmsi-505	154	234	male	male	NOUN
ajmsi-505	154	235	,	,	PUNCT
ajmsi-505	154	236	f	f	PROPN
ajmsi-505	154	237	=	=	ADJ
ajmsi-505	154	238	total	total	ADJ
ajmsi-505	154	239	female	female	NOUN
ajmsi-505	154	240	,	,	PUNCT
ajmsi-505	155	1	+	+	NOUN
ajmsi-505	155	2	=	=	ADJ
ajmsi-505	155	3	positive	positive	ADJ
ajmsi-505	155	4	m.	m.	NOUN
ajmsi-505	155	5	tb	tb	ADP
ajmsi-505	155	6	cultures	culture	NOUN
ajmsi-505	155	7	,	,	PUNCT
ajmsi-505	155	8	dst=	dst=	PROPN
ajmsi-505	155	9	drugs	drug	NOUN
ajmsi-505	155	10	susceptibility	susceptibility	NOUN
ajmsi-505	155	11	testing	testing	NOUN
ajmsi-505	155	12	.	.	PUNCT
ajmsi-505	156	1	results	result	NOUN
ajmsi-505	156	2	of	of	ADP
ajmsi-505	156	3	dst	dst	NOUN
ajmsi-505	156	4	for	for	ADP
ajmsi-505	156	5	category	category	NOUN
ajmsi-505	156	6	ii	ii	NOUN
ajmsi-505	156	7	patients	patient	NOUN
ajmsi-505	156	8	showed	show	VERB
ajmsi-505	156	9	a	a	DET
ajmsi-505	156	10	slight	slight	ADJ
ajmsi-505	156	11	decline	decline	NOUN
ajmsi-505	156	12	in	in	ADP
ajmsi-505	156	13	cases	case	NOUN
ajmsi-505	156	14	of	of	ADP
ajmsi-505	156	15	mdr	mdr	PROPN
ajmsi-505	156	16	-	-	NOUN
ajmsi-505	156	17	tb	tb	NOUN
ajmsi-505	156	18	from	from	ADP
ajmsi-505	156	19	10(38.5	10(38.5	NUM
ajmsi-505	156	20	%	%	NOUN
ajmsi-505	156	21	)	)	PUNCT
ajmsi-505	156	22	to	to	ADP
ajmsi-505	156	23	9(34.6	9(34.6	NOUN
ajmsi-505	156	24	%	%	NOUN
ajmsi-505	156	25	)	)	PUNCT
ajmsi-505	156	26	with	with	ADP
ajmsi-505	156	27	a	a	DET
ajmsi-505	156	28	corresponding	corresponding	ADJ
ajmsi-505	156	29	decrease	decrease	NOUN
ajmsi-505	156	30	in	in	ADP
ajmsi-505	156	31	the	the	DET
ajmsi-505	156	32	total	total	ADJ
ajmsi-505	156	33	number	number	NOUN
ajmsi-505	156	34	of	of	ADP
ajmsi-505	156	35	rifampicin	rifampicin	VERB
ajmsi-505	156	36	resistance	resistance	NOUN
ajmsi-505	156	37	of	of	ADP
ajmsi-505	156	38	26(9.7	26(9.7	NUM
ajmsi-505	156	39	%	%	NOUN
ajmsi-505	156	40	)	)	PUNCT
ajmsi-505	156	41	detected	detect	VERB
ajmsi-505	156	42	as	as	SCONJ
ajmsi-505	156	43	shown	show	VERB
ajmsi-505	156	44	in	in	ADP
ajmsi-505	156	45	table	table	NOUN
ajmsi-505	156	46	3	3	NUM
ajmsi-505	156	47	the	the	DET
ajmsi-505	156	48	least	least	ADJ
ajmsi-505	156	49	cases	case	NOUN
ajmsi-505	156	50	of	of	ADP
ajmsi-505	156	51	mdr	mdr	PROPN
ajmsi-505	156	52	-	-	NOUN
ajmsi-505	156	53	tb	tb	NOUN
ajmsi-505	156	54	of	of	ADP
ajmsi-505	156	55	7(26.9	7(26.9	NUM
ajmsi-505	156	56	%	%	NOUN
ajmsi-505	156	57	)	)	PUNCT
ajmsi-505	156	58	were	be	AUX
ajmsi-505	156	59	detected	detect	VERB
ajmsi-505	156	60	in	in	ADP
ajmsi-505	156	61	category	category	NOUN
ajmsi-505	156	62	iii	iii	NUM
ajmsi-505	156	63	patients	patient	NOUN
ajmsi-505	156	64	while	while	SCONJ
ajmsi-505	156	65	rifampicin	rifampicin	VERB
ajmsi-505	156	66	resistance	resistance	NOUN
ajmsi-505	156	67	was	be	AUX
ajmsi-505	156	68	detected	detect	VERB
ajmsi-505	156	69	in	in	ADP
ajmsi-505	156	70	24(90	24(90	NUM
ajmsi-505	156	71	%	%	NOUN
ajmsi-505	156	72	)	)	PUNCT
ajmsi-505	156	73	of	of	ADP
ajmsi-505	156	74	cases	case	NOUN
ajmsi-505	156	75	as	as	SCONJ
ajmsi-505	156	76	shown	show	VERB
ajmsi-505	156	77	in	in	ADP
ajmsi-505	156	78	table	table	NOUN
ajmsi-505	156	79	4	4	NUM
ajmsi-505	156	80	.	.	PUNCT
ajmsi-505	157	1	there	there	PRON
ajmsi-505	157	2	was	be	VERB
ajmsi-505	157	3	no	no	DET
ajmsi-505	157	4	statistical	statistical	ADJ
ajmsi-505	157	5	difference	difference	NOUN
ajmsi-505	157	6	in	in	ADP
ajmsi-505	157	7	mdr	mdr	PROPN
ajmsi-505	157	8	-	-	NOUN
ajmsi-505	157	9	tb	tb	NOUN
ajmsi-505	157	10	between	between	ADP
ajmsi-505	157	11	category	category	NOUN
ajmsi-505	157	12	i	i	PRON
ajmsi-505	157	13	and	and	CCONJ
ajmsi-505	157	14	category	category	NOUN
ajmsi-505	157	15	iii	iii	PROPN
ajmsi-505	157	16	(	(	PUNCT
ajmsi-505	157	17	p>0.05	p>0.05	NOUN
ajmsi-505	157	18	)	)	PUNCT
ajmsi-505	157	19	.	.	PUNCT
ajmsi-505	158	1	however	however	ADV
ajmsi-505	158	2	,	,	PUNCT
ajmsi-505	158	3	cases	case	VERB
ajmsi-505	158	4	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	158	5	pa	pa	PROPN
ajmsi-505	158	6	ge	ge	PROPN
ajmsi-505	158	7	6	6	NUM
ajmsi-505	158	8	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	NOUN
ajmsi-505	158	9	am	be	AUX
ajmsi-505	158	10	.	.	PUNCT
ajmsi-505	159	1	j.	j.	PROPN
ajmsi-505	159	2	med	med	PROPN
ajmsi-505	159	3	.	.	PUNCT
ajmsi-505	160	1	sci	sci	PROPN
ajmsi-505	160	2	.	.	PUNCT
ajmsi-505	160	3	innov	innov	PROPN
ajmsi-505	160	4	.	.	PUNCT
ajmsi-505	161	1	1(1	1(1	NUM
ajmsi-505	161	2	)	)	PUNCT
ajmsi-505	161	3	1	1	NUM
ajmsi-505	161	4	-	-	SYM
ajmsi-505	161	5	9	9	NUM
ajmsi-505	161	6	,	,	PUNCT
ajmsi-505	161	7	2022	2022	NUM
ajmsi-505	161	8	of	of	ADP
ajmsi-505	161	9	mdr	mdr	PROPN
ajmsi-505	161	10	-	-	PROPN
ajmsi-505	161	11	tb	tb	PROPN
ajmsi-505	161	12	were	be	AUX
ajmsi-505	161	13	statistically	statistically	ADV
ajmsi-505	161	14	higher	high	ADJ
ajmsi-505	161	15	in	in	ADP
ajmsi-505	161	16	category	category	NOUN
ajmsi-505	161	17	i	i	NOUN
ajmsi-505	161	18	than	than	ADP
ajmsi-505	161	19	category	category	NOUN
ajmsi-505	161	20	iii	iii	NUM
ajmsi-505	161	21	patients	patient	NOUN
ajmsi-505	161	22	.	.	PUNCT
ajmsi-505	162	1	the	the	DET
ajmsi-505	162	2	age	age	NOUN
ajmsi-505	162	3	group	group	NOUN
ajmsi-505	162	4	41	41	NUM
ajmsi-505	162	5	-	-	SYM
ajmsi-505	162	6	50	50	NUM
ajmsi-505	162	7	years	year	NOUN
ajmsi-505	162	8	had	have	VERB
ajmsi-505	162	9	the	the	DET
ajmsi-505	162	10	highest	high	ADJ
ajmsi-505	162	11	cases	case	NOUN
ajmsi-505	162	12	of	of	ADP
ajmsi-505	162	13	mdr	mdr	PROPN
ajmsi-505	162	14	-	-	PROPN
ajmsi-505	162	15	tb	tb	NOUN
ajmsi-505	162	16	followed	follow	VERB
ajmsi-505	162	17	by	by	ADP
ajmsi-505	162	18	the	the	DET
ajmsi-505	162	19	age	age	NOUN
ajmsi-505	162	20	group	group	NOUN
ajmsi-505	162	21	31	31	NUM
ajmsi-505	162	22	-	-	SYM
ajmsi-505	162	23	40	40	NUM
ajmsi-505	162	24	years	year	NOUN
ajmsi-505	162	25	(	(	PUNCT
ajmsi-505	162	26	mean	mean	VERB
ajmsi-505	162	27	age	age	NOUN
ajmsi-505	162	28	group	group	NOUN
ajmsi-505	162	29	35	35	NUM
ajmsi-505	162	30	-	-	SYM
ajmsi-505	162	31	45	45	NUM
ajmsi-505	162	32	years	year	NOUN
ajmsi-505	162	33	)	)	PUNCT
ajmsi-505	162	34	both	both	PRON
ajmsi-505	162	35	of	of	ADP
ajmsi-505	162	36	which	which	PRON
ajmsi-505	162	37	accounted	account	VERB
ajmsi-505	162	38	for	for	ADP
ajmsi-505	162	39	10(38.5	10(38.5	NUM
ajmsi-505	162	40	%	%	NOUN
ajmsi-505	162	41	)	)	PUNCT
ajmsi-505	162	42	and	and	CCONJ
ajmsi-505	162	43	6(23.1	6(23.1	ADJ
ajmsi-505	162	44	%	%	NOUN
ajmsi-505	162	45	)	)	PUNCT
ajmsi-505	162	46	cases	case	NOUN
ajmsi-505	162	47	respectively	respectively	ADV
ajmsi-505	162	48	,	,	PUNCT
ajmsi-505	162	49	thereby	thereby	ADV
ajmsi-505	162	50	placing	place	VERB
ajmsi-505	162	51	the	the	DET
ajmsi-505	162	52	two	two	NUM
ajmsi-505	162	53	age	age	NOUN
ajmsi-505	162	54	groups	group	NOUN
ajmsi-505	162	55	at	at	ADP
ajmsi-505	162	56	relatively	relatively	ADV
ajmsi-505	162	57	higher	high	ADJ
ajmsi-505	162	58	risk	risk	NOUN
ajmsi-505	162	59	of	of	ADP
ajmsi-505	162	60	developing	develop	VERB
ajmsi-505	162	61	mdr	mdr	PROPN
ajmsi-505	162	62	-	-	NOUN
ajmsi-505	162	63	tb	tb	PROPN
ajmsi-505	162	64	.	.	PUNCT
ajmsi-505	163	1	demographic	demographic	ADJ
ajmsi-505	163	2	characteristics	characteristic	NOUN
ajmsi-505	163	3	of	of	ADP
ajmsi-505	163	4	the	the	DET
ajmsi-505	163	5	268	268	NUM
ajmsi-505	163	6	m.	m.	NOUN
ajmsi-505	163	7	tuberculosis	tuberculosis	NOUN
ajmsi-505	163	8	strains	strain	NOUN
ajmsi-505	163	9	analyzed	analyze	VERB
ajmsi-505	163	10	in	in	ADP
ajmsi-505	163	11	tables	table	NOUN
ajmsi-505	163	12	2	2	NUM
ajmsi-505	163	13	and	and	CCONJ
ajmsi-505	163	14	3	3	NUM
ajmsi-505	163	15	(	(	PUNCT
ajmsi-505	163	16	re	re	VERB
ajmsi-505	163	17	-	-	ADJ
ajmsi-505	163	18	treated	treat	VERB
ajmsi-505	163	19	cases	case	NOUN
ajmsi-505	163	20	)	)	PUNCT
ajmsi-505	163	21	and	and	CCONJ
ajmsi-505	163	22	table	table	NOUN
ajmsi-505	163	23	4	4	NUM
ajmsi-505	163	24	(	(	PUNCT
ajmsi-505	163	25	treatment	treatment	NOUN
ajmsi-505	163	26	naive	naive	ADJ
ajmsi-505	163	27	)	)	PUNCT
ajmsi-505	163	28	recorded	record	VERB
ajmsi-505	163	29	19(7.1	19(7.1	NUM
ajmsi-505	163	30	%	%	NOUN
ajmsi-505	163	31	)	)	PUNCT
ajmsi-505	163	32	and	and	CCONJ
ajmsi-505	163	33	6(2.6	6(2.6	NUM
ajmsi-505	163	34	%	%	NOUN
ajmsi-505	163	35	)	)	PUNCT
ajmsi-505	163	36	cases	case	NOUN
ajmsi-505	163	37	respectively	respectively	ADV
ajmsi-505	163	38	.	.	PUNCT
ajmsi-505	164	1	following	follow	VERB
ajmsi-505	164	2	in	in	ADP
ajmsi-505	164	3	-	-	PUNCT
ajmsi-505	164	4	vitro	vitro	X
ajmsi-505	164	5	transduction	transduction	NOUN
ajmsi-505	164	6	(	(	PUNCT
ajmsi-505	164	7	induced	induced	ADJ
ajmsi-505	164	8	mutation	mutation	NOUN
ajmsi-505	164	9	)	)	PUNCT
ajmsi-505	164	10	of	of	ADP
ajmsi-505	164	11	m.	m.	NOUN
ajmsi-505	164	12	tuberculosis	tuberculosis	NOUN
ajmsi-505	164	13	strains	strain	NOUN
ajmsi-505	164	14	from	from	ADP
ajmsi-505	164	15	category	category	NOUN
ajmsi-505	164	16	iii	iii	NUM
ajmsi-505	164	17	patients	patient	NOUN
ajmsi-505	164	18	,	,	PUNCT
ajmsi-505	164	19	there	there	PRON
ajmsi-505	164	20	was	be	VERB
ajmsi-505	164	21	an	an	DET
ajmsi-505	164	22	increase	increase	NOUN
ajmsi-505	164	23	in	in	ADP
ajmsi-505	164	24	the	the	DET
ajmsi-505	164	25	number	number	NOUN
ajmsi-505	164	26	of	of	ADP
ajmsi-505	164	27	mdr	mdr	PROPN
ajmsi-505	164	28	-	-	PROPN
ajmsi-505	164	29	tb	tb	NOUN
ajmsi-505	164	30	detected	detect	VERB
ajmsi-505	164	31	in	in	ADP
ajmsi-505	164	32	this	this	DET
ajmsi-505	164	33	category	category	NOUN
ajmsi-505	164	34	of	of	ADP
ajmsi-505	164	35	patients	patient	NOUN
ajmsi-505	164	36	from	from	ADP
ajmsi-505	164	37	7(26.9	7(26.9	NUM
ajmsi-505	164	38	%	%	NOUN
ajmsi-505	164	39	)	)	PUNCT
ajmsi-505	164	40	to	to	ADP
ajmsi-505	164	41	10(38.5	10(38.5	NUM
ajmsi-505	164	42	%	%	NOUN
ajmsi-505	164	43	)	)	PUNCT
ajmsi-505	164	44	cases	case	NOUN
ajmsi-505	164	45	as	as	SCONJ
ajmsi-505	164	46	shown	show	VERB
ajmsi-505	164	47	in	in	ADP
ajmsi-505	164	48	table	table	NOUN
ajmsi-505	164	49	5	5	NUM
ajmsi-505	164	50	.	.	PUNCT
ajmsi-505	165	1	however	however	ADV
ajmsi-505	165	2	,	,	PUNCT
ajmsi-505	165	3	there	there	PRON
ajmsi-505	165	4	was	be	VERB
ajmsi-505	165	5	no	no	DET
ajmsi-505	165	6	statistical	statistical	ADJ
ajmsi-505	165	7	significance	significance	NOUN
ajmsi-505	165	8	in	in	ADP
ajmsi-505	165	9	the	the	DET
ajmsi-505	165	10	number	number	NOUN
ajmsi-505	165	11	of	of	ADP
ajmsi-505	165	12	mdr	mdr	PROPN
ajmsi-505	165	13	-	-	PROPN
ajmsi-505	165	14	tb	tb	NOUN
ajmsi-505	165	15	detected	detect	VERB
ajmsi-505	165	16	in	in	ADP
ajmsi-505	165	17	category	category	NOUN
ajmsi-505	165	18	iii	iii	NOUN
ajmsi-505	165	19	before	before	ADP
ajmsi-505	165	20	and	and	CCONJ
ajmsi-505	165	21	after	after	ADP
ajmsi-505	165	22	transduction	transduction	NOUN
ajmsi-505	165	23	protocols	protocol	NOUN
ajmsi-505	165	24	(	(	PUNCT
ajmsi-505	165	25	p>0.05	p>0.05	PROPN
ajmsi-505	165	26	)	)	PUNCT
ajmsi-505	165	27	.	.	PUNCT
ajmsi-505	166	1	overall	overall	ADJ
ajmsi-505	166	2	results	result	NOUN
ajmsi-505	166	3	of	of	ADP
ajmsi-505	166	4	susceptibility	susceptibility	NOUN
ajmsi-505	166	5	for	for	ADP
ajmsi-505	166	6	all	all	DET
ajmsi-505	166	7	the	the	DET
ajmsi-505	166	8	tested	test	VERB
ajmsi-505	166	9	anti	anti	ADJ
ajmsi-505	166	10	-	-	ADJ
ajmsi-505	166	11	tb	tb	ADJ
ajmsi-505	166	12	drugs	drug	NOUN
ajmsi-505	166	13	shows	show	VERB
ajmsi-505	166	14	a	a	DET
ajmsi-505	166	15	cumulative	cumulative	ADJ
ajmsi-505	166	16	susceptibility	susceptibility	NOUN
ajmsi-505	166	17	of	of	ADP
ajmsi-505	166	18	1012(84.3	1012(84.3	NUM
ajmsi-505	166	19	%	%	NOUN
ajmsi-505	166	20	)	)	PUNCT
ajmsi-505	166	21	and	and	CCONJ
ajmsi-505	166	22	resistance	resistance	NOUN
ajmsi-505	166	23	of	of	ADP
ajmsi-505	166	24	189(15.7	189(15.7	NUM
ajmsi-505	166	25	%	%	NOUN
ajmsi-505	166	26	)	)	PUNCT
ajmsi-505	166	27	.	.	PUNCT
ajmsi-505	167	1	etambutol	etambutol	NOUN
ajmsi-505	167	2	showed	show	VERB
ajmsi-505	167	3	the	the	DET
ajmsi-505	167	4	highest	high	ADJ
ajmsi-505	167	5	resistance	resistance	NOUN
ajmsi-505	167	6	of	of	ADP
ajmsi-505	167	7	91(34.0	91(34.0	NUM
ajmsi-505	167	8	%	%	NOUN
ajmsi-505	167	9	)	)	PUNCT
ajmsi-505	167	10	followed	follow	VERB
ajmsi-505	167	11	by	by	ADP
ajmsi-505	167	12	rifampicin	rifampicin	VERB
ajmsi-505	167	13	with	with	ADP
ajmsi-505	167	14	82(30.6	82(30.6	ADJ
ajmsi-505	167	15	%	%	NOUN
ajmsi-505	167	16	)	)	PUNCT
ajmsi-505	167	17	of	of	ADP
ajmsi-505	167	18	cases	case	NOUN
ajmsi-505	167	19	,	,	PUNCT
ajmsi-505	167	20	the	the	DET
ajmsi-505	167	21	least	least	ADJ
ajmsi-505	167	22	cases	case	NOUN
ajmsi-505	167	23	of	of	ADP
ajmsi-505	167	24	resistance	resistance	NOUN
ajmsi-505	167	25	were	be	AUX
ajmsi-505	167	26	table	table	NOUN
ajmsi-505	167	27	5	5	NUM
ajmsi-505	167	28	:	:	PUNCT
ajmsi-505	167	29	anti	anti	ADJ
ajmsi-505	167	30	-	-	ADJ
ajmsi-505	167	31	tb	tb	ADP
ajmsi-505	167	32	dst	dst	NOUN
ajmsi-505	167	33	of	of	ADP
ajmsi-505	167	34	category	category	PROPN
ajmsi-505	167	35	iii	iii	PROPN
ajmsi-505	167	36	(	(	PUNCT
ajmsi-505	167	37	control	control	NOUN
ajmsi-505	167	38	group	group	NOUN
ajmsi-505	167	39	)	)	PUNCT
ajmsi-505	167	40	patients	patient	NOUN
ajmsi-505	167	41	after	after	ADP
ajmsi-505	167	42	htlv-3	htlv-3	NUM
ajmsi-505	167	43	transduction	transduction	NOUN
ajmsi-505	167	44	protocol	protocol	NOUN
ajmsi-505	167	45	age	age	NOUN
ajmsi-505	167	46	(	(	PUNCT
ajmsi-505	167	47	years	year	NOUN
ajmsi-505	167	48	)	)	PUNCT
ajmsi-505	167	49	no	no	NOUN
ajmsi-505	167	50	.	.	PUNCT
ajmsi-505	167	51	of	of	ADP
ajmsi-505	167	52	m.	m.	NOUN
ajmsi-505	167	53	tb	tb	ADP
ajmsi-505	167	54	+	+	NUM
ajmsi-505	167	55	cultures	cultures	PROPN
ajmsi-505	167	56	mdr	mdr	PROPN
ajmsi-505	167	57	-	-	PROPN
ajmsi-505	167	58	tb	tb	ADP
ajmsi-505	167	59	detected	detect	VERB
ajmsi-505	167	60	rif	rif	PROPN
ajmsi-505	167	61	inh	inh	PROPN
ajmsi-505	167	62	s	s	PART
ajmsi-505	168	1	pza	pza	NOUN
ajmsi-505	168	2	emb	emb	NOUN
ajmsi-505	168	3	r	r	NOUN
ajmsi-505	168	4	s	s	NOUN
ajmsi-505	168	5	r	r	NOUN
ajmsi-505	168	6	s	s	NOUN
ajmsi-505	168	7	r	r	NOUN
ajmsi-505	168	8	s	s	NOUN
ajmsi-505	168	9	r	r	NOUN
ajmsi-505	168	10	s	s	NOUN
ajmsi-505	168	11	r	r	NOUN
ajmsi-505	168	12	s	s	X
ajmsi-505	168	13	<	<	X
ajmsi-505	168	14	1	1	NUM
ajmsi-505	168	15	–	–	SYM
ajmsi-505	168	16	10	10	NUM
ajmsi-505	168	17	1	1	NUM
ajmsi-505	168	18	0	0	NUM
ajmsi-505	168	19	0	0	NUM
ajmsi-505	168	20	1	1	NUM
ajmsi-505	168	21	1	1	NUM
ajmsi-505	168	22	0	0	NUM
ajmsi-505	168	23	0	0	NUM
ajmsi-505	168	24	1	1	NUM
ajmsi-505	168	25	0	0	NUM
ajmsi-505	168	26	1	1	NUM
ajmsi-505	168	27	0	0	NUM
ajmsi-505	168	28	1	1	NUM
ajmsi-505	168	29	11	11	NUM
ajmsi-505	168	30	–	–	PUNCT
ajmsi-505	168	31	20	20	NUM
ajmsi-505	168	32	2	2	NUM
ajmsi-505	168	33	1	1	NUM
ajmsi-505	168	34	2	2	NUM
ajmsi-505	168	35	0	0	NUM
ajmsi-505	168	36	1	1	NUM
ajmsi-505	168	37	1	1	NUM
ajmsi-505	168	38	0	0	NUM
ajmsi-505	168	39	2	2	NUM
ajmsi-505	168	40	0	0	NUM
ajmsi-505	168	41	2	2	NUM
ajmsi-505	168	42	0	0	NUM
ajmsi-505	168	43	2	2	NUM
ajmsi-505	168	44	21	21	NUM
ajmsi-505	168	45	–	–	PUNCT
ajmsi-505	168	46	30	30	NUM
ajmsi-505	168	47	13	13	NUM
ajmsi-505	168	48	2	2	NUM
ajmsi-505	168	49	5	5	NUM
ajmsi-505	168	50	8	8	NUM
ajmsi-505	168	51	2	2	NUM
ajmsi-505	168	52	11	11	NUM
ajmsi-505	168	53	9	9	NUM
ajmsi-505	168	54	4	4	NUM
ajmsi-505	168	55	3	3	NUM
ajmsi-505	168	56	10	10	NUM
ajmsi-505	168	57	9	9	NUM
ajmsi-505	168	58	4	4	NUM
ajmsi-505	168	59	31	31	NUM
ajmsi-505	168	60	–	–	PUNCT
ajmsi-505	168	61	40	40	NUM
ajmsi-505	168	62	18	18	NUM
ajmsi-505	168	63	3	3	NUM
ajmsi-505	168	64	7	7	NUM
ajmsi-505	168	65	11	11	NUM
ajmsi-505	168	66	3	3	NUM
ajmsi-505	168	67	15	15	NUM
ajmsi-505	168	68	11	11	NUM
ajmsi-505	168	69	7	7	NUM
ajmsi-505	168	70	4	4	NUM
ajmsi-505	168	71	14	14	NUM
ajmsi-505	168	72	11	11	NUM
ajmsi-505	168	73	7	7	NUM
ajmsi-505	168	74	41	41	NUM
ajmsi-505	168	75	–	–	PUNCT
ajmsi-505	168	76	50	50	NUM
ajmsi-505	168	77	8	8	NUM
ajmsi-505	168	78	2	2	NUM
ajmsi-505	168	79	2	2	NUM
ajmsi-505	168	80	6	6	NUM
ajmsi-505	168	81	3	3	NUM
ajmsi-505	168	82	5	5	NUM
ajmsi-505	168	83	4	4	NUM
ajmsi-505	168	84	4	4	NUM
ajmsi-505	168	85	1	1	NUM
ajmsi-505	168	86	7	7	NUM
ajmsi-505	168	87	4	4	NUM
ajmsi-505	168	88	4	4	NUM
ajmsi-505	168	89	51	51	NUM
ajmsi-505	168	90	–	–	PUNCT
ajmsi-505	168	91	60	60	NUM
ajmsi-505	168	92	6	6	NUM
ajmsi-505	168	93	2	2	NUM
ajmsi-505	168	94	2	2	NUM
ajmsi-505	168	95	4	4	NUM
ajmsi-505	168	96	4	4	NUM
ajmsi-505	168	97	2	2	NUM
ajmsi-505	168	98	2	2	NUM
ajmsi-505	168	99	4	4	NUM
ajmsi-505	168	100	0	0	NUM
ajmsi-505	168	101	6	6	NUM
ajmsi-505	168	102	2	2	NUM
ajmsi-505	168	103	4	4	NUM
ajmsi-505	168	104	61	61	NUM
ajmsi-505	168	105	–	–	PUNCT
ajmsi-505	168	106	70	70	NUM
ajmsi-505	168	107	2	2	NUM
ajmsi-505	168	108	0	0	NUM
ajmsi-505	168	109	0	0	NUM
ajmsi-505	168	110	2	2	NUM
ajmsi-505	168	111	0	0	NUM
ajmsi-505	168	112	2	2	NUM
ajmsi-505	168	113	0	0	NUM
ajmsi-505	168	114	2	2	NUM
ajmsi-505	168	115	0	0	NUM
ajmsi-505	168	116	2	2	NUM
ajmsi-505	168	117	0	0	NUM
ajmsi-505	168	118	2	2	NUM
ajmsi-505	168	119	≥	≥	NOUN
ajmsi-505	168	120	71	71	NUM
ajmsi-505	168	121	2	2	NUM
ajmsi-505	168	122	0	0	NUM
ajmsi-505	168	123	0	0	NUM
ajmsi-505	168	124	2	2	NUM
ajmsi-505	168	125	1	1	NUM
ajmsi-505	168	126	1	1	NUM
ajmsi-505	168	127	0	0	NUM
ajmsi-505	168	128	2	2	NUM
ajmsi-505	168	129	0	0	NUM
ajmsi-505	168	130	2	2	NUM
ajmsi-505	168	131	0	0	NUM
ajmsi-505	168	132	2	2	NUM
ajmsi-505	168	133	total	total	NOUN
ajmsi-505	168	134	79	79	NUM
ajmsi-505	168	135	26	26	NUM
ajmsi-505	168	136	54	54	NUM
ajmsi-505	168	137	9	9	NUM
ajmsi-505	168	138	70	70	NUM
ajmsi-505	168	139	7	7	NUM
ajmsi-505	168	140	72	72	NUM
ajmsi-505	168	141	12	12	NUM
ajmsi-505	168	142	69	69	NUM
ajmsi-505	168	143	24	24	NUM
ajmsi-505	168	144	57	57	NUM
ajmsi-505	168	145	t=-300.00	t=-300.00	NOUN
ajmsi-505	168	146	,	,	PUNCT
ajmsi-505	168	147	df	df	PROPN
ajmsi-505	168	148	=	=	NUM
ajmsi-505	168	149	14	14	NUM
ajmsi-505	168	150	,	,	PUNCT
ajmsi-505	168	151	p<0.05	p<0.05	NOUN
ajmsi-505	168	152	key	key	ADJ
ajmsi-505	168	153	:	:	PUNCT
ajmsi-505	168	154	emb	emb	NOUN
ajmsi-505	168	155	=	=	SYM
ajmsi-505	168	156	etambutol	etambutol	NOUN
ajmsi-505	168	157	,	,	PUNCT
ajmsi-505	168	158	m.	m.	NOUN
ajmsi-505	168	159	tb	tb	NOUN
ajmsi-505	168	160	=	=	PUNCT
ajmsi-505	168	161	mycobacterium	mycobacterium	NOUN
ajmsi-505	168	162	tuberculosis	tuberculosis	NOUN
ajmsi-505	168	163	,	,	PUNCT
ajmsi-505	168	164	mdr	mdr	PROPN
ajmsi-505	168	165	-	-	PROPN
ajmsi-505	168	166	tb=	tb=	PROPN
ajmsi-505	168	167	multi	multi	ADJ
ajmsi-505	168	168	-	-	ADJ
ajmsi-505	168	169	drug	drug	ADJ
ajmsi-505	168	170	resistant	resistant	ADJ
ajmsi-505	168	171	tuberculosis	tuberculosis	NOUN
ajmsi-505	168	172	,	,	PUNCT
ajmsi-505	168	173	r	r	NOUN
ajmsi-505	168	174	=	=	SYM
ajmsi-505	168	175	resistant	resistant	ADJ
ajmsi-505	168	176	,	,	PUNCT
ajmsi-505	168	177	s	s	NOUN
ajmsi-505	168	178	=	=	NOUN
ajmsi-505	168	179	susceptible	susceptible	ADJ
ajmsi-505	168	180	,	,	PUNCT
ajmsi-505	168	181	rif	rif	PROPN
ajmsi-505	168	182	=	=	NOUN
ajmsi-505	168	183	rifampicin	rifampicin	VERB
ajmsi-505	168	184	,	,	PUNCT
ajmsi-505	168	185	inh	inh	PROPN
ajmsi-505	168	186	=	=	SYM
ajmsi-505	168	187	isoniazid	isoniazid	NOUN
ajmsi-505	168	188	,	,	PUNCT
ajmsi-505	168	189	s	s	PART
ajmsi-505	168	190	=	=	NOUN
ajmsi-505	168	191	streptomycin	streptomycin	PROPN
ajmsi-505	168	192	,	,	PUNCT
ajmsi-505	168	193	pza	pza	NOUN
ajmsi-505	168	194	=	=	SYM
ajmsi-505	168	195	parazinamide	parazinamide	NOUN
ajmsi-505	168	196	,	,	PUNCT
ajmsi-505	168	197	m	m	NOUN
ajmsi-505	168	198	=	=	NOUN
ajmsi-505	168	199	total	total	ADJ
ajmsi-505	168	200	male	male	NOUN
ajmsi-505	168	201	,	,	PUNCT
ajmsi-505	168	202	f	f	PROPN
ajmsi-505	168	203	=	=	ADJ
ajmsi-505	168	204	total	total	ADJ
ajmsi-505	168	205	female	female	NOUN
ajmsi-505	168	206	,	,	PUNCT
ajmsi-505	168	207	+	+	NOUN
ajmsi-505	168	208	=	=	ADJ
ajmsi-505	168	209	positive	positive	ADJ
ajmsi-505	168	210	m.	m.	NOUN
ajmsi-505	168	211	tb	tb	ADP
ajmsi-505	168	212	cultures	culture	NOUN
ajmsi-505	168	213	,	,	PUNCT
ajmsi-505	168	214	dst=	dst=	PROPN
ajmsi-505	168	215	drugs	drug	NOUN
ajmsi-505	168	216	susceptibility	susceptibility	NOUN
ajmsi-505	168	217	testing	testing	NOUN
ajmsi-505	168	218	produced	produce	VERB
ajmsi-505	168	219	by	by	ADP
ajmsi-505	168	220	isoniazid	isoniazid	NOUN
ajmsi-505	168	221	which	which	PRON
ajmsi-505	168	222	recorded	record	VERB
ajmsi-505	168	223	27(10.1	27(10.1	ADJ
ajmsi-505	168	224	%	%	NOUN
ajmsi-505	168	225	)	)	PUNCT
ajmsi-505	168	226	making	make	VERB
ajmsi-505	168	227	it	it	PRON
ajmsi-505	168	228	the	the	DET
ajmsi-505	168	229	most	most	ADV
ajmsi-505	168	230	effective	effective	ADJ
ajmsi-505	168	231	anti	anti	ADJ
ajmsi-505	168	232	-	-	ADJ
ajmsi-505	168	233	tb	tb	ADJ
ajmsi-505	168	234	drug	drug	NOUN
ajmsi-505	168	235	in	in	ADP
ajmsi-505	168	236	the	the	DET
ajmsi-505	168	237	study	study	NOUN
ajmsi-505	168	238	population	population	NOUN
ajmsi-505	168	239	.	.	PUNCT
ajmsi-505	169	1	266(99.3	266(99.3	NUM
ajmsi-505	169	2	%	%	NOUN
ajmsi-505	169	3	)	)	PUNCT
ajmsi-505	169	4	of	of	ADP
ajmsi-505	169	5	the	the	DET
ajmsi-505	169	6	m.	m.	NOUN
ajmsi-505	169	7	tuberculosis	tuberculosis	NOUN
ajmsi-505	169	8	isolates	isolate	NOUN
ajmsi-505	169	9	produced	produce	VERB
ajmsi-505	169	10	various	various	ADJ
ajmsi-505	169	11	degrees	degree	NOUN
ajmsi-505	169	12	of	of	ADP
ajmsi-505	169	13	susceptibility	susceptibility	NOUN
ajmsi-505	169	14	and	and	CCONJ
ajmsi-505	169	15	resistance	resistance	NOUN
ajmsi-505	169	16	to	to	ADP
ajmsi-505	169	17	the	the	DET
ajmsi-505	169	18	five	five	NUM
ajmsi-505	169	19	tested	test	VERB
ajmsi-505	169	20	anti	anti	ADJ
ajmsi-505	169	21	-	-	ADJ
ajmsi-505	169	22	tb	tb	ADJ
ajmsi-505	169	23	drugs	drug	NOUN
ajmsi-505	169	24	.	.	PUNCT
ajmsi-505	170	1	however	however	ADV
ajmsi-505	170	2	,	,	PUNCT
ajmsi-505	170	3	2(0.7	2(0.7	NUM
ajmsi-505	170	4	%	%	NOUN
ajmsi-505	170	5	)	)	PUNCT
ajmsi-505	170	6	showed	show	VERB
ajmsi-505	170	7	100	100	NUM
ajmsi-505	170	8	%	%	NOUN
ajmsi-505	170	9	susceptibility	susceptibility	NOUN
ajmsi-505	170	10	to	to	ADP
ajmsi-505	170	11	all	all	DET
ajmsi-505	170	12	the	the	DET
ajmsi-505	170	13	five	five	NUM
ajmsi-505	170	14	tested	test	VERB
ajmsi-505	170	15	anti	anti	ADJ
ajmsi-505	170	16	-	-	ADJ
ajmsi-505	170	17	tb	tb	ADJ
ajmsi-505	170	18	drugs	drug	NOUN
ajmsi-505	170	19	with	with	ADP
ajmsi-505	170	20	no	no	DET
ajmsi-505	170	21	trace	trace	NOUN
ajmsi-505	170	22	of	of	ADP
ajmsi-505	170	23	drugs	drug	NOUN
ajmsi-505	170	24	resistance	resistance	NOUN
ajmsi-505	170	25	.	.	PUNCT
ajmsi-505	171	1	meanwhile	meanwhile	ADV
ajmsi-505	171	2	all	all	DET
ajmsi-505	171	3	the	the	DET
ajmsi-505	171	4	m.	m.	NOUN
ajmsi-505	171	5	tuberculosis	tuberculosis	NOUN
ajmsi-505	171	6	strains	strain	NOUN
ajmsi-505	171	7	were	be	AUX
ajmsi-505	171	8	resistant	resistant	ADJ
ajmsi-505	171	9	to	to	ADP
ajmsi-505	171	10	at	at	ADV
ajmsi-505	171	11	least	least	ADV
ajmsi-505	171	12	one	one	NUM
ajmsi-505	171	13	or	or	CCONJ
ajmsi-505	171	14	more	more	ADJ
ajmsi-505	171	15	anti	anti	ADJ
ajmsi-505	171	16	-	-	ADJ
ajmsi-505	171	17	tb	tb	ADJ
ajmsi-505	171	18	drugs	drug	NOUN
ajmsi-505	171	19	thereby	thereby	ADV
ajmsi-505	171	20	implying	imply	VERB
ajmsi-505	171	21	complete	complete	ADJ
ajmsi-505	171	22	absence	absence	NOUN
ajmsi-505	171	23	of	of	ADP
ajmsi-505	171	24	mono	mono	NOUN
ajmsi-505	171	25	-	-	PUNCT
ajmsi-505	171	26	drug	drug	NOUN
ajmsi-505	171	27	resistant	resistant	ADJ
ajmsi-505	171	28	tuberculosis	tuberculosis	NOUN
ajmsi-505	171	29	in	in	ADP
ajmsi-505	171	30	the	the	DET
ajmsi-505	171	31	study	study	NOUN
ajmsi-505	171	32	population	population	NOUN
ajmsi-505	171	33	.	.	PUNCT
ajmsi-505	172	1	it	it	PRON
ajmsi-505	172	2	is	be	AUX
ajmsi-505	172	3	equally	equally	ADV
ajmsi-505	172	4	noteworthy	noteworthy	ADJ
ajmsi-505	172	5	that	that	SCONJ
ajmsi-505	172	6	no	no	DET
ajmsi-505	172	7	strain	strain	NOUN
ajmsi-505	172	8	was	be	AUX
ajmsi-505	172	9	completely	completely	ADV
ajmsi-505	172	10	resistant	resistant	ADJ
ajmsi-505	172	11	to	to	ADP
ajmsi-505	172	12	all	all	DET
ajmsi-505	172	13	the	the	DET
ajmsi-505	172	14	tested	test	VERB
ajmsi-505	172	15	anti	anti	ADJ
ajmsi-505	172	16	-	-	ADJ
ajmsi-505	172	17	tb	tb	ADJ
ajmsi-505	172	18	drugs	drug	NOUN
ajmsi-505	172	19	as	as	SCONJ
ajmsi-505	172	20	summarized	summarize	VERB
ajmsi-505	172	21	in	in	ADP
ajmsi-505	172	22	table	table	NOUN
ajmsi-505	172	23	6	6	NUM
ajmsi-505	172	24	.	.	PUNCT
ajmsi-505	172	25	table	table	NOUN
ajmsi-505	172	26	6	6	NUM
ajmsi-505	172	27	:	:	PUNCT
ajmsi-505	172	28	cumulative	cumulative	ADJ
ajmsi-505	172	29	results	result	NOUN
ajmsi-505	172	30	of	of	ADP
ajmsi-505	172	31	anti	anti	ADJ
ajmsi-505	172	32	-	-	ADJ
ajmsi-505	172	33	tb	tb	ADJ
ajmsi-505	172	34	dst	dst	NOUN
ajmsi-505	172	35	category	category	NOUN
ajmsi-505	172	36	rif	rif	VERB
ajmsi-505	173	1	no	no	INTJ
ajmsi-505	173	2	(	(	PUNCT
ajmsi-505	173	3	%	%	INTJ
ajmsi-505	173	4	)	)	PUNCT
ajmsi-505	173	5	inh	inh	PROPN
ajmsi-505	174	1	no	no	INTJ
ajmsi-505	174	2	(	(	PUNCT
ajmsi-505	174	3	%	%	INTJ
ajmsi-505	174	4	)	)	PUNCT
ajmsi-505	174	5	s	s	VERB
ajmsi-505	174	6	no	no	PRON
ajmsi-505	174	7	(	(	PUNCT
ajmsi-505	174	8	%	%	NOUN
ajmsi-505	174	9	)	)	PUNCT
ajmsi-505	174	10	pza	pza	NOUN
ajmsi-505	175	1	no	no	INTJ
ajmsi-505	175	2	(	(	PUNCT
ajmsi-505	175	3	%	%	NOUN
ajmsi-505	175	4	)	)	PUNCT
ajmsi-505	175	5	emb	emb	NOUN
ajmsi-505	175	6	no	no	INTJ
ajmsi-505	175	7	(	(	PUNCT
ajmsi-505	175	8	%	%	NOUN
ajmsi-505	175	9	)	)	PUNCT
ajmsi-505	176	1	r	r	NOUN
ajmsi-505	176	2	s	s	NOUN
ajmsi-505	176	3	r	r	NOUN
ajmsi-505	176	4	s	s	NOUN
ajmsi-505	176	5	r	r	NOUN
ajmsi-505	176	6	s	s	NOUN
ajmsi-505	176	7	r	r	NOUN
ajmsi-505	176	8	s	s	NOUN
ajmsi-505	176	9	r	r	NOUN
ajmsi-505	176	10	s	s	NOUN
ajmsi-505	176	11	cat	cat	NOUN
ajmsi-505	176	12	i	i	PRON
ajmsi-505	176	13	32(11.9	32(11.9	ADJ
ajmsi-505	176	14	)	)	PUNCT
ajmsi-505	176	15	55(20.5	55(20.5	NUM
ajmsi-505	176	16	)	)	PUNCT
ajmsi-505	176	17	11(4.1	11(4.1	NUM
ajmsi-505	176	18	)	)	PUNCT
ajmsi-505	176	19	76(28.4	76(28.4	NOUN
ajmsi-505	176	20	)	)	PUNCT
ajmsi-505	176	21	16	16	NUM
ajmsi-505	176	22	(	(	PUNCT
ajmsi-505	176	23	5.0	5.0	NUM
ajmsi-505	176	24	)	)	PUNCT
ajmsi-505	176	25	71(26.5	71(26.5	NUM
ajmsi-505	176	26	)	)	PUNCT
ajmsi-505	176	27	3(1.1	3(1.1	NUM
ajmsi-505	176	28	)	)	PUNCT
ajmsi-505	176	29	84	84	NUM
ajmsi-505	176	30	(	(	PUNCT
ajmsi-505	176	31	31.3	31.3	NUM
ajmsi-505	176	32	)	)	PUNCT
ajmsi-505	176	33	49	49	NUM
ajmsi-505	176	34	(	(	PUNCT
ajmsi-505	176	35	18.3	18.3	NUM
ajmsi-505	176	36	)	)	PUNCT
ajmsi-505	176	37	38	38	NUM
ajmsi-505	176	38	(	(	PUNCT
ajmsi-505	176	39	14.2	14.2	NUM
ajmsi-505	176	40	)	)	PUNCT
ajmsi-505	176	41	cat	cat	NOUN
ajmsi-505	176	42	ii	ii	PROPN
ajmsi-505	176	43	26(9.7	26(9.7	NUM
ajmsi-505	176	44	)	)	PUNCT
ajmsi-505	176	45	54(20.1	54(20.1	NUM
ajmsi-505	176	46	)	)	PUNCT
ajmsi-505	176	47	9(3.4	9(3.4	NOUN
ajmsi-505	176	48	)	)	PUNCT
ajmsi-505	176	49	70(26.1	70(26.1	NOUN
ajmsi-505	176	50	)	)	PUNCT
ajmsi-505	176	51	7	7	NUM
ajmsi-505	176	52	(	(	PUNCT
ajmsi-505	176	53	2.6	2.6	NUM
ajmsi-505	176	54	)	)	PUNCT
ajmsi-505	176	55	72(26.9	72(26.9	NOUN
ajmsi-505	176	56	)	)	PUNCT
ajmsi-505	176	57	12(4.5	12(4.5	NUM
ajmsi-505	176	58	)	)	PUNCT
ajmsi-505	176	59	69	69	NUM
ajmsi-505	176	60	(	(	PUNCT
ajmsi-505	176	61	25.7	25.7	NUM
ajmsi-505	176	62	)	)	PUNCT
ajmsi-505	176	63	24	24	NUM
ajmsi-505	176	64	(	(	PUNCT
ajmsi-505	176	65	9.0	9.0	NUM
ajmsi-505	176	66	)	)	PUNCT
ajmsi-505	176	67	57	57	NUM
ajmsi-505	176	68	(	(	PUNCT
ajmsi-505	176	69	21.3	21.3	NUM
ajmsi-505	176	70	)	)	PUNCT
ajmsi-505	176	71	cat	cat	NOUN
ajmsi-505	176	72	iii	iii	PROPN
ajmsi-505	176	73	24(9.0	24(9.0	NUM
ajmsi-505	176	74	)	)	PUNCT
ajmsi-505	176	75	78(29.1	78(29.1	NOUN
ajmsi-505	176	76	)	)	PUNCT
ajmsi-505	176	77	7(2.6	7(2.6	NUM
ajmsi-505	176	78	)	)	PUNCT
ajmsi-505	176	79	95(35.4	95(35.4	NOUN
ajmsi-505	176	80	)	)	PUNCT
ajmsi-505	176	81	13	13	NUM
ajmsi-505	176	82	(	(	PUNCT
ajmsi-505	176	83	4.9	4.9	NUM
ajmsi-505	176	84	)	)	PUNCT
ajmsi-505	176	85	89(33.2	89(33.2	NOUN
ajmsi-505	176	86	)	)	PUNCT
ajmsi-505	176	87	18(6.7	18(6.7	NUM
ajmsi-505	176	88	)	)	PUNCT
ajmsi-505	176	89	84	84	NUM
ajmsi-505	176	90	(	(	PUNCT
ajmsi-505	176	91	31.3	31.3	NUM
ajmsi-505	176	92	)	)	PUNCT
ajmsi-505	176	93	18	18	NUM
ajmsi-505	176	94	(	(	PUNCT
ajmsi-505	176	95	6.7	6.7	NUM
ajmsi-505	176	96	)	)	PUNCT
ajmsi-505	176	97	84	84	NUM
ajmsi-505	176	98	(	(	PUNCT
ajmsi-505	176	99	31.3	31.3	NUM
ajmsi-505	176	100	)	)	PUNCT
ajmsi-505	176	101	total	total	NOUN
ajmsi-505	176	102	(	(	PUNCT
ajmsi-505	176	103	%	%	NOUN
ajmsi-505	176	104	)	)	PUNCT
ajmsi-505	176	105	82	82	NUM
ajmsi-505	176	106	(	(	PUNCT
ajmsi-505	176	107	30.6	30.6	NUM
ajmsi-505	176	108	%	%	NOUN
ajmsi-505	176	109	)	)	PUNCT
ajmsi-505	176	110	187	187	NUM
ajmsi-505	176	111	(	(	PUNCT
ajmsi-505	176	112	69.8	69.8	NUM
ajmsi-505	176	113	%	%	NOUN
ajmsi-505	176	114	)	)	PUNCT
ajmsi-505	176	115	27	27	NUM
ajmsi-505	176	116	(	(	PUNCT
ajmsi-505	176	117	10.1	10.1	NUM
ajmsi-505	176	118	%	%	NOUN
ajmsi-505	176	119	)	)	PUNCT
ajmsi-505	176	120	241	241	NUM
ajmsi-505	176	121	(	(	PUNCT
ajmsi-505	176	122	89.9	89.9	NUM
ajmsi-505	176	123	%	%	NOUN
ajmsi-505	176	124	)	)	PUNCT
ajmsi-505	176	125	36	36	NUM
ajmsi-505	176	126	(	(	PUNCT
ajmsi-505	176	127	13.4	13.4	NUM
ajmsi-505	176	128	%	%	NOUN
ajmsi-505	176	129	)	)	PUNCT
ajmsi-505	176	130	168	168	NUM
ajmsi-505	176	131	(	(	PUNCT
ajmsi-505	176	132	62.7	62.7	NUM
ajmsi-505	176	133	%	%	NOUN
ajmsi-505	176	134	)	)	PUNCT
ajmsi-505	176	135	33	33	NUM
ajmsi-505	176	136	(	(	PUNCT
ajmsi-505	176	137	12.3	12.3	NUM
ajmsi-505	176	138	%	%	NOUN
ajmsi-505	176	139	)	)	PUNCT
ajmsi-505	176	140	237	237	NUM
ajmsi-505	176	141	(	(	PUNCT
ajmsi-505	176	142	88.4	88.4	NUM
ajmsi-505	176	143	%	%	NOUN
ajmsi-505	176	144	)	)	PUNCT
ajmsi-505	176	145	91	91	NUM
ajmsi-505	176	146	(	(	PUNCT
ajmsi-505	176	147	34.0	34.0	NUM
ajmsi-505	176	148	%	%	NOUN
ajmsi-505	176	149	)	)	PUNCT
ajmsi-505	176	150	179	179	NUM
ajmsi-505	176	151	(	(	PUNCT
ajmsi-505	176	152	66.8	66.8	NUM
ajmsi-505	176	153	%	%	NOUN
ajmsi-505	176	154	)	)	PUNCT
ajmsi-505	176	155	key	key	NOUN
ajmsi-505	176	156	:	:	PUNCT
ajmsi-505	176	157	cat	cat	NOUN
ajmsi-505	177	1	i	i	NOUN
ajmsi-505	177	2	=	=	VERB
ajmsi-505	177	3	category	category	NOUN
ajmsi-505	177	4	i	i	NOUN
ajmsi-505	177	5	,	,	PUNCT
ajmsi-505	177	6	cat	cat	PROPN
ajmsi-505	177	7	ii	ii	PROPN
ajmsi-505	177	8	=	=	PROPN
ajmsi-505	177	9	category	category	PROPN
ajmsi-505	177	10	ii	ii	PROPN
ajmsi-505	177	11	,	,	PUNCT
ajmsi-505	177	12	cat	cat	PROPN
ajmsi-505	177	13	ii	ii	PROPN
ajmsi-505	177	14	=	=	PROPN
ajmsi-505	177	15	category	category	PROPN
ajmsi-505	177	16	iii	iii	PROPN
ajmsi-505	177	17	,	,	PUNCT
ajmsi-505	177	18	rif	rif	PROPN
ajmsi-505	177	19	=	=	PUNCT
ajmsi-505	177	20	rifampicin	rifampicin	VERB
ajmsi-505	177	21	,	,	PUNCT
ajmsi-505	177	22	inh	inh	PROPN
ajmsi-505	177	23	=	=	SYM
ajmsi-505	177	24	isoniazid	isoniazid	NOUN
ajmsi-505	177	25	,	,	PUNCT
ajmsi-505	177	26	s	s	PART
ajmsi-505	177	27	=	=	NOUN
ajmsi-505	177	28	streptomycin	streptomycin	PROPN
ajmsi-505	177	29	,	,	PUNCT
ajmsi-505	177	30	pza	pza	NOUN
ajmsi-505	177	31	=	=	SYM
ajmsi-505	177	32	parazinamide	parazinamide	NOUN
ajmsi-505	177	33	,	,	PUNCT
ajmsi-505	177	34	emb	emb	NOUN
ajmsi-505	177	35	=	=	PUNCT
ajmsi-505	177	36	etambutol	etambutol	NOUN
ajmsi-505	177	37	,	,	PUNCT
ajmsi-505	177	38	r	r	NOUN
ajmsi-505	177	39	=	=	SYM
ajmsi-505	177	40	resistant	resistant	ADJ
ajmsi-505	177	41	,	,	PUNCT
ajmsi-505	177	42	s	s	NOUN
ajmsi-505	177	43	=	=	NOUN
ajmsi-505	177	44	susceptible	susceptible	ADJ
ajmsi-505	177	45	,	,	PUNCT
ajmsi-505	177	46	no	no	INTJ
ajmsi-505	177	47	.	.	PUNCT
ajmsi-505	178	1	=	=	NOUN
ajmsi-505	178	2	number	number	NOUN
ajmsi-505	178	3	,	,	PUNCT
ajmsi-505	178	4	%	%	NOUN
ajmsi-505	178	5	=	=	SYM
ajmsi-505	178	6	percentage	percentage	NOUN
ajmsi-505	178	7	,	,	PUNCT
ajmsi-505	178	8	dst=	dst=	PROPN
ajmsi-505	178	9	drugs	drug	NOUN
ajmsi-505	178	10	susceptibility	susceptibility	NOUN
ajmsi-505	178	11	testing	testing	NOUN
ajmsi-505	178	12	.	.	PUNCT
ajmsi-505	179	1	cases	case	NOUN
ajmsi-505	179	2	.	.	PUNCT
ajmsi-505	180	1	male	male	NOUN
ajmsi-505	180	2	accounted	account	VERB
ajmsi-505	180	3	for	for	ADP
ajmsi-505	180	4	36(58.1	36(58.1	NUM
ajmsi-505	180	5	%	%	NOUN
ajmsi-505	180	6	)	)	PUNCT
ajmsi-505	180	7	while	while	SCONJ
ajmsi-505	180	8	female	female	ADJ
ajmsi-505	180	9	accounted	account	VERB
ajmsi-505	180	10	for	for	ADP
ajmsi-505	180	11	26(41.9	26(41.9	NUM
ajmsi-505	180	12	%	%	NOUN
ajmsi-505	180	13	)	)	PUNCT
ajmsi-505	180	14	of	of	ADP
ajmsi-505	180	15	the	the	DET
ajmsi-505	180	16	cases	case	NOUN
ajmsi-505	180	17	as	as	SCONJ
ajmsi-505	180	18	contained	contain	VERB
ajmsi-505	180	19	in	in	ADP
ajmsi-505	180	20	table	table	NOUN
ajmsi-505	180	21	7	7	NUM
ajmsi-505	180	22	.	.	PUNCT
ajmsi-505	181	1	t	t	NOUN
ajmsi-505	181	2	=	=	PUNCT
ajmsi-505	182	1	148.48	148.48	NUM
ajmsi-505	182	2	,	,	PUNCT
ajmsi-505	182	3	df	df	PROPN
ajmsi-505	182	4	=	=	SYM
ajmsi-505	182	5	13	13	NUM
ajmsi-505	182	6	,	,	PUNCT
ajmsi-505	182	7	p	p	X
ajmsi-505	182	8	<	<	X
ajmsi-505	182	9	0.05	0.05	NUM
ajmsi-505	182	10	results	result	NOUN
ajmsi-505	182	11	of	of	ADP
ajmsi-505	182	12	genexpert	genexpert	ADJ
ajmsi-505	182	13	for	for	ADP
ajmsi-505	182	14	all	all	DET
ajmsi-505	182	15	the	the	DET
ajmsi-505	182	16	380	380	NUM
ajmsi-505	182	17	sputum	sputum	NOUN
ajmsi-505	182	18	samples	sample	NOUN
ajmsi-505	182	19	showed	show	VERB
ajmsi-505	182	20	rifampicin	rifampicin	VERB
ajmsi-505	182	21	resistance	resistance	NOUN
ajmsi-505	182	22	was	be	AUX
ajmsi-505	182	23	detected	detect	VERB
ajmsi-505	182	24	in	in	ADP
ajmsi-505	182	25	62(16.3	62(16.3	ADJ
ajmsi-505	182	26	%	%	NOUN
ajmsi-505	182	27	)	)	PUNCT
ajmsi-505	183	1	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	183	2	pa	pa	PROPN
ajmsi-505	183	3	ge	ge	PROPN
ajmsi-505	183	4	7	7	NUM
ajmsi-505	183	5	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	183	6	am	be	AUX
ajmsi-505	183	7	.	.	PUNCT
ajmsi-505	184	1	j.	j.	PROPN
ajmsi-505	184	2	med	med	PROPN
ajmsi-505	184	3	.	.	PUNCT
ajmsi-505	185	1	sci	sci	PROPN
ajmsi-505	185	2	.	.	PUNCT
ajmsi-505	185	3	innov	innov	PROPN
ajmsi-505	185	4	.	.	PUNCT
ajmsi-505	186	1	1(1	1(1	NUM
ajmsi-505	186	2	)	)	PUNCT
ajmsi-505	186	3	1	1	NUM
ajmsi-505	186	4	-	-	SYM
ajmsi-505	186	5	9	9	NUM
ajmsi-505	186	6	,	,	PUNCT
ajmsi-505	186	7	2022	2022	NUM
ajmsi-505	186	8	discussion	discussion	NOUN
ajmsi-505	186	9	the	the	DET
ajmsi-505	186	10	results	result	NOUN
ajmsi-505	186	11	obtained	obtain	VERB
ajmsi-505	186	12	from	from	ADP
ajmsi-505	186	13	this	this	DET
ajmsi-505	186	14	study	study	NOUN
ajmsi-505	186	15	attest	attest	NOUN
ajmsi-505	186	16	to	to	ADP
ajmsi-505	186	17	the	the	DET
ajmsi-505	186	18	fact	fact	NOUN
ajmsi-505	186	19	that	that	SCONJ
ajmsi-505	186	20	mdr	mdr	PROPN
ajmsi-505	186	21	-	-	PROPN
ajmsi-505	186	22	tb	tb	PROPN
ajmsi-505	186	23	,	,	PUNCT
ajmsi-505	186	24	which	which	PRON
ajmsi-505	186	25	is	be	AUX
ajmsi-505	186	26	an	an	DET
ajmsi-505	186	27	emerging	emerge	VERB
ajmsi-505	186	28	epidemic	epidemic	NOUN
ajmsi-505	186	29	,	,	PUNCT
ajmsi-505	186	30	is	be	AUX
ajmsi-505	186	31	not	not	PART
ajmsi-505	186	32	just	just	ADV
ajmsi-505	186	33	prevalent	prevalent	ADJ
ajmsi-505	186	34	in	in	ADP
ajmsi-505	186	35	parts	part	NOUN
ajmsi-505	186	36	of	of	ADP
ajmsi-505	186	37	benue	benue	NOUN
ajmsi-505	186	38	state	state	NOUN
ajmsi-505	186	39	,	,	PUNCT
ajmsi-505	186	40	but	but	CCONJ
ajmsi-505	186	41	it	it	PRON
ajmsi-505	186	42	is	be	AUX
ajmsi-505	186	43	on	on	ADP
ajmsi-505	186	44	the	the	DET
ajmsi-505	186	45	increase	increase	NOUN
ajmsi-505	186	46	as	as	SCONJ
ajmsi-505	186	47	compared	compare	VERB
ajmsi-505	186	48	to	to	ADP
ajmsi-505	186	49	the	the	DET
ajmsi-505	186	50	estimated	estimate	VERB
ajmsi-505	186	51	5.3	5.3	NUM
ajmsi-505	186	52	%	%	NOUN
ajmsi-505	186	53	rate	rate	NOUN
ajmsi-505	186	54	of	of	ADP
ajmsi-505	186	55	global	global	PROPN
ajmsi-505	186	56	mdr	mdr	PROPN
ajmsi-505	186	57	-	-	PROPN
ajmsi-505	186	58	tb	tb	X
ajmsi-505	186	59	(	(	PUNCT
ajmsi-505	186	60	who	who	PRON
ajmsi-505	186	61	,	,	PUNCT
ajmsi-505	186	62	2011	2011	NUM
ajmsi-505	186	63	)	)	PUNCT
ajmsi-505	186	64	.	.	PUNCT
ajmsi-505	187	1	the	the	DET
ajmsi-505	187	2	prevalence	prevalence	NOUN
ajmsi-505	187	3	of	of	ADP
ajmsi-505	187	4	mdr	mdr	PROPN
ajmsi-505	187	5	-	-	PROPN
ajmsi-505	187	6	tb	tb	NOUN
ajmsi-505	187	7	in	in	ADP
ajmsi-505	187	8	the	the	DET
ajmsi-505	187	9	study	study	NOUN
ajmsi-505	187	10	population	population	NOUN
ajmsi-505	187	11	was	be	AUX
ajmsi-505	187	12	9.7	9.7	NUM
ajmsi-505	187	13	%	%	NOUN
ajmsi-505	187	14	(	(	PUNCT
ajmsi-505	187	15	retreated	retreat	VERB
ajmsi-505	187	16	cases	case	NOUN
ajmsi-505	187	17	7.1	7.1	NUM
ajmsi-505	187	18	%	%	NOUN
ajmsi-505	187	19	;	;	PUNCT
ajmsi-505	187	20	treatment	treatment	NOUN
ajmsi-505	187	21	naive	naive	ADJ
ajmsi-505	187	22	2.6	2.6	NUM
ajmsi-505	187	23	%	%	NOUN
ajmsi-505	187	24	)	)	PUNCT
ajmsi-505	187	25	out	out	ADP
ajmsi-505	187	26	of	of	ADP
ajmsi-505	187	27	the	the	DET
ajmsi-505	187	28	268	268	NUM
ajmsi-505	187	29	isolated	isolated	ADJ
ajmsi-505	187	30	strains	strain	NOUN
ajmsi-505	187	31	of	of	ADP
ajmsi-505	187	32	m.	m.	NOUN
ajmsi-505	187	33	tuberculosis	tuberculosis	NOUN
ajmsi-505	187	34	.	.	PUNCT
ajmsi-505	188	1	there	there	PRON
ajmsi-505	188	2	was	be	VERB
ajmsi-505	188	3	a	a	DET
ajmsi-505	188	4	higher	high	ADJ
ajmsi-505	188	5	proportion	proportion	NOUN
ajmsi-505	188	6	of	of	ADP
ajmsi-505	188	7	mdr	mdr	PROPN
ajmsi-505	188	8	-	-	NOUN
ajmsi-505	188	9	tb	tb	NOUN
ajmsi-505	188	10	within	within	ADP
ajmsi-505	188	11	the	the	DET
ajmsi-505	188	12	age	age	NOUN
ajmsi-505	188	13	group	group	NOUN
ajmsi-505	188	14	31	31	NUM
ajmsi-505	188	15	–	–	PUNCT
ajmsi-505	188	16	40	40	NUM
ajmsi-505	188	17	and	and	CCONJ
ajmsi-505	188	18	41	41	NUM
ajmsi-505	188	19	–	–	SYM
ajmsi-505	188	20	50	50	NUM
ajmsi-505	188	21	(	(	PUNCT
ajmsi-505	188	22	mean	mean	VERB
ajmsi-505	188	23	age	age	NOUN
ajmsi-505	188	24	limit	limit	NOUN
ajmsi-505	188	25	35	35	NUM
ajmsi-505	188	26	–	–	PUNCT
ajmsi-505	188	27	45	45	NUM
ajmsi-505	188	28	)	)	PUNCT
ajmsi-505	188	29	.	.	PUNCT
ajmsi-505	189	1	this	this	DET
ajmsi-505	189	2	age	age	NOUN
ajmsi-505	189	3	range	range	NOUN
ajmsi-505	189	4	represents	represent	VERB
ajmsi-505	189	5	the	the	DET
ajmsi-505	189	6	most	most	ADV
ajmsi-505	189	7	economically	economically	ADV
ajmsi-505	189	8	productive	productive	ADJ
ajmsi-505	189	9	and	and	CCONJ
ajmsi-505	189	10	viable	viable	ADJ
ajmsi-505	189	11	workforce	workforce	NOUN
ajmsi-505	189	12	both	both	CCONJ
ajmsi-505	189	13	in	in	ADP
ajmsi-505	189	14	the	the	DET
ajmsi-505	189	15	private	private	ADJ
ajmsi-505	189	16	and	and	CCONJ
ajmsi-505	189	17	public	public	ADJ
ajmsi-505	189	18	sectors	sector	NOUN
ajmsi-505	189	19	.	.	PUNCT
ajmsi-505	190	1	as	as	ADP
ajmsi-505	190	2	a	a	DET
ajmsi-505	190	3	result	result	NOUN
ajmsi-505	190	4	,	,	PUNCT
ajmsi-505	190	5	the	the	DET
ajmsi-505	190	6	need	need	NOUN
ajmsi-505	190	7	to	to	PART
ajmsi-505	190	8	urgently	urgently	ADV
ajmsi-505	190	9	attend	attend	VERB
ajmsi-505	190	10	to	to	ADP
ajmsi-505	190	11	the	the	DET
ajmsi-505	190	12	menace	menace	NOUN
ajmsi-505	190	13	of	of	ADP
ajmsi-505	190	14	mdr	mdr	PROPN
ajmsi-505	190	15	-	-	NOUN
ajmsi-505	190	16	tb	tb	NOUN
ajmsi-505	190	17	in	in	ADP
ajmsi-505	190	18	benue	benue	NOUN
ajmsi-505	190	19	state	state	NOUN
ajmsi-505	190	20	can	can	AUX
ajmsi-505	190	21	not	not	PART
ajmsi-505	190	22	be	be	AUX
ajmsi-505	190	23	over	over	ADP
ajmsi-505	190	24	emphasized	emphasize	VERB
ajmsi-505	190	25	.	.	PUNCT
ajmsi-505	191	1	other	other	ADJ
ajmsi-505	191	2	research	research	NOUN
ajmsi-505	191	3	groups	group	NOUN
ajmsi-505	191	4	also	also	ADV
ajmsi-505	191	5	reported	report	VERB
ajmsi-505	191	6	that	that	SCONJ
ajmsi-505	191	7	anti	anti	ADJ
ajmsi-505	191	8	-	-	ADJ
ajmsi-505	191	9	tb	tb	ADJ
ajmsi-505	191	10	drugs	drug	NOUN
ajmsi-505	191	11	resistance	resistance	NOUN
ajmsi-505	191	12	peaks	peak	NOUN
ajmsi-505	191	13	within	within	ADP
ajmsi-505	191	14	the	the	DET
ajmsi-505	191	15	age	age	NOUN
ajmsi-505	191	16	range	range	NOUN
ajmsi-505	191	17	of	of	ADP
ajmsi-505	191	18	25	25	NUM
ajmsi-505	191	19	–	–	SYM
ajmsi-505	191	20	35	35	NUM
ajmsi-505	191	21	years	year	NOUN
ajmsi-505	191	22	(	(	PUNCT
ajmsi-505	191	23	lawson	lawson	PROPN
ajmsi-505	191	24	et	et	PROPN
ajmsi-505	191	25	al	al	PROPN
ajmsi-505	191	26	.	.	PROPN
ajmsi-505	191	27	,	,	PUNCT
ajmsi-505	191	28	2011	2011	NUM
ajmsi-505	191	29	;	;	PUNCT
ajmsi-505	191	30	uzoewulu	uzoewulu	PROPN
ajmsi-505	191	31	et	et	PROPN
ajmsi-505	191	32	al	al	PROPN
ajmsi-505	191	33	.	.	PROPN
ajmsi-505	191	34	,	,	PUNCT
ajmsi-505	191	35	2014	2014	NUM
ajmsi-505	191	36	)	)	PUNCT
ajmsi-505	191	37	.	.	PUNCT
ajmsi-505	192	1	results	result	NOUN
ajmsi-505	192	2	of	of	ADP
ajmsi-505	192	3	this	this	DET
ajmsi-505	192	4	study	study	NOUN
ajmsi-505	192	5	with	with	ADP
ajmsi-505	192	6	strong	strong	ADJ
ajmsi-505	192	7	,	,	PUNCT
ajmsi-505	192	8	significant	significant	ADJ
ajmsi-505	192	9	statistical	statistical	ADJ
ajmsi-505	192	10	differences	difference	NOUN
ajmsi-505	192	11	between	between	ADP
ajmsi-505	192	12	male	male	ADJ
ajmsi-505	192	13	and	and	CCONJ
ajmsi-505	192	14	female	female	ADJ
ajmsi-505	192	15	mdr	mdr	PROPN
ajmsi-505	192	16	-	-	PROPN
ajmsi-505	192	17	tb	tb	ADP
ajmsi-505	192	18	resistance	resistance	NOUN
ajmsi-505	192	19	rates	rate	NOUN
ajmsi-505	192	20	,	,	PUNCT
ajmsi-505	192	21	with	with	ADP
ajmsi-505	192	22	male	male	ADJ
ajmsi-505	192	23	patients	patient	NOUN
ajmsi-505	192	24	having	have	VERB
ajmsi-505	192	25	more	more	ADV
ajmsi-505	192	26	resistant	resistant	ADJ
ajmsi-505	192	27	strains	strain	NOUN
ajmsi-505	192	28	agree	agree	VERB
ajmsi-505	192	29	with	with	ADP
ajmsi-505	192	30	the	the	DET
ajmsi-505	192	31	work	work	NOUN
ajmsi-505	192	32	by	by	ADP
ajmsi-505	192	33	uzoewulu	uzoewulu	ADJ
ajmsi-505	192	34	and	and	CCONJ
ajmsi-505	192	35	co	co	NOUN
ajmsi-505	192	36	-	-	NOUN
ajmsi-505	192	37	workers	worker	NOUN
ajmsi-505	192	38	(	(	PUNCT
ajmsi-505	192	39	uzoewulu	uzoewulu	PROPN
ajmsi-505	192	40	et	et	PROPN
ajmsi-505	192	41	al	al	PROPN
ajmsi-505	192	42	.	.	PROPN
ajmsi-505	192	43	,	,	PUNCT
ajmsi-505	192	44	2014	2014	NUM
ajmsi-505	192	45	)	)	PUNCT
ajmsi-505	192	46	.	.	PUNCT
ajmsi-505	193	1	this	this	PRON
ajmsi-505	193	2	underscores	underscore	VERB
ajmsi-505	193	3	the	the	DET
ajmsi-505	193	4	enormous	enormous	ADJ
ajmsi-505	193	5	role	role	NOUN
ajmsi-505	193	6	of	of	ADP
ajmsi-505	193	7	male	male	ADJ
ajmsi-505	193	8	patients	patient	NOUN
ajmsi-505	193	9	in	in	ADP
ajmsi-505	193	10	the	the	DET
ajmsi-505	193	11	epidemiology	epidemiology	NOUN
ajmsi-505	193	12	of	of	ADP
ajmsi-505	193	13	drug	drug	NOUN
ajmsi-505	193	14	resistant	resistant	ADJ
ajmsi-505	193	15	tuberculosis	tuberculosis	NOUN
ajmsi-505	193	16	in	in	ADP
ajmsi-505	193	17	the	the	DET
ajmsi-505	193	18	study	study	NOUN
ajmsi-505	193	19	population	population	NOUN
ajmsi-505	193	20	.	.	PUNCT
ajmsi-505	194	1	this	this	PRON
ajmsi-505	194	2	may	may	AUX
ajmsi-505	194	3	be	be	AUX
ajmsi-505	194	4	due	due	ADJ
ajmsi-505	194	5	to	to	ADP
ajmsi-505	194	6	the	the	DET
ajmsi-505	194	7	fact	fact	NOUN
ajmsi-505	194	8	that	that	SCONJ
ajmsi-505	194	9	most	most	ADJ
ajmsi-505	194	10	females	female	NOUN
ajmsi-505	194	11	are	be	AUX
ajmsi-505	194	12	economically	economically	ADV
ajmsi-505	194	13	disadvantaged	disadvantaged	ADJ
ajmsi-505	194	14	in	in	ADP
ajmsi-505	194	15	seeking	seek	VERB
ajmsi-505	194	16	appropriate	appropriate	ADJ
ajmsi-505	194	17	medical	medical	ADJ
ajmsi-505	194	18	attention	attention	NOUN
ajmsi-505	194	19	,	,	PUNCT
ajmsi-505	194	20	in	in	ADP
ajmsi-505	194	21	addition	addition	NOUN
ajmsi-505	194	22	to	to	ADP
ajmsi-505	194	23	social	social	ADJ
ajmsi-505	194	24	and	and	CCONJ
ajmsi-505	194	25	cultural	cultural	ADJ
ajmsi-505	194	26	beliefs	belief	NOUN
ajmsi-505	194	27	that	that	PRON
ajmsi-505	194	28	place	place	VERB
ajmsi-505	194	29	women	woman	NOUN
ajmsi-505	194	30	under	under	ADP
ajmsi-505	194	31	movement	movement	NOUN
ajmsi-505	194	32	restrictions	restriction	NOUN
ajmsi-505	194	33	.	.	PUNCT
ajmsi-505	195	1	other	other	ADJ
ajmsi-505	195	2	studies	study	NOUN
ajmsi-505	195	3	reported	report	VERB
ajmsi-505	195	4	stigma	stigma	NOUN
ajmsi-505	195	5	as	as	ADP
ajmsi-505	195	6	a	a	DET
ajmsi-505	195	7	principal	principal	ADJ
ajmsi-505	195	8	factor	factor	NOUN
ajmsi-505	195	9	(	(	PUNCT
ajmsi-505	195	10	uzoewulu	uzoewulu	PROPN
ajmsi-505	195	11	et	et	PROPN
ajmsi-505	195	12	al	al	PROPN
ajmsi-505	195	13	.	.	PROPN
ajmsi-505	195	14	,	,	PUNCT
ajmsi-505	195	15	2014	2014	NUM
ajmsi-505	195	16	)	)	PUNCT
ajmsi-505	195	17	.	.	PUNCT
ajmsi-505	196	1	the	the	DET
ajmsi-505	196	2	rate	rate	NOUN
ajmsi-505	196	3	of	of	ADP
ajmsi-505	196	4	mdr	mdr	PROPN
ajmsi-505	196	5	-	-	PROPN
ajmsi-505	196	6	tb	tb	ADP
ajmsi-505	196	7	9.7	9.7	NUM
ajmsi-505	196	8	%	%	NOUN
ajmsi-505	196	9	in	in	ADP
ajmsi-505	196	10	this	this	DET
ajmsi-505	196	11	study	study	NOUN
ajmsi-505	196	12	is	be	AUX
ajmsi-505	196	13	higher	high	ADJ
ajmsi-505	196	14	than	than	ADP
ajmsi-505	196	15	the	the	DET
ajmsi-505	196	16	estimated	estimate	VERB
ajmsi-505	196	17	5.3	5.3	NUM
ajmsi-505	196	18	%	%	NOUN
ajmsi-505	196	19	rate	rate	NOUN
ajmsi-505	196	20	of	of	ADP
ajmsi-505	196	21	global	global	PROPN
ajmsi-505	196	22	mdr	mdr	PROPN
ajmsi-505	196	23	-	-	PROPN
ajmsi-505	196	24	tb	tb	X
ajmsi-505	196	25	(	(	PUNCT
ajmsi-505	196	26	who	who	PRON
ajmsi-505	196	27	,	,	PUNCT
ajmsi-505	196	28	2011	2011	NUM
ajmsi-505	196	29	)	)	PUNCT
ajmsi-505	196	30	.	.	PUNCT
ajmsi-505	197	1	the	the	DET
ajmsi-505	197	2	rate	rate	NOUN
ajmsi-505	197	3	of	of	ADP
ajmsi-505	197	4	mdr	mdr	PROPN
ajmsi-505	197	5	-	-	PROPN
ajmsi-505	197	6	tb	tb	ADP
ajmsi-505	197	7	2.6	2.6	NUM
ajmsi-505	197	8	%	%	NOUN
ajmsi-505	197	9	in	in	ADP
ajmsi-505	197	10	newly	newly	ADV
ajmsi-505	197	11	diagnosed	diagnose	VERB
ajmsi-505	197	12	tb	tb	ADP
ajmsi-505	197	13	cases	case	NOUN
ajmsi-505	197	14	has	have	VERB
ajmsi-505	197	15	no	no	DET
ajmsi-505	197	16	statistical	statistical	ADJ
ajmsi-505	197	17	difference	difference	NOUN
ajmsi-505	197	18	between	between	ADP
ajmsi-505	197	19	current	current	ADJ
ajmsi-505	197	20	estimated	estimate	VERB
ajmsi-505	197	21	rate	rate	NOUN
ajmsi-505	197	22	of	of	ADP
ajmsi-505	197	23	mdr	mdr	PROPN
ajmsi-505	197	24	-	-	PROPN
ajmsi-505	197	25	tb	tb	ADP
ajmsi-505	197	26	2.2	2.2	NUM
ajmsi-505	197	27	%	%	NOUN
ajmsi-505	197	28	for	for	ADP
ajmsi-505	197	29	new	new	ADJ
ajmsi-505	197	30	cases	case	NOUN
ajmsi-505	197	31	in	in	ADP
ajmsi-505	197	32	nigeria	nigeria	PROPN
ajmsi-505	197	33	and	and	CCONJ
ajmsi-505	197	34	2.9	2.9	NUM
ajmsi-505	197	35	%	%	NOUN
ajmsi-505	197	36	new	new	ADJ
ajmsi-505	197	37	cases	case	NOUN
ajmsi-505	197	38	in	in	ADP
ajmsi-505	197	39	current	current	ADJ
ajmsi-505	197	40	national	national	ADJ
ajmsi-505	197	41	survey	survey	NOUN
ajmsi-505	197	42	,	,	PUNCT
ajmsi-505	197	43	although	although	SCONJ
ajmsi-505	197	44	slightly	slightly	ADV
ajmsi-505	197	45	lower	low	ADJ
ajmsi-505	197	46	,	,	PUNCT
ajmsi-505	197	47	but	but	CCONJ
ajmsi-505	197	48	mdr	mdr	PROPN
ajmsi-505	197	49	-	-	PROPN
ajmsi-505	197	50	tb	tb	NOUN
ajmsi-505	197	51	of	of	ADP
ajmsi-505	197	52	7.1	7.1	NUM
ajmsi-505	197	53	%	%	NOUN
ajmsi-505	197	54	in	in	ADP
ajmsi-505	197	55	previously	previously	ADV
ajmsi-505	197	56	treated	treat	VERB
ajmsi-505	197	57	cases	case	NOUN
ajmsi-505	197	58	is	be	AUX
ajmsi-505	197	59	lower	low	ADJ
ajmsi-505	197	60	compared	compare	VERB
ajmsi-505	197	61	to	to	ADP
ajmsi-505	197	62	the	the	DET
ajmsi-505	197	63	estimated	estimate	VERB
ajmsi-505	197	64	rate	rate	NOUN
ajmsi-505	197	65	of	of	ADP
ajmsi-505	197	66	mdr	mdr	PROPN
ajmsi-505	197	67	-	-	PROPN
ajmsi-505	197	68	tb	tb	ADP
ajmsi-505	197	69	9.4%(who	9.4%(who	NUM
ajmsi-505	197	70	,	,	PUNCT
ajmsi-505	197	71	2012	2012	NUM
ajmsi-505	197	72	)	)	PUNCT
ajmsi-505	197	73	and	and	CCONJ
ajmsi-505	197	74	even	even	ADV
ajmsi-505	197	75	grossly	grossly	ADV
ajmsi-505	197	76	lower	low	ADJ
ajmsi-505	197	77	than	than	ADP
ajmsi-505	197	78	the	the	DET
ajmsi-505	197	79	14	14	NUM
ajmsi-505	197	80	%	%	NOUN
ajmsi-505	197	81	from	from	ADP
ajmsi-505	197	82	the	the	DET
ajmsi-505	197	83	current	current	ADJ
ajmsi-505	197	84	national	national	ADJ
ajmsi-505	197	85	survey	survey	NOUN
ajmsi-505	197	86	on	on	ADP
ajmsi-505	197	87	mdr	mdr	PROPN
ajmsi-505	197	88	-	-	NOUN
ajmsi-505	197	89	tb	tb	PROPN
ajmsi-505	197	90	in	in	ADP
ajmsi-505	197	91	nigeria	nigeria	PROPN
ajmsi-505	197	92	(	(	PUNCT
ajmsi-505	197	93	who	who	PRON
ajmsi-505	197	94	,	,	PUNCT
ajmsi-505	197	95	2011	2011	NUM
ajmsi-505	197	96	)	)	PUNCT
ajmsi-505	197	97	,	,	PUNCT
ajmsi-505	197	98	but	but	CCONJ
ajmsi-505	197	99	is	be	AUX
ajmsi-505	197	100	within	within	ADP
ajmsi-505	197	101	the	the	DET
ajmsi-505	197	102	trend	trend	NOUN
ajmsi-505	197	103	for	for	ADP
ajmsi-505	197	104	african	african	ADJ
ajmsi-505	197	105	countries	country	NOUN
ajmsi-505	197	106	in	in	ADP
ajmsi-505	197	107	which	which	PRON
ajmsi-505	197	108	3.9	3.9	NUM
ajmsi-505	197	109	–	–	PUNCT
ajmsi-505	197	110	5.0	5.0	NUM
ajmsi-505	197	111	%	%	NOUN
ajmsi-505	197	112	was	be	AUX
ajmsi-505	197	113	reported	report	VERB
ajmsi-505	197	114	for	for	ADP
ajmsi-505	197	115	new	new	ADJ
ajmsi-505	197	116	tb	tb	NOUN
ajmsi-505	197	117	cases	case	NOUN
ajmsi-505	197	118	and	and	CCONJ
ajmsi-505	197	119	16.7	16.7	NUM
ajmsi-505	197	120	%	%	NOUN
ajmsi-505	197	121	in	in	ADP
ajmsi-505	197	122	previously	previously	ADV
ajmsi-505	197	123	treated	treat	VERB
ajmsi-505	197	124	cases	case	NOUN
ajmsi-505	197	125	(	(	PUNCT
ajmsi-505	197	126	who	who	PRON
ajmsi-505	197	127	,	,	PUNCT
ajmsi-505	197	128	2006	2006	NUM
ajmsi-505	197	129	)	)	PUNCT
ajmsi-505	197	130	.	.	PUNCT
ajmsi-505	198	1	these	these	DET
ajmsi-505	198	2	results	result	NOUN
ajmsi-505	198	3	closely	closely	ADV
ajmsi-505	198	4	agree	agree	VERB
ajmsi-505	198	5	with	with	ADP
ajmsi-505	198	6	the	the	DET
ajmsi-505	198	7	report	report	NOUN
ajmsi-505	198	8	by	by	ADP
ajmsi-505	198	9	uzoewulu	uzoewulu	ADJ
ajmsi-505	198	10	and	and	CCONJ
ajmsi-505	198	11	coreseachers	coreseacher	NOUN
ajmsi-505	198	12	.	.	PUNCT
ajmsi-505	199	1	(	(	PUNCT
ajmsi-505	199	2	uzoewulu	uzoewulu	PROPN
ajmsi-505	199	3	et	et	PROPN
ajmsi-505	199	4	al	al	PROPN
ajmsi-505	199	5	.	.	PROPN
ajmsi-505	199	6	,	,	PUNCT
ajmsi-505	199	7	2014	2014	NUM
ajmsi-505	199	8	)	)	PUNCT
ajmsi-505	199	9	,	,	PUNCT
ajmsi-505	199	10	who	who	PRON
ajmsi-505	199	11	reported	report	VERB
ajmsi-505	199	12	mdrtb	mdrtb	NOUN
ajmsi-505	199	13	of	of	ADP
ajmsi-505	199	14	7.7	7.7	NUM
ajmsi-505	199	15	%	%	NOUN
ajmsi-505	199	16	.	.	PUNCT
ajmsi-505	200	1	kolo	kolo	PROPN
ajmsi-505	200	2	,	,	PUNCT
ajmsi-505	200	3	idigbe	idigbe	NOUN
ajmsi-505	200	4	and	and	CCONJ
ajmsi-505	200	5	co	co	NOUN
ajmsi-505	200	6	-	-	NOUN
ajmsi-505	200	7	reseachers	reseacher	NOUN
ajmsi-505	200	8	,	,	PUNCT
ajmsi-505	200	9	lawson	lawson	PROPN
ajmsi-505	200	10	and	and	CCONJ
ajmsi-505	200	11	co	co	NOUN
ajmsi-505	200	12	-	-	NOUN
ajmsi-505	200	13	reseachers	reseacher	NOUN
ajmsi-505	200	14	,	,	PUNCT
ajmsi-505	200	15	and	and	CCONJ
ajmsi-505	200	16	akaninyene	akaninyene	NOUN
ajmsi-505	200	17	and	and	CCONJ
ajmsi-505	200	18	co	co	NOUN
ajmsi-505	200	19	-	-	NOUN
ajmsi-505	200	20	reseachers	reseacher	NOUN
ajmsi-505	200	21	(	(	PUNCT
ajmsi-505	200	22	kolo	kolo	PROPN
ajmsi-505	200	23	,	,	PUNCT
ajmsi-505	200	24	1991	1991	NUM
ajmsi-505	200	25	;	;	PUNCT
ajmsi-505	200	26	idigbe	idigbe	NOUN
ajmsi-505	200	27	et	et	PROPN
ajmsi-505	200	28	al	al	PROPN
ajmsi-505	200	29	.	.	PROPN
ajmsi-505	200	30	,1992	,1992	PROPN
ajmsi-505	200	31	;	;	PUNCT
ajmsi-505	200	32	lawson	lawson	PROPN
ajmsi-505	200	33	et	et	PROPN
ajmsi-505	200	34	al	al	PROPN
ajmsi-505	200	35	.	.	PROPN
ajmsi-505	200	36	,	,	PUNCT
ajmsi-505	200	37	2011	2011	NUM
ajmsi-505	200	38	;	;	PUNCT
ajmsi-505	200	39	akaninyene	akaninyene	VERB
ajmsi-505	200	40	et	et	PROPN
ajmsi-505	200	41	al	al	PROPN
ajmsi-505	200	42	.	.	PROPN
ajmsi-505	200	43	,	,	PUNCT
ajmsi-505	200	44	2013	2013	NUM
ajmsi-505	200	45	)	)	PUNCT
ajmsi-505	200	46	all	all	PRON
ajmsi-505	200	47	reported	report	VERB
ajmsi-505	200	48	similar	similar	ADJ
ajmsi-505	200	49	findings	finding	NOUN
ajmsi-505	200	50	.	.	PUNCT
ajmsi-505	201	1	comparative	comparative	ADJ
ajmsi-505	201	2	analysis	analysis	NOUN
ajmsi-505	201	3	of	of	ADP
ajmsi-505	201	4	the	the	DET
ajmsi-505	201	5	three	three	NUM
ajmsi-505	201	6	categories	category	NOUN
ajmsi-505	201	7	of	of	ADP
ajmsi-505	201	8	patients	patient	NOUN
ajmsi-505	201	9	revealed	reveal	VERB
ajmsi-505	201	10	that	that	SCONJ
ajmsi-505	201	11	category	category	NOUN
ajmsi-505	201	12	i	i	PRON
ajmsi-505	201	13	patients	patient	VERB
ajmsi-505	201	14	(	(	PUNCT
ajmsi-505	201	15	patients	patient	NOUN
ajmsi-505	201	16	with	with	ADP
ajmsi-505	201	17	hiv	hiv	PROPN
ajmsi-505	201	18	-	-	PUNCT
ajmsi-505	201	19	tb	tb	NOUN
ajmsi-505	201	20	coinfection	coinfection	NOUN
ajmsi-505	201	21	that	that	PRON
ajmsi-505	201	22	tested	test	VERB
ajmsi-505	201	23	afb	afb	NOUN
ajmsi-505	201	24	positive	positive	ADJ
ajmsi-505	201	25	after	after	ADP
ajmsi-505	201	26	2	2	NUM
ajmsi-505	201	27	months	month	NOUN
ajmsi-505	201	28	of	of	ADP
ajmsi-505	201	29	tb	tb	ADP
ajmsi-505	201	30	treatment	treatment	NOUN
ajmsi-505	201	31	)	)	PUNCT
ajmsi-505	201	32	recorded	record	VERB
ajmsi-505	201	33	higher	high	ADJ
ajmsi-505	201	34	cases	case	NOUN
ajmsi-505	201	35	of	of	ADP
ajmsi-505	201	36	mdr	mdr	PROPN
ajmsi-505	201	37	-	-	PROPN
ajmsi-505	201	38	tb	tb	PROPN
ajmsi-505	201	39	compared	compare	VERB
ajmsi-505	201	40	to	to	ADP
ajmsi-505	201	41	category	category	PROPN
ajmsi-505	201	42	ii	ii	NOUN
ajmsi-505	201	43	patients	patient	NOUN
ajmsi-505	201	44	(	(	PUNCT
ajmsi-505	201	45	patients	patient	NOUN
ajmsi-505	201	46	with	with	ADP
ajmsi-505	201	47	only	only	ADV
ajmsi-505	201	48	tb	tb	ADP
ajmsi-505	201	49	infection	infection	NOUN
ajmsi-505	201	50	,	,	PUNCT
ajmsi-505	201	51	that	that	PRON
ajmsi-505	201	52	still	still	ADV
ajmsi-505	201	53	test	test	VERB
ajmsi-505	201	54	sputum	sputum	PROPN
ajmsi-505	201	55	afb	afb	PROPN
ajmsi-505	201	56	positive	positive	ADJ
ajmsi-505	201	57	after	after	ADP
ajmsi-505	201	58	2	2	NUM
ajmsi-505	201	59	months	month	NOUN
ajmsi-505	201	60	of	of	ADP
ajmsi-505	201	61	tb	tb	ADP
ajmsi-505	201	62	treatment	treatment	NOUN
ajmsi-505	201	63	)	)	PUNCT
ajmsi-505	201	64	.	.	PUNCT
ajmsi-505	202	1	both	both	DET
ajmsi-505	202	2	categories	category	NOUN
ajmsi-505	202	3	account	account	VERB
ajmsi-505	202	4	for	for	ADP
ajmsi-505	202	5	10	10	NUM
ajmsi-505	202	6	(	(	PUNCT
ajmsi-505	202	7	38.5	38.5	NUM
ajmsi-505	202	8	%	%	NOUN
ajmsi-505	202	9	)	)	PUNCT
ajmsi-505	202	10	and	and	CCONJ
ajmsi-505	202	11	9	9	NUM
ajmsi-505	202	12	(	(	PUNCT
ajmsi-505	202	13	34.6	34.6	NUM
ajmsi-505	202	14	%	%	NOUN
ajmsi-505	202	15	)	)	PUNCT
ajmsi-505	202	16	cases	case	NOUN
ajmsi-505	202	17	of	of	ADP
ajmsi-505	202	18	mdr	mdr	PROPN
ajmsi-505	202	19	-	-	NOUN
ajmsi-505	202	20	tb	tb	ADP
ajmsi-505	202	21	respectively	respectively	ADV
ajmsi-505	202	22	.	.	PUNCT
ajmsi-505	203	1	statistical	statistical	ADJ
ajmsi-505	203	2	analysis	analysis	NOUN
ajmsi-505	203	3	shows	show	VERB
ajmsi-505	203	4	no	no	DET
ajmsi-505	203	5	significant	significant	ADJ
ajmsi-505	203	6	difference	difference	NOUN
ajmsi-505	203	7	(	(	PUNCT
ajmsi-505	203	8	p>0.05	p>0.05	NOUN
ajmsi-505	203	9	)	)	PUNCT
ajmsi-505	203	10	.	.	PUNCT
ajmsi-505	204	1	however	however	ADV
ajmsi-505	204	2	,	,	PUNCT
ajmsi-505	204	3	mdr	mdr	PROPN
ajmsi-505	204	4	-	-	PROPN
ajmsi-505	204	5	tb	tb	NOUN
ajmsi-505	204	6	detected	detect	VERB
ajmsi-505	204	7	in	in	ADP
ajmsi-505	204	8	category	category	NOUN
ajmsi-505	204	9	i	i	PRON
ajmsi-505	204	10	is	be	AUX
ajmsi-505	204	11	statistically	statistically	ADV
ajmsi-505	204	12	higher	high	ADJ
ajmsi-505	204	13	than	than	ADP
ajmsi-505	204	14	mdr	mdr	PROPN
ajmsi-505	204	15	-	-	PROPN
ajmsi-505	204	16	tb	tb	NOUN
ajmsi-505	204	17	detected	detect	VERB
ajmsi-505	204	18	in	in	ADP
ajmsi-505	204	19	category	category	NOUN
ajmsi-505	204	20	iii	iii	NUM
ajmsi-505	204	21	patients	patient	NOUN
ajmsi-505	204	22	(	(	PUNCT
ajmsi-505	204	23	patients	patient	NOUN
ajmsi-505	204	24	with	with	ADP
ajmsi-505	204	25	only	only	ADV
ajmsi-505	204	26	tb	tb	ADP
ajmsi-505	204	27	infection	infection	NOUN
ajmsi-505	204	28	,	,	PUNCT
ajmsi-505	204	29	and	and	CCONJ
ajmsi-505	204	30	are	be	AUX
ajmsi-505	204	31	yet	yet	ADV
ajmsi-505	204	32	to	to	PART
ajmsi-505	204	33	commence	commence	VERB
ajmsi-505	204	34	tb	tb	ADP
ajmsi-505	204	35	treatment	treatment	NOUN
ajmsi-505	204	36	)	)	PUNCT
ajmsi-505	204	37	,	,	PUNCT
ajmsi-505	204	38	in	in	ADP
ajmsi-505	204	39	which	which	PRON
ajmsi-505	204	40	mdr	mdr	PROPN
ajmsi-505	204	41	-	-	PROPN
ajmsi-505	204	42	tb	tb	PROPN
ajmsi-505	204	43	was	be	AUX
ajmsi-505	204	44	detected	detect	VERB
ajmsi-505	204	45	in	in	ADP
ajmsi-505	204	46	only	only	ADV
ajmsi-505	204	47	7(26.9	7(26.9	NUM
ajmsi-505	204	48	%	%	NOUN
ajmsi-505	204	49	)	)	PUNCT
ajmsi-505	204	50	cases	case	NOUN
ajmsi-505	204	51	.	.	PUNCT
ajmsi-505	205	1	the	the	DET
ajmsi-505	205	2	relatively	relatively	ADV
ajmsi-505	205	3	higher	high	ADJ
ajmsi-505	205	4	number	number	NOUN
ajmsi-505	205	5	of	of	ADP
ajmsi-505	205	6	mdrtb	mdrtb	NOUN
ajmsi-505	205	7	detected	detect	VERB
ajmsi-505	205	8	in	in	ADP
ajmsi-505	205	9	category	category	NOUN
ajmsi-505	205	10	i	i	PRON
ajmsi-505	205	11	patients	patient	NOUN
ajmsi-505	205	12	underscores	underscore	VERB
ajmsi-505	205	13	the	the	DET
ajmsi-505	205	14	enormous	enormous	ADJ
ajmsi-505	205	15	impact	impact	NOUN
ajmsi-505	205	16	of	of	ADP
ajmsi-505	205	17	hiv	hiv	PROPN
ajmsi-505	205	18	as	as	ADP
ajmsi-505	205	19	one	one	NUM
ajmsi-505	205	20	of	of	ADP
ajmsi-505	205	21	the	the	DET
ajmsi-505	205	22	key	key	ADJ
ajmsi-505	205	23	factors	factor	NOUN
ajmsi-505	205	24	underlying	underlie	VERB
ajmsi-505	205	25	an	an	DET
ajmsi-505	205	26	approximately	approximately	ADV
ajmsi-505	205	27	1	1	NUM
ajmsi-505	205	28	%	%	NOUN
ajmsi-505	205	29	annual	annual	ADJ
ajmsi-505	205	30	increase	increase	NOUN
ajmsi-505	205	31	in	in	ADP
ajmsi-505	205	32	the	the	DET
ajmsi-505	205	33	global	global	ADJ
ajmsi-505	205	34	tb	tb	NOUN
ajmsi-505	205	35	incidence	incidence	NOUN
ajmsi-505	205	36	as	as	SCONJ
ajmsi-505	205	37	reported	report	VERB
ajmsi-505	205	38	by	by	ADP
ajmsi-505	205	39	lawn	lawn	NOUN
ajmsi-505	205	40	and	and	CCONJ
ajmsi-505	205	41	gavin	gavin	PROPN
ajmsi-505	205	42	,	,	PUNCT
ajmsi-505	205	43	(	(	PUNCT
ajmsi-505	205	44	2014	2014	NUM
ajmsi-505	205	45	)	)	PUNCT
ajmsi-505	205	46	in	in	ADP
ajmsi-505	205	47	a	a	DET
ajmsi-505	205	48	retrospective	retrospective	ADJ
ajmsi-505	205	49	study	study	NOUN
ajmsi-505	205	50	on	on	ADP
ajmsi-505	205	51	the	the	DET
ajmsi-505	205	52	epidemiology	epidemiology	NOUN
ajmsi-505	205	53	of	of	ADP
ajmsi-505	205	54	hiv	hiv	PROPN
ajmsi-505	205	55	-	-	PUNCT
ajmsi-505	205	56	associated	associate	VERB
ajmsi-505	205	57	tuberculosis	tuberculosis	NOUN
ajmsi-505	205	58	(	(	PUNCT
ajmsi-505	205	59	hiv	hiv	NOUN
ajmsi-505	205	60	-	-	PUNCT
ajmsi-505	205	61	tb	tb	NOUN
ajmsi-505	205	62	)	)	PUNCT
ajmsi-505	205	63	from	from	ADP
ajmsi-505	205	64	2007	2007	NUM
ajmsi-505	205	65	-	-	SYM
ajmsi-505	205	66	2008	2008	NUM
ajmsi-505	205	67	.	.	PUNCT
ajmsi-505	206	1	findings	finding	NOUN
ajmsi-505	206	2	in	in	ADP
ajmsi-505	206	3	this	this	DET
ajmsi-505	206	4	study	study	NOUN
ajmsi-505	206	5	are	be	AUX
ajmsi-505	206	6	also	also	ADV
ajmsi-505	206	7	consistent	consistent	ADJ
ajmsi-505	206	8	with	with	ADP
ajmsi-505	206	9	the	the	DET
ajmsi-505	206	10	report	report	NOUN
ajmsi-505	206	11	by	by	ADP
ajmsi-505	206	12	dean	dean	PROPN
ajmsi-505	206	13	and	and	CCONJ
ajmsi-505	206	14	co	co	NOUN
ajmsi-505	206	15	-	-	NOUN
ajmsi-505	206	16	researchers	researcher	NOUN
ajmsi-505	206	17	(	(	PUNCT
ajmsi-505	206	18	2014	2014	NUM
ajmsi-505	206	19	)	)	PUNCT
ajmsi-505	206	20	,	,	PUNCT
ajmsi-505	206	21	who	who	PRON
ajmsi-505	206	22	reported	report	VERB
ajmsi-505	206	23	a	a	DET
ajmsi-505	206	24	positive	positive	ADJ
ajmsi-505	206	25	association	association	NOUN
ajmsi-505	206	26	between	between	ADP
ajmsi-505	206	27	hiv	hiv	PROPN
ajmsi-505	206	28	infection	infection	NOUN
ajmsi-505	206	29	and	and	CCONJ
ajmsi-505	206	30	mdrtb	mdrtb	NOUN
ajmsi-505	206	31	disease	disease	NOUN
ajmsi-505	206	32	using	use	VERB
ajmsi-505	206	33	data	datum	NOUN
ajmsi-505	206	34	of	of	ADP
ajmsi-505	206	35	member	member	NOUN
ajmsi-505	206	36	states	state	NOUN
ajmsi-505	206	37	of	of	ADP
ajmsi-505	206	38	the	the	DET
ajmsi-505	206	39	world	world	PROPN
ajmsi-505	206	40	health	health	NOUN
ajmsi-505	206	41	organization	organization	NOUN
ajmsi-505	206	42	(	(	PUNCT
ajmsi-505	206	43	who	who	PRON
ajmsi-505	206	44	,	,	PUNCT
ajmsi-505	206	45	2014	2014	NUM
ajmsi-505	206	46	)	)	PUNCT
ajmsi-505	206	47	.	.	PUNCT
ajmsi-505	207	1	eleven	eleven	NUM
ajmsi-505	207	2	out	out	ADP
ajmsi-505	207	3	of	of	ADP
ajmsi-505	207	4	the	the	DET
ajmsi-505	207	5	24	24	NUM
ajmsi-505	207	6	countries	country	NOUN
ajmsi-505	207	7	for	for	ADP
ajmsi-505	207	8	which	which	PRON
ajmsi-505	207	9	analysis	analysis	NOUN
ajmsi-505	207	10	was	be	AUX
ajmsi-505	207	11	performed	perform	VERB
ajmsi-505	207	12	,	,	PUNCT
ajmsi-505	207	13	hiv	hiv	PROPN
ajmsi-505	207	14	-	-	PUNCT
ajmsi-505	207	15	positive	positive	ADJ
ajmsi-505	207	16	tb	tb	NOUN
ajmsi-505	207	17	patients	patient	NOUN
ajmsi-505	207	18	had	have	VERB
ajmsi-505	207	19	significantly	significantly	ADV
ajmsi-505	207	20	higher	high	ADJ
ajmsi-505	207	21	odds	odd	NOUN
ajmsi-505	207	22	(	(	PUNCT
ajmsi-505	207	23	p<0.05	p<0.05	NOUN
ajmsi-505	207	24	)	)	PUNCT
ajmsi-505	207	25	of	of	ADP
ajmsi-505	207	26	mdr	mdr	PROPN
ajmsi-505	207	27	-	-	PROPN
ajmsi-505	207	28	tb	tb	ADP
ajmsi-505	207	29	disease	disease	NOUN
ajmsi-505	207	30	than	than	ADP
ajmsi-505	207	31	hiv	hiv	PROPN
ajmsi-505	207	32	negative	negative	ADJ
ajmsi-505	207	33	tb	tb	ADP
ajmsi-505	207	34	patients	patient	NOUN
ajmsi-505	207	35	.	.	PUNCT
ajmsi-505	208	1	for	for	ADP
ajmsi-505	208	2	almost	almost	ADV
ajmsi-505	208	3	all	all	PRON
ajmsi-505	208	4	of	of	ADP
ajmsi-505	208	5	these	these	DET
ajmsi-505	208	6	11	11	NUM
ajmsi-505	208	7	countries	country	NOUN
ajmsi-505	208	8	,	,	PUNCT
ajmsi-505	208	9	the	the	DET
ajmsi-505	208	10	prevalence	prevalence	NOUN
ajmsi-505	208	11	of	of	ADP
ajmsi-505	208	12	mdrtb	mdrtb	NOUN
ajmsi-505	208	13	among	among	ADP
ajmsi-505	208	14	newly	newly	ADV
ajmsi-505	208	15	diagnosed	diagnose	VERB
ajmsi-505	208	16	tb	tb	ADP
ajmsi-505	208	17	cases	case	NOUN
ajmsi-505	208	18	was	be	AUX
ajmsi-505	208	19	higher	high	ADJ
ajmsi-505	208	20	than	than	ADP
ajmsi-505	208	21	the	the	DET
ajmsi-505	208	22	estimated	estimate	VERB
ajmsi-505	208	23	global	global	ADJ
ajmsi-505	208	24	average	average	NOUN
ajmsi-505	208	25	of	of	ADP
ajmsi-505	208	26	3.6	3.6	NUM
ajmsi-505	208	27	%	%	NOUN
ajmsi-505	208	28	(	(	PUNCT
ajmsi-505	208	29	95	95	NUM
ajmsi-505	208	30	%	%	NOUN
ajmsi-505	208	31	ci	ci	NOUN
ajmsi-505	208	32	2.1	2.1	NUM
ajmsi-505	208	33	–	–	PUNCT
ajmsi-505	208	34	5.1	5.1	NUM
ajmsi-505	208	35	%	%	NOUN
ajmsi-505	208	36	)	)	PUNCT
ajmsi-505	208	37	.	.	PUNCT
ajmsi-505	209	1	rifampicin	rifampicin	VERB
ajmsi-505	209	2	resistance	resistance	NOUN
ajmsi-505	209	3	of	of	ADP
ajmsi-505	209	4	82(30.6	82(30.6	ADJ
ajmsi-505	209	5	%	%	NOUN
ajmsi-505	209	6	)	)	PUNCT
ajmsi-505	209	7	cases	case	NOUN
ajmsi-505	209	8	detected	detect	VERB
ajmsi-505	209	9	by	by	ADP
ajmsi-505	209	10	in	in	ADP
ajmsi-505	209	11	-	-	PUNCT
ajmsi-505	209	12	vitro	vitro	X
ajmsi-505	209	13	culture	culture	NOUN
ajmsi-505	209	14	and	and	CCONJ
ajmsi-505	209	15	dst	dst	PROPN
ajmsi-505	209	16	is	be	AUX
ajmsi-505	209	17	statistically	statistically	ADV
ajmsi-505	209	18	higher	high	ADJ
ajmsi-505	209	19	than	than	ADP
ajmsi-505	209	20	the	the	DET
ajmsi-505	209	21	62(16.3	62(16.3	ADJ
ajmsi-505	209	22	%	%	NOUN
ajmsi-505	209	23	)	)	PUNCT
ajmsi-505	209	24	cases	case	NOUN
ajmsi-505	209	25	detected	detect	VERB
ajmsi-505	209	26	by	by	ADP
ajmsi-505	209	27	genexpert	genexpert	ADJ
ajmsi-505	209	28	automated	automate	VERB
ajmsi-505	209	29	machine	machine	NOUN
ajmsi-505	209	30	.	.	PUNCT
ajmsi-505	210	1	although	although	SCONJ
ajmsi-505	210	2	this	this	PRON
ajmsi-505	210	3	underscores	underscore	VERB
ajmsi-505	210	4	the	the	DET
ajmsi-505	210	5	diagnostic	diagnostic	ADJ
ajmsi-505	210	6	advantage	advantage	NOUN
ajmsi-505	210	7	and	and	CCONJ
ajmsi-505	210	8	higher	high	ADJ
ajmsi-505	210	9	sensitivity	sensitivity	NOUN
ajmsi-505	210	10	of	of	ADP
ajmsi-505	210	11	in	in	ADP
ajmsi-505	210	12	-	-	PUNCT
ajmsi-505	210	13	vitro	vitro	X
ajmsi-505	210	14	culture	culture	NOUN
ajmsi-505	210	15	over	over	ADP
ajmsi-505	210	16	genexpert	genexpert	PROPN
ajmsi-505	210	17	machine	machine	NOUN
ajmsi-505	210	18	,	,	PUNCT
ajmsi-505	210	19	there	there	PRON
ajmsi-505	210	20	was	be	VERB
ajmsi-505	210	21	no	no	DET
ajmsi-505	210	22	statistically	statistically	ADV
ajmsi-505	210	23	significant	significant	ADJ
ajmsi-505	210	24	difference	difference	NOUN
ajmsi-505	210	25	between	between	ADP
ajmsi-505	210	26	the	the	DET
ajmsi-505	210	27	two	two	NUM
ajmsi-505	210	28	testing	testing	NOUN
ajmsi-505	210	29	methods	method	NOUN
ajmsi-505	210	30	(	(	PUNCT
ajmsi-505	210	31	p>0.05	p>0.05	PROPN
ajmsi-505	210	32	)	)	PUNCT
ajmsi-505	210	33	,	,	PUNCT
ajmsi-505	210	34	genexpert	genexpert	PROPN
ajmsi-505	210	35	is	be	AUX
ajmsi-505	210	36	however	however	ADV
ajmsi-505	210	37	faster	fast	ADV
ajmsi-505	210	38	and	and	CCONJ
ajmsi-505	210	39	much	much	ADV
ajmsi-505	210	40	easier	easy	ADJ
ajmsi-505	210	41	to	to	PART
ajmsi-505	210	42	perform	perform	VERB
ajmsi-505	210	43	even	even	ADV
ajmsi-505	210	44	in	in	ADP
ajmsi-505	210	45	remote	remote	ADJ
ajmsi-505	210	46	areas	area	NOUN
ajmsi-505	210	47	.	.	PUNCT
ajmsi-505	211	1	table	table	NOUN
ajmsi-505	211	2	7	7	NUM
ajmsi-505	211	3	:	:	PUNCT
ajmsi-505	211	4	age	age	NOUN
ajmsi-505	211	5	and	and	CCONJ
ajmsi-505	211	6	sex	sex	NOUN
ajmsi-505	211	7	distribution	distribution	NOUN
ajmsi-505	211	8	for	for	ADP
ajmsi-505	211	9	m.	m.	NOUN
ajmsi-505	211	10	tuberculosis	tuberculosis	NOUN
ajmsi-505	211	11	rifampicin	rifampicin	VERB
ajmsi-505	211	12	resistance	resistance	NOUN
ajmsi-505	211	13	by	by	ADP
ajmsi-505	211	14	genexpert	genexpert	ADJ
ajmsi-505	211	15	age	age	NOUN
ajmsi-505	211	16	(	(	PUNCT
ajmsi-505	211	17	years	year	NOUN
ajmsi-505	211	18	)	)	PUNCT
ajmsi-505	211	19	males	male	NOUN
ajmsi-505	211	20	no	no	INTJ
ajmsi-505	211	21	.	.	PUNCT
ajmsi-505	212	1	(	(	PUNCT
ajmsi-505	212	2	%	%	INTJ
ajmsi-505	212	3	)	)	PUNCT
ajmsi-505	212	4	females	female	NOUN
ajmsi-505	212	5	no	no	INTJ
ajmsi-505	212	6	.	.	PUNCT
ajmsi-505	213	1	(	(	PUNCT
ajmsi-505	213	2	%	%	INTJ
ajmsi-505	213	3	)	)	PUNCT
ajmsi-505	213	4	total	total	NOUN
ajmsi-505	213	5	no	no	INTJ
ajmsi-505	213	6	.	.	PUNCT
ajmsi-505	214	1	(	(	PUNCT
ajmsi-505	214	2	%	%	INTJ
ajmsi-505	214	3	)	)	PUNCT
ajmsi-505	215	1	<	<	X
ajmsi-505	215	2	1	1	NUM
ajmsi-505	215	3	–	–	SYM
ajmsi-505	215	4	10	10	NUM
ajmsi-505	215	5	11	11	NUM
ajmsi-505	215	6	–	–	PUNCT
ajmsi-505	215	7	20	20	NUM
ajmsi-505	215	8	4	4	NUM
ajmsi-505	215	9	(	(	PUNCT
ajmsi-505	215	10	6.5	6.5	NUM
ajmsi-505	215	11	)	)	PUNCT
ajmsi-505	215	12	1	1	NUM
ajmsi-505	215	13	(	(	PUNCT
ajmsi-505	215	14	1.6	1.6	NUM
ajmsi-505	215	15	)	)	PUNCT
ajmsi-505	215	16	5	5	NUM
ajmsi-505	215	17	(	(	PUNCT
ajmsi-505	215	18	8.1	8.1	NUM
ajmsi-505	215	19	)	)	PUNCT
ajmsi-505	215	20	21	21	NUM
ajmsi-505	215	21	–	–	PUNCT
ajmsi-505	215	22	30	30	NUM
ajmsi-505	215	23	18	18	NUM
ajmsi-505	215	24	(	(	PUNCT
ajmsi-505	215	25	29.0	29.0	NUM
ajmsi-505	215	26	)	)	PUNCT
ajmsi-505	215	27	9	9	NUM
ajmsi-505	215	28	(	(	PUNCT
ajmsi-505	215	29	14.5	14.5	NUM
ajmsi-505	215	30	)	)	PUNCT
ajmsi-505	215	31	27	27	NUM
ajmsi-505	215	32	(	(	PUNCT
ajmsi-505	215	33	43.5	43.5	NUM
ajmsi-505	215	34	)	)	PUNCT
ajmsi-505	215	35	31	31	NUM
ajmsi-505	215	36	–	–	PUNCT
ajmsi-505	215	37	40	40	NUM
ajmsi-505	215	38	11	11	NUM
ajmsi-505	215	39	(	(	PUNCT
ajmsi-505	215	40	17.7	17.7	NUM
ajmsi-505	215	41	)	)	PUNCT
ajmsi-505	215	42	10	10	NUM
ajmsi-505	215	43	(	(	PUNCT
ajmsi-505	215	44	16.1	16.1	NUM
ajmsi-505	215	45	)	)	PUNCT
ajmsi-505	215	46	21	21	NUM
ajmsi-505	215	47	(	(	PUNCT
ajmsi-505	215	48	33.9	33.9	NUM
ajmsi-505	215	49	)	)	PUNCT
ajmsi-505	215	50	41	41	NUM
ajmsi-505	215	51	–	–	PUNCT
ajmsi-505	215	52	50	50	NUM
ajmsi-505	215	53	3	3	NUM
ajmsi-505	215	54	(	(	PUNCT
ajmsi-505	215	55	4.8	4.8	NUM
ajmsi-505	215	56	)	)	PUNCT
ajmsi-505	215	57	5	5	NUM
ajmsi-505	215	58	(	(	PUNCT
ajmsi-505	215	59	8.1	8.1	NUM
ajmsi-505	215	60	)	)	PUNCT
ajmsi-505	215	61	8	8	NUM
ajmsi-505	215	62	(	(	PUNCT
ajmsi-505	215	63	12.9	12.9	NUM
ajmsi-505	215	64	)	)	PUNCT
ajmsi-505	215	65	51	51	NUM
ajmsi-505	215	66	–	–	PUNCT
ajmsi-505	215	67	60	60	NUM
ajmsi-505	215	68	>	>	SYM
ajmsi-505	215	69	61	61	NUM
ajmsi-505	215	70	–	–	SYM
ajmsi-505	215	71	70	70	NUM
ajmsi-505	215	72	1	1	NUM
ajmsi-505	215	73	(	(	PUNCT
ajmsi-505	215	74	1.6	1.6	NUM
ajmsi-505	215	75	)	)	PUNCT
ajmsi-505	215	76	1	1	NUM
ajmsi-505	215	77	(	(	PUNCT
ajmsi-505	215	78	1.6	1.6	NUM
ajmsi-505	215	79	)	)	PUNCT
ajmsi-505	215	80	total	total	NOUN
ajmsi-505	215	81	36	36	NUM
ajmsi-505	215	82	(	(	PUNCT
ajmsi-505	215	83	58.1	58.1	NUM
ajmsi-505	215	84	%	%	NOUN
ajmsi-505	215	85	)	)	PUNCT
ajmsi-505	215	86	26	26	NUM
ajmsi-505	215	87	(	(	PUNCT
ajmsi-505	215	88	41.9	41.9	NUM
ajmsi-505	215	89	%	%	NOUN
ajmsi-505	215	90	)	)	PUNCT
ajmsi-505	215	91	62	62	NUM
ajmsi-505	215	92	(	(	PUNCT
ajmsi-505	215	93	16.3	16.3	NUM
ajmsi-505	215	94	%	%	NOUN
ajmsi-505	215	95	)	)	PUNCT
ajmsi-505	216	1	t	t	NOUN
ajmsi-505	216	2	=	=	PUNCT
ajmsi-505	217	1	148.48	148.48	NUM
ajmsi-505	217	2	,	,	PUNCT
ajmsi-505	217	3	df	df	PROPN
ajmsi-505	217	4	=	=	SYM
ajmsi-505	217	5	13	13	NUM
ajmsi-505	217	6	,	,	PUNCT
ajmsi-505	217	7	p	p	X
ajmsi-505	217	8	<	<	X
ajmsi-505	217	9	0.05	0.05	NUM
ajmsi-505	217	10	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	NOUN
ajmsi-505	217	11	pa	pa	PROPN
ajmsi-505	217	12	ge	ge	PROPN
ajmsi-505	217	13	8	8	NUM
ajmsi-505	217	14	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	217	15	am	be	AUX
ajmsi-505	217	16	.	.	PUNCT
ajmsi-505	218	1	j.	j.	PROPN
ajmsi-505	218	2	med	med	PROPN
ajmsi-505	218	3	.	.	PUNCT
ajmsi-505	219	1	sci	sci	PROPN
ajmsi-505	219	2	.	.	PUNCT
ajmsi-505	219	3	innov	innov	PROPN
ajmsi-505	219	4	.	.	PUNCT
ajmsi-505	220	1	1(1	1(1	NUM
ajmsi-505	220	2	)	)	PUNCT
ajmsi-505	220	3	1	1	NUM
ajmsi-505	220	4	-	-	SYM
ajmsi-505	220	5	9	9	NUM
ajmsi-505	220	6	,	,	PUNCT
ajmsi-505	220	7	2022	2022	NUM
ajmsi-505	220	8	apart	apart	ADV
ajmsi-505	220	9	from	from	ADP
ajmsi-505	220	10	various	various	ADJ
ajmsi-505	220	11	evidences	evidence	NOUN
ajmsi-505	220	12	suggesting	suggest	VERB
ajmsi-505	220	13	hiv	hiv	PROPN
ajmsi-505	220	14	infection	infection	NOUN
ajmsi-505	220	15	as	as	ADP
ajmsi-505	220	16	a	a	DET
ajmsi-505	220	17	risk	risk	NOUN
ajmsi-505	220	18	factor	factor	NOUN
ajmsi-505	220	19	for	for	ADP
ajmsi-505	220	20	mdr	mdr	PROPN
ajmsi-505	220	21	-	-	PROPN
ajmsi-505	220	22	tb	tb	PROPN
ajmsi-505	220	23	,	,	PUNCT
ajmsi-505	220	24	it	it	PRON
ajmsi-505	220	25	has	have	AUX
ajmsi-505	220	26	been	be	AUX
ajmsi-505	220	27	specifically	specifically	ADV
ajmsi-505	220	28	associated	associate	VERB
ajmsi-505	220	29	with	with	ADP
ajmsi-505	220	30	acquired	acquire	VERB
ajmsi-505	220	31	rifampicin	rifampicin	VERB
ajmsi-505	220	32	resistance	resistance	NOUN
ajmsi-505	220	33	(	(	PUNCT
ajmsi-505	220	34	jennyavital	jennyavital	ADJ
ajmsi-505	220	35	,	,	PUNCT
ajmsi-505	220	36	1997	1997	NUM
ajmsi-505	220	37	;	;	PUNCT
ajmsi-505	220	38	munsiff	munsiff	NOUN
ajmsi-505	220	39	et	et	PROPN
ajmsi-505	220	40	al	al	PROPN
ajmsi-505	220	41	.	.	PROPN
ajmsi-505	220	42	,	,	PUNCT
ajmsi-505	220	43	1997	1997	NUM
ajmsi-505	220	44	)	)	PUNCT
ajmsi-505	220	45	.	.	PUNCT
ajmsi-505	221	1	this	this	PRON
ajmsi-505	221	2	is	be	AUX
ajmsi-505	221	3	suggestive	suggestive	ADJ
ajmsi-505	221	4	of	of	ADP
ajmsi-505	221	5	a	a	DET
ajmsi-505	221	6	critical	critical	ADJ
ajmsi-505	221	7	overlap	overlap	NOUN
ajmsi-505	221	8	between	between	ADP
ajmsi-505	221	9	hiv	hiv	PROPN
ajmsi-505	221	10	and	and	CCONJ
ajmsi-505	221	11	the	the	DET
ajmsi-505	221	12	global	global	ADJ
ajmsi-505	221	13	multidrug	multidrug	NOUN
ajmsi-505	221	14	resistant	resistant	ADJ
ajmsi-505	221	15	tb	tb	X
ajmsi-505	221	16	(	(	PUNCT
ajmsi-505	221	17	mdr	mdr	PROPN
ajmsi-505	221	18	-	-	NOUN
ajmsi-505	221	19	tb	tb	NOUN
ajmsi-505	221	20	)	)	PUNCT
ajmsi-505	221	21	.	.	PUNCT
ajmsi-505	222	1	although	although	SCONJ
ajmsi-505	222	2	,	,	PUNCT
ajmsi-505	222	3	it	it	PRON
ajmsi-505	222	4	is	be	AUX
ajmsi-505	222	5	yet	yet	ADV
ajmsi-505	222	6	unclear	unclear	ADJ
ajmsi-505	222	7	whether	whether	SCONJ
ajmsi-505	222	8	hiv	hiv	PROPN
ajmsi-505	222	9	is	be	AUX
ajmsi-505	222	10	driving	drive	VERB
ajmsi-505	222	11	a	a	DET
ajmsi-505	222	12	disproportionate	disproportionate	ADJ
ajmsi-505	222	13	increase	increase	NOUN
ajmsi-505	222	14	in	in	ADP
ajmsi-505	222	15	mdr	mdr	PROPN
ajmsi-505	222	16	-	-	NOUN
ajmsi-505	222	17	tb	tb	ADP
ajmsi-505	222	18	cases	case	NOUN
ajmsi-505	222	19	at	at	ADP
ajmsi-505	222	20	a	a	DET
ajmsi-505	222	21	population	population	NOUN
ajmsi-505	222	22	level	level	NOUN
ajmsi-505	222	23	,	,	PUNCT
ajmsi-505	222	24	results	result	NOUN
ajmsi-505	222	25	of	of	ADP
ajmsi-505	222	26	in	in	ADP
ajmsi-505	222	27	-	-	PUNCT
ajmsi-505	222	28	vitro	vitro	X
ajmsi-505	222	29	mycobacterium	mycobacterium	NOUN
ajmsi-505	222	30	tuberculosis	tuberculosis	NOUN
ajmsi-505	222	31	transduction	transduction	NOUN
ajmsi-505	222	32	protocol	protocol	NOUN
ajmsi-505	222	33	(	(	PUNCT
ajmsi-505	222	34	induced	induced	ADJ
ajmsi-505	222	35	mutation	mutation	NOUN
ajmsi-505	222	36	)	)	PUNCT
ajmsi-505	222	37	in	in	ADP
ajmsi-505	222	38	the	the	DET
ajmsi-505	222	39	current	current	ADJ
ajmsi-505	222	40	study	study	NOUN
ajmsi-505	222	41	recorded	record	VERB
ajmsi-505	222	42	an	an	DET
ajmsi-505	222	43	increase	increase	NOUN
ajmsi-505	222	44	from	from	ADP
ajmsi-505	222	45	7(26.9	7(26.9	ADJ
ajmsi-505	222	46	%	%	NOUN
ajmsi-505	222	47	)	)	PUNCT
ajmsi-505	222	48	to	to	ADP
ajmsi-505	222	49	10(38.5	10(38.5	NUM
ajmsi-505	222	50	%	%	NOUN
ajmsi-505	222	51	)	)	PUNCT
ajmsi-505	222	52	cases	case	NOUN
ajmsi-505	222	53	in	in	ADP
ajmsi-505	222	54	50	50	NUM
ajmsi-505	222	55	%	%	NOUN
ajmsi-505	222	56	of	of	ADP
ajmsi-505	222	57	the	the	DET
ajmsi-505	222	58	study	study	NOUN
ajmsi-505	222	59	population	population	NOUN
ajmsi-505	222	60	.	.	PUNCT
ajmsi-505	223	1	this	this	PRON
ajmsi-505	223	2	may	may	AUX
ajmsi-505	223	3	be	be	AUX
ajmsi-505	223	4	attributed	attribute	VERB
ajmsi-505	223	5	to	to	ADP
ajmsi-505	223	6	mutation	mutation	NOUN
ajmsi-505	223	7	in	in	ADP
ajmsi-505	223	8	the	the	DET
ajmsi-505	223	9	nucleotide	nucleotide	ADJ
ajmsi-505	223	10	sequence	sequence	NOUN
ajmsi-505	223	11	of	of	ADP
ajmsi-505	223	12	the	the	DET
ajmsi-505	223	13	mycobacterium	mycobacterium	NOUN
ajmsi-505	223	14	tuberculosis	tuberculosis	NOUN
ajmsi-505	223	15	,	,	PUNCT
ajmsi-505	223	16	which	which	PRON
ajmsi-505	223	17	may	may	AUX
ajmsi-505	223	18	confer	confer	VERB
ajmsi-505	223	19	antibiotic	antibiotic	ADJ
ajmsi-505	223	20	resistance	resistance	NOUN
ajmsi-505	223	21	on	on	ADP
ajmsi-505	223	22	the	the	DET
ajmsi-505	223	23	organism	organism	NOUN
ajmsi-505	223	24	.	.	PUNCT
ajmsi-505	224	1	if	if	SCONJ
ajmsi-505	224	2	such	such	ADJ
ajmsi-505	224	3	genetic	genetic	ADJ
ajmsi-505	224	4	changes	change	NOUN
ajmsi-505	224	5	are	be	AUX
ajmsi-505	224	6	scientifically	scientifically	ADV
ajmsi-505	224	7	proven	prove	VERB
ajmsi-505	224	8	,	,	PUNCT
ajmsi-505	224	9	they	they	PRON
ajmsi-505	224	10	may	may	AUX
ajmsi-505	224	11	be	be	AUX
ajmsi-505	224	12	rightly	rightly	ADV
ajmsi-505	224	13	attributed	attribute	VERB
ajmsi-505	224	14	as	as	ADP
ajmsi-505	224	15	contributing	contribute	VERB
ajmsi-505	224	16	to	to	ADP
ajmsi-505	224	17	the	the	DET
ajmsi-505	224	18	emergence	emergence	NOUN
ajmsi-505	224	19	of	of	ADP
ajmsi-505	224	20	mono	mono	NOUN
ajmsi-505	224	21	and	and	CCONJ
ajmsi-505	224	22	multiple	multiple	ADJ
ajmsi-505	224	23	drug	drug	NOUN
ajmsi-505	224	24	resistance	resistance	NOUN
ajmsi-505	224	25	in	in	ADP
ajmsi-505	224	26	the	the	DET
ajmsi-505	224	27	genome	genome	NOUN
ajmsi-505	224	28	of	of	ADP
ajmsi-505	224	29	mycobacterium	mycobacterium	NOUN
ajmsi-505	224	30	tuberculosis	tuberculosis	NOUN
ajmsi-505	224	31	.	.	PUNCT
ajmsi-505	225	1	several	several	ADJ
ajmsi-505	225	2	studies	study	NOUN
ajmsi-505	225	3	have	have	AUX
ajmsi-505	225	4	reported	report	VERB
ajmsi-505	225	5	that	that	SCONJ
ajmsi-505	225	6	mycobacterium	mycobacterium	NOUN
ajmsi-505	225	7	tuberculosis	tuberculosis	NOUN
ajmsi-505	225	8	does	do	AUX
ajmsi-505	225	9	not	not	PART
ajmsi-505	225	10	exhibit	exhibit	VERB
ajmsi-505	225	11	an	an	DET
ajmsi-505	225	12	elevated	elevated	ADJ
ajmsi-505	225	13	mutation	mutation	NOUN
ajmsi-505	225	14	rate	rate	NOUN
ajmsi-505	225	15	relative	relative	ADJ
ajmsi-505	225	16	to	to	ADP
ajmsi-505	225	17	most	most	ADJ
ajmsi-505	225	18	other	other	ADJ
ajmsi-505	225	19	bacteria	bacteria	NOUN
ajmsi-505	225	20	under	under	ADP
ajmsi-505	225	21	in	in	ADP
ajmsi-505	225	22	-	-	PUNCT
ajmsi-505	225	23	vitro	vitro	X
ajmsi-505	225	24	conditions	condition	NOUN
ajmsi-505	225	25	(	(	PUNCT
ajmsi-505	225	26	david	david	PROPN
ajmsi-505	225	27	,	,	PUNCT
ajmsi-505	225	28	1970	1970	NUM
ajmsi-505	225	29	;	;	PUNCT
ajmsi-505	225	30	siddimizrahi	siddimizrahi	NOUN
ajmsi-505	225	31	,	,	PUNCT
ajmsi-505	225	32	and	and	CCONJ
ajmsi-505	225	33	andersen	andersen	PROPN
ajmsi-505	225	34	,	,	PUNCT
ajmsi-505	225	35	1998	1998	NUM
ajmsi-505	225	36	;	;	PUNCT
ajmsi-505	225	37	ford	ford	PROPN
ajmsi-505	225	38	et	et	PROPN
ajmsi-505	225	39	al	al	PROPN
ajmsi-505	225	40	.	.	PROPN
ajmsi-505	225	41	,	,	PUNCT
ajmsi-505	225	42	2011	2011	NUM
ajmsi-505	225	43	)	)	PUNCT
ajmsi-505	225	44	.	.	PUNCT
ajmsi-505	226	1	it	it	PRON
ajmsi-505	226	2	is	be	AUX
ajmsi-505	226	3	not	not	PART
ajmsi-505	226	4	entirely	entirely	ADV
ajmsi-505	226	5	clear	clear	ADJ
ajmsi-505	226	6	,	,	PUNCT
ajmsi-505	226	7	though	though	ADV
ajmsi-505	226	8	,	,	PUNCT
ajmsi-505	226	9	whether	whether	SCONJ
ajmsi-505	226	10	a	a	DET
ajmsi-505	226	11	relatively	relatively	ADV
ajmsi-505	226	12	low	low	ADJ
ajmsi-505	226	13	mutation	mutation	NOUN
ajmsi-505	226	14	rate	rate	NOUN
ajmsi-505	226	15	is	be	AUX
ajmsi-505	226	16	sufficient	sufficient	ADJ
ajmsi-505	226	17	to	to	PART
ajmsi-505	226	18	account	account	VERB
ajmsi-505	226	19	for	for	ADP
ajmsi-505	226	20	the	the	DET
ajmsi-505	226	21	elevated	elevated	ADJ
ajmsi-505	226	22	rates	rate	NOUN
ajmsi-505	226	23	of	of	ADP
ajmsi-505	226	24	acquired	acquire	VERB
ajmsi-505	226	25	drug	drug	NOUN
ajmsi-505	226	26	resistance	resistance	NOUN
ajmsi-505	226	27	observed	observe	VERB
ajmsi-505	226	28	clinically	clinically	ADV
ajmsi-505	226	29	(	(	PUNCT
ajmsi-505	226	30	mcgrath	mcgrath	PROPN
ajmsi-505	226	31	et	et	PROPN
ajmsi-505	226	32	al	al	PROPN
ajmsi-505	226	33	.	.	PROPN
ajmsi-505	226	34	,	,	PUNCT
ajmsi-505	226	35	2013	2013	NUM
ajmsi-505	226	36	)	)	PUNCT
ajmsi-505	226	37	.	.	PUNCT
ajmsi-505	227	1	studies	study	NOUN
ajmsi-505	227	2	by	by	ADP
ajmsi-505	227	3	ford	ford	PROPN
ajmsi-505	227	4	and	and	CCONJ
ajmsi-505	227	5	co	co	NOUN
ajmsi-505	227	6	-	-	NOUN
ajmsi-505	227	7	researchers	researcher	NOUN
ajmsi-505	227	8	(	(	PUNCT
ajmsi-505	227	9	2011	2011	NUM
ajmsi-505	227	10	)	)	PUNCT
ajmsi-505	227	11	,	,	PUNCT
ajmsi-505	227	12	using	use	VERB
ajmsi-505	227	13	whole	whole	ADJ
ajmsi-505	227	14	genome	genome	NOUN
ajmsi-505	227	15	sequencing	sequence	VERB
ajmsi-505	227	16	(	(	PUNCT
ajmsi-505	227	17	wgs	wgs	NOUN
ajmsi-505	227	18	)	)	PUNCT
ajmsi-505	227	19	technology	technology	NOUN
ajmsi-505	227	20	to	to	PART
ajmsi-505	227	21	estimate	estimate	VERB
ajmsi-505	227	22	the	the	DET
ajmsi-505	227	23	mutation	mutation	NOUN
ajmsi-505	227	24	rate	rate	NOUN
ajmsi-505	227	25	of	of	ADP
ajmsi-505	227	26	mycobacterium	mycobacterium	NOUN
ajmsi-505	227	27	tuberculosis	tuberculosis	NOUN
ajmsi-505	227	28	during	during	ADP
ajmsi-505	227	29	latent	latent	NOUN
ajmsi-505	227	30	infections	infection	NOUN
ajmsi-505	227	31	in	in	ADP
ajmsi-505	227	32	non	non	ADJ
ajmsi-505	227	33	-	-	ADJ
ajmsi-505	227	34	human	human	ADJ
ajmsi-505	227	35	primates	primate	NOUN
ajmsi-505	227	36	reported	report	VERB
ajmsi-505	227	37	a	a	DET
ajmsi-505	227	38	slightly	slightly	ADV
ajmsi-505	227	39	elevated	elevated	ADJ
ajmsi-505	227	40	but	but	CCONJ
ajmsi-505	227	41	not	not	PART
ajmsi-505	227	42	significant	significant	ADJ
ajmsi-505	227	43	increase	increase	NOUN
ajmsi-505	227	44	in	in	ADP
ajmsi-505	227	45	drug	drug	NOUN
ajmsi-505	227	46	resistance	resistance	NOUN
ajmsi-505	227	47	in	in	ADP
ajmsi-505	227	48	vivo	vivo	NOUN
ajmsi-505	227	49	.	.	PUNCT
ajmsi-505	228	1	sun	sun	NOUN
ajmsi-505	228	2	and	and	CCONJ
ajmsi-505	228	3	co	co	NOUN
ajmsi-505	228	4	-	-	NOUN
ajmsi-505	228	5	researchers	researcher	NOUN
ajmsi-505	228	6	(	(	PUNCT
ajmsi-505	228	7	2012	2012	NUM
ajmsi-505	228	8	)	)	PUNCT
ajmsi-505	228	9	,	,	PUNCT
ajmsi-505	228	10	in	in	ADP
ajmsi-505	228	11	their	their	PRON
ajmsi-505	228	12	research	research	NOUN
ajmsi-505	228	13	utilized	utilize	VERB
ajmsi-505	228	14	more	more	ADV
ajmsi-505	228	15	sensitive	sensitive	ADJ
ajmsi-505	228	16	wgs	wgs	NOUN
ajmsi-505	228	17	technology	technology	NOUN
ajmsi-505	228	18	to	to	PART
ajmsi-505	228	19	track	track	VERB
ajmsi-505	228	20	genome	genome	NOUN
ajmsi-505	228	21	changes	change	NOUN
ajmsi-505	228	22	in	in	ADP
ajmsi-505	228	23	serial	serial	ADJ
ajmsi-505	228	24	sputum	sputum	NOUN
ajmsi-505	228	25	samples	sample	NOUN
ajmsi-505	228	26	obtained	obtain	VERB
ajmsi-505	228	27	from	from	ADP
ajmsi-505	228	28	three	three	NUM
ajmsi-505	228	29	patients	patient	NOUN
ajmsi-505	228	30	over	over	ADP
ajmsi-505	228	31	the	the	DET
ajmsi-505	228	32	course	course	NOUN
ajmsi-505	228	33	of	of	ADP
ajmsi-505	228	34	anti	anti	ADJ
ajmsi-505	228	35	-	-	ADJ
ajmsi-505	228	36	tb	tb	ADP
ajmsi-505	228	37	treatment	treatment	NOUN
ajmsi-505	228	38	and	and	CCONJ
ajmsi-505	228	39	reported	report	VERB
ajmsi-505	228	40	a	a	DET
ajmsi-505	228	41	higher	high	ADJ
ajmsi-505	228	42	degree	degree	NOUN
ajmsi-505	228	43	of	of	ADP
ajmsi-505	228	44	diversity	diversity	NOUN
ajmsi-505	228	45	in	in	ADP
ajmsi-505	228	46	the	the	DET
ajmsi-505	228	47	serial	serial	ADJ
ajmsi-505	228	48	clinical	clinical	ADJ
ajmsi-505	228	49	specimens	specimen	NOUN
ajmsi-505	228	50	,	,	PUNCT
ajmsi-505	228	51	an	an	DET
ajmsi-505	228	52	observation	observation	NOUN
ajmsi-505	228	53	that	that	PRON
ajmsi-505	228	54	is	be	AUX
ajmsi-505	228	55	consistent	consistent	ADJ
ajmsi-505	228	56	with	with	ADP
ajmsi-505	228	57	the	the	DET
ajmsi-505	228	58	idea	idea	NOUN
ajmsi-505	228	59	that	that	SCONJ
ajmsi-505	228	60	mutation	mutation	NOUN
ajmsi-505	228	61	rate	rate	NOUN
ajmsi-505	228	62	in	in	ADP
ajmsi-505	228	63	vivo	vivo	NOUN
ajmsi-505	228	64	might	might	AUX
ajmsi-505	228	65	be	be	AUX
ajmsi-505	228	66	higher	high	ADJ
ajmsi-505	228	67	than	than	SCONJ
ajmsi-505	228	68	previously	previously	ADV
ajmsi-505	228	69	reported	report	VERB
ajmsi-505	228	70	.	.	PUNCT
ajmsi-505	229	1	thus	thus	ADV
ajmsi-505	229	2	the	the	DET
ajmsi-505	229	3	levels	level	NOUN
ajmsi-505	229	4	of	of	ADP
ajmsi-505	229	5	genetic	genetic	ADJ
ajmsi-505	229	6	diversity	diversity	NOUN
ajmsi-505	229	7	identified	identify	VERB
ajmsi-505	229	8	in	in	ADP
ajmsi-505	229	9	the	the	DET
ajmsi-505	229	10	studies	study	NOUN
ajmsi-505	229	11	above	above	ADV
ajmsi-505	229	12	imply	imply	VERB
ajmsi-505	229	13	that	that	DET
ajmsi-505	229	14	m.	m.	NOUN
ajmsi-505	229	15	tuberculosis	tuberculosis	NOUN
ajmsi-505	229	16	might	might	AUX
ajmsi-505	229	17	have	have	VERB
ajmsi-505	229	18	an	an	DET
ajmsi-505	229	19	elevated	elevated	ADJ
ajmsi-505	229	20	mutation	mutation	NOUN
ajmsi-505	229	21	rate	rate	NOUN
ajmsi-505	229	22	within	within	ADP
ajmsi-505	229	23	the	the	DET
ajmsi-505	229	24	host	host	NOUN
ajmsi-505	229	25	compared	compare	VERB
ajmsi-505	229	26	to	to	ADP
ajmsi-505	229	27	that	that	PRON
ajmsi-505	229	28	calculated	calculate	VERB
ajmsi-505	229	29	in	in	ADP
ajmsi-505	229	30	vitro	vitro	NOUN
ajmsi-505	229	31	,	,	PUNCT
ajmsi-505	229	32	thereby	thereby	ADV
ajmsi-505	229	33	highlighting	highlight	VERB
ajmsi-505	229	34	the	the	DET
ajmsi-505	229	35	need	need	NOUN
ajmsi-505	229	36	for	for	ADP
ajmsi-505	229	37	further	far	ADV
ajmsi-505	229	38	in	in	ADP
ajmsi-505	229	39	vivo	vivo	ADJ
ajmsi-505	229	40	studies	study	NOUN
ajmsi-505	229	41	to	to	PART
ajmsi-505	229	42	truly	truly	ADV
ajmsi-505	229	43	ascertain	ascertain	VERB
ajmsi-505	229	44	the	the	DET
ajmsi-505	229	45	role	role	NOUN
ajmsi-505	229	46	of	of	ADP
ajmsi-505	229	47	hiv	hiv	PROPN
ajmsi-505	229	48	in	in	ADP
ajmsi-505	229	49	the	the	DET
ajmsi-505	229	50	emergence	emergence	NOUN
ajmsi-505	229	51	of	of	ADP
ajmsi-505	229	52	mdr	mdr	PROPN
ajmsi-505	229	53	-	-	PROPN
ajmsi-505	229	54	tb	tb	NOUN
ajmsi-505	229	55	especially	especially	ADV
ajmsi-505	229	56	for	for	ADP
ajmsi-505	229	57	tb	tb	NOUN
ajmsi-505	229	58	-	-	PUNCT
ajmsi-505	229	59	patients	patient	NOUN
ajmsi-505	229	60	co	co	ADJ
ajmsi-505	229	61	-	-	VERB
ajmsi-505	229	62	infected	infected	ADJ
ajmsi-505	229	63	with	with	ADP
ajmsi-505	229	64	hiv	hiv	PROPN
ajmsi-505	229	65	/	/	SYM
ajmsi-505	229	66	aids	aids	PROPN
ajmsi-505	229	67	.	.	PUNCT
ajmsi-505	230	1	conclusion	conclusion	NOUN
ajmsi-505	230	2	in	in	ADP
ajmsi-505	230	3	conclusion	conclusion	NOUN
ajmsi-505	230	4	,	,	PUNCT
ajmsi-505	230	5	results	result	NOUN
ajmsi-505	230	6	of	of	ADP
ajmsi-505	230	7	this	this	DET
ajmsi-505	230	8	genetic	genetic	ADJ
ajmsi-505	230	9	study	study	NOUN
ajmsi-505	230	10	on	on	ADP
ajmsi-505	230	11	the	the	DET
ajmsi-505	230	12	role	role	NOUN
ajmsi-505	230	13	of	of	ADP
ajmsi-505	230	14	hiv	hiv	PROPN
ajmsi-505	230	15	in	in	ADP
ajmsi-505	230	16	the	the	DET
ajmsi-505	230	17	emergence	emergence	NOUN
ajmsi-505	230	18	of	of	ADP
ajmsi-505	230	19	mdr	mdr	PROPN
ajmsi-505	230	20	-	-	PROPN
ajmsi-505	230	21	tb	tb	PROPN
ajmsi-505	230	22	,	,	PUNCT
ajmsi-505	230	23	promise	promise	VERB
ajmsi-505	230	24	to	to	PART
ajmsi-505	230	25	offer	offer	VERB
ajmsi-505	230	26	useful	useful	ADJ
ajmsi-505	230	27	,	,	PUNCT
ajmsi-505	230	28	effective	effective	ADJ
ajmsi-505	230	29	,	,	PUNCT
ajmsi-505	230	30	and	and	CCONJ
ajmsi-505	230	31	ground	ground	NOUN
ajmsi-505	230	32	breaking	break	VERB
ajmsi-505	230	33	molecular	molecular	ADJ
ajmsi-505	230	34	approach	approach	NOUN
ajmsi-505	230	35	in	in	ADP
ajmsi-505	230	36	the	the	DET
ajmsi-505	230	37	fight	fight	NOUN
ajmsi-505	230	38	against	against	ADP
ajmsi-505	230	39	mono	mono	NOUN
ajmsi-505	230	40	,	,	PUNCT
ajmsi-505	230	41	multiple	multiple	ADJ
ajmsi-505	230	42	,	,	PUNCT
ajmsi-505	230	43	and	and	CCONJ
ajmsi-505	230	44	extensivelydrug	extensivelydrug	NOUN
ajmsi-505	230	45	resistance	resistance	NOUN
ajmsi-505	230	46	(	(	PUNCT
ajmsi-505	230	47	xdr	xdr	PROPN
ajmsi-505	230	48	)	)	PUNCT
ajmsi-505	230	49	.	.	PUNCT
ajmsi-505	231	1	drug	drug	NOUN
ajmsi-505	231	2	resistance	resistance	NOUN
ajmsi-505	231	3	has	have	AUX
ajmsi-505	231	4	hampered	hamper	VERB
ajmsi-505	231	5	many	many	ADJ
ajmsi-505	231	6	public	public	ADJ
ajmsi-505	231	7	health	health	NOUN
ajmsi-505	231	8	targets	target	NOUN
ajmsi-505	231	9	and	and	CCONJ
ajmsi-505	231	10	interventions	intervention	NOUN
ajmsi-505	231	11	such	such	ADJ
ajmsi-505	231	12	as	as	ADP
ajmsi-505	231	13	“	"	PUNCT
ajmsi-505	231	14	stop	stop	VERB
ajmsi-505	231	15	tb”-target	tb”-target	PROPN
ajmsi-505	231	16	of	of	ADP
ajmsi-505	231	17	achieving	achieve	VERB
ajmsi-505	231	18	70	70	NUM
ajmsi-505	231	19	%	%	NOUN
ajmsi-505	231	20	case	case	NOUN
ajmsi-505	231	21	detection	detection	NOUN
ajmsi-505	231	22	and	and	CCONJ
ajmsi-505	231	23	85	85	NUM
ajmsi-505	231	24	%	%	NOUN
ajmsi-505	231	25	cure	cure	NOUN
ajmsi-505	231	26	rate	rate	NOUN
ajmsi-505	231	27	by	by	ADP
ajmsi-505	231	28	2005	2005	NUM
ajmsi-505	231	29	,	,	PUNCT
ajmsi-505	231	30	and	and	CCONJ
ajmsi-505	231	31	“	"	PUNCT
ajmsi-505	231	32	stop	stop	VERB
ajmsi-505	231	33	tb”-target	tb”-target	PROPN
ajmsi-505	231	34	of	of	ADP
ajmsi-505	231	35	50	50	NUM
ajmsi-505	231	36	%	%	NOUN
ajmsi-505	231	37	reduction	reduction	NOUN
ajmsi-505	231	38	in	in	ADP
ajmsi-505	231	39	the	the	DET
ajmsi-505	231	40	global	global	ADJ
ajmsi-505	231	41	burden	burden	NOUN
ajmsi-505	231	42	of	of	ADP
ajmsi-505	231	43	tb	tb	ADP
ajmsi-505	231	44	disease	disease	NOUN
ajmsi-505	231	45	(	(	PUNCT
ajmsi-505	231	46	deaths	death	NOUN
ajmsi-505	231	47	and	and	CCONJ
ajmsi-505	231	48	prevalence	prevalence	NOUN
ajmsi-505	231	49	)	)	PUNCT
ajmsi-505	231	50	by	by	ADP
ajmsi-505	231	51	2015	2015	NUM
ajmsi-505	231	52	(	(	PUNCT
ajmsi-505	231	53	who	who	PRON
ajmsi-505	231	54	,	,	PUNCT
ajmsi-505	231	55	2011	2011	NUM
ajmsi-505	231	56	)	)	PUNCT
ajmsi-505	231	57	.	.	PUNCT
ajmsi-505	232	1	previous	previous	ADJ
ajmsi-505	232	2	studies	study	NOUN
ajmsi-505	232	3	have	have	AUX
ajmsi-505	232	4	shown	show	VERB
ajmsi-505	232	5	that	that	SCONJ
ajmsi-505	232	6	anti	anti	ADJ
ajmsi-505	232	7	-	-	ADJ
ajmsi-505	232	8	tb	tb	ADJ
ajmsi-505	232	9	drugs	drug	NOUN
ajmsi-505	232	10	resistance	resistance	NOUN
ajmsi-505	232	11	arise	arise	VERB
ajmsi-505	232	12	from	from	ADP
ajmsi-505	232	13	patient/	patient/	NUM
ajmsi-505	232	14	service	service	NOUN
ajmsi-505	232	15	related	relate	VERB
ajmsi-505	232	16	causes	cause	NOUN
ajmsi-505	232	17	such	such	ADJ
ajmsi-505	232	18	as	as	ADP
ajmsi-505	232	19	poor	poor	ADJ
ajmsi-505	232	20	patient	patient	NOUN
ajmsi-505	232	21	adherence/	adherence/	NUM
ajmsi-505	232	22	compliance	compliance	NOUN
ajmsi-505	232	23	,	,	PUNCT
ajmsi-505	232	24	wrong	wrong	ADJ
ajmsi-505	232	25	regimens	regimen	NOUN
ajmsi-505	232	26	,	,	PUNCT
ajmsi-505	232	27	inadequate	inadequate	ADJ
ajmsi-505	232	28	supervision	supervision	NOUN
ajmsi-505	232	29	,	,	PUNCT
ajmsi-505	232	30	and	and	CCONJ
ajmsi-505	232	31	lengthy	lengthy	ADJ
ajmsi-505	232	32	duration	duration	NOUN
ajmsi-505	232	33	of	of	ADP
ajmsi-505	232	34	treatment	treatment	NOUN
ajmsi-505	232	35	.	.	PUNCT
ajmsi-505	233	1	the	the	DET
ajmsi-505	233	2	need	need	NOUN
ajmsi-505	233	3	to	to	PART
ajmsi-505	233	4	direct	direct	VERB
ajmsi-505	233	5	more	more	ADJ
ajmsi-505	233	6	attention	attention	NOUN
ajmsi-505	233	7	on	on	ADP
ajmsi-505	233	8	molecular	molecular	ADJ
ajmsi-505	233	9	aspects	aspect	NOUN
ajmsi-505	233	10	of	of	ADP
ajmsi-505	233	11	anti	anti	ADJ
ajmsi-505	233	12	-	-	ADJ
ajmsi-505	233	13	tb	tb	ADJ
ajmsi-505	233	14	drugs	drug	NOUN
ajmsi-505	233	15	resistance	resistance	NOUN
ajmsi-505	233	16	however	however	ADV
ajmsi-505	233	17	is	be	AUX
ajmsi-505	233	18	fast	fast	ADV
ajmsi-505	233	19	becoming	become	VERB
ajmsi-505	233	20	a	a	DET
ajmsi-505	233	21	top	top	ADJ
ajmsi-505	233	22	priority	priority	NOUN
ajmsi-505	233	23	,	,	PUNCT
ajmsi-505	233	24	especially	especially	ADV
ajmsi-505	233	25	since	since	SCONJ
ajmsi-505	233	26	mdr	mdr	PROPN
ajmsi-505	233	27	-	-	PROPN
ajmsi-505	233	28	tb	tb	PROPN
ajmsi-505	233	29	is	be	AUX
ajmsi-505	233	30	an	an	DET
ajmsi-505	233	31	emerging	emerge	VERB
ajmsi-505	233	32	public	public	ADJ
ajmsi-505	233	33	health	health	NOUN
ajmsi-505	233	34	epidemic	epidemic	NOUN
ajmsi-505	233	35	,	,	PUNCT
ajmsi-505	233	36	requiring	require	VERB
ajmsi-505	233	37	novel	novel	NOUN
ajmsi-505	233	38	tb	tb	ADP
ajmsi-505	233	39	drugs	drug	NOUN
ajmsi-505	233	40	to	to	PART
ajmsi-505	233	41	adequately	adequately	ADV
ajmsi-505	233	42	combat	combat	VERB
ajmsi-505	233	43	it	it	PRON
ajmsi-505	233	44	.	.	PUNCT
ajmsi-505	234	1	this	this	PRON
ajmsi-505	234	2	is	be	AUX
ajmsi-505	234	3	necessary	necessary	ADJ
ajmsi-505	234	4	if	if	SCONJ
ajmsi-505	234	5	the	the	DET
ajmsi-505	234	6	“	"	PUNCT
ajmsi-505	234	7	stop	stop	VERB
ajmsi-505	234	8	tb	tb	NOUN
ajmsi-505	234	9	”	"	PUNCT
ajmsi-505	234	10	targets	target	NOUN
ajmsi-505	234	11	of	of	ADP
ajmsi-505	234	12	less	less	ADJ
ajmsi-505	234	13	than	than	ADP
ajmsi-505	234	14	one	one	NUM
ajmsi-505	234	15	patient	patient	NOUN
ajmsi-505	234	16	per	per	ADP
ajmsi-505	234	17	million	million	NUM
ajmsi-505	234	18	populations	population	NOUN
ajmsi-505	234	19	by	by	ADP
ajmsi-505	234	20	year	year	NOUN
ajmsi-505	234	21	2050	2050	NUM
ajmsi-505	234	22	must	must	AUX
ajmsi-505	234	23	be	be	AUX
ajmsi-505	234	24	achieved	achieve	VERB
ajmsi-505	234	25	.	.	PUNCT
ajmsi-505	235	1	recommendations	recommendation	NOUN
ajmsi-505	235	2	based	base	VERB
ajmsi-505	235	3	on	on	ADP
ajmsi-505	235	4	the	the	DET
ajmsi-505	235	5	results	result	NOUN
ajmsi-505	235	6	of	of	ADP
ajmsi-505	235	7	the	the	DET
ajmsi-505	235	8	present	present	ADJ
ajmsi-505	235	9	study	study	NOUN
ajmsi-505	235	10	,	,	PUNCT
ajmsi-505	235	11	we	we	PRON
ajmsi-505	235	12	hereby	hereby	ADV
ajmsi-505	235	13	recommend	recommend	VERB
ajmsi-505	235	14	that	that	SCONJ
ajmsi-505	235	15	this	this	DET
ajmsi-505	235	16	genetic	genetic	ADJ
ajmsi-505	235	17	study	study	NOUN
ajmsi-505	235	18	should	should	AUX
ajmsi-505	235	19	be	be	AUX
ajmsi-505	235	20	stepped	step	VERB
ajmsi-505	235	21	up	up	ADP
ajmsi-505	235	22	under	under	ADV
ajmsi-505	235	23	in	in	ADP
ajmsi-505	235	24	vivo	vivo	ADJ
ajmsi-505	235	25	conditions	condition	NOUN
ajmsi-505	235	26	using	use	VERB
ajmsi-505	235	27	the	the	DET
ajmsi-505	235	28	actual	actual	ADJ
ajmsi-505	235	29	human	human	ADJ
ajmsi-505	235	30	immunodeficiency	immunodeficiency	NOUN
ajmsi-505	235	31	virus	virus	NOUN
ajmsi-505	235	32	(	(	PUNCT
ajmsi-505	235	33	hiv	hiv	PROPN
ajmsi-505	235	34	)	)	PUNCT
ajmsi-505	235	35	as	as	ADP
ajmsi-505	235	36	the	the	DET
ajmsi-505	235	37	transducing	transduce	VERB
ajmsi-505	235	38	phage	phage	NOUN
ajmsi-505	235	39	in	in	ADP
ajmsi-505	235	40	order	order	NOUN
ajmsi-505	235	41	to	to	PART
ajmsi-505	235	42	ascertain	ascertain	VERB
ajmsi-505	235	43	the	the	DET
ajmsi-505	235	44	true	true	ADJ
ajmsi-505	235	45	nature	nature	NOUN
ajmsi-505	235	46	of	of	ADP
ajmsi-505	235	47	mutation	mutation	NOUN
ajmsi-505	235	48	conferring	confer	VERB
ajmsi-505	235	49	antibiotics	antibiotic	NOUN
ajmsi-505	235	50	resistance	resistance	NOUN
ajmsi-505	235	51	.	.	PUNCT
ajmsi-505	236	1	the	the	DET
ajmsi-505	236	2	nature	nature	NOUN
ajmsi-505	236	3	of	of	ADP
ajmsi-505	236	4	mutation	mutation	NOUN
ajmsi-505	236	5	conferring	confer	VERB
ajmsi-505	236	6	anti	anti	ADJ
ajmsi-505	236	7	-	-	ADJ
ajmsi-505	236	8	tb	tb	ADJ
ajmsi-505	236	9	drugs	drug	NOUN
ajmsi-505	236	10	resistance	resistance	NOUN
ajmsi-505	236	11	most	most	ADV
ajmsi-505	236	12	especially	especially	ADV
ajmsi-505	236	13	mdr	mdr	PROPN
ajmsi-505	236	14	-	-	PROPN
ajmsi-505	236	15	tb	tb	PROPN
ajmsi-505	236	16	should	should	AUX
ajmsi-505	236	17	be	be	AUX
ajmsi-505	236	18	well	well	ADV
ajmsi-505	236	19	defined	define	VERB
ajmsi-505	236	20	and	and	CCONJ
ajmsi-505	236	21	documented	document	VERB
ajmsi-505	236	22	especially	especially	ADV
ajmsi-505	236	23	that	that	SCONJ
ajmsi-505	236	24	the	the	DET
ajmsi-505	236	25	dna	dna	NOUN
ajmsi-505	236	26	of	of	ADP
ajmsi-505	236	27	mycobacterium	mycobacterium	NOUN
ajmsi-505	236	28	tuberculosis	tuberculosis	NOUN
ajmsi-505	236	29	has	have	AUX
ajmsi-505	236	30	been	be	AUX
ajmsi-505	236	31	fully	fully	ADV
ajmsi-505	236	32	sequenced	sequence	VERB
ajmsi-505	236	33	.	.	PUNCT
ajmsi-505	237	1	in	in	ADP
ajmsi-505	237	2	-	-	PUNCT
ajmsi-505	237	3	depth	depth	NOUN
ajmsi-505	237	4	understanding	understanding	NOUN
ajmsi-505	237	5	of	of	ADP
ajmsi-505	237	6	the	the	DET
ajmsi-505	237	7	molecular	molecular	ADJ
ajmsi-505	237	8	biology	biology	NOUN
ajmsi-505	237	9	of	of	ADP
ajmsi-505	237	10	mycobacterium	mycobacterium	NOUN
ajmsi-505	237	11	tuberculosis	tuberculosis	NOUN
ajmsi-505	237	12	genetic	genetic	ADJ
ajmsi-505	237	13	dynamics	dynamic	NOUN
ajmsi-505	237	14	can	can	AUX
ajmsi-505	237	15	be	be	AUX
ajmsi-505	237	16	very	very	ADV
ajmsi-505	237	17	useful	useful	ADJ
ajmsi-505	237	18	to	to	ADP
ajmsi-505	237	19	pharmaceutical	pharmaceutical	ADJ
ajmsi-505	237	20	industry	industry	NOUN
ajmsi-505	237	21	as	as	ADP
ajmsi-505	237	22	targets	target	NOUN
ajmsi-505	237	23	in	in	ADP
ajmsi-505	237	24	the	the	DET
ajmsi-505	237	25	design	design	NOUN
ajmsi-505	237	26	of	of	ADP
ajmsi-505	237	27	novel	novel	ADJ
ajmsi-505	237	28	anti	anti	ADJ
ajmsi-505	237	29	-	-	ADJ
ajmsi-505	237	30	tb	tb	ADJ
ajmsi-505	237	31	drugs	drug	NOUN
ajmsi-505	237	32	.	.	PUNCT
ajmsi-505	238	1	design	design	NOUN
ajmsi-505	238	2	of	of	ADP
ajmsi-505	238	3	newer	new	ADJ
ajmsi-505	238	4	automated	automate	VERB
ajmsi-505	238	5	systems	system	NOUN
ajmsi-505	238	6	in	in	ADP
ajmsi-505	238	7	tb	tb	ADP
ajmsi-505	238	8	diagnosis	diagnosis	NOUN
ajmsi-505	238	9	and	and	CCONJ
ajmsi-505	238	10	antibiotics	antibiotic	NOUN
ajmsi-505	238	11	susceptibility	susceptibility	NOUN
ajmsi-505	238	12	testing	testing	NOUN
ajmsi-505	238	13	that	that	PRON
ajmsi-505	238	14	includes	include	VERB
ajmsi-505	238	15	other	other	ADJ
ajmsi-505	238	16	antitb	antitb	NOUN
ajmsi-505	238	17	drugs	drug	NOUN
ajmsi-505	238	18	such	such	ADJ
ajmsi-505	238	19	as	as	ADP
ajmsi-505	238	20	isoniazid	isoniazid	NOUN
ajmsi-505	238	21	,	,	PUNCT
ajmsi-505	238	22	parazinamide	parazinamide	ADV
ajmsi-505	238	23	and	and	CCONJ
ajmsi-505	238	24	ethambutol	ethambutol	VERB
ajmsi-505	238	25	in	in	ADP
ajmsi-505	238	26	addition	addition	NOUN
ajmsi-505	238	27	to	to	ADP
ajmsi-505	238	28	rifampicin	rifampicin	VERB
ajmsi-505	238	29	is	be	AUX
ajmsi-505	238	30	strongly	strongly	ADV
ajmsi-505	238	31	recommended	recommend	VERB
ajmsi-505	238	32	.	.	PUNCT
ajmsi-505	239	1	automated	automate	VERB
ajmsi-505	239	2	systems	system	NOUN
ajmsi-505	239	3	offer	offer	VERB
ajmsi-505	239	4	quicker	quick	ADJ
ajmsi-505	239	5	turnaround	turnaround	NOUN
ajmsi-505	239	6	time	time	NOUN
ajmsi-505	239	7	(	(	PUNCT
ajmsi-505	239	8	tat	tat	NOUN
ajmsi-505	239	9	)	)	PUNCT
ajmsi-505	239	10	and	and	CCONJ
ajmsi-505	239	11	should	should	AUX
ajmsi-505	239	12	be	be	AUX
ajmsi-505	239	13	employed	employ	VERB
ajmsi-505	239	14	in	in	ADP
ajmsi-505	239	15	routine	routine	ADJ
ajmsi-505	239	16	clinical	clinical	ADJ
ajmsi-505	239	17	practice	practice	NOUN
ajmsi-505	239	18	while	while	SCONJ
ajmsi-505	239	19	in	in	ADP
ajmsi-505	239	20	vitro	vitro	X
ajmsi-505	239	21	sputum	sputum	PROPN
ajmsi-505	239	22	culture	culture	NOUN
ajmsi-505	239	23	for	for	ADP
ajmsi-505	239	24	tb	tb	NOUN
ajmsi-505	239	25	that	that	PRON
ajmsi-505	239	26	takes	take	VERB
ajmsi-505	239	27	longer	long	ADJ
ajmsi-505	239	28	time	time	NOUN
ajmsi-505	239	29	should	should	AUX
ajmsi-505	239	30	be	be	AUX
ajmsi-505	239	31	restricted	restrict	VERB
ajmsi-505	239	32	to	to	PART
ajmsi-505	239	33	research	research	NOUN
ajmsi-505	239	34	purposes	purpose	NOUN
ajmsi-505	239	35	.	.	PUNCT
ajmsi-505	240	1	references	reference	NOUN
ajmsi-505	240	2	akaninyene	akaninyene	VERB
ajmsi-505	240	3	,	,	PUNCT
ajmsi-505	240	4	o.	o.	PROPN
ajmsi-505	240	5	,	,	PUNCT
ajmsi-505	240	6	victor	victor	PROPN
ajmsi-505	240	7	,	,	PUNCT
ajmsi-505	240	8	u.	u.	PROPN
ajmsi-505	240	9	,	,	PUNCT
ajmsi-505	240	10	abdulrazak	abdulrazak	PROPN
ajmsi-505	240	11	,	,	PUNCT
ajmsi-505	240	12	h.	h.	PROPN
ajmsi-505	240	13	,	,	PUNCT
ajmsi-505	240	14	soter	soter	PROPN
ajmsi-505	240	15	,	,	PUNCT
ajmsi-505	240	16	a.	a.	PROPN
ajmsi-505	240	17	,	,	PUNCT
ajmsi-505	240	18	&	&	CCONJ
ajmsi-505	240	19	lawson	lawson	PROPN
ajmsi-505	240	20	,	,	PUNCT
ajmsi-505	240	21	l.	l.	PROPN
ajmsi-505	240	22	(	(	PUNCT
ajmsi-505	240	23	2013	2013	NUM
ajmsi-505	240	24	)	)	PUNCT
ajmsi-505	240	25	.	.	PUNCT
ajmsi-505	241	1	clinical	clinical	ADJ
ajmsi-505	241	2	study	study	NOUN
ajmsi-505	241	3	of	of	ADP
ajmsi-505	241	4	drug	drug	NOUN
ajmsi-505	241	5	resistance	resistance	NOUN
ajmsi-505	241	6	among	among	ADP
ajmsi-505	241	7	pulmonary	pulmonary	ADJ
ajmsi-505	241	8	tuberculosis	tuberculosis	NOUN
ajmsi-505	241	9	patients	patient	NOUN
ajmsi-505	241	10	in	in	ADP
ajmsi-505	241	11	calabar	calabar	PROPN
ajmsi-505	241	12	,	,	PUNCT
ajmsi-505	241	13	nigeria	nigeria	PROPN
ajmsi-505	241	14	.	.	PUNCT
ajmsi-505	242	1	pulmonary	pulmonary	ADJ
ajmsi-505	242	2	medicine	medicine	NOUN
ajmsi-505	242	3	,	,	PUNCT
ajmsi-505	242	4	10,10	10,10	NUM
ajmsi-505	242	5	-	-	SYM
ajmsi-505	242	6	16	16	NUM
ajmsi-505	242	7	.	.	PUNCT
ajmsi-505	243	1	american	american	PROPN
ajmsi-505	243	2	thoracic	thoracic	PROPN
ajmsi-505	243	3	society	society	NOUN
ajmsi-505	243	4	and	and	CCONJ
ajmsi-505	243	5	centers	center	NOUN
ajmsi-505	243	6	for	for	ADP
ajmsi-505	243	7	disease	disease	NOUN
ajmsi-505	243	8	control	control	NOUN
ajmsi-505	243	9	and	and	CCONJ
ajmsi-505	243	10	prevention	prevention	NOUN
ajmsi-505	243	11	.	.	PUNCT
ajmsi-505	244	1	(	(	PUNCT
ajmsi-505	244	2	2000	2000	NUM
ajmsi-505	244	3	)	)	PUNCT
ajmsi-505	244	4	.	.	PUNCT
ajmsi-505	245	1	diagnostic	diagnostic	ADJ
ajmsi-505	245	2	standards	standard	NOUN
ajmsi-505	245	3	and	and	CCONJ
ajmsi-505	245	4	classification	classification	NOUN
ajmsi-505	245	5	of	of	ADP
ajmsi-505	245	6	tuberculosis	tuberculosis	NOUN
ajmsi-505	245	7	in	in	ADP
ajmsi-505	245	8	adults	adult	NOUN
ajmsi-505	245	9	and	and	CCONJ
ajmsi-505	245	10	children	child	NOUN
ajmsi-505	245	11	.	.	PUNCT
ajmsi-505	246	1	american	american	ADJ
ajmsi-505	246	2	journal	journal	PROPN
ajmsi-505	246	3	respiratory	respiratory	ADJ
ajmsi-505	246	4	critical	critical	ADJ
ajmsi-505	246	5	care	care	NOUN
ajmsi-505	246	6	medecine	medecine	NOUN
ajmsi-505	246	7	,	,	PUNCT
ajmsi-505	246	8	161(4	161(4	NUM
ajmsi-505	246	9	)	)	PUNCT
ajmsi-505	246	10	,	,	PUNCT
ajmsi-505	246	11	1376–1395	1376–1395	NUM
ajmsi-505	246	12	.	.	PUNCT
ajmsi-505	247	1	bardarov	bardarov	PROPN
ajmsi-505	247	2	,	,	PUNCT
ajmsi-505	247	3	s.	s.	PROPN
ajmsi-505	247	4	,	,	PUNCT
ajmsi-505	247	5	bardarov	bardarov	PROPN
ajmsi-505	247	6	jr	jr	PROPN
ajmsi-505	247	7	,	,	PUNCT
ajmsi-505	247	8	s.	s.	PROPN
ajmsi-505	247	9	,	,	PUNCT
ajmsi-505	247	10	pavelka	pavelka	PROPN
ajmsi-505	247	11	jr	jr	PROPN
ajmsi-505	247	12	,	,	PUNCT
ajmsi-505	247	13	m.	m.	PROPN
ajmsi-505	247	14	s.	s.	PROPN
ajmsi-505	247	15	,	,	PUNCT
ajmsi-505	247	16	sambandamurthy	sambandamurthy	ADJ
ajmsi-505	247	17	,	,	PUNCT
ajmsi-505	247	18	v.	v.	PROPN
ajmsi-505	247	19	,	,	PUNCT
ajmsi-505	247	20	larsen	larsen	PROPN
ajmsi-505	247	21	,	,	PUNCT
ajmsi-505	247	22	m.	m.	NOUN
ajmsi-505	247	23	,	,	PUNCT
ajmsi-505	247	24	tufariello	tufariello	PROPN
ajmsi-505	247	25	,	,	PUNCT
ajmsi-505	247	26	j.	j.	PROPN
ajmsi-505	247	27	,	,	PUNCT
ajmsi-505	247	28	...	...	PUNCT
ajmsi-505	247	29	&	&	CCONJ
ajmsi-505	247	30	jacobs	jacobs	PROPN
ajmsi-505	247	31	jr	jr	PROPN
ajmsi-505	247	32	,	,	PUNCT
ajmsi-505	247	33	w.	w.	PROPN
ajmsi-505	247	34	r.	r.	PROPN
ajmsi-505	247	35	(	(	PUNCT
ajmsi-505	247	36	2002	2002	NUM
ajmsi-505	247	37	)	)	PUNCT
ajmsi-505	247	38	.	.	PUNCT
ajmsi-505	248	1	specialized	specialized	ADJ
ajmsi-505	248	2	transduction	transduction	NOUN
ajmsi-505	248	3	:	:	PUNCT
ajmsi-505	248	4	an	an	DET
ajmsi-505	248	5	efficient	efficient	ADJ
ajmsi-505	248	6	method	method	NOUN
ajmsi-505	248	7	for	for	ADP
ajmsi-505	248	8	generating	generate	VERB
ajmsi-505	248	9	marked	mark	VERB
ajmsi-505	248	10	and	and	CCONJ
ajmsi-505	248	11	unmarked	unmarked	ADJ
ajmsi-505	248	12	targeted	target	VERB
ajmsi-505	248	13	gene	gene	NOUN
ajmsi-505	248	14	disruptions	disruption	NOUN
ajmsi-505	248	15	in	in	ADP
ajmsi-505	248	16	mycobacterium	mycobacterium	NOUN
ajmsi-505	248	17	tuberculosis	tuberculosis	NOUN
ajmsi-505	248	18	,	,	PUNCT
ajmsi-505	248	19	m.	m.	NOUN
ajmsi-505	248	20	bovis	bovi	VERB
ajmsi-505	248	21	bcg	bcg	PROPN
ajmsi-505	248	22	and	and	CCONJ
ajmsi-505	248	23	m.	m.	PROPN
ajmsi-505	248	24	smegmatis	smegmatis	PROPN
ajmsi-505	248	25	.	.	PUNCT
ajmsi-505	249	1	microbiology	microbiology	NOUN
ajmsi-505	249	2	,	,	PUNCT
ajmsi-505	249	3	148(10	148(10	NUM
ajmsi-505	249	4	)	)	PUNCT
ajmsi-505	249	5	,	,	PUNCT
ajmsi-505	249	6	3007	3007	NUM
ajmsi-505	249	7	-	-	SYM
ajmsi-505	249	8	3017	3017	NUM
ajmsi-505	249	9	.	.	PUNCT
ajmsi-505	250	1	cegielski	cegielski	PROPN
ajmsi-505	250	2	,	,	PUNCT
ajmsi-505	250	3	j.	j.	PROPN
ajmsi-505	250	4	p.	p.	PROPN
ajmsi-505	250	5	(	(	PUNCT
ajmsi-505	250	6	2010	2010	NUM
ajmsi-505	250	7	)	)	PUNCT
ajmsi-505	250	8	.	.	PUNCT
ajmsi-505	251	1	extensively	extensively	ADV
ajmsi-505	251	2	drug	drug	NOUN
ajmsi-505	251	3	-	-	PUNCT
ajmsi-505	251	4	resistant	resistant	ADJ
ajmsi-505	251	5	tuberculosis:“there	tuberculosis:“there	NUM
ajmsi-505	251	6	must	must	AUX
ajmsi-505	251	7	be	be	AUX
ajmsi-505	251	8	some	some	DET
ajmsi-505	251	9	kind	kind	NOUN
ajmsi-505	251	10	of	of	ADP
ajmsi-505	251	11	way	way	NOUN
ajmsi-505	251	12	out	out	ADP
ajmsi-505	251	13	of	of	ADP
ajmsi-505	251	14	here	here	ADV
ajmsi-505	251	15	”	"	PUNCT
ajmsi-505	251	16	.	.	PUNCT
ajmsi-505	252	1	clinical	clinical	ADJ
ajmsi-505	252	2	infectious	infectious	ADJ
ajmsi-505	252	3	diseases	disease	NOUN
ajmsi-505	252	4	,	,	PUNCT
ajmsi-505	252	5	50(3	50(3	NUM
ajmsi-505	252	6	)	)	PUNCT
ajmsi-505	252	7	,	,	PUNCT
ajmsi-505	252	8	s195	s195	PROPN
ajmsi-505	252	9	-	-	PUNCT
ajmsi-505	252	10	s200	s200	PROPN
ajmsi-505	252	11	.	.	PUNCT
ajmsi-505	253	1	cepheid	cepheid	PROPN
ajmsi-505	253	2	genexpert	genexpert	PROPN
ajmsi-505	253	3	mtb	mtb	PROPN
ajmsi-505	253	4	-	-	PUNCT
ajmsi-505	253	5	rif	rif	NOUN
ajmsi-505	253	6	assay	assay	PROPN
ajmsi-505	253	7	g4	g4	PROPN
ajmsi-505	253	8	version	version	NOUN
ajmsi-505	253	9	5	5	NUM
ajmsi-505	253	10	operation	operation	NOUN
ajmsi-505	253	11	manual	manual	NOUN
ajmsi-505	253	12	,	,	PUNCT
ajmsi-505	253	13	2014	2014	NUM
ajmsi-505	253	14	.	.	PUNCT
ajmsi-505	254	1	david	david	PROPN
ajmsi-505	254	2	,	,	PUNCT
ajmsi-505	254	3	h.	h.	PROPN
ajmsi-505	254	4	l.	l.	PROPN
ajmsi-505	254	5	(	(	PUNCT
ajmsi-505	254	6	1970	1970	NUM
ajmsi-505	254	7	)	)	PUNCT
ajmsi-505	254	8	.	.	PUNCT
ajmsi-505	255	1	probability	probability	NOUN
ajmsi-505	255	2	distribution	distribution	NOUN
ajmsi-505	255	3	of	of	ADP
ajmsi-505	255	4	drugresistant	drugresistant	ADJ
ajmsi-505	255	5	mutants	mutant	NOUN
ajmsi-505	255	6	in	in	ADP
ajmsi-505	255	7	unselected	unselected	ADJ
ajmsi-505	255	8	populations	population	NOUN
ajmsi-505	255	9	of	of	ADP
ajmsi-505	255	10	mycobacterium	mycobacterium	NOUN
ajmsi-505	255	11	tuberculosis	tuberculosis	NOUN
ajmsi-505	255	12	.	.	PUNCT
ajmsi-505	256	1	applied	apply	VERB
ajmsi-505	256	2	microbiology	microbiology	NOUN
ajmsi-505	256	3	,	,	PUNCT
ajmsi-505	256	4	20(5	20(5	NUM
ajmsi-505	256	5	)	)	PUNCT
ajmsi-505	256	6	,	,	PUNCT
ajmsi-505	256	7	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	256	8	pa	pa	PROPN
ajmsi-505	256	9	ge	ge	PROPN
ajmsi-505	256	10	9	9	NUM
ajmsi-505	256	11	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-505	256	12	am	be	AUX
ajmsi-505	256	13	.	.	PUNCT
ajmsi-505	257	1	j.	j.	PROPN
ajmsi-505	257	2	med	med	PROPN
ajmsi-505	257	3	.	.	PUNCT
ajmsi-505	258	1	sci	sci	PROPN
ajmsi-505	258	2	.	.	PUNCT
ajmsi-505	258	3	innov	innov	PROPN
ajmsi-505	258	4	.	.	PUNCT
ajmsi-505	259	1	1(1	1(1	NUM
ajmsi-505	259	2	)	)	PUNCT
ajmsi-505	259	3	1	1	NUM
ajmsi-505	259	4	-	-	SYM
ajmsi-505	259	5	9	9	NUM
ajmsi-505	259	6	,	,	PUNCT
ajmsi-505	259	7	2022	2022	NUM
ajmsi-505	259	8	810	810	NUM
ajmsi-505	259	9	-	-	SYM
ajmsi-505	259	10	814	814	NUM
ajmsi-505	259	11	.	.	PUNCT
ajmsi-505	260	1	dean	dean	PROPN
ajmsi-505	260	2	,	,	PUNCT
ajmsi-505	260	3	a.	a.	PROPN
ajmsi-505	260	4	s.	s.	PROPN
ajmsi-505	260	5	,	,	PUNCT
ajmsi-505	260	6	zignol	zignol	NOUN
ajmsi-505	260	7	,	,	PUNCT
ajmsi-505	260	8	m.	m.	NOUN
ajmsi-505	260	9	,	,	PUNCT
ajmsi-505	260	10	falzon	falzon	NOUN
ajmsi-505	260	11	,	,	PUNCT
ajmsi-505	260	12	d.	d.	PROPN
ajmsi-505	260	13	,	,	PUNCT
ajmsi-505	260	14	getahun	getahun	PROPN
ajmsi-505	260	15	,	,	PUNCT
ajmsi-505	260	16	h.	h.	PROPN
ajmsi-505	260	17	,	,	PUNCT
ajmsi-505	260	18	&	&	CCONJ
ajmsi-505	260	19	floyd	floyd	PROPN
ajmsi-505	260	20	,	,	PUNCT
ajmsi-505	260	21	k.	k.	PROPN
ajmsi-505	260	22	(	(	PUNCT
ajmsi-505	260	23	2014	2014	NUM
ajmsi-505	260	24	)	)	PUNCT
ajmsi-505	260	25	.	.	PUNCT
ajmsi-505	261	1	hiv	hiv	PROPN
ajmsi-505	261	2	and	and	CCONJ
ajmsi-505	261	3	multidrug	multidrug	NOUN
ajmsi-505	261	4	-	-	PUNCT
ajmsi-505	261	5	resistant	resistant	ADJ
ajmsi-505	261	6	tuberculosis	tuberculosis	NOUN
ajmsi-505	261	7	:	:	PUNCT
ajmsi-505	261	8	overlapping	overlap	VERB
ajmsi-505	261	9	epidemics	epidemic	NOUN
ajmsi-505	261	10	.	.	PUNCT
ajmsi-505	262	1	european	european	ADJ
ajmsi-505	262	2	respiratory	respiratory	ADJ
ajmsi-505	262	3	journal	journal	NOUN
ajmsi-505	262	4	,	,	PUNCT
ajmsi-505	262	5	44(1	44(1	PROPN
ajmsi-505	262	6	)	)	PUNCT
ajmsi-505	262	7	,	,	PUNCT
ajmsi-505	262	8	251	251	NUM
ajmsi-505	262	9	-	-	SYM
ajmsi-505	262	10	254	254	NUM
ajmsi-505	262	11	.	.	PUNCT
ajmsi-505	263	1	forbes	forbes	PROPN
ajmsi-505	263	2	,	,	PUNCT
ajmsi-505	263	3	b.	b.	PROPN
ajmsi-505	263	4	a.	a.	PROPN
ajmsi-505	263	5	,	,	PUNCT
ajmsi-505	263	6	sahm	sahm	PROPN
ajmsi-505	263	7	,	,	PUNCT
ajmsi-505	263	8	d.	d.	PROPN
ajmsi-505	263	9	f.	f.	PROPN
ajmsi-505	263	10	,	,	PUNCT
ajmsi-505	263	11	&	&	CCONJ
ajmsi-505	263	12	weissfeld	weissfeld	PROPN
ajmsi-505	263	13	,	,	PUNCT
ajmsi-505	263	14	a.	a.	PROPN
ajmsi-505	263	15	s.	s.	PROPN
ajmsi-505	263	16	(	(	PUNCT
ajmsi-505	263	17	2007	2007	NUM
ajmsi-505	263	18	)	)	PUNCT
ajmsi-505	263	19	.	.	PUNCT
ajmsi-505	264	1	diagnostic	diagnostic	ADJ
ajmsi-505	264	2	microbiology	microbiology	NOUN
ajmsi-505	264	3	(	(	PUNCT
ajmsi-505	264	4	pp	pp	ADJ
ajmsi-505	264	5	.	.	PUNCT
ajmsi-505	265	1	288	288	NUM
ajmsi-505	265	2	-	-	SYM
ajmsi-505	265	3	302	302	NUM
ajmsi-505	265	4	)	)	PUNCT
ajmsi-505	265	5	.	.	PUNCT
ajmsi-505	266	1	st	st	PROPN
ajmsi-505	266	2	louis	louis	PROPN
ajmsi-505	266	3	:	:	PUNCT
ajmsi-505	266	4	mosby	mosby	PROPN
ajmsi-505	266	5	.	.	PUNCT
ajmsi-505	267	1	ford	ford	PROPN
ajmsi-505	267	2	,	,	PUNCT
ajmsi-505	267	3	c.	c.	PROPN
ajmsi-505	267	4	b.	b.	PROPN
ajmsi-505	267	5	,	,	PUNCT
ajmsi-505	267	6	lin	lin	PROPN
ajmsi-505	267	7	,	,	PUNCT
ajmsi-505	267	8	p.	p.	PROPN
ajmsi-505	267	9	l.	l.	PROPN
ajmsi-505	267	10	,	,	PUNCT
ajmsi-505	267	11	chase	chase	PROPN
ajmsi-505	267	12	,	,	PUNCT
ajmsi-505	267	13	m.	m.	NOUN
ajmsi-505	267	14	r.	r.	PROPN
ajmsi-505	267	15	,	,	PUNCT
ajmsi-505	267	16	shah	shah	PROPN
ajmsi-505	267	17	,	,	PUNCT
ajmsi-505	267	18	r.	r.	PROPN
ajmsi-505	267	19	r.	r.	PROPN
ajmsi-505	267	20	,	,	PUNCT
ajmsi-505	267	21	iartchouk	iartchouk	PRON
ajmsi-505	267	22	,	,	PUNCT
ajmsi-505	267	23	o.	o.	PROPN
ajmsi-505	267	24	,	,	PUNCT
ajmsi-505	267	25	galagan	galagan	NOUN
ajmsi-505	267	26	,	,	PUNCT
ajmsi-505	267	27	j.	j.	PROPN
ajmsi-505	267	28	,	,	PUNCT
ajmsi-505	267	29	...	...	PUNCT
ajmsi-505	267	30	&	&	CCONJ
ajmsi-505	267	31	fortune	fortune	PROPN
ajmsi-505	267	32	,	,	PUNCT
ajmsi-505	268	1	s.	s.	PROPN
ajmsi-505	268	2	m.	m.	PROPN
ajmsi-505	268	3	(	(	PUNCT
ajmsi-505	268	4	2011	2011	NUM
ajmsi-505	268	5	)	)	PUNCT
ajmsi-505	268	6	.	.	PUNCT
ajmsi-505	269	1	use	use	NOUN
ajmsi-505	269	2	of	of	ADP
ajmsi-505	269	3	whole	whole	ADJ
ajmsi-505	269	4	genome	genome	NOUN
ajmsi-505	269	5	sequencing	sequence	VERB
ajmsi-505	269	6	to	to	PART
ajmsi-505	269	7	estimate	estimate	VERB
ajmsi-505	269	8	the	the	DET
ajmsi-505	269	9	mutation	mutation	NOUN
ajmsi-505	269	10	rate	rate	NOUN
ajmsi-505	269	11	of	of	ADP
ajmsi-505	269	12	mycobacterium	mycobacterium	NOUN
ajmsi-505	269	13	tuberculosis	tuberculosis	NOUN
ajmsi-505	269	14	during	during	ADP
ajmsi-505	269	15	latent	latent	ADJ
ajmsi-505	269	16	infection	infection	NOUN
ajmsi-505	269	17	.	.	PUNCT
ajmsi-505	270	1	nature	nature	NOUN
ajmsi-505	270	2	genetics	genetic	NOUN
ajmsi-505	270	3	,	,	PUNCT
ajmsi-505	270	4	43(5	43(5	NUM
ajmsi-505	270	5	)	)	PUNCT
ajmsi-505	270	6	,	,	PUNCT
ajmsi-505	270	7	482	482	NUM
ajmsi-505	270	8	-	-	SYM
ajmsi-505	270	9	486	486	NUM
ajmsi-505	270	10	.	.	PUNCT
ajmsi-505	271	1	idigbe	idigbe	PROPN
ajmsi-505	271	2	,	,	PUNCT
ajmsi-505	271	3	e.	e.	PROPN
ajmsi-505	271	4	o.	o.	PROPN
ajmsi-505	271	5	,	,	PUNCT
ajmsi-505	271	6	duque	duque	PROPN
ajmsi-505	271	7	,	,	PUNCT
ajmsi-505	271	8	j.	j.	PROPN
ajmsi-505	271	9	p.	p.	PROPN
ajmsi-505	271	10	,	,	PUNCT
ajmsi-505	271	11	john	john	PROPN
ajmsi-505	271	12	,	,	PUNCT
ajmsi-505	271	13	e.	e.	PROPN
ajmsi-505	271	14	k.	k.	PROPN
ajmsi-505	271	15	,	,	PUNCT
ajmsi-505	271	16	&	&	CCONJ
ajmsi-505	271	17	annam	annam	PROPN
ajmsi-505	271	18	,	,	PUNCT
ajmsi-505	271	19	o.	o.	NOUN
ajmsi-505	271	20	(	(	PUNCT
ajmsi-505	271	21	1992	1992	NUM
ajmsi-505	271	22	)	)	PUNCT
ajmsi-505	271	23	.	.	PUNCT
ajmsi-505	272	1	resistance	resistance	NOUN
ajmsi-505	272	2	to	to	PART
ajmsi-505	272	3	antituberculosis	antituberculosis	VERB
ajmsi-505	272	4	drugs	drug	NOUN
ajmsi-505	272	5	in	in	ADP
ajmsi-505	272	6	treated	treat	VERB
ajmsi-505	272	7	patients	patient	NOUN
ajmsi-505	272	8	in	in	ADP
ajmsi-505	272	9	lagos	lagos	PROPN
ajmsi-505	272	10	,	,	PUNCT
ajmsi-505	272	11	nigeria	nigeria	PROPN
ajmsi-505	272	12	.	.	PUNCT
ajmsi-505	273	1	the	the	DET
ajmsi-505	273	2	journal	journal	NOUN
ajmsi-505	273	3	of	of	ADP
ajmsi-505	273	4	tropical	tropical	ADJ
ajmsi-505	273	5	medicine	medicine	NOUN
ajmsi-505	273	6	and	and	CCONJ
ajmsi-505	273	7	hygiene	hygiene	NOUN
ajmsi-505	273	8	,	,	PUNCT
ajmsi-505	273	9	95(3	95(3	NUM
ajmsi-505	273	10	)	)	PUNCT
ajmsi-505	273	11	,	,	PUNCT
ajmsi-505	273	12	186	186	NUM
ajmsi-505	273	13	-	-	SYM
ajmsi-505	273	14	191	191	NUM
ajmsi-505	273	15	.	.	PUNCT
ajmsi-505	274	1	jenny	jenny	NOUN
ajmsi-505	274	2	-	-	PUNCT
ajmsi-505	274	3	avital	avital	PROPN
ajmsi-505	274	4	,	,	PUNCT
ajmsi-505	274	5	e.	e.	PROPN
ajmsi-505	274	6	r.	r.	PROPN
ajmsi-505	274	7	(	(	PUNCT
ajmsi-505	274	8	2002	2002	NUM
ajmsi-505	274	9	)	)	PUNCT
ajmsi-505	274	10	.	.	PUNCT
ajmsi-505	275	1	acquired	acquire	VERB
ajmsi-505	275	2	rifampin	rifampin	NOUN
ajmsi-505	275	3	resistance	resistance	NOUN
ajmsi-505	275	4	in	in	ADP
ajmsi-505	275	5	aids	aids	PROPN
ajmsi-505	275	6	-	-	PUNCT
ajmsi-505	275	7	related	relate	VERB
ajmsi-505	275	8	tb	tb	NOUN
ajmsi-505	275	9	.	.	PUNCT
ajmsi-505	276	1	aids	aids	PROPN
ajmsi-505	276	2	clinical	clinical	ADJ
ajmsi-505	276	3	care	care	NOUN
ajmsi-505	276	4	,	,	PUNCT
ajmsi-505	276	5	14(8	14(8	NUM
ajmsi-505	276	6	)	)	PUNCT
ajmsi-505	276	7	,	,	PUNCT
ajmsi-505	276	8	72	72	NUM
ajmsi-505	276	9	-	-	SYM
ajmsi-505	276	10	73	73	NUM
ajmsi-505	276	11	.	.	PUNCT
ajmsi-505	277	1	joshua	joshua	PROPN
ajmsi-505	277	2	,	,	PUNCT
ajmsi-505	277	3	o.	o.	PROPN
ajmsi-505	277	4	o.	o.	PROPN
ajmsi-505	277	5	,	,	PUNCT
ajmsi-505	277	6	gospel	gospel	NOUN
ajmsi-505	277	7	,	,	PUNCT
ajmsi-505	277	8	t.	t.	PROPN
ajmsi-505	277	9	o.	o.	PROPN
ajmsi-505	277	10	,	,	PUNCT
ajmsi-505	277	11	emeka	emeka	PROPN
ajmsi-505	277	12	,	,	PUNCT
ajmsi-505	277	13	u.	u.	PROPN
ajmsi-505	277	14	e.	e.	PROPN
ajmsi-505	277	15	,	,	PUNCT
ajmsi-505	277	16	&	&	CCONJ
ajmsi-505	277	17	chukwukere	chukwukere	ADV
ajmsi-505	277	18	,	,	PUNCT
ajmsi-505	277	19	e.	e.	PROPN
ajmsi-505	277	20	(	(	PUNCT
ajmsi-505	277	21	2013	2013	NUM
ajmsi-505	277	22	)	)	PUNCT
ajmsi-505	277	23	.	.	PUNCT
ajmsi-505	278	1	nigerian	nigerian	PROPN
ajmsi-505	278	2	national	national	ADJ
ajmsi-505	278	3	tb	tb	ADP
ajmsi-505	278	4	standard	standard	ADJ
ajmsi-505	278	5	operating	operating	NOUN
ajmsi-505	278	6	procedures	procedure	NOUN
ajmsi-505	278	7	manual	manual	NOUN
ajmsi-505	278	8	for	for	ADP
ajmsi-505	278	9	laboratories	laboratory	NOUN
ajmsi-505	278	10	.	.	PUNCT
ajmsi-505	279	1	national	national	ADJ
ajmsi-505	279	2	tuberculosis	tuberculosis	NOUN
ajmsi-505	279	3	and	and	CCONJ
ajmsi-505	279	4	leprosy	leprosy	NOUN
ajmsi-505	279	5	control	control	NOUN
ajmsi-505	279	6	programme	programme	NOUN
ajmsi-505	279	7	(	(	PUNCT
ajmsi-505	279	8	ntblcp	ntblcp	NOUN
ajmsi-505	279	9	)	)	PUNCT
ajmsi-505	279	10	,	,	PUNCT
ajmsi-505	279	11	ministry	ministry	PROPN
ajmsi-505	279	12	of	of	ADP
ajmsi-505	279	13	health	health	PROPN
ajmsi-505	279	14	,	,	PUNCT
ajmsi-505	279	15	nigeria	nigeria	PROPN
ajmsi-505	279	16	and	and	CCONJ
ajmsi-505	279	17	american	american	ADJ
ajmsi-505	279	18	society	society	NOUN
ajmsi-505	279	19	for	for	ADP
ajmsi-505	279	20	microbiology	microbiology	NOUN
ajmsi-505	279	21	,	,	PUNCT
ajmsi-505	279	22	ist	ist	NOUN
ajmsi-505	279	23	edition	edition	NOUN
ajmsi-505	279	24	,	,	PUNCT
ajmsi-505	279	25	1	1	NUM
ajmsi-505	279	26	-	-	SYM
ajmsi-505	279	27	244	244	NUM
ajmsi-505	279	28	.	.	PUNCT
ajmsi-505	280	1	kolo	kolo	PROPN
ajmsi-505	280	2	,	,	PUNCT
ajmsi-505	280	3	i.	i.	PROPN
ajmsi-505	280	4	bacteriological	bacteriological	PROPN
ajmsi-505	280	5	and	and	CCONJ
ajmsi-505	280	6	drug	drug	NOUN
ajmsi-505	280	7	sensitivity	sensitivity	NOUN
ajmsi-505	280	8	studies	study	NOUN
ajmsi-505	280	9	on	on	ADP
ajmsi-505	280	10	mycobacteria	mycobacterium	NOUN
ajmsi-505	280	11	isolated	isolate	VERB
ajmsi-505	280	12	from	from	ADP
ajmsi-505	280	13	tuberculosis	tuberculosis	NOUN
ajmsi-505	280	14	patients	patient	NOUN
ajmsi-505	280	15	and	and	CCONJ
ajmsi-505	280	16	their	their	PRON
ajmsi-505	280	17	close	close	ADJ
ajmsi-505	280	18	contacts	contact	NOUN
ajmsi-505	280	19	in	in	ADP
ajmsi-505	280	20	abuth	abuth	PROPN
ajmsi-505	280	21	,	,	PUNCT
ajmsi-505	280	22	zaria	zaria	PROPN
ajmsi-505	280	23	,	,	PUNCT
ajmsi-505	280	24	nigeria	nigeria	PROPN
ajmsi-505	280	25	.	.	PUNCT
ajmsi-505	280	26	1991	1991	NUM
ajmsi-505	280	27	(	(	PUNCT
ajmsi-505	280	28	doctoral	doctoral	ADJ
ajmsi-505	280	29	dissertation	dissertation	NOUN
ajmsi-505	280	30	,	,	PUNCT
ajmsi-505	280	31	phd	phd	NOUN
ajmsi-505	280	32	thesis	thesis	NOUN
ajmsi-505	280	33	,	,	PUNCT
ajmsi-505	280	34	zaria	zaria	PROPN
ajmsi-505	280	35	,	,	PUNCT
ajmsi-505	280	36	nigeria	nigeria	PROPN
ajmsi-505	280	37	)	)	PUNCT
ajmsi-505	280	38	.	.	PUNCT
ajmsi-505	281	1	kumar	kumar	PROPN
ajmsi-505	281	2	,	,	PUNCT
ajmsi-505	281	3	v.	v.	PROPN
ajmsi-505	281	4	,	,	PUNCT
ajmsi-505	281	5	abbas	abbas	PROPN
ajmsi-505	281	6	,	,	PUNCT
ajmsi-505	281	7	a.	a.	PROPN
ajmsi-505	281	8	k.	k.	PROPN
ajmsi-505	281	9	,	,	PUNCT
ajmsi-505	281	10	fausto	fausto	PROPN
ajmsi-505	281	11	,	,	PUNCT
ajmsi-505	281	12	n.	n.	NOUN
ajmsi-505	281	13	,	,	PUNCT
ajmsi-505	281	14	and	and	CCONJ
ajmsi-505	281	15	mitchell	mitchell	PROPN
ajmsi-505	281	16	,	,	PUNCT
ajmsi-505	281	17	r.	r.	PROPN
ajmsi-505	281	18	n.	n.	PROPN
ajmsi-505	281	19	(	(	PUNCT
ajmsi-505	281	20	2007	2007	NUM
ajmsi-505	281	21	)	)	PUNCT
ajmsi-505	281	22	.	.	PUNCT
ajmsi-505	282	1	robbins	robbins	PROPN
ajmsi-505	282	2	basic	basic	ADJ
ajmsi-505	282	3	pathology	pathology	NOUN
ajmsi-505	282	4	(	(	PUNCT
ajmsi-505	282	5	8th	8th	ADJ
ajmsi-505	282	6	ed	ed	NOUN
ajmsi-505	282	7	.	.	PUNCT
ajmsi-505	282	8	)	)	PUNCT
ajmsi-505	282	9	.	.	PUNCT
ajmsi-505	283	1	pp960	pp960	PROPN
ajmsi-505	283	2	saunders	saunders	PROPN
ajmsi-505	283	3	elsevier	elsevier	PROPN
ajmsi-505	283	4	.	.	PUNCT
ajmsi-505	284	1	lawn	lawn	PROPN
ajmsi-505	284	2	,	,	PUNCT
ajmsi-505	284	3	s.	s.	PROPN
ajmsi-505	284	4	d.	d.	PROPN
ajmsi-505	284	5	,	,	PUNCT
ajmsi-505	284	6	&	&	CCONJ
ajmsi-505	284	7	churchyard	churchyard	PROPN
ajmsi-505	284	8	,	,	PUNCT
ajmsi-505	284	9	g.	g.	PROPN
ajmsi-505	284	10	(	(	PUNCT
ajmsi-505	284	11	2009	2009	NUM
ajmsi-505	284	12	)	)	PUNCT
ajmsi-505	284	13	.	.	PUNCT
ajmsi-505	285	1	epidemiology	epidemiology	NOUN
ajmsi-505	285	2	of	of	ADP
ajmsi-505	285	3	hiv	hiv	PROPN
ajmsi-505	285	4	-	-	PUNCT
ajmsi-505	285	5	associated	associate	VERB
ajmsi-505	285	6	tuberculosis	tuberculosis	NOUN
ajmsi-505	285	7	running	run	VERB
ajmsi-505	285	8	head	head	NOUN
ajmsi-505	285	9	:	:	PUNCT
ajmsi-505	285	10	epidemiology	epidemiology	NOUN
ajmsi-505	285	11	of	of	ADP
ajmsi-505	285	12	tb	tb	PROPN
ajmsi-505	285	13	/	/	SYM
ajmsi-505	285	14	hiv	hiv	PROPN
ajmsi-505	285	15	.	.	PUNCT
ajmsi-505	286	1	current	current	ADJ
ajmsi-505	286	2	opinion	opinion	NOUN
ajmsi-505	286	3	in	in	ADP
ajmsi-505	286	4	hiv	hiv	PROPN
ajmsi-505	286	5	and	and	CCONJ
ajmsi-505	286	6	aids	aids	PROPN
ajmsi-505	286	7	,	,	PUNCT
ajmsi-505	286	8	4(4	4(4	NUM
ajmsi-505	286	9	)	)	PUNCT
ajmsi-505	286	10	,	,	PUNCT
ajmsi-505	286	11	325	325	NUM
ajmsi-505	286	12	.	.	PUNCT
ajmsi-505	287	1	lawson	lawson	PROPN
ajmsi-505	287	2	,	,	PUNCT
ajmsi-505	287	3	l.	l.	PROPN
ajmsi-505	287	4	,	,	PUNCT
ajmsi-505	287	5	yassin	yassin	PROPN
ajmsi-505	287	6	,	,	PUNCT
ajmsi-505	287	7	m.	m.	NOUN
ajmsi-505	287	8	a.	a.	PROPN
ajmsi-505	287	9	,	,	PUNCT
ajmsi-505	287	10	abdurrahman	abdurrahman	NOUN
ajmsi-505	287	11	,	,	PUNCT
ajmsi-505	287	12	s.	s.	PROPN
ajmsi-505	287	13	t.	t.	PROPN
ajmsi-505	287	14	,	,	PUNCT
ajmsi-505	287	15	parry	parry	PROPN
ajmsi-505	287	16	,	,	PUNCT
ajmsi-505	287	17	c.	c.	PROPN
ajmsi-505	287	18	m.	m.	NOUN
ajmsi-505	287	19	,	,	PUNCT
ajmsi-505	287	20	dacombe	dacombe	NOUN
ajmsi-505	287	21	,	,	PUNCT
ajmsi-505	287	22	r.	r.	PROPN
ajmsi-505	287	23	,	,	PUNCT
ajmsi-505	287	24	sogaolu	sogaolu	NOUN
ajmsi-505	287	25	,	,	PUNCT
ajmsi-505	287	26	o.	o.	NOUN
ajmsi-505	287	27	m.	m.	NOUN
ajmsi-505	287	28	,	,	PUNCT
ajmsi-505	287	29	...	...	PUNCT
ajmsi-505	287	30	&	&	CCONJ
ajmsi-505	287	31	cuevas	cuevas	PROPN
ajmsi-505	287	32	,	,	PUNCT
ajmsi-505	287	33	l.	l.	PROPN
ajmsi-505	287	34	e.	e.	PROPN
ajmsi-505	287	35	(	(	PUNCT
ajmsi-505	287	36	2011	2011	NUM
ajmsi-505	287	37	)	)	PUNCT
ajmsi-505	287	38	.	.	PUNCT
ajmsi-505	288	1	resistance	resistance	NOUN
ajmsi-505	288	2	to	to	ADP
ajmsi-505	288	3	first	first	ADJ
ajmsi-505	288	4	-	-	PUNCT
ajmsi-505	288	5	line	line	NOUN
ajmsi-505	288	6	tuberculosis	tuberculosis	NOUN
ajmsi-505	288	7	drugs	drug	NOUN
ajmsi-505	288	8	in	in	ADP
ajmsi-505	288	9	three	three	NUM
ajmsi-505	288	10	cities	city	NOUN
ajmsi-505	288	11	of	of	ADP
ajmsi-505	288	12	nigeria	nigeria	PROPN
ajmsi-505	288	13	.	.	PUNCT
ajmsi-505	289	1	tropical	tropical	ADJ
ajmsi-505	289	2	medicine	medicine	PROPN
ajmsi-505	289	3	&	&	CCONJ
ajmsi-505	289	4	international	international	PROPN
ajmsi-505	289	5	health	health	NOUN
ajmsi-505	289	6	,	,	PUNCT
ajmsi-505	289	7	16(8	16(8	NUM
ajmsi-505	289	8	)	)	PUNCT
ajmsi-505	289	9	,	,	PUNCT
ajmsi-505	289	10	974	974	NUM
ajmsi-505	289	11	-	-	SYM
ajmsi-505	289	12	980	980	NUM
ajmsi-505	289	13	.	.	PUNCT
ajmsi-505	290	1	mcgrath	mcgrath	PROPN
ajmsi-505	290	2	,	,	PUNCT
ajmsi-505	290	3	m.	m.	NOUN
ajmsi-505	290	4	,	,	PUNCT
ajmsi-505	290	5	gey	gey	PROPN
ajmsi-505	290	6	van	van	PROPN
ajmsi-505	290	7	pittius	pittius	PROPN
ajmsi-505	290	8	,	,	PUNCT
ajmsi-505	290	9	n.	n.	PROPN
ajmsi-505	290	10	c.	c.	PROPN
ajmsi-505	290	11	,	,	PUNCT
ajmsi-505	290	12	van	van	PROPN
ajmsi-505	290	13	helden	helden	PROPN
ajmsi-505	290	14	,	,	PUNCT
ajmsi-505	290	15	p.	p.	PROPN
ajmsi-505	290	16	d.	d.	PROPN
ajmsi-505	290	17	,	,	PUNCT
ajmsi-505	290	18	warren	warren	PROPN
ajmsi-505	290	19	,	,	PUNCT
ajmsi-505	290	20	r.	r.	PROPN
ajmsi-505	290	21	m.	m.	PROPN
ajmsi-505	290	22	,	,	PUNCT
ajmsi-505	290	23	&	&	CCONJ
ajmsi-505	290	24	warner	warner	PROPN
ajmsi-505	290	25	,	,	PUNCT
ajmsi-505	290	26	d.	d.	PROPN
ajmsi-505	290	27	f.	f.	PROPN
ajmsi-505	290	28	(	(	PUNCT
ajmsi-505	290	29	2014	2014	NUM
ajmsi-505	290	30	)	)	PUNCT
ajmsi-505	290	31	.	.	PUNCT
ajmsi-505	291	1	mutation	mutation	NOUN
ajmsi-505	291	2	rate	rate	NOUN
ajmsi-505	291	3	and	and	CCONJ
ajmsi-505	291	4	the	the	DET
ajmsi-505	291	5	emergence	emergence	NOUN
ajmsi-505	291	6	of	of	ADP
ajmsi-505	291	7	drug	drug	NOUN
ajmsi-505	291	8	resistance	resistance	NOUN
ajmsi-505	291	9	in	in	ADP
ajmsi-505	291	10	mycobacterium	mycobacterium	NOUN
ajmsi-505	291	11	tuberculosis	tuberculosis	NOUN
ajmsi-505	291	12	.	.	PUNCT
ajmsi-505	292	1	journal	journal	NOUN
ajmsi-505	292	2	of	of	ADP
ajmsi-505	292	3	antimicrobial	antimicrobial	ADJ
ajmsi-505	292	4	chemotherapy	chemotherapy	NOUN
ajmsi-505	292	5	,	,	PUNCT
ajmsi-505	292	6	69(2	69(2	NOUN
ajmsi-505	292	7	)	)	PUNCT
ajmsi-505	292	8	,	,	PUNCT
ajmsi-505	292	9	292	292	NUM
ajmsi-505	292	10	-	-	SYM
ajmsi-505	292	11	302	302	NUM
ajmsi-505	292	12	.	.	PUNCT
ajmsi-505	293	1	mizrahi	mizrahi	PROPN
ajmsi-505	293	2	,	,	PUNCT
ajmsi-505	293	3	v.	v.	PROPN
ajmsi-505	293	4	,	,	PUNCT
ajmsi-505	293	5	&	&	CCONJ
ajmsi-505	293	6	andersen	andersen	PROPN
ajmsi-505	293	7	,	,	PUNCT
ajmsi-505	293	8	s.	s.	PROPN
ajmsi-505	293	9	j.	j.	PROPN
ajmsi-505	293	10	(	(	PUNCT
ajmsi-505	293	11	1998	1998	NUM
ajmsi-505	293	12	)	)	PUNCT
ajmsi-505	293	13	.	.	PUNCT
ajmsi-505	294	1	dna	dna	PROPN
ajmsi-505	294	2	repair	repair	VERB
ajmsi-505	294	3	in	in	ADP
ajmsi-505	294	4	mycobacterium	mycobacterium	NOUN
ajmsi-505	294	5	tuberculosis	tuberculosis	NOUN
ajmsi-505	294	6	.	.	PUNCT
ajmsi-505	295	1	what	what	PRON
ajmsi-505	295	2	have	have	AUX
ajmsi-505	295	3	we	we	PRON
ajmsi-505	295	4	learnt	learn	VERB
ajmsi-505	295	5	from	from	ADP
ajmsi-505	295	6	the	the	DET
ajmsi-505	295	7	genome	genome	NOUN
ajmsi-505	295	8	sequence	sequence	NOUN
ajmsi-505	295	9	?	?	PUNCT
ajmsi-505	295	10	.	.	PUNCT
ajmsi-505	296	1	molecular	molecular	ADJ
ajmsi-505	296	2	microbiology	microbiology	NOUN
ajmsi-505	296	3	,	,	PUNCT
ajmsi-505	296	4	29(6	29(6	NUM
ajmsi-505	296	5	)	)	PUNCT
ajmsi-505	296	6	,	,	PUNCT
ajmsi-505	296	7	1331	1331	NUM
ajmsi-505	296	8	-	-	SYM
ajmsi-505	296	9	1339	1339	NUM
ajmsi-505	296	10	.	.	PUNCT
ajmsi-505	297	1	munsiff	munsiff	NOUN
ajmsi-505	297	2	,	,	PUNCT
ajmsi-505	297	3	s.	s.	PROPN
ajmsi-505	297	4	s.	s.	PROPN
ajmsi-505	297	5	,	,	PUNCT
ajmsi-505	297	6	joseph	joseph	PROPN
ajmsi-505	297	7	,	,	PUNCT
ajmsi-505	297	8	s.	s.	PROPN
ajmsi-505	297	9	,	,	PUNCT
ajmsi-505	297	10	ebrahimzadeh	ebrahimzadeh	PROPN
ajmsi-505	297	11	,	,	PUNCT
ajmsi-505	297	12	a.	a.	NOUN
ajmsi-505	297	13	,	,	PUNCT
ajmsi-505	297	14	&	&	CCONJ
ajmsi-505	297	15	frieden	frieden	PROPN
ajmsi-505	297	16	,	,	PUNCT
ajmsi-505	297	17	t.	t.	PROPN
ajmsi-505	297	18	r.	r.	PROPN
ajmsi-505	297	19	(	(	PUNCT
ajmsi-505	297	20	1997	1997	NUM
ajmsi-505	297	21	)	)	PUNCT
ajmsi-505	297	22	.	.	PUNCT
ajmsi-505	298	1	rifampin	rifampin	NOUN
ajmsi-505	298	2	-	-	PUNCT
ajmsi-505	298	3	monoresistant	monoresistant	ADJ
ajmsi-505	298	4	tuberculosis	tuberculosis	NOUN
ajmsi-505	298	5	in	in	ADP
ajmsi-505	298	6	new	new	PROPN
ajmsi-505	298	7	york	york	PROPN
ajmsi-505	298	8	city	city	PROPN
ajmsi-505	298	9	,	,	PUNCT
ajmsi-505	298	10	1993–1994	1993–1994	NUM
ajmsi-505	298	11	.	.	PUNCT
ajmsi-505	299	1	clinical	clinical	ADJ
ajmsi-505	299	2	infectious	infectious	ADJ
ajmsi-505	299	3	diseases	disease	NOUN
ajmsi-505	299	4	,	,	PUNCT
ajmsi-505	299	5	25(6	25(6	NOUN
ajmsi-505	299	6	)	)	PUNCT
ajmsi-505	299	7	,	,	PUNCT
ajmsi-505	299	8	1465	1465	NUM
ajmsi-505	299	9	-	-	SYM
ajmsi-505	299	10	1467	1467	NUM
ajmsi-505	299	11	.	.	PUNCT
ajmsi-505	300	1	national	national	ADJ
ajmsi-505	300	2	tuberculosis	tuberculosis	NOUN
ajmsi-505	300	3	and	and	CCONJ
ajmsi-505	300	4	leprosy	leprosy	NOUN
ajmsi-505	300	5	control	control	NOUN
ajmsi-505	300	6	programme	programme	PROPN
ajmsi-505	300	7	.	.	PUNCT
ajmsi-505	301	1	workers	worker	NOUN
ajmsi-505	301	2	manual	manual	NOUN
ajmsi-505	301	3	.	.	PUNCT
ajmsi-505	302	1	4th	4th	ADJ
ajmsi-505	302	2	edition	edition	NOUN
ajmsi-505	302	3	,	,	PUNCT
ajmsi-505	302	4	(	(	PUNCT
ajmsi-505	302	5	2005	2005	NUM
ajmsi-505	302	6	)	)	PUNCT
ajmsi-505	302	7	.	.	PUNCT
ajmsi-505	303	1	federal	federal	PROPN
ajmsi-505	303	2	ministry	ministry	PROPN
ajmsi-505	303	3	of	of	ADP
ajmsi-505	303	4	health	health	PROPN
ajmsi-505	303	5	,	,	PUNCT
ajmsi-505	303	6	department	department	NOUN
ajmsi-505	303	7	of	of	ADP
ajmsi-505	303	8	public	public	ADJ
ajmsi-505	303	9	health	health	NOUN
ajmsi-505	303	10	,	,	PUNCT
ajmsi-505	303	11	abuja	abuja	PROPN
ajmsi-505	303	12	.	.	PUNCT
ajmsi-505	304	1	pp	pp	ADV
ajmsi-505	304	2	338	338	NUM
ajmsi-505	304	3	siddiqui	siddiqui	NOUN
ajmsi-505	304	4	and	and	CCONJ
ajmsi-505	304	5	rusch	rusch	PROPN
ajmsi-505	304	6	-	-	PUNCT
ajmsi-505	304	7	gerdes	gerde	NOUN
ajmsi-505	304	8	(	(	PUNCT
ajmsi-505	304	9	2006	2006	NUM
ajmsi-505	304	10	)	)	PUNCT
ajmsi-505	304	11	.	.	PUNCT
ajmsi-505	305	1	mgit	mgit	ADJ
ajmsi-505	305	2	procedure	procedure	NOUN
ajmsi-505	305	3	manual	manual	NOUN
ajmsi-505	305	4	,	,	PUNCT
ajmsi-505	305	5	geneva	geneva	PROPN
ajmsi-505	305	6	,	,	PUNCT
ajmsi-505	305	7	switzerland	switzerland	PROPN
ajmsi-505	305	8	:	:	PUNCT
ajmsi-505	305	9	foundation	foundation	NOUN
ajmsi-505	305	10	for	for	ADP
ajmsi-505	305	11	innovative	innovative	ADJ
ajmsi-505	305	12	new	new	ADJ
ajmsi-505	305	13	diagnostics	diagnostic	NOUN
ajmsi-505	305	14	.	.	PUNCT
ajmsi-505	306	1	sun	sun	PROPN
ajmsi-505	306	2	,	,	PUNCT
ajmsi-505	306	3	g.	g.	PROPN
ajmsi-505	306	4	,	,	PUNCT
ajmsi-505	306	5	luo	luo	PROPN
ajmsi-505	306	6	,	,	PUNCT
ajmsi-505	306	7	t.	t.	PROPN
ajmsi-505	306	8	,	,	PUNCT
ajmsi-505	306	9	yang	yang	PROPN
ajmsi-505	306	10	,	,	PUNCT
ajmsi-505	306	11	c.	c.	PROPN
ajmsi-505	306	12	,	,	PUNCT
ajmsi-505	306	13	dong	dong	PROPN
ajmsi-505	306	14	,	,	PUNCT
ajmsi-505	306	15	x.	x.	PROPN
ajmsi-505	306	16	,	,	PUNCT
ajmsi-505	306	17	li	li	PROPN
ajmsi-505	306	18	,	,	PUNCT
ajmsi-505	306	19	j.	j.	PROPN
ajmsi-505	306	20	,	,	PUNCT
ajmsi-505	306	21	zhu	zhu	PROPN
ajmsi-505	306	22	,	,	PUNCT
ajmsi-505	306	23	y.	y.	PROPN
ajmsi-505	306	24	,	,	PUNCT
ajmsi-505	306	25	...	...	PUNCT
ajmsi-505	306	26	&	&	CCONJ
ajmsi-505	306	27	gao	gao	PROPN
ajmsi-505	306	28	,	,	PUNCT
ajmsi-505	306	29	q.	q.	PROPN
ajmsi-505	306	30	(	(	PUNCT
ajmsi-505	306	31	2012	2012	NUM
ajmsi-505	306	32	)	)	PUNCT
ajmsi-505	306	33	.	.	PUNCT
ajmsi-505	307	1	dynamic	dynamic	ADJ
ajmsi-505	307	2	population	population	NOUN
ajmsi-505	307	3	changes	change	NOUN
ajmsi-505	307	4	in	in	ADP
ajmsi-505	307	5	mycobacterium	mycobacterium	NOUN
ajmsi-505	307	6	tuberculosis	tuberculosis	NOUN
ajmsi-505	307	7	during	during	ADP
ajmsi-505	307	8	acquisition	acquisition	NOUN
ajmsi-505	307	9	and	and	CCONJ
ajmsi-505	307	10	fixation	fixation	NOUN
ajmsi-505	307	11	of	of	ADP
ajmsi-505	307	12	drug	drug	NOUN
ajmsi-505	307	13	resistance	resistance	NOUN
ajmsi-505	307	14	in	in	ADP
ajmsi-505	307	15	patients	patient	NOUN
ajmsi-505	307	16	.	.	PUNCT
ajmsi-505	308	1	the	the	DET
ajmsi-505	308	2	journal	journal	NOUN
ajmsi-505	308	3	of	of	ADP
ajmsi-505	308	4	infectious	infectious	ADJ
ajmsi-505	308	5	diseases	disease	NOUN
ajmsi-505	308	6	,	,	PUNCT
ajmsi-505	308	7	206(11	206(11	NUM
ajmsi-505	308	8	)	)	PUNCT
ajmsi-505	308	9	,	,	PUNCT
ajmsi-505	308	10	1724	1724	NUM
ajmsi-505	308	11	-	-	SYM
ajmsi-505	308	12	1733	1733	NUM
ajmsi-505	308	13	.	.	PUNCT
ajmsi-505	309	1	uzoewulu	uzoewulu	VERB
ajmsi-505	309	2	,	,	PUNCT
ajmsi-505	309	3	n.	n.	PROPN
ajmsi-505	309	4	g.	g.	PROPN
ajmsi-505	309	5	,	,	PUNCT
ajmsi-505	309	6	ibeh	ibeh	PROPN
ajmsi-505	309	7	,	,	PUNCT
ajmsi-505	309	8	i.	i.	PROPN
ajmsi-505	309	9	n.	n.	PROPN
ajmsi-505	309	10	,	,	PUNCT
ajmsi-505	309	11	lawson	lawson	PROPN
ajmsi-505	309	12	,	,	PUNCT
ajmsi-505	309	13	l.	l.	PROPN
ajmsi-505	309	14	,	,	PUNCT
ajmsi-505	309	15	goyal	goyal	PROPN
ajmsi-505	309	16	,	,	PUNCT
ajmsi-505	309	17	m.	m.	NOUN
ajmsi-505	309	18	,	,	PUNCT
ajmsi-505	309	19	umenyonu	umenyonu	NOUN
ajmsi-505	309	20	,	,	PUNCT
ajmsi-505	309	21	n.	n.	NOUN
ajmsi-505	309	22	,	,	PUNCT
ajmsi-505	309	23	ofiaeli	ofiaeli	PROPN
ajmsi-505	309	24	,	,	PUNCT
ajmsi-505	309	25	r.	r.	PROPN
ajmsi-505	309	26	o.	o.	PROPN
ajmsi-505	309	27	,	,	PUNCT
ajmsi-505	309	28	&	&	CCONJ
ajmsi-505	309	29	okonkwo	okonkwo	PROPN
ajmsi-505	309	30	,	,	PUNCT
ajmsi-505	309	31	r.	r.	PROPN
ajmsi-505	309	32	(	(	PUNCT
ajmsi-505	309	33	2014	2014	NUM
ajmsi-505	309	34	)	)	PUNCT
ajmsi-505	309	35	.	.	PUNCT
ajmsi-505	310	1	drug	drug	NOUN
ajmsi-505	310	2	resistant	resistant	ADJ
ajmsi-505	310	3	mycobacterium	mycobacterium	NOUN
ajmsi-505	310	4	tuberculosis	tuberculosis	NOUN
ajmsi-505	310	5	in	in	ADP
ajmsi-505	310	6	tertiary	tertiary	ADJ
ajmsi-505	310	7	hospital	hospital	NOUN
ajmsi-505	310	8	south	south	PROPN
ajmsi-505	310	9	east	east	PROPN
ajmsi-505	310	10	,	,	PUNCT
ajmsi-505	310	11	nigeria	nigeria	PROPN
ajmsi-505	310	12	.	.	PUNCT
ajmsi-505	311	1	journal	journal	PROPN
ajmsi-505	311	2	of	of	ADP
ajmsi-505	311	3	medical	medical	ADJ
ajmsi-505	311	4	microbiology	microbiology	NOUN
ajmsi-505	311	5	&	&	CCONJ
ajmsi-505	311	6	diagnosis	diagnosis	NOUN
ajmsi-505	311	7	,	,	PUNCT
ajmsi-505	311	8	3(2	3(2	NUM
ajmsi-505	311	9	)	)	PUNCT
ajmsi-505	311	10	,	,	PUNCT
ajmsi-505	311	11	1	1	X
ajmsi-505	311	12	.	.	PUNCT
ajmsi-505	312	1	van	van	PROPN
ajmsi-505	312	2	crevel	crevel	PROPN
ajmsi-505	312	3	,	,	PUNCT
ajmsi-505	312	4	r.	r.	PROPN
ajmsi-505	312	5	,	,	PUNCT
ajmsi-505	312	6	ottenhoff	ottenhoff	PROPN
ajmsi-505	312	7	,	,	PUNCT
ajmsi-505	312	8	t.	t.	PROPN
ajmsi-505	312	9	h.	h.	PROPN
ajmsi-505	312	10	,	,	PUNCT
ajmsi-505	312	11	&	&	CCONJ
ajmsi-505	312	12	van	van	PROPN
ajmsi-505	312	13	der	der	PROPN
ajmsi-505	312	14	meer	meer	PROPN
ajmsi-505	312	15	,	,	PUNCT
ajmsi-505	312	16	j.	j.	PROPN
ajmsi-505	312	17	w.	w.	PROPN
ajmsi-505	312	18	(	(	PUNCT
ajmsi-505	312	19	2002	2002	NUM
ajmsi-505	312	20	)	)	PUNCT
ajmsi-505	312	21	.	.	PUNCT
ajmsi-505	313	1	innate	innate	ADJ
ajmsi-505	313	2	immunity	immunity	NOUN
ajmsi-505	313	3	to	to	ADP
ajmsi-505	313	4	mycobacterium	mycobacterium	NOUN
ajmsi-505	313	5	tuberculosis	tuberculosis	NOUN
ajmsi-505	313	6	.	.	PUNCT
ajmsi-505	314	1	clinical	clinical	ADJ
ajmsi-505	314	2	microbiology	microbiology	NOUN
ajmsi-505	314	3	reviews	review	NOUN
ajmsi-505	314	4	,	,	PUNCT
ajmsi-505	314	5	15(2	15(2	NUM
ajmsi-505	314	6	)	)	PUNCT
ajmsi-505	314	7	,	,	PUNCT
ajmsi-505	314	8	294	294	NUM
ajmsi-505	314	9	-	-	SYM
ajmsi-505	314	10	309	309	NUM
ajmsi-505	314	11	.	.	PUNCT
ajmsi-505	315	1	willey	willey	PROPN
ajmsi-505	315	2	,	,	PUNCT
ajmsi-505	315	3	j.	j.	PROPN
ajmsi-505	315	4	m.	m.	PROPN
ajmsi-505	315	5	,	,	PUNCT
ajmsi-505	315	6	sherwood	sherwood	PROPN
ajmsi-505	315	7	,	,	PUNCT
ajmsi-505	315	8	l.	l.	PROPN
ajmsi-505	315	9	,	,	PUNCT
ajmsi-505	315	10	&	&	CCONJ
ajmsi-505	315	11	woolverton	woolverton	PROPN
ajmsi-505	315	12	,	,	PUNCT
ajmsi-505	315	13	c.	c.	PROPN
ajmsi-505	315	14	j.	j.	PROPN
ajmsi-505	315	15	(	(	PUNCT
ajmsi-505	315	16	2011	2011	NUM
ajmsi-505	315	17	)	)	PUNCT
ajmsi-505	315	18	.	.	PUNCT
ajmsi-505	316	1	prescott	prescott	PROPN
ajmsi-505	316	2	’s	’s	PART
ajmsi-505	316	3	microbiology	microbiology	NOUN
ajmsi-505	316	4	,	,	PUNCT
ajmsi-505	316	5	7	7	NUM
ajmsi-505	316	6	.	.	PUNCT
ajmsi-505	316	7	new	new	PROPN
ajmsi-505	316	8	york	york	PROPN
ajmsi-505	316	9	:	:	PUNCT
ajmsi-505	316	10	mcgraw	mcgraw	PROPN
ajmsi-505	316	11	-	-	PUNCT
ajmsi-505	316	12	hill	hill	NOUN
ajmsi-505	316	13	.	.	PUNCT
ajmsi-505	317	1	world	world	PROPN
ajmsi-505	317	2	health	health	PROPN
ajmsi-505	317	3	organization	organization	NOUN
ajmsi-505	317	4	(	(	PUNCT
ajmsi-505	317	5	2006	2006	NUM
ajmsi-505	317	6	)	)	PUNCT
ajmsi-505	317	7	.	.	PUNCT
ajmsi-505	318	1	global	global	ADJ
ajmsi-505	318	2	tuberculosis	tuberculosis	NOUN
ajmsi-505	318	3	control	control	NOUN
ajmsi-505	318	4	report	report	NOUN
ajmsi-505	318	5	,	,	PUNCT
ajmsi-505	318	6	annex	annex	VERB
ajmsi-505	318	7	1	1	NUM
ajmsi-505	318	8	profiles	profile	NOUN
ajmsi-505	318	9	of	of	ADP
ajmsi-505	318	10	high	high	ADJ
ajmsi-505	318	11	-	-	PUNCT
ajmsi-505	318	12	burden	burden	NOUN
ajmsi-505	318	13	countries	country	NOUN
ajmsi-505	318	14	.	.	PUNCT
ajmsi-505	319	1	world	world	PROPN
ajmsi-505	319	2	health	health	PROPN
ajmsi-505	319	3	organization	organization	NOUN
ajmsi-505	319	4	(	(	PUNCT
ajmsi-505	319	5	2011	2011	NUM
ajmsi-505	319	6	)	)	PUNCT
ajmsi-505	319	7	.	.	PUNCT
ajmsi-505	320	1	the	the	DET
ajmsi-505	320	2	sixteenth	sixteenth	ADJ
ajmsi-505	320	3	global	global	ADJ
ajmsi-505	320	4	report	report	NOUN
ajmsi-505	320	5	on	on	ADP
ajmsi-505	320	6	tuberculosis	tuberculosis	NOUN
ajmsi-505	320	7	.	.	PUNCT
ajmsi-505	321	1	who	who	PRON
ajmsi-505	321	2	(	(	PUNCT
ajmsi-505	321	3	2012	2012	NUM
ajmsi-505	321	4	)	)	PUNCT
ajmsi-505	321	5	.	.	PUNCT
ajmsi-505	322	1	global	global	ADJ
ajmsi-505	322	2	tuberculosis	tuberculosis	NOUN
ajmsi-505	322	3	control	control	NOUN
ajmsi-505	322	4	,	,	PUNCT
ajmsi-505	322	5	geneva	geneva	PROPN
ajmsi-505	322	6	;	;	PUNCT
ajmsi-505	322	7	14	14	NUM
ajmsi-505	322	8	www.who.int/tb/publications/global_report	www.who.int/tb/publications/global_report	NOUN
ajmsi-505	322	9	.	.	PUNCT
ajmsi-505	323	1	who	who	PRON
ajmsi-505	323	2	(	(	PUNCT
ajmsi-505	323	3	2014	2014	NUM
ajmsi-505	323	4	)	)	PUNCT
ajmsi-505	323	5	.	.	PUNCT
ajmsi-505	324	1	global	global	ADJ
ajmsi-505	324	2	tuberculosis	tuberculosis	NOUN
ajmsi-505	324	3	report	report	NOUN
ajmsi-505	324	4	www.who.int/	www.who.int/	PROPN
ajmsi-505	324	5	tb	tb	PROPN
ajmsi-505	324	6	/	/	SYM
ajmsi-505	324	7	data	data	PROPN
ajmsi-505	324	8	.	.	PUNCT
ajmsi-505	325	1	www.raosoft.com/samplesize.html	www.raosoft.com/samplesize.html	PROPN
ajmsi-505	325	2	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN